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Abstract 
 
This PhD thesis explores the risk of falling of stage 5 chronic kidney disease (CKD-5) 
patients receiving haemodialysis (HD) therapy. Previous research has suggested that 
multiple risk factors such as older age, comorbidities, polypharmacy, and frailty contribute 
primarily to the increased risk of falling in this clinical population. However, HD patients 
are also characterised by severe cardiovascular disease burden that often manifests with 
symptoms of orthostatic intolerance, impaired blood pressure control and syncope, all of 
which may be implicated in the aetiology of falling. The aim of this thesis was to address 
important research questions, such as: Are frailty and its physical function/activity 
components associated with falling in CKD-5 patients on HD? Are baroreflex function 
and the cardiovascular responses to orthostasis also associated with falling? What is the 
relative importance of frailty and cardiovascular function as potential exercise-modifiable 
risk factors for falls in this patient group? 
A prospective observational study involving 76 prevalent HD patients (61.1±14 years) 
confirmed previous observations that CKD-5 patients on HD are at higher risk of falls 
compared to the non-uraemic population, as 37.7% of research participants experienced 
at least one fall during a 12-month follow-up, and the incidence of falls recorded was 1.16 
falls/person-year. Although participants classified as fallers did not appear to differ from 
non-fallers in single physical function measures such as timed-up and go (TUG), 5 
repetitions chair sit to stands (CSTS-5), or muscle strength, frailty and lower postural 
balance were associated with increased odds of falling. In addition, baroreflex function 
indices reflecting frequency of baroreflex activation, as well as the blood pressure 
response to a five-minute 60° head-up tilt test (HUT-60°) were associated with increased 
odds of falling and a greater number of falls. More importantly, we showed that modelling 
the risk of falling by adding a cardiovascular function variable to a frailty-only model 
improved significantly the prediction of number of falls experienced by CKD-5 patients 
on HD. 
Overall, this PhD thesis revealed that cardiovascular mechanisms implicated in the short-
term regulation of blood pressure showed a greater relative importance than frailty in 
predicting falls in the study participants. These findings challenge the current assumption 
that frailty is the primary factor involved in the aetiology of falls in CKD-5 patients on 
HD. The clinical implications of this novel observation are also discussed from a 
preventive and rehabilitative perspective. 
 
Key words: Stage 5 chronic kidney disease, haemodialysis, falls, frailty, cardiovascular 
function. 
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1 
 
CHAPTER 1: GENERAL INTRODUCTION AND LITERATURE REVIEW 
 
1.1 GENERAL INTRODUCTION TO CKD-5 
1.1.1 Stage 5 chronic kidney disease 
The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice 
Guideline for the Evaluation and Management of chronic kidney disease (CKD) defines 
kidney disease as an abnormality of the kidney structure or function with repercussions 
on health, which can occur abruptly and may either resolve or become chronic (KDIGO 
CKD work group., 2013). CKD is a term that represents a variety of disorders affecting 
the kidney structure and function for > 3 months with variable clinical manifestation. The 
diagnosis of CKD is based on the presence of markers of kidney damage, such as 
albuminuria, altered albumin-to-creatinine ratio, electrolyte abnormalities deriving from 
tubular disorders, urine sediment abnormalities, or other histologic or structural 
abnormalities detected by imaging, and/or decreased glomerular filtration rate (GFR) 
(Levin et al., 2014). Overall, it is recommended to classify CKD in terms of cause and 
GFR and albuminuria categories. Nevertheless, the severity of CKD is most commonly 
classified based on different thresholds of GFR, and a classification in 5 stages of organ 
impairment, presented below, is currently used by nephrologists worldwide: 
 
Table 1.1. Classification of CKD based on severity of kidney impairment. 
CKD stage GFR (ml/min/1.73m2) Kidney function 
CKD-1 > 90  Normal or high 
CKD-2 60 – 89 Mildly decreased (relatively 
to young adults levels) 
CKD-3a 45 – 59 Mildly to moderately 
decreased 
CKD-3b 30 – 44 Moderately to severely 
decreased 
CKD-4 15 – 29 Severely decreased 
CKD-5 ˂ 15 Kidney failure 
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Stage 5 CKD (CKD-5) is the last, and more severe, stage of CKD and is also sometimes 
referred to as end-stage renal disease (ESRD). The main feature of CKD-5 is the kidney 
failure which requires renal replacement therapy (RRT) to guarantee survival (National 
Kidney foundation 2002). 
RRT can take the form of peritoneal dialysis, haemodialysis (HD), or kidney 
transplantation (Schena et al., 2000), out of which HD therapy is the most common option 
for incident patients (UK Renal Registry (UKRR) 2016). HD is a treatment that consists 
of an extracorporeal removal of the waste products, such as urea and creatinine, which 
cannot be eliminated otherwise by the non-functioning kidneys. This treatment is usually 
performed in an outpatient dialysis centre, or at home in some cases, thrice weekly for 3 
to 5 hours depending on the patient’s size. 
 
1.1.2 Prevalence and incidence of CKD-5   
About 6% of the UK population is estimated to be affected by stages 3 to 5 CKD (Roderick 
et al., 2011). In 2010, over 2,500,000 people were estimated to be undergoing RRT 
worldwide, and the large majority, around 78%, were receiving dialysis either in the form 
of peritoneal dialysis or HD, while the remainder were living with a renal transplant 
(Liyanage et al., 2015). In the UK, this equates to 61,256 people suffering from CKD-5 
requiring RRT in 2015 (UKRR 2016), a substantial increase of 39% compared to the 2006 
UKRR projections (UKRR 2006). This increase in incidence over a period of 10 years 
may reflect the worrying rapid increase of this health condition and subsequent high costs 
for the National Health System (NHS), which is the main provider for health care and 
treatment in the UK for almost all CKD-5 patients. Hospital HD is the most common form 
of dialysis in the UK, with 41% of RRT patients requiring this treatment modality (UKRR 
2016), and it is also the most expensive, with a yearly estimated cost per patient of over £ 
35,000 (Baboolal et al., 2008). 
In 2015, 5026 people were receiving RRT in Scotland, according to the Scottish Renal 
Registry Report (SRRR) and 42% of them were treated with dialysis (SRRR 2016). 
Among these dialysis patients, 86% were undergoing hospital-based HD, 2.5% were 
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performing home HD, while 3% and 8% were using continuous ambulatory peritoneal 
dialysis (CAPD) and automated peritoneal dialysis (APD) respectively. The health burden 
arising from CKD-5 and therefore from RRT has been increasing at an alarming rate in 
Scotland, considering that the annual incidence of RRT has almost tripled from 37 to 106 
per million population in the last 30 years (SRRR 2016). 
Similar trends emerge from the U.S., where in 2015 the annual incidence of ESRD was 
378 per million population, which has also almost tripled in the last 30 years (USRDS 
2017). In addition, the most common treatment for ESRD in the U.S. is HD, as the large 
majority (63%) of patients requiring RRT is maintained with this treatment (USRDS 
2017). 
The most common cause of CKD-5 in the UK remains diabetes, which accounts for 27.5% 
of the single primary renal diagnoses (UKRR 2016), and is followed by 
glomerulonephritis (14.1%), polycystic kidney (7.4%) and hypertension (6.8%). These 
trends are also reflected in Scotland, where diabetes is the lead cause of CKD-5, with 28% 
of all primary renal diagnoses (SRRR 2016). Interestingly, the last 50 years have seen a 
reshaping of the leading causes of CKD-5 due to the rampant increase of type 2 diabetes 
mellitus (Winocour 2018): in the 1960-1971 decade, 40% and 0% of the patients starting 
RRT were diagnosed with glomerulonephritis and diabetic nephropathy respectively, as 
the cause of renal failure. More than 40 years later, these figures were reversed with 16% 
and 28% of incident RRT patients diagnosed with glomerulonephritis and diabetes as 
primary renal diagnosis (SRRR 2016). 
Lastly, the median age of CKD-5 patients requiring RRT has also increased in the last 10 
years. Particularly, the median age of prevalent patients requiring RRT has increased by 
4 years since 2005, with HD patients being significantly older (median= 67 years) than 
patients maintained on peritoneal dialysis (median= 64 years), and patients living with a 
kidney transplant (median= 54 years) (UKRR 2016). 
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1.1.3. Prognosis and survival in CKD-5 
The 2012 KDIGO guidelines recommend considering the following information when 
predicting prognosis of CKD: 1) GFR category, 2) albuminuria category, 3) the cause of 
CKD, 4) comorbidity levels and other risk factors (Levin et al., 2014).   
 
Table 1.2. Prognosis of CKD based on GFR and albuminuria categories. 
 Albuminuria categories (description and 
range) 
Normal to 
mildly 
increased 
Moderately 
increased 
Severely 
increased 
˂ 30mg/g  30 – 
300mg/g 
> 30mg/g 
G
F
R
 c
at
eg
o
ri
es
 (
m
l/
m
in
 
p
er
 1
.7
3
 m
2
) 
CKD-1 > 90    
CKD-2 60 – 89    
CKD-3a 45 – 59    
CKD-3b 30 – 44    
CKD-4 15 – 29    
CKD-5 ˂ 15    
Green: low risk (no CKD in absence of other markers of KD); Yellow: moderately 
increased risk; Orange: high risk; Red: very high risk. 
 
The same model (Table 1.2) is also recommended to make the decision as to when to refer 
a patient to the specialist services for a timely planning of RRT (Table 1.3), before the 
patient reaches the CKD-5 stage. A timely referral to the specialist is defined as a time ≥ 
1 year (Levin et al., 2014). 
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Table 1.3. Recommendations for a timely referral to the specialist services for planning 
RRT. 
 Albuminuria categories (description and 
range) 
Normal to 
mildly 
increased 
Moderately 
increased 
Severely 
increased 
˂ 30mg/g  30 – 
300mg/g 
> 30mg/g 
G
F
R
 
ca
te
g
o
ri
es
 
(m
l/
m
in
 
p
er
 1
.7
3
 m
2
) 
CKD-1 > 90  Monitor Refer* 
CKD-2 60 – 89  Monitor Refer* 
CKD-3a 45 – 59 Monitor Monitor Refer 
CKD-3b 30 – 44 Monitor Monitor Refer 
CKD-4 15 – 29 Refer* Refer* Refer 
CKD-5 ˂ 15 Refer Refer Refer 
*Referring clinicians may want to discuss about the local arrangements for referral with 
their nephrology service. 
 
In North America and in the UK, the most common modality of RRT for incident patients 
is HD therapy (USRDS 2017; UKRR 2016): after 90 days upon starting RRT, 67.3% of 
CKD-5 patients were maintained on HD in the UK. 
Although HD is a life-saving treatment in CKD-5, the prognosis of these patients remains 
very poor as dialysis initiation is associated with a decline in functional status, low health-
related quality of life and frailty (Johansen et al., 2013). In addition, survival analyses 
show that the relative one-year risk of death for prevalent RRT patients aged 35-39 is 
roughly 22 times higher than the non-uraemic population (UKRR 2016). The 1-year 
survival rate, 90 days after starting RRT, was even lower in Scotland compared to the UK 
average (83.1% vs 90.2%) in 2015 (SRRR 2016), and the 5-year survival rate was as low 
as 43% for those started on RRT between 1996 and 2011. Considering patients of all ages, 
the 10-year survival drops to 25%. 
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In 2015, the most common causes of death in CKD-5 patients undergoing RRT were due 
to cardiovascular disease (22%), followed by infection-related deaths (21%) and RRT 
withdrawal (14%) (UKRR 2016). 
 
1.1.4 Impact of CKD-5 on general health and current management 
While the very early stages of CKD are often asymptomatic, progression to CKD-5 
frequently leads to clinical manifestation of symptoms such as tiredness, nausea, and 
itchiness arising from the impaired ability of kidneys to regulate fluid and electrolyte 
balance and eliminate metabolic by-products. Further complications are hypertension, 
bone and mineral disease, and anaemia (Murabito et al., 2018) as a result of the 
compromised capacity of kidneys to produce erythropoietin, which is required to produce 
red blood cells. In addition, CKD represents a model of premature and accelerated ageing, 
mainly as a result of chronic inflammation, activation of pro-ageing mechanisms, 
sympathetic-vagal imbalance and alteration of the stress resistance pathways (Kooman et 
al., 2014). The main features of this premature ageing are muscle wasting, and consequent 
physical function deterioration, but also accelerated vascular ageing (London 2018). 
Moreover, vascular disease can also affect the small vessels in the brain which could lead 
to white matter lesions (Bronas et al., 2017), and therefore a so-called “triad” of physical, 
vascular and cognitive impairment often results from this state of premature ageing. The 
sum of these symptoms and complications translate into a high burden of disease that is 
typically manifested through increased cardiovascular risk, high number of 
hospitalisations and overall lower quality of life (Balogun et al., 2017). 
In the context of CKD-5, the clinical health management consists of RRT primarily, in 
the form of dialysis or kidney transplantation, followed by pharmacological treatment to 
correct high blood pressure and blood and bone deficiencies, and nutritional interventions 
to carefully adjust the diet (Romagnani et al., 2017). In addition to these current prevailing 
management plans, the Kidney Disease Outcomes and Quality Initiative (KDOQI) and the 
KDIGO clinical practice guidelines for the management of CKD (Inker et al., 2014; 
KDIGO CKD work group., 2013) have encouraged nephrologists to promote physical 
activity in CKD patients to counteract the progressive decline in physical function. 
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However, this practice remains largely inconsistent among renal healthcare providers 
(Zelle et al., 2017) and is an area that necessitates further guidance to improve the health 
management of these patients. Particularly, CKD-5 patients maintained on HD are in great 
need of physical activity counselling to counteract the well-known detrimental effect of 
dialysis-related sedentary behaviour on physical function (Manfredini et al., 2012), which 
may accelerate the onset of frailty. The high frailty rates observed in CKD-5 (Kojima et 
al., 2017), in conjunction with ageing processes (UKRR, 2016) are also responsible for 
adverse health outcomes that are typically managed by the geriatric medicine, such as falls 
and fall-related injuries. 
 
1.2 LITERATURE REVIEW 
 
1.2.1 General introduction to falls in the general population 
1.2.1.1 Estimates of falls in the non-uraemic population 
The World Health Organization (WHO) global report on falls prevention in older age 
(WHO 2008) states that approximately 28%-35% of people aged 65 years and older 
experience at least one fall every year. This proportion increases even more with older age 
and higher frailty levels, as 32%-42% of people older than 70 years of age are thought to 
fall each year, and up to 50% of elderly residents of nursing homes may experience falls 
at least once a year (WHO 2008). 
These data are alarming in light of the fact that the global population is ageing. By 2050, 
the number of people aged 60 years and older would have more than doubled, and 
particularly the segment of the population that is expanding more rapidly is the over 80 
years old group, which is predicted to constitute 20% of the older population by 2050 (UN 
2004). Although survival into older age can be regarded as evidence of success of medical 
and pharmaceutical advancements, the growing number of older adults is most likely to 
result into an increase of falls-related injuries and relative medical expenses. 
Falls can result in a variety of injuries, need for medical attention interventions, 
hospitalisations and even death. It is estimated that the rates of emergency department 
visits due to falls-related injuries, in Australia and in the UK, amount to 550-890 per 
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million population, and the falls injury rates resulting in hospital admission range from 
160-300 per million population in the segment of the population aged 60 years and older 
(WHO 2008). The most common injuries that lead to hospitalisations, as a consequence 
of a fall, encompass traumatic brain injuries, upper limb injuries, and hip fracture. In the 
population over 65 years of age, these and other falls-related injuries account for more 
than 50% of the hospital admission due to injury (WHO 2008). In particular, hip fractures 
seem to have the most tragic consequences among all the falls-related injuries, as they 
require longer hospitalisation periods and approximately one in five patients dies within 
1 year after sustaining a hip fracture as a result of a fall (Zuckerman 1996). 
Overall, falls represent two thirds of deaths from unintentional injuries in older adults, 
which is the fifth cause of death in this sub-section of the population, after cardiovascular 
disease, cancer, stroke and pulmonary diseases (Rubenstein et al., 2006).             
 
1.2.1.2 The economic burden of falls 
Falls and fall-related injuries have a considerable economic impact on the health systems 
that is going to increase even further due to current predictions and upward trends in 
average and older age groups in the global population.  
The WHO global report on the prevention of falls in older age (2008) characterised the 
economic burden of falls in terms of direct and indirect costs. The direct costs reflect 
expenses by the health care systems for medications and services for the treatment and 
rehabilitation of injuries arising from falls. The greatest of these expenses is the cost for 
hospital inpatient services (WHO 2008). The cost of hospitalisations for falls-related 
injuries depends greatly on the country of interest and, generally speaking, these 
projections are available for the developed countries only. 
NHS data (2008) suggest that, due to the global aging population, the number of fallers 
over 85 years of age could increase from 100,000 to 200,000 over the next 20 years, with 
an estimated increase in direct costs from falls of £200 million. In addition to these costs, 
the WHO also highlighted some indirect costs for the household economy which are 
attributable to the possible productivity loss of family caregivers (WHO 2008). 
 
9 
 
1.2.1.3 Risk factors 
The WHO global report on the prevention of falls in older age (2008) has identified several 
risk factors that are linked to an increased risk of falling. These risk factors can be grouped 
in four main categories, namely biological, behavioural, environmental, and 
socioeconomic factors. Falls often result as a complex interaction of these. 
Biological risk factors refer to the physiological state of the human body and encompass 
both non-modifiable factors such as gender and age, and partly modifiable factors like the 
physical decline and the comorbidity burden and symptoms associated with ageing. A 
great number of prospective cohort studies and systematic reviews have concluded that 
muscle weakness, unsteady gait, poor balance, cognitive and visual impairments are the 
main biological risk factors for falls in the population of community-dwelling older adults 
(Tinetti et al., 1988; Rubenstein et al., 2006; Ambrose et al., 2013; Enderlin et al., 2015; 
Cuevas-Trisan et al., 2019). In addition, it has been pointed out that these biological 
factors often interplay with environmental and/or behavioural factors in the aetiology of 
falling (Klenk et al., 2017). For instance, some behavioural factors such as lack of physical 
exercise/sedentary behaviour will contribute to the loss of muscle mass, which is an 
inevitable consequence of the ageing process, while engaging in an active lifestyle and 
following exercise programs aimed to maintain endurance, strength, flexibility have been 
shown to prevent falls by reducing the risk of developing chronic diseases (Cuevas-Trisan 
2017). In addition to the lack of exercise, other behavioural risk factors of falls include 
the use/misuse of multiple medications/substances or an excessive alcohol intake, and the 
use of inappropriate footwear (WHO 2008). All these risky behaviours are highly 
modifiable and should therefore be considered in multifaceted interventions for the 
prevention of falls. 
Along with the behavioural factors, the environmental risk factors are also modifiable. 
This category of risk refers to the interaction between the physical conditions of one 
individual and the potential environment hazards, both at home and in public spaces. It 
should be acknowledged that this class of factors does not constitute a risk of falling per 
se, but rather it’s the combined effect of underlying personal risk factors and the exposure 
to the environmental ones that can result in falls and falls-related injuries. Established 
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environmental risk factors for falls are: poor building design, poor lightening in public 
places or at home, cracked or uneven sidewalks, and slippery surfaces and stairs (WHO 
2008).        
Lastly, the WHO identified a further category of risk factors, namely the socioeconomic 
factors, which reflect how the economic status and the social conditions of individuals 
may influence the risk of falling. These risk factors encompass low income and education 
levels, lack of social interaction, inadequate housing, lack of community resources, and 
limited access to health and social services. 
Even though various elements of the four categories cited above may be modified by 
different kind of interventions aimed to decrease the risk of falling, the WHO highlighted 
that two categories in particular are highly responsive to focused and evidence-based 
interventions, namely the environmental and behavioural risk factors. It is estimated that 
30% to 50% of falls are attributable to environmental causes (Rubenstein et al., 2006), 
therefore home and public-modification of the environment play an important role in the 
prevention of falls in the elderly population.  
Behavioural change is the other key element to address in order to minimise risk of falling. 
Generally speaking, this can be achieved by adopting an active lifestyle and by limiting 
risky behaviours like alcohol and substance misuse. Physical exercise has been the main 
interest of much research in efforts to prevent falls (Figure 1.1). A Cochrane systematic 
review highlighted how single exercise modalities were the most common intervention in 
randomised trials aimed to reduce falls in older adults living in the community (Gillespie 
et al., 2012). This review concluded that home and group-based exercise interventions 
reduced both the risk of falling and the rate of falls in this population. In addition, another 
Cochrane systematic review recently concluded that the most effective exercise 
interventions to reduce falls in elderly people are the ones involving balance and 
functional exercises primarily (Sherrington et al., 2019). These authors concluded that a 
combination of balance and resistance training is also probably effective in preventing 
falls.  
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Figure 1.1. Forest plot of exercise trials to reduce falls in older adults living in the 
community. Exercise versus control (Sherrington et al., 2017, p. 1752). 
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1.2.2 Falls in the population of CKD-5 patients on HD 
1.2.2.1 Premise 
Several prospective cohort studies conducted in CKD-5 populations have highlighted that 
26.3% to 55% of HD patients suffer at least one fall every year (Abdel-Rahman et al., 
2011; Polinder-Bos et al., 2014). The incidence of falls in these patients ranges from 0.38 
to 1.76 falls/patient-year (Abdel-Rahman et al., 2011; Roberts et al., 2007). These 
estimates of falls are elevated compared to those of non-uraemic individuals and a recent 
systematic review concluded that dialysis patients are a group of people at high risk of 
falling (Lopez-Soto et al., 2015). These findings are of clinical importance because HD 
patients are at high risk of fractures (Dey et al., 2017), and an accidental fall may worsen 
quality of life and the burden of disease in these patients, who tend to have low functional 
status and high frailty rates already. 
This PhD thesis will contribute to expand the currently available epidemiological data on 
falls in the CKD-5 population of patients maintained on HD, and will also explore which 
factors are most likely to contribute to falls in this group of people. In particular, this PhD 
research project will focus on the identification of which exercise-modifiable factors may 
be more closely associated with an increased risk of falling in HD patients. Findings 
arising from this thesis will inform researchers and healthcare providers about 
prioritization of outcome assessment for monitoring, and hopefully managing, falls risk 
in the CKD-5 population on HD. 
 
1.2.2.2 Estimates of falls        
The first study that investigated the risk of falls in HD patients was published by a British 
research group in 2003 (Roberts et al., 2003). The investigators reported observations 
from clinical practice that a greater number of HD patients were being referred to the 
specialist falls services, possibly due to the increased proportion of older (>65 years) 
CKD-5 patients starting RRT. Therefore, they hypothesised that a combination of risk 
factors encompassing old age, CKD-5-related autonomic failure, and hypotensive spells, 
triggered by HD therapy and/or by antihypertensive medications, could lead to orthostatic 
hypotension and to an increased number of falls in these patients. Although this first study 
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was limited in sample size (n° of study participants= 47) and in the methodology of falls 
appraisal (not-otherwise specified recall of falls in the previous year), the investigators 
concluded that HD patients have a high incidence of falls, with 27.7% of patients recalling 
at least one fall in the past year, as well as significant post-dialysis postural hypotension 
and occurrence of hypotensive symptoms. 
Similarly to Roberts et al., (2003), a Canadian research group also reported their findings 
on the prevalence of falls among HD patients over 65 years of age (Cook et al., 2005). 
The rationale for their investigation was also based on the observation that the dialysis 
population was older on average, as 50% of CKD-5 patients starting RRT were aged 65 
years and older in Canada at the time of the study (Canadian Institute for Health 
Information, 2002). The authors hypothesised that this age shift in patients starting RRT 
could potentially lead to a substantial increase of adverse outcomes, such as falls and falls-
related morbidity, which are typical problems managed by geriatric medicine services. 
Particularly, patients over 65 years treated with dialysis would have the well-established 
risk factors of falling for senior citizens, namely muscle weakness, unsteady gait, poor 
balance, etc. (Rubenstein et al., 2006), as well as additional complications, such as the 
fluid and electrolyte shifts, that result from HD therapy and that may expose them to an 
additional risk of dizziness, hypotension and falls compared to the non-uraemic 
population. The results on the prevalence of falls among the patients from the two dialysis 
centres involved in this study were remarkably similar to those of Roberts and colleagues, 
as 27% of these patients reported at least one fall in the previous 12 months. The authors 
concluded that falls are highly prevalent in older HD patients, and also that the true 
prevalence of falls might have been underestimated in their investigation due to the 
retrospective observational method of falls ascertainment, which could result in recall 
inaccuracies (Cummings et al., 1988). 
The first study that investigated the incidence of falls in HD patients prospectively was 
conducted by Desmet et al., (2005). This study aimed to highlight the possible risk factors 
of falls as well as to describe the incidence of falls among HD patients from seven HD 
units in Belgium. Although the ascertainment of falls was obtained over a relatively short 
follow-up period (8 weeks), the results from the study indicated that the estimated 
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incidence of falls in these patients was 1.18 falls/patient-year, approximately 2.4 times 
higher than the incidence previously described in non-institutionalised senior citizens 
(O’Loughlin et al., 1993). Therefore, the authors concluded that the risk of falling in CKD-
5 patients on HD was higher than in the general healthy population of older adults. 
A further prospective investigation on the incidence of falls and associated risk factors 
was conducted by Cook and colleagues in 2006 (Cook et al., 2006). This was the first 
study that extended the observational follow-up of falls to at least 12 months and 
consequently, it provided important information on the yearly incidence of falls in CKD-
5 patients undergoing HD therapy. This research group also concluded that the risk of 
falling in HD patients was higher than in the non-uraemic population. Both the incidence 
of new fallers and number of falls were extraordinarily high, with 47% of patients 
experiencing at least one fall over the 12-month follow-up period (an excess of 
approximately 17% compared to healthy older adults (WHO 2008)), and 27.8% with two 
or more falls. The incidence of falls was even higher than the incidence estimated by 
Desmet et al., (2005), with 1.60 falls/persons-year. 
After the first study published in 2003, Roberts et al., (2007) conducted a prospective 
observational study of the incidence of falls, syncope and dizziness in HD patients to 
corroborate the results emerged from their preliminary study. In addition to a high 
incidence of falls of 1.76 falls/persons-year in patients over 65 years of age, with 38% of 
them experiencing at least one fall over 6 months, this work also highlighted a frequent 
occurrence of dizziness, syncopal and pre-syncopal events in dialysis patients of all ages. 
Dizziness in particular was very common, as 78% of patients of all ages reported this 
symptom during the 6-month observational follow-up, while about 49% of patients 
reported they experienced a near-faint, which was classified as a pre-syncopal event, at 
least once. 
Abdel-Rahman and colleagues (2011) conducted a prospective cohort study of the 
incidence of falls, over a 12-month follow-up period, and the long-term morbidity related 
to these falls in two HD centres in the US. Overall, 26.3% of the patients experienced one 
fall during the prospective observational period. However, those aged 65 years and older 
fell more frequently, as 38.2% reported at least a fall during the follow-up, compared to 
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the 16.7% of the patients younger than 65 years. The incidence of number of falls 
sustained was also higher in the older group of patients, with 0.59 falls/persons-year for 
the patients over 65 years of age as opposed to the 0.21 falls/persons-year of the younger 
group of patients. 
Different results on the role of age were found by McAdams-DeMarco et al., (2013), who 
conducted a prospective cohort study aimed to explore the association between frailty and 
falls in CKD-5 patients undergoing HD therapy in a single dialysis centre in the U.S. In 
this study, 28.3% of the study participants reported at least one fall during a follow-up 
visit 6 months after the baseline assessment. No significant difference in terms of falling 
behaviour was found between younger and older HD patients, as 25.9% and 29.3% of 
patients younger and older than 65 years respectively experienced at least one fall over 
the follow-up period. 
A remarkably similar prevalence of fallers among HD patients of all ages was found in a 
large cross-sectional study (Kutner et al., 2014). This study examined the association 
between potentially modifiable risk factors and history of falls in 762 prevalent HD 
patients in the U.S: 28.4% of these patients reported having fallen in the past 12 months, 
and 16.3% had multiple falls. 
Polinder-Bos et al., (2014) found a much higher proportion of fallers among elderly 
dialysis patients from two HD centres in the Netherlands. The appraisal of falls was 
conducted prospectively, over 12 months, in this investigation: 55% of the study 
participants experienced at least one fall during the observational follow-up, and 41% of 
patients with falls were classified as recurrent fallers. 
In a more recent study, Kono et al., (2018) conducted a prospective study over a longer 
observational follow-up period in Japan. This research group reported that 41% of their 
study participants fell at least once during the 2-year study period. Unfortunately, they did 
not report the number of falls experienced by patients, and therefore the incidence of falls 
cannot be calculated.  
A very high incidence of falls was reported by Noto-Kadou-Kaza et al., (2015), who 
conducted a prospective investigation of falls in younger (mean age= 40.23 years) HD 
patients, over a short follow-up period (4 weeks). About 23% of patients fell at least one 
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time over this observational period, and the yearly incidence of the number of falls was 
estimated to be 3.2 falls/persons-year. 
The lowest proportion of patients experiencing at least one fall over 12 months was found 
by Wang et al., (2017), who conducted a prospective longitudinal study to examine the 
relationship between physical functioning measures and falls in a group of HD patients. 
They found that only 16% of these patients had experienced falls over one year period: it 
should be acknowledged though that, even if the study was conducted prospectively, the 
ascertainment of falls was obtained exclusively at the end of the 12-month observational 
follow-up period, by means of a self-administered questionnaire. Therefore, the 
information on falls is likely to be subjected to a higher recall bias compared to those 
prospective studies which used more frequent (bi-weekly/monthly) follow-ups during the 
observational period. 
In addition to the studies cited above, two investigations examined the incidence of falls 
that were severe enough to require presentation to an emergency department (Rossier et 
al., 2012), or hospitalisation (Delgado et al., 2015). These studies were conducted 
prospectively over a longer follow-up period and found comparable results: Rossier and 
colleagues reported that 28.6% of their study participants had experienced at least one 
severe fall over a mean follow-up of 20.6 months, while Delgado reported 283 first events 
for fall and/or fracture in 1053 HD patients, resulting in 26.9% of patients experiencing a 
severe fracture over a median follow-up of 30 months. 
Lastly, a Canadian research group addressed the research question as to whether CKD-5 
patients maintained on peritoneal dialysis had a similar incidence of falls of patients 
undergoing HD therapy (Farragher et al., 2014). They conducted a prospective cohort 
study of the incidence of falls and associated risk factors in 74 peritoneal dialysis patients 
over a period of 15 months: the results highlighted that 54% of these patients experienced 
at least one fall during the follow-up, and also that the incidence of falls was very high 
with 1.7 falls/persons-year. Therefore, the authors concluded that the risk of falling in 
these patients is higher than in the general population, and the results also suggest that, 
regardless of their treatment modality (e.g. peritoneal dialysis/HD), the risk of 
experiencing falls is high in all CKD-5 patients on dialysis. 
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1.2.2.3 Study designs and methodological considerations           
The study designs and methods of the studies investigating the risk of falling in HD 
patients are synthesised in Table 1.4. The large majority of these studies used an 
observational prospective design to capture the falls-related information (Desmet et al., 
2005; Cook et al., 2006; Roberts et al., 2007; Abdel-Rahman et al., 2011; Rossier et al., 
2012; McAdams-DeMarco et al., 2013; Farragher et al., 2014; Polinder-Bos et al., 2014; 
Noto-Kadou-Kaza et al., 2015; Delgado et al., 2015; Wang et al., 2017; Kono et al., 2018), 
while only three studies used a cross-sectional design with retrospective data relating to 
falls (Roberts et al., 2003; Cook et al., 2005; Kutner et al., 2014). 
The research setting in which the studies were conducted varied from one (Roberts et al., 
2003) to 14 (Kutner et al., 2014) dialysis centres in the UK, Canada, Belgium, U.S., 
Switzerland, Netherlands, Morocco, Australia, and Japan. One study abstracted data from 
a subgroup of patients from the Comprehensive Dialysis Study, a large prospective cohort 
study conducted in 297 Renal Units across the U.S. (Delgado et al., 2015). Due to the 
great heterogeneity in the research settings, the sample sizes of the different studies also 
differed considerably. The smallest number of patients studied was 47 (Roberts et al., 
2003), while the largest was 1053 (Delgado et al., 2015). Nevertheless, an even larger 
study was conducted by Naylor et al., (2014) who investigated the incidence of fracture 
in CKD by means of a population-based cohort study in 679114 patients diagnosed with 
CKD. 
In all those studies with retrospective designs, the history of falls information relates to 
the previous 12 months (Roberts et al. 2003; Cook et al., 2005; Kutner et al., 2014), while 
the observational follow-up of the falls-related information in the prospective studies 
ranged from 4 weeks to 36 months (Naylor et al., 2014; Wang et al., 2017). 
Another crucial methodological aspect is the operational definition of a “fall”. While a 
few studies did not provide a clear definition of a “fall” (Roberts et al., 2003; Roberts et 
al., 2007; McAdams-DeMarco et al., 2013; Noto-Kadou-Kaza et al., 2015), the most 
common definition adopted was “an event that resulted in a person coming to rest 
inadvertently on the ground or other lower level" (Desmet et al., 2005; Cook et al., 2006; 
Abdel-Rahman et al., 2011; Rossier et al., 2012; Kutner et al., 2014; Farragher et al., 2014; 
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Polinder-Bos et al., 2014; Kono et al., 2018). Other similar definitions were less 
exhaustive, such as “a fall to the ground or lower level” (Cook et al., 2005), or more 
detailed, such as “an incident in which the body unintentionally comes to rest on the 
ground or other lower level which is not as a result of a violent blow, loss of consciousness, 
sudden onset of paralysis as in stroke or an epileptic seizure" (Wang et al., 2017). Other 
studies restricted the operational definition of a fall to only those falling events that were 
severe enough to require presentation to an emergency department, hospitalisations, or 
fractures (Rossier et al., 2012; Delgado et al., 2015; Naylor et al., 2014). 
The observational method used to collect the falls-related data plays also a determinant 
role on the heterogeneity of the study results on the incidence of falls, along with the 
follow-up duration. All retrospective studies did not differ in terms of observational 
method used, as the prevalence of falls was simply obtained by asking the participants if 
they had experienced any falls in the previous 12 months (Roberts et al., 2003; Cook et 
al., 2005; Kutner et al., 2014). The studies with prospective designs, on the contrary, were 
more heterogeneous with regard to the modalities of falls ascertainment. The most 
common observational method for these studies was an interview on the occurrence of 
any possible fall by a research nurse, on a weekly basis (Desmet et al., 2005; Polinder-
Bos et al., 2014; Noto-Kadou-Kaza et al., 2015), or every couple of weeks (Cook et al., 
2006; Farragher et al., 2014). The most frequent ascertainment of falls was used by 
Roberts et al., (2007), who administered a questionnaire on falls to the study participants 
during each HD session for 6 months. The most infrequent ascertainments, on the other 
hand, were performed by McAdams-DeMarco et al., (2013) and Wang et al., (2017), who 
obtained self-reported information about falls from the study participants only at the end 
of the observational follow-up period. Only in one study, the interviews on the occurrence 
of falls were carried out by a nephrologist (Abdel-Rahman et al., 2011). As for those 
studies that investigated the incidence of severe falls only, the information relating to these 
falls was abstracted from the patients’ medical records or from other electronic 
documentation that was generated automatically as a result of the admission to an 
emergency department/hospitalisation (Rossier et al., 2012; Naylor et al., 2014; Delgado 
et al., 2015). 
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Table 1.4. Summary of studies investigating risk of falling in patients on dialysis. Study designs and methodological considerations. 
Author Population Study design Sample size Observational period Definition of a fall Observational method 
Roberts et 
al., 2003 
CKD-5 
patients on 
HD. 
Retrospective 
cross- 
sectional 
study. 
47. Previous 12 months. Not provided. Patients were asked if they 
had fallen in the previous 12 
months. 
Cook et 
al., 2005 
CKD-5 
patients on 
HD. 
Retrospective 
cross- 
sectional 
study. 
135. Previous 12 months. Not provided. Patients were asked if they 
had fallen in the previous 12 
months. 
Desmet et 
al., 2005 
CKD-5 
patients on 
HD. 
Prospective 
observational 
study. 
308. 8 weeks. "An event that results in 
coming inadvertently to 
the ground". 
HD nurses interviewed 
patients on the occurrence of 
falls for an 8-week period, at 
least one a week. 
Cook et 
al., 2006 
CKD-5 
patients on 
HD. 
Prospective 
cohort study. 
162. Median: 468 days 
(365-506 range). 
"An event that resulted 
in a person's coming to 
rest inadvertently on the 
ground or other lower 
level". 
Biweekly patient interviews 
in the HD centre by a 
research nurse. 
Roberts et 
al., 2007 
 
 
  
CKD-5 
patients on 
HD. 
Prospective 
cohort study. 
78. 6 months. Not provided. HD nurses administered a 
falls questionnaire during 
each dialysis treatment 
session for a 6-month period. 
      (Continued) 
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Table 1.4. (Continued)      
Author Population Study design Sample size Observational period Definition of a fall Observational method 
Abdel-
Rahman et 
al., 2011 
CKD-5 
patients on 
HD. 
Prospective 
cohort study. 
76. 12 months. "An event which 
resulted in a person 
coming to rest 
inadvertently on the 
ground or other lower 
level". 
Weekly interviews by a 
nephrologist in the HD 
centre. 
Rossier et 
al., 2012 
CKD-5 
patients on 
HD. 
Prospective 
cohort study. 
84. Mean: 20.6 months. "A fall requiring 
presentation to an 
emergency department, 
and/or hospitalisation". 
Severe falls were recorded 
based on the visits to the 
emergency departments of 
the study hospital, or other 
affiliated hospitals. 
McAdams-
DeMarco 
et al., 
2013 
CKD-5 
patients on 
HD. 
Prospective 
cohort study. 
95. Median: 6.7 months. Not provided. Patients who survived at least 
5 months self-reported the 
number of falls at the follow-
up visit. 
Kutner et 
al., 2014 
CKD-5 
patients on 
HD. 
Retrospective 
cross- 
sectional 
study. 
762. Previous 12 months. "An event that resulted 
in a person coming to 
rest inadvertently on the 
ground, floor or other 
lower level". 
Patients self-reported falls 
occurred during the previous 
12 months. 
      (Continued) 
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Table 1.4. (Continued)      
Author Population Study design Sample size Observational period Definition of a fall Observational method 
Farragher 
et al., 
2014 
CKD-5 
patients on 
chronic 
peritoneal 
dialysis. 
Prospective 
cohort study. 
74. 15 months. "An event that resulted 
in a person coming to 
rest inadvertently on the 
ground or other lower 
level". 
Patients (and/or caregivers) 
were contacted by telephone, 
or face to face, every 15 days. 
Polinder-
Bos et al., 
2014 
CKD-5 
patients on 
HD and 
chronic 
peritoneal 
dialysis. 
Prospective 
observational 
study. 
49. 12 months. "An event which 
resulted in a person 
coming to rest on the 
ground or another lower 
level". 
HD nurses interviewed 
patients on a weekly basis 
during the first three months, 
and phone calls once a month 
after the third month. 
Naylor et 
al., 2014 
All stages 
CKD patients. 
Prospective 
cohort study. 
679114. 3 years. Not provided.   Six databases were used to 
extract information on falls 
with hospitalisation, and 
fractures. 
Noto-
Kadou-
Kaza et 
al., 2015 
CKD-5 
patients on 
HD. 
Prospective 
observational 
study. 
70. 4 weeks. Not provided. Patients were interviewed 
weekly on the occurrence of 
falls for 4 consecutive weeks. 
      (Continued) 
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Table 1.4. (Continued)      
Author Population Study design Sample size Observational period Definition of a fall Observational method 
Delgado 
et al., 
2015 
CKD-5 
patients on 
HD. 
Prospective 
cohort study.  
1053. Median: 2.5 years 
(25th - 75th percentile= 
1.0 - 3.9 years). 
Falls or fractures that 
were severe enough to 
require medical 
evaluation via Medicare 
claims data or 
hospitalisation. 
Falls and fractures were 
identified through Medicare 
claims data. 
Wang et 
al., 2017 
CKD-5 
patients on 
HD. 
Prospective 
exploratory 
longitudinal 
study. 
51. 12 and 36 months 
(primary and 
secondary end-point). 
"An incident in which 
the body unintentionally 
comes to rest on the 
ground or other lower 
level which is not as a 
result of a violent blow, 
loss of consciousness, 
paralysis, or an epileptic 
seizure". 
The patients completed a falls 
questionnaire (at 12 and 36 
months) asking about falls 
occurred in the preceding 12 
months.  
Kono et 
al., 2018 
CKD-5 
patients on 
HD. 
Prospective 
observational 
study. 
223. 24 months. "An event that resulted 
in a person’s 
body part, coming into 
contact 
inadvertently with the 
ground or floor". 
Nursing staff ascertained 
whether the study 
participants fell or not at each 
dialysis treatment. 
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1.2.2.4 Demographics 
The demographic characteristics of study participants from the studies investigating the 
risk of falling in HD patients are summarised in Table 1.5. The mean age of study 
participants was higher than 60 years old in most of the studies (Roberts et al., 2003; Cook 
et al., 2005; Desmet et al., 2005; Cook et al., 2006; Abdel-Rahman et al., 2011; Rossier et 
al. 2012; McAdams-DeMarco et al., 2013; Farragher et al., 2014; Polinder-Bos et al., 
2014; Delgado et al., 2015; Wang et al., 2017; Kono et al., 2018), and a few of these 
studies included only patients over 65 years of age (Roberts et al., 2003; Cook et al., 2005; 
Cook et al., 2006; Farragher et al., 2014; Polinder-Bos et al., 2014). The mean age of the 
youngest study population was 40.3±16.8 years (Noto-Kadou-Kaza et al., 2015). 
The shortest dialysis vintage of the study participants was 4.2 months (interquartile range: 
3.7-4.9) (Delgado et al., 2015), while the longest was 162±81.6 months (Noto-Kadou-
Kaza et al., 2015). Almost all studies included prevalent CKD-5 patients maintained on 
dialysis with a median dialysis vintage of 21.6 months (Rossier et al., 2012) or higher. 
Only one study included incident dialysis patients (Delgado et al., 2015). 
Patient comorbidities were not described in three studies (Roberts et al., 2003; Cook et 
al., 2005; Roberts et al., 2007) and were generally reported as either the prevalence of 
comorbid conditions in the study population (Desmet et al., 2005; Abdel-Rahman et al., 
2011; Rossier et al., 2012; Farragher et al., 2014; Polinder-Bos et al., 2014; Delgado et 
al., 2015; Kono et al., 2018) or the number of comorbidities (Cook et al., 2006; McAdams-
DeMarco et al., 2013; Wang et al., 2017). Not surprisingly, the most common 
comorbidities found in the study populations were cardiovascular disease, with prevalence 
rates ranging from 22% (Kono et al., 2018) to 65% (Polinder-Bos et al., 2014), and 
diabetes, with prevalence rates ranging from 32% (Farragher et al., 2014) to 58.5% 
(Delgado et al., 2015). Other commonly reported medical conditions were depression, 
which was diagnosed in 8% (Polinder-Bos et al., 2014) to 23.8% (Rossier et al., 2012) of 
patients, and dementia, which was diagnosed in 1.9% (Desmet et al., 2005) to 11.9% 
(Rossier et al., 2012) of patients. 
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1.2.2.5 Characteristics of falls 
Some prospective studies reported the characteristics of falls recorded over the follow-up 
period in terms of location, timing, and kind of activity leading to the fall. 
All the studies that recorded information on the location of falls reported the patients’ 
home as the most common site. Desmet et al., (2005) found that 82% of the falls occurred 
at home, 7% in public sites, and 9% in other locations, while Polinder-Bos et al., (2014) 
also confirmed that the most common location of falls was at home (57.5% of falls), 
followed by outdoors (35% of falls), the HD centre (5% of falls), and nursing homes (2.5% 
of falls). In addition, Rossier et al., (2012) highlighted that 54.2% of the falls were severe 
enough to require presentation to an emergency department occurred at home, 16.2% in 
the HD centre, 12.9% in a public site, and 12.9% during a hospitalisation. Noto-Kadou-
Kaza et al., (2015) reported that 87.5% of falls occurred outside the HD centre. 
As far as the timing of falls is concerned, some research has suggested that the post-
dialysis period might be a critical time for falls (Roberts et al., 2003). This hypothesis 
does not seem to be confirmed by prospective studies, which did not find a clear 
relationship between the post-HD timeframe and the occurrence of falls (Cook et al., 2006; 
Abdel-Rahman et al., 2011; Rossier et al., 2012; Polinder-Bos et al., 2014). Only two 
prospective studies with a short follow-up reported that the majority of falls occurred after 
dialysis. Desmet et al., (2005) found that 61.5% of the falls happened within the 22 hours 
post-HD, while 23% of the falls recorded occurred within the 22 hours preceding HD 
therapy. Similarly, Noto-Kadou-Kaza et al., (2015) reported that 87.5% of the falls 
occurred after the dialysis session, nevertheless the definition of the post-dialysis period 
was not provided in the study. Conversely, Cook et al., (2006) observed that falls occurred 
on dialysis and non-dialysis days with a similar frequency, while two other studies found 
that only 30.8% and 50% (41% post-dialysis) of the falls occurred on a dialysis day 
(Abdel-Rahman et al., 2011; Polinder-Bos et al., 2014). Likewise, Rossier et al., (2012) 
highlighted that 37.5% of patients with falls experienced them within 24 hours after the 
last dialysis session. 
Two studies also extracted information as to what kind of activity was associated with the 
falling event, and they both reported walking indoors as the most common activity 
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preceding a fall (Cook et al., 2006; Farragher et al., 2014). Cook et al., (2006) found that 
falling while walking indoors was the most frequent occurrence (29.8%), followed by 
standing up from the seated position (23.6%), walking outdoors (13.4%) and standing up 
from a lying position (9.2%). Farragher et al., (2014), on the other hand, documented that 
51% of falls occurred when walking indoors, while 12% and 11% of falls occurred when 
walking outdoors and sitting down from the standing position. 
 
1.2.2.6 Risk factors of falling 
The risk factors of falling emerging from the studies described above are summarised in 
Table 1.5. A variety of risk factors for falls were identified with older age (Desmet et al., 
2005; Roberts et al., 2007; Rossier et al., 2012; Kutner et al., 2014; Farragher et al., 2014; 
Delgado et al., 2015; Kono et al., 2018), previous history of falls (Cook et al., 2006; 
Rossier et al., 2012; Farragher et al., 2014), polypharmacy (Desmet et al., 2005; 
McAdams-DeMarco et al., 2013), depression and/or antidepressant use (Desmet et al., 
2005; Rossier et al., 2012; Kutner et al., 2014), comorbidity (Cook et al., 2006; Farragher 
et al., 2014), frailty (McAdams-DeMarco et al., 2013; Kutner et al., 2014; Noto-Kadou-
Kaza et al., 2015; Delgado et al., 2015), and low blood pressure with or without 
symptomatology (Roberts et al., 2003; Cook et al., 2006; Polinder-Bos et al., 2014; Noto-
Kadou-Kaza et al., 2015; Kono et al., 2018) being the most commonly reported. 
Contrasting results emerged for the effect of sex. Two studies found male gender to be 
associated with falls (Cook et al., 2006; Farragher et al., 2014), while three other studies 
reported female gender to be associated with falling behaviour (Abdel-Rahman et al., 
2011; McAdams-DeMarco et al., 2013; Delgado et al., 2015). 
A couple of studies (Roberts et al., 2003; Cook et al., 2005) did not seek to identify risk 
factors as such, although they described the study population by comparing patients with 
and without falls in terms of potential discriminative factors. Cook et al., (2005), for 
instance, found no significant differences in age (p=0.32) and sex (p=0.28) between fallers 
and non-fallers, while Roberts et al., (2003) reported that orthostatic hypotension was 
manifested in 34.8% of patients before dialysis, and in 69.6% after dialysis (p= 0.02), and 
there was a significant higher number of patients who had falls in the post-dialysis 
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orthostatic hypotension group (p-value not reported). Therefore, the authors suggested 
that post-dialysis hypotension may be associated with falls and syncope in HD patients. 
Four years later, the authors from this last study conducted a prospective investigation of 
the incidence of dizziness, falls, and syncope (Roberts et al., 2007). The results of this 
study indicated that age was significantly associated with falls, as 38% of patients over 65 
years of age experienced at least one fall compared to only 4% of the younger patients (p˂ 
0.001). However, no relationship between pre- and post-dialysis blood pressure, or post-
dialysis orthostatic blood pressure and falls (or other symptoms, i.e. dizziness and 
syncope) was reported.  
Desmet et al., (2005) identified older age (OR: 1.057/y, 95% CI: 1.013 - 1.103, p=0.01), 
diabetes (OR: 2.747, 95% CI: 1.175 - 6.410, p=0.02), total number of prescribed drugs 
(OR: 1.190/drug, 95% CI: 1.040 - 1.362, p=0.011), antidepressant use (OR: 5.263, 95% 
CI: 2.262 - 12.195, p= 0.0001), and failing to walk 10 meters (OR: 2.057, 95% CI: 1.321 
- 3.202, p=0.001) as independent predictors of falls in logistic regression analysis. In 
addition, other physical function performance tests (arising, balance with eyes closed, one-
leg standing) were significantly worse in the patients who had falls in univariate analysis 
only, while no differences were found in lying and standing post-dialysis blood pressure 
between fallers and non-fallers. Moreover, the authors also validated the predictive 
logistic model derived from their study in another cohort of patients who were also 
assessed for the same risk factors at baseline and for falls by means of a 6-month follow-
up: the model was significant (p= 0.0099) and classified correctly 81.3% of these patients. 
An odds regression model was used by Cook et al., (2006) who found that previous history 
of falls (OR: 2.33, 95% CI: 1.22 - 4.45, p= 0.01), male gender (OR: 1.98, 95% CI: 1.02 - 
3.81, p= 0.04), Charlson comorbidity index score (OR: 1.24, 95% CI: 1.04 - 1.47, p=0.01), 
mean pre-dialysis systolic blood pressure (OR: 0.85, 95% CI: 0.72 - 1.00, p= 0.05) were 
predictive of falls. In contrast to Desmet et al., (2005), no statistically significant 
association between age and falls emerged from the analysis (OR: 1.57, 95% CI: 0.93 - 
2.65, p= 0.09). Also, no significant differences in physical performance measures between 
fallers and non-fallers were identified in this study. 
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Abdel-Rahman et al., (2011), on the other hand, found that both female gender (OR: 4.64, 
95% CI: 1.61 - 14.45, p= 0.006) and older age (OR: 3.10, 95% CI: 1.09 - 9.42, p= 0.038) 
were associated with increased odds of falling in univariate logistic regression analysis. 
All the remainder factors potentially linked to falls, such as biochemistry values, 
comorbidity and blood pressure did not show any significant association with falling status 
in this study. 
Rossier et al., (2012) conducted a prospective investigation of the risk factors for severe 
falls, resulting in admission to an emergency ward. This research group highlighted that 
age (OR: 1.13, 95% CI: 1.03 - 1.3, p= 0.009), depression (OR: 7.6, 95% CI: 1.8 - 32.6, 
p=0.006), malnutrition (OR: 8.4, 95% CI: 1.7 - 42.4, p= 0.01), previous history of falls 
(OR: 4.9, 95% CI: 1.2 - 19.4, p= 0.02) were associated with severe falling accidents in 
univariate logistic regression analysis. In this investigation, participants also underwent 
the performance-oriented mobility assessment (POMA): although patients who 
experienced falls tended to have lower POMA scores compared to patients free from falls, 
the POMA score was not found to be an independent predictor of falls. 
The first study to highlight an association between frailty and falls in HD patients was 
performed by McAdams-DeMarco et al., (2013). In this study, the authors reported that 
frailty, assessed by means of the Fried’s frailty phenotype (Fried et al., 2001) was 
predictive of a 3.09-fold higher number of falls in Poisson regression analysis (95% CI: 
1.38 - 6.90, p= 0.006), after adjustment for age, race, sex, comorbidity, number of 
prescribed medications, disability, education, and marital status. In addition, female 
gender (1.84, 95% CI: 1.06 - 3.19, p˂ 0.05) was also associated with a higher number of 
falls in this study. 
Kutner et al., (2014) also found a significant association of frailty with history of falls in 
a larger cohort of HD patients. In this retrospective study, frail patients were more than 
twice as likely to have had falls in the previous year (OR: 2.39, 95% CI: 1.22 - 4.71, p= 
0.01). In addition, the multivariable logistic regression analysis showed that the study 
participants with depression and/or using antidepressants were more likely to be fallers 
(OR: 1.83, 95% CI: 1.23 - 2.74, p= 0.003) than participants without depression and not 
using antidepressants. Age (OR: 1.02, 95% CI: 1.01 - 1.04, p= 0.01) was also associated 
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with falling status, while the odds of having falls were lower in association with a higher 
cognitive function score (OR: 0.99, 95% CI: 0.97 - 0.99, p= 0.01). 
The cognitive status was not associated with falls in a study by Farragher et al., (2014), 
who prospectively investigated the incidence of falls in CKD-5 patients on peritoneal 
dialysis. In this study, a multivariable random effects Poisson regression analysis revealed 
that the patients’ previous history of falls (RR: 2.37, 95% CI: 0.98 - 5.70, p= 0.05) was 
the only statistically significant factor associated with higher number of falls. 
Nevertheless, the study participants who had falls were also more likely to be men, older, 
to have a shorter dialysis vintage and higher comorbidity. The results did not highlight 
any relationship between blood pressure and falls. 
On the contrary, Polinder-Bos et al., (2014) found that the pre-dialysis systolic blood 
pressure was lower in a group of dialysis patients with falls compared to those who were 
falls-free (130±19 mmHg vs 143±22 mmHg, p= 0.04). The Cox regression analysis 
performed in this study showed that the risk of experiencing a fall increased by 30% for 
every 5 mmHg of lower pre-dialysis blood pressure (HR: 1.30, 95% CI: 1.03 - 1.65, p= 
0.03). A rise of 10 ρmol/l in parathyroid hormone also increased the risk of falling by 22% 
(HR: 1.22, 95% CI: 1.06 - 1.39, p= 0.004). No significant differences in physical function 
status and medications were found between fallers and non-fallers in the same study. 
A significant association between low blood pressure and falls was also reported also by 
Noto-Kadou-Kaza et al., (2015). In this short-term prospective study, the authors 
performed a multivariate logistic regression analysis which revealed that intradialytic 
hypotension was significantly associated with falls (OR: 2, 95% CI: 1.8-2.2, p=0.006). 
Frailty (p= 0.047) was also associated with the falling status in univariate analysis. 
In agreement with the results of McAdams-DeMarco et al., (2013), Kutner et al., (2014), 
and Noto-Kadou-Kaza et al., (2015), self-reported frailty was found to be associated with 
a higher risk of first fracture or fall (HR: 1.60, 95% CI: 1.16 - 2.20, p˂ 0.01) in a larger 
prospective study (Delgado et al., 2015). The Cox proportional hazards regression analysis 
performed in this investigation also revealed that female gender (HR: 1.70, 95% CI: 1.33 
- 2.17, p˂ 0.0001), white race (HR: 1.36, 95% CI: 1.02 - 1.82, p˂ 0.01), and age/per 10 
years (HR: 1.20, 95% CI: 1.10 - 1.33, p˂ 0.0001) were associated with falls and fractures. 
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Wang et al., (2017) conducted a prospective longitudinal study of physical function, 
quality of life and falls in HD patients. The authors analysed the association between 
physical function and falls by means of negative binomial regression analysis. This 
analysis revealed that lower ankle dorsiflexion strength and lower mobility, assessed 
through the short physical performance battery (SPPB), predicted a higher number of falls 
after 12 months in univariate analysis (RR: 0.62, p= 0.02 and RR: 0.71, p˂ 0.01). After 
36 months, lower mobility predicted a higher number of falls in both univariate and 
multivariate analysis (RR: 0.75, p˂ 0.01 and RR: 0.72 p= 0.02). 
Lastly, a recent study aimed to develop and validate a fall-risk assessment tool (Kono et 
al., 2018). The development of such a tool was based on those factors that were 
significantly and independently associated with a higher number of falls during the 
observational study period: older age (HR: 1.67, 95% CI: 1.04–2.67), C-reactive protein 
(HR: 2.07, 95% CI: 1.10–3.90), low geriatric nutritional risk index (HR 1.04, 95% CI 
1.01–1.08), low mobility, a score ˂ 8 in the SPPB (HR 2.54, 95% CI 1.54–5.10), low 
handgrip strength (HR 1.57, 95% CI 1.04–2.36), and intradialytic hypotension (HR: 1.56, 
95% CI 1.03–2.36).  
 
1.2.2.7 Consequences of falls 
The consequences of falls experienced by dialysis patients are summarised in Table 1.5. 
The majority of the studies investigating falls in CKD-5 patients on dialysis reported the 
consequences and/or complications of the falls experienced by study participants. The 
most commonly reported complications of falls were fractures (Cook et al., 2005; Desmet 
et al., 2005; Cook et al., 2006; Rossier et al., 2012; Kutner et al., 2014; Farragher et al., 
2014; Polinder-Bos et al., 2014; Naylor et al., 2014; Delgado et al., 2015), hospitalisations 
(Cook et al., 2006; Kutner et al., 2014; Farragher et al., 2014; Polinder-Bos et al., 2014; 
Bowling et al., 2018), and death (Cook et al., 2006; Rossier et al., 2012; Farragher et al., 
2014; Li et al., 2008; Bowling et al., 2018). 
Two retrospective studies reported that 4% (Cook et al., 2005) and 11.2% (Kutner et al., 
2014) of the study participants who had reported falls in the previous 12 months 
experienced fractures as a result of these falls. Kutner and colleagues also reported that 
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71% of the patients who sustained these fractures, which mainly involved the hips, upper 
and lower limbs, were also hospitalised. 
In the study by Desmet et al., (2005), 32% of the falls sustained by patients over the 8-
week observational follow-up were complicated by fractures or wounds requiring medical 
care, while 10.7% of the falls recorded met the definition of a serious fall given by the 
authors, namely a fall requiring hospitalisation, or resulting in fracture or death. 
Cook et al., (2006) found that 4% of the patients who had falls sustained fractures, 7% 
had head trauma with loss of consciousness, 16% required hospitalisation, and 4% died as 
a direct consequence of the fall-related injury within 7 days from the time of the fall. 
Overall, 19% of the falls required some form of medical attention. 
The study conducted by Abdel-Rahman et al., (2011) revealed that 15.4% of the older 
group (over 65 years) and 14.3% of the younger group of HD patients suffered a severe 
injury (definition of severe injury not provided) as a direct consequence of the falls 
occurred during the prospective observational follow-up. 
Rossier et al., (2012) conducted a prospective investigation of the incidence of falls that 
were severe enough to require presentation to an emergency room. The results from this 
study indicated that 54.8% of these falls were complicated by fractures: 35.3% of these 
fractures involved the hip, 17.7% the pelvis, and 11.8% the ribs. 3.2% of the falls also 
resulted in death as a consequence of the injuries sustained. 
One study exploring the risk of falling in peritoneal dialysis patients (Farragher et al., 
2014) reported that 6% of the falls incurred by these patients led to a fracture, 6% caused 
a head injury, 14% resulted in hospitalisation, and 24% required presentation to an 
emergency department. In addition, the authors conducted survival analyses over an 
extended follow-up period and found that the number of falls were a significant predictor 
of mortality (HR: 1.62, 95% CI: 1.29 – 2.02, p˂ 0.001). 
In 2008, Li et al., (2008) also performed survival analyses on the results from a previous 
study investigating the incidence of falls in HD patients (Cook et al., 2006). Similarly to 
Farragher et al., (2014), the Cox regression analysis revealed that falls were an 
independent risk of death (HR: 1.78, 95% CI: 1.07–2.98, p= 0.03). 
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Polinder-Bos et al., (2014), and Noto-Kadou-Kaza et al., (2015) conducted two smaller 
prospective investigations of the incidence of falls in dialysis patients. The following 
complications of falls were described as part of their results: not otherwise specified minor 
complications in 53% of falls, fractures in 15% of falls, hospitalisation required in 15% 
of falls (Polinder-Bos et al., 2014); and haematoma in 41.18% of the patients who had 
falls, not otherwise specified wounds in 23.53%, dislocations in 5.88% (Noto-Kadou-
Kaza et al., 2015). In addition, both authors reported that, overall, 45% of falls recorded 
(Polinder-Bos et al., 2014), and 47.05% of the patients with falls (Noto-Kadou-Kaza et 
al., 2015) required some form of medical help. 
In the study by Naylor et al., (2014), the complications of falls as such could not be 
described as fractures only represented the primary outcome of this prospective 
investigation. Nevertheless, the authors reported the location of first fracture during 
follow-up for CKD-5 patients (hips: 54.2%, forearm: 19.2%, pelvis: 18.2%, proximal 
humerus: 8.4%). 
More recently, Bowling et al., (2018) conducted a prospective investigation of the adverse 
health outcomes of severe falls-related injuries occurred in the year preceding HD 
initiation in older dialysis patients. The Cox regression analysis performed in this study 
revealed that patients with a positive history of severe fall injuries were at a significant 
higher risk of further serious fall-related injuries (HR: 2.65, 95% CI: 2.41–2.91), post-
acute skilled nursing facility utilisation (HR: 1.40, 95% CI: 1.30–1.50), hospitalisation 
(HR: 1.11, 95% CI: 1.06–1.16), and death (HR: 1.14, 95% CI: 1.06–1.22). 
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Table 1.5. Summary of studies investigating risk of falling in patients on dialysis. Study findings. 
Author Prevalence of falls Incidence of falls Age Sex Risk factors Consequences 
Roberts et 
al., 2003 
27.7% Not available. Mean: 
78.2±5.3 
years. 
51%F 
49%M 
Post-dialysis orthostatic 
hypotension was more 
frequent among those 
patients who had falls. 
Not available. 
Cook et 
al., 2005 
27% Not available. Mean: 
74.9±6.2 
years. 
61%M 
39%F 
No significant differences in 
age and sex were found 
between fallers and non-
fallers. 
4% of patients volunteered 
they had sustained a fracture 
or head injury as a result of the 
falls experienced. 
Desmet et 
al., 2005 
12.7% 1.18 falls/person-
year. 
Median: 
70.9 years 
(range: 
25-93). 
56%M 
44%F 
Older age, diabetes, total 
number of prescribed 
drugs, antidepressant use, 
and failing to walk 10 
meters were independent 
predictors of falls in logistic 
regression analysis. 
32% of falls were complicated 
by wounds requiring medical 
care or fractures. 10.7% of 
falls met the authors' 
definition of a serious fall. 
Cook et 
al., 2006 
47% 1.60 falls/person-
year. 
Mean: 
74.7±6.1 
years. 
57%M 
43%F 
Previous history of falls, 
male gender, comorbidity, 
pre-dialysis blood pressure 
were predictive of falls in 
proportional odds 
regression analysis. 
19% of falls required medical 
attention; 7% of fallers 
sustained head injuries with 
loss of consciousness; 4% 
sustained fractures; 16% were 
hospitalised; 4% died. 
      (Continued) 
33 
 
Table 1.5. (Continued)      
Author Prevalence of falls Incidence of falls Age Sex Risk factors Consequences 
Roberts et 
al., 2007 
 
 
 
 
38% 1.76 falls/person-
year. 
Mean: 58 
years. 
34.6%F 
65.4%M 
There was a significantly 
higher incidence of falls in 
the older patients. 
Not available. 
Abdel-
Rahman et 
al., 2011 
26.3% 0.38 falls/person-
year. 
Mean: 
62.4±16.1 
years. 
38.2% F 
61.8% M 
Age ˃65 years and female 
gender were associated with 
falls in univariate logistic 
regression analysis. 
15.4% of elderly fallers and 
14.3% of younger fallers 
sustained severe injury as a 
result of a fall. 
Rossier et 
al., 2012 
28.6% 0.22 severe 
falls/person-year. 
Median: 
69.5 years 
(range 
26-85). 
33%F 
67%M 
Older age, depression, 
malnutrition, previous 
history of falls, and POMA 
were associated with severe 
falls in univariate logistic 
regression analysis. 
54.8% of falls were 
complicated by fractures of 
the hip (35.3%), pelvis 
(17.7%), ribs (11.8%), and 
death (3.2%). 
McAdams-
DeMarco 
et al., 
2013 
28.3% Not available. Mean: 
60.5±12.6 
years. 
46.3% F 
53.7% M 
Frailty predicted a higher 
number of falls in Poisson 
regression analysis. Female 
gender, medication 
use/drug, high school 
education or higher were 
also associated with falls. 
Not available. 
      (Continued) 
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Table 1.5. (Continued)      
Author Prevalence of falls Incidence of falls Age Sex Risk factors Consequences 
Kutner et 
al., 2014 
28.4% 0.88 falls/person-
year. 
Mean: 
57.1±14.1 
years.  
59.2%M 
40.8%F 
Frailty, depression, older 
age, and lower cognitive 
function were associated 
with increased odds of 
falling in multivariable 
logistic regression analysis. 
11.2% of fallers sustained 
fractures (primarily involving 
the upper and lower limbs). 
71% of these patients were 
hospitalised. 
Farragher 
et al., 
2014 
54% 1.7 falls/person-
year. 
Mean: 
76.2±7.5 
years. 
55%M 
45%F 
Previous history of falls 
was associated with higher 
number of falls in 
multivariable random 
effects Poisson regression 
analysis. 
6% of falls resulted in a 
fracture, 6% resulted in head 
trauma (reported by patient), 
24% resulted in an emergency 
room visit, 14% led to 
hospitalisation. 
Polinder-
Bos et al., 
2014 
55% 0.85 falls/person-
year. 
Median: 
79.3 years 
(range: 
70-89). 
71% M 
29% F 
Lower pre-dialysis systolic 
blood pressure and higher 
parathyroid hormone were 
predictive of falls in Cox 
regression analysis. 
53% of falls had minor 
complications, 15% were 
complicated by fractures, 15% 
required hospitalisation; 45% 
required medical help. 
      (Continued) 
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Table 1.5. (Continued)      
Author Prevalence of falls Incidence of falls Age Sex Risk factors Consequences 
Naylor et 
al., 2014 
Not available. Not available. Mean: 62 
years. 
42.8%F 
57.2%M 
Lower eGFR was 
associated with a higher 
number of fractures or falls 
with hospitalisation. 
Location of first fracture in 
follow-up: Hip: 54.2%, 
Forearm: 19.2%, Proximal 
humerus: 8.4%, Pelvis: 18.2% 
(Group ˂15ml/min per 1.73m² 
eGFR or on dialysis). 
Noto-
Kadou-
Kaza et 
al., 2015 
22.9% 3.2 falls/person-
year. 
Mean: 
40.3±16.8 
years. 
50%F 
50%M 
Hypotension, frailty, and 
sensory deficit were 
associated with increased 
odds of falling in univariate 
logistic regression analysis. 
The falls resulted in 
haematoma (41.2%), wounds 
(23.5%), dislocations (5.9%), 
and no consequences (29.4%). 
47.1% of patients informed a 
doctor about the fall they had. 
Delgado 
et al., 
2015 
26.9% of patients 
experienced either 
a severe fall or a 
fracture. 
Not available. Median: 
63 years 
(52-73). 
45%F 
55%M 
Self-reported frailty, 
female gender, older age, 
white race were associated 
with a higher risk of first fall 
or fracture in Cox 
regression analysis. 
Not available. 
      (Continued) 
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Table 1.5. (Continued)      
Author Prevalence of falls Incidence of falls Age Sex Risk factors Consequences 
Wang et 
al., 2017 
16% Not available. Mean: 
63±13.7 
years. 
63%M 
37%F 
Lower muscle strength and 
lower mobility (SPPB) were 
predictors of falls in 
univariate negative 
binomial regression 
analysis. 
Not available. 
Kono et 
al., 2018 
41% Not available. Mean: 
69.4±11.6 
years. 
60%M 
40%F 
Older age, C-reactive 
protein, lower geriatric 
nutritional risk index, 
SPPB, low handgrip 
strength, and intradialytic 
hypotension were 
associated with falls in Cox 
regression analysis. 
Not available. 
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1.2.3 Frailty in CKD-5 
Frailty is a biological syndrome of decreased reserve and resistance to stressors, resulting 
from cumulative declines across multiple physiologic systems, and causing vulnerability 
to adverse outcomes (Fried et al., 2001). 
This syndrome was first defined by Fried et al., (2001), who studied the association 
between a phenotype of frailty and adverse outcomes such as falls, disabilities in activities 
of daily living (ADL), hospitalisations, and mortality in a large cohort of older adults from 
the Cardiovascular Health Study. The results from this study showed that this frailty 
phenotype was independently predictive of these adverse outcomes, and demonstrated for 
the first time that frailty is a construct at least partly independent from disability and 
comorbidity. Because of this qualitative distinction, the assessment of frailty in a clinical 
setting has gained attention in light of its preventability and potential reversibility, which 
would delay or hinder the onset of adverse health outcomes. The frailty phenotype 
introduced by Fried is characterised by five components: shrinkage, low levels of physical 
activity, poor strength, low gait speed and self-reported exhaustion. Those individuals who 
meet at least 3 out of the 5 criteria are defined as frail. 
Although this is the most commonly used definition of frailty, other tools for the 
assessment of frailty have been developed since the Fried’s phenotype was introduced. 
These tools encompass the Groningen frailty indicator (Steverink et al., 2001), the Clinical 
frailty scale (Rockwood et al., 2005), the Frailty Index (Rockwood et al., 2007), and the 
FRAIL scale (Morley et al., 2012), which represent either a modification of the Fried’s 
frailty phenotype, or a quantitative assessment of increased vulnerability. For instance, the 
Frailty Index shifts the focus of attention to the accumulation of deficits across different 
physiologic systems (Rockwood et al., 2007), rather than to sarcopenia and other age-
related modifications as the principal pathophysiological aspect (Fried et al., 2001). 
Chronic Kidney Disease (CKD) is consistently associated with frailty or decreased 
physical function (Walker et al., 2013). According to a recent systematic review, the 
prevalence of frailty among stages 1-4 CKD ranges from 7% to 42.6% (Chowdhury et al., 
2017), and it has been suggested that it may represent both a health outcome and an 
independent predictor of adverse outcomes in CKD (Afilalo et al., 2009).   
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Several risk factors including chronic inflammation, acidaemia, hormonal changes, and 
malnutrition might accelerate the development of frailty in CKD (Kojima et al., 2017), 
which is further exacerbated by a process of premature and accelerated ageing (Kooman 
et al., 2014). 
Kooman et al., (2014) described the main mechanisms that could lead to premature ageing 
in CKD, which include an increase in allostatic load, mediated by oxidative stress and 
persistent inflammation, the activation of the stress resistance response and consequent 
alteration of the anabolic and catabolic responses, and the inevitable increase of pro-
ageing factors such as hyperphosphatemia, angiotensin II, and accumulation of interstitial 
sodium. These risk factors would lead to the main features of premature ageing, namely 
muscle wasting and accelerated vascular disease (Kooman et al., 2014). The consequences 
of these pathophysiological features of premature ageing are that, regardless of age, CKD 
patients tend to have greater physical function deficits than otherwise healthy older adults 
(Painter et al., 2013), and that the prevalence of frailty in CKD is higher than in the healthy 
elderly population (Chowdhury et al., 2017). 
In addition, it has been shown that lower estimated glomerular filtration rates (eGFR) are 
associated with a worse frailty status (Reese et al., 2013), meaning that the severity of 
CKD is associated with frailty in a graded manner. This relationship reflects how the 
progression of CKD could lead to worse physical function and, by the time one patient 
reaches CKD-5 and HD, he/she will be more likely to be frail than at the earlier stages. 
Therefore, not surprisingly, the prevalence of frailty is higher in CKD-5 patients 
undergoing HD therapy compared to non-dialysis dependent CKD patients, with rates 
ranging from 14% to 73% (Chowdhury et al., 2017). Large observational studies have 
found that the prevalence of frailty in incident dialysis patients is very high (Johansen et 
al., 2007; Bao et al., 2012), and that dialysis initiation does not result in an improvement 
of frailty (Johansen et al., 2013). On the contrary, progression on dialysis seems to be 
associated with a further decrease of physical function (Kurella-Tamura et al., 2009). 
In addition, frailty in HD patients has been found to be independently associated with 
various adverse outcomes such as hospitalisations and mortality (Johansen et al., 2007; 
Bao et al., 2012; Alfaadhel et al., 2015; Lee et al., 2017), number of falls (McAdams-
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DeMarco et al., 2013), cardiovascular disease (Kutner et al., 2014b), and lower cognitive 
function (McAdams-De Marco et al., 2015a).   
The large discrepancy in frailty prevalence among HD populations reported in the current 
literature (Chowdhury et al., 2017) is at least partly attributed to the great heterogeneity 
of tools that have been used to measure frailty in the various studies. A systematic review 
on the frailty measurement tools in CKD found that the large majority (72%) of studies 
used the Fried’s frailty phenotype, while the remainder investigations employed one or a 
combination of the frailty scales named above (Chowdhury et al., 2017). Another 
systematic review (Kojima et al., 2017) performed a meta-analysis by calculating the 
pooled prevalence of frailty, assessed by means of the Fried’s frailty phenotype: what 
emerged from this research is that the prevalence of frailty was considerably higher when 
the frailty criteria were established by self-report rather than by objective measurements. 
More precisely, when the gait speed and strength components of frailty were assessed by 
means of an objective physical performance measure, the pooled prevalence of frailty was 
36.8% (Figure 1.2), while when these two components were evaluated by means of a 
surrogate self-reported physical functioning measure (a score less than 75 in the physical 
function scale of the SF-36 quality of life questionnaire), the pooled prevalence of frailty 
was 67%, almost double than the objectively measured one. Although the estimates of 
objective/subjective frailty emerging from this meta-analysis may be biased, considering 
that the included studies were heterogeneous in terms of exact operationalisation of 
physical frailty (e.g. Delgado et al., 2013 employed physical function and activity scores 
under the lowest quintile as opposed to the standard Fried’s cut-off values used in the 
other studies (Figure 1.2)), the findings raise the question as to whether a self-reported 
assessment of frailty may be a valid method in dialysis patients. Johansen et al., (2014) 
performed a comparison of self-reported and objective measurements of frailty, based on 
the frailty phenotype, in HD patients. The authors found that the self-reported assessment 
of frailty had a high sensitivity (90%), but only limited specificity (64%), and positive 
predictive value (54%). The implications of this are that an assessment of frailty based on 
objective measurements might be preferable to self-report evaluations in HD patients, due 
to the better accuracy of the first method. Nevertheless, self-reported definitions of frailty 
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have been shown to have a similar prognostic value to the objectively measured frailty 
phenotype, being strongly associated with negative health outcomes and mortality 
(Johansen et al., 2016). In light of this association, despite the lower accuracy, assessing 
frailty with self-report information might be more feasible in a clinical setting, where 
objective measures of frailty are not always available (Johansen et al., 2016). 
 
Figure 1.2. Forest plot of prevalence of frailty in CKD-5 based on the Fried’s phenotype 
(Kojima et al., 2017, p. 1994). 
 
 
1.2.3.1 Modifiability of frailty in CKD-5 
The question as to whether frailty can be modified or even reversed in the general 
population of older adults living in the community has been addressed by many 
randomised controlled trials (Cameron et al., 2013; Kim et al., 2015; Tarazona-
Santabalbina et al., 2016; Liao et al., 2019). The results from these investigations have 
generally indicated that physical frailty, as assessed by means of phenotypic frailty (Fried 
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et al., 2001), can be at least partially reversed following exercise interventions (Travers et 
al., 2019). In particular, the components of weakness, slowness, low physical activity and 
exhaustion seem to be positively affected by multicomponent exercise programs involving 
strength, balance, aerobic and flexibility training (Kim et al., 2015; Tarazona-Santabalbina 
et al., 2016; Liao et al., 2019). Moreover, a recent systematic review concluded that a 
combination of protein supplementation and strength training is effective in delaying or 
reversing frailty in primary care (Travers et al., 2019). 
There is still no consensus reached by the renal care community regarding the extent 
frailty may be preventable or reversible in HD patients and which treatment strategies may 
be more efficient and or effective. However, three main courses of intervention have been 
suggested to combat premature ageing and consequently frailty, namely the correction of 
the CKD-related pro-ageing factors (such as oxidative stress, inflammation, and 
hyperphosphatemia), physical exercise, and optimal nutrition (Kooman et al., 2014). 
Even though there’s no current direct evidence that the frailty status can be prevented or 
reversed by means of physical exercise in HD patients, a few studies have examined the 
effect of various kinds of exercise interventions on strength and physical function, which 
are core components of the frailty phenotype, and found promising results (Ling et al., 
2003; Storer et al., 2005; Greenwood et al., 2012; Bullani et al., 2012; Kirkman et al., 
2014). Although these encouraging findings do not constitute ultimate proof that frailty 
can be reversed, they certainly show that at least three out of five components of the 
Fried’s frailty phenotype, i.e. low physical activity levels, poor strength, and low gait 
speed can be modified by means of an exercise intervention in HD patients, which is 
indirect evidence of the exercise-modifiable nature of frailty in this population. More 
recently, it has been suggested that, considering the physical activity barriers HD patients 
are exposed to (Johansen et al., 2010), pre-habilitation of frail patients approaching the 
start of dialysis might be a beneficial treatment strategy (Sheshadri et al., 2017). 
Lastly, it should be acknowledged that kidney transplantation was found to be associated 
with an improvement of the frailty status 3 months after the transplant (McAdams-
DeMarco et al., 2015b), which highlights indirectly how this treatment modality is 
generally the most preferred in the management of CKD-5 (Pesavento et al., 2009). 
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1.2.3.2 Physical function in CKD-5 
Impaired physical function is one of the core components of the frailty phenotype, as both 
low gait speed and poor muscle strength are embedded in the operational definition of 
frailty provided by Fried et al., (2001). Several studies have reported various degrees of 
physical function impairment in CKD-5, with a few observational studies showing how 
physical function declines as a function of time in HD patients (Kurella-Tamura et al., 
2009; Sutcliffe et al., 2018). 
Kurella-Tamura et al., (2009) assessed the self-reported functional status in a large group 
of nursing home residents starting HD and repeated the assessment at 3 and 12 months 
from dialysis initiation: the results from this study are staggering, as only 39% of the 
patients taking part in the investigation preserved their functional status 3 months after 
starting dialysis, and only 13% preserved it at 12 months. 
In a more recent study, Sutcliffe et al., (2018) analysed the degree of physical function 
deterioration in a smaller cohort of patients starting HD in Australia. The authors reported 
a 30% decrease in number of 30 seconds chair sit to stands, as well as a 9% increase in 
the timed-up and go test, meaning a deterioration of this kind of performance.  
In addition, echoing the results from Kurella-Tamura et al., (2009), another recent 
investigation showed that, during a 2-year follow up, only 15.3% of prevalent HD patients 
maintained their (self-reported) physical function levels, and the trajectory of physical 
function deterioration was even more marked in patients aged over 75 years of age, with 
only 3.6% of these preserving their physical function after 2 years (van Loon et al., 2017). 
Recent research has also focused the attention to the effects of different dialysis modalities 
on the physical function decline trend, suggesting that this latter is not influenced by the 
dialysis modality, as HD and peritoneal dialysis patients seem to have similar functional 
status (Iyasere et al., 2016; Painter et al., 2017). 
The question as to how CKD-5 patients compare to healthy individuals in terms of 
physical function has also been addressed by a number of scientific reports. The values of 
peak oxygen uptake (VO2peak), for instance, have been shown to be significantly reduced 
in CKD-5 patients, who in average score 60% to 70% of the age-predicted values 
(Johansen et al., 1999; Smart et al., 2011). In the context of CKD-5, a VO2peak threshold 
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value of 17.5mL/min/Kg was shown to have important prognostic value, as strongly 
associated with survival (Sietsema et al., 2004), and very often HD patients present with 
VO2peak values lower than this threshold (Kouidi et al., 1998). In addition, it has been 
pointed out that the actual VO2peak of CKD-5 patients may be considerably lower than the 
results reported in the scientific literature, given that not all CKD-5 patients, especially 
HD patients, are eligible to undergo a peak exercise assessment due to severely limited 
mobility or to significant CVD (Painter, 2005). 
Slow gait speed is a commonly reported component of frailty (Fried et al., 2001), and in 
HD patients it has been shown to be associated with mortality (Kutner et al., 2015) and 
increased number of hospitalisations (Kutner et al., 2014). Kutner et al., (2015) classified 
a large group of prevalent HD patients in different gait speed categories, and at least 24% 
of these patients presented with a gait speed slower than the threshold value indicative of 
frailty (Fried et al., 2001). In addition, smaller studies comparing gait speed in HD patients 
and healthy individuals suggest that HD patients have an 18% (Blake et al., 2004) to 34% 
(Johansen et al., 2003a) reduced self-selected gait speed compared to healthy subjects.  
Low handgrip strength is another component of the frailty phenotype, which is indicative 
of poor muscle strength (Fried et al., 2001). A systematic review revealed that handgrip 
testing is extensively used in CKD-5 patients on HD, and that this kind of assessment is a 
valid tool for the prediction of clinical complications (Leal et al., 2011). This systematic 
review reported that the average handgrip scores for HD patients ranged from 12 to 38Kg 
in men, and 11 to 26Kg in women, and although it is difficult to extrapolate what 
percentage of these patients meet the frailty criteria of low handgrip strength, a few studies 
suggest that the average handgrip strength of dialysis patients may be lower than the 
threshold value indicative of frailty (Qureshi et al., 1998; Constantin-Teodosiu et al., 
2002; Wang et al., 2005). In addition, studies comparing CKD-5 patients with the non-
uraemic population suggest that handgrip strength is reduced by 26 to 51% in patients who 
are on dialysis (Stenvinkel et al., 2002; Wang et al., 2005, Silva et al., 2011). A recent 
study also reported that poor muscle strength, assessed by means of handgrip test, is an 
independent predictor of all-cause mortality in HD patients (Vogt et al., 2016). 
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A further measure of muscle strength commonly reported, in the context of physical 
function assessment in CKD-5, is lower limb strength assessed by means of dynamometry 
(Koufaki et al., 2010). Even though the lack of normative data limits the comparison of 
CKD patients with the general healthy population, a study by Johansen et al., (2003) 
reported that lower limb strength, as assessed by dynamometry, was approximately 22% 
lower than in non-uraemic control subjects. Conversely, Blake et al., (2004) reported a 
45% lower limb strength in HD patients compared to a group of healthy individuals. The 
clinical and prognostic value of low muscle strength assessed by means of dynamometry 
has been the focus of recent investigations. Particularly, lower limb strength was found to 
be an independent predictor of slow gait (Abe et al., 2016) and increased mortality 
(Matsuzawa et al., 2014) in HD patients. 
The ability to perform chair sit-to-stands has also been used commonly as a surrogate 
measure of lower limb function in the context of CKD (Painter et al., 2005). In a feasibility 
study, Painter et al., (2000) reported that chair sit-to stand testing in HD patients was 
significantly impaired (25% of healthy age-predicted values), while Blake et al., (2004) 
found a 28% lower sit-to-stand performance in HD patients compared to healthy controls. 
Interestingly, the 5 repetitions chair sit-to-stand test (CSTS-5) has been shown to have 
proven clinical value, as cut-off values of >15 seconds and >16.7 seconds have been found 
to be predictive of recurrent and injurious falls respectively (Buatois et al., 2008; Ward et 
al., 2015). 
Analogously to the CSTS-5, the timed up and go test (TUG) has been described to have 
clinical value, as a time >14 seconds to perform this task has been shown to discriminate 
individuals with history of recurrent falls (Shumway-Cook et al., 2000). In addition, a cut-
off value of >10 seconds was shown to be strongly associated with a higher degree of 
disability in activities of daily living in older HD patients (Cook et al., 2008). In this study, 
Cook and colleagues report a staggering 80% of patients unable to perform the TUG at all 
(7%) or under 10 seconds (73%) and, echoing these results, a study conducted on pre-
dialysis patients revealed that the average time to perform the TUG in these patients was 
above the threshold value for greater functional disability (10 seconds) by 12% 
(Roshanravan et al., 2013).  
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Even though postural balance usually lies outside the domain of physical function 
assessment in CKD patients (Koufaki et al., 2010), an increasing number of studies on 
balance control, involving static posturography, have been conducted in CKD-5 patients 
in the last 5 years (Shin et al., 2014; Magnard et al., 2014; Zanotto et al., 2017). Shin et 
al., (2014), for instance, compared the static balance in a small group of HD patients with 
healthy controls, finding an increased postural sway in all the variables examined, with 
differences ranging from +22% to +139% in HD patients. Similarly, Magnard et al., 
(2014) reported increased postural sway, meaning worse balance control, in HD patients 
compared to healthy individuals. The significant differences in the variables examined 
ranged from +32% to +47% in the group of HD patients. Notably, Blake et al., (2004) had 
also found an increased postural sway (+33%) in a small group of HD patients compared 
to healthy subjects. Although the clinical utility of static posturography-based 
measurements of balance is still not recognized unanimously by the scientific community, 
some research has demonstrated the potential of this kind of assessment in discriminating 
recurrent fallers from non-fallers among elderly individuals (Bigelow et al., 2011). 
In conclusion, the evidence of impaired physical function in the context of CKD-5, and 
among dialysis patients in particular, is overwhelming. The role of physical activity and 
exercise in improving physical function in these patients is equally overwhelming (Painter 
et al., 2005). Recent systematic reviews with meta-analysis highlighted how various 
modalities of exercise training have resulted effective in improving self-reported physical 
functioning, maximum oxygen consumption, the 6-minute walk test, lower limb muscle 
strength and quality of life (Heiwe et al., 2014; Sheng et al., 2014; Chung et al., 2017; 
Matsuzawa et al., 2017). In addition, some exercise intervention studies also suggest that 
exercise training can improve other physical function outcomes such as the TUG (Heiwe 
et al., 2001; Storer et al., 2005), the CSTS-5 (Manfredini et al., 2017), and postural balance 
(Frih et al., 2018) in CKD-5 patients. 
 
1.2.3.3 Physical activity behaviour in CKD-5 
Physical activity is another crucial component of the Fried’s frailty phenotype (Fried et 
al., 2001), as low self-reported levels of physical activity is one of the criteria around 
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which frailty is operationalised and among all the frailty components, it is intrinsically the 
most exercise-modifiable. 
In the last 20 years, several studies reported information on the physical activity patterns 
and/or behaviour of CKD-5 patients (Painter et al., 2000; Johansen et al., 2000; O’Hare et 
al., 2003; Tentori et al., 2010; Matsuzawa et al., 2012; Painter et al., 2017; Broers et al., 
2017; Cupisti et al., 2017). These studies consistently documented that HD patients have 
significantly reduced levels of physical activity compared to age-matched non-uraemic 
individuals, which are indicative of marked sedentary behaviour (Johansen et al., 2010; 
Stringuetta-Belik et al., 2012; Matsuzawa et al., 2012). The clinical implications of these 
low physical activity levels involve multiple domains of health. For instance, global 
physical function is affected due to the well-known negative effects of sedentary 
behaviour on bone and skeletal muscle function (Kurella-Tamura et al., 2009), but also 
cardiovascular and mental health seem to be negatively influenced (Johansen et al., 2010; 
Tsai et al., 2017). Overall, sedentary behaviour has been linked to lower quality of life as 
well as to the development of adverse clinical outcomes such as hospitalisations, major 
cardiovascular events and mortality in CKD-5 patients (O’Hare et al., 2003; Tentori et al., 
2010; Tsai et al., 2017). 
Both subjective and objective assessments of physical activity have been widely employed 
to characterise physical activity or sedentary behaviour in the context of CKD-5. As 
expected, very large epidemiological studies such as the Dialysis Outcomes and Practice 
Pattern Study (DOPPS) and the Dialysis Mortality and Morbidity Study (DMMS) used 
self-reported measures of physical activity due to their higher feasibility. The results of 
these studies are comparable, as both studies highlighted how 35% to 44% of the dialysis 
patients from their cohorts never or almost never engaged in any kind of structured 
physical activity, with 38% to 42% of them having severe limitations in performing 
moderate physical activity (O’Hare et al., 2003; Tentori et al., 2010). In the same way, 
studies using standardised questionnaires, such as the international physical activity 
questionnaire (IPAQ), have shown that 27% to 40% of prevalent HD patients are 
completely inactive by self-report (Li et al., 2010; Stringuetta-Belik et al., 2012).   
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On the other hand, smaller studies, with sample sizes ranging from n= 24 to n= 202 (Mafra 
et al., 2011; Matsuzawa et al., 2012), used objective measurements of physical activity 
such as pedometers or uni-axial and tri-axial accelerometers. Similarly, studies aiming to 
compare the physical activity patterns of CKD-5 patients with those of healthy individuals 
also used objective measurements of physical activity, due to their greater precision and 
reliability. These studies have shown, with great variability, how HD patients present with 
reduced number of daily step counts (-26% to -164%) compared to healthy controls 
(Mafra et al., 2011; Broers et al., 2017). Typically, these studies have reported that HD 
patients take on average 2800 to 7100 steps per day, which is 29% to 72% less than the 
current recommendations for a healthy lifestyle (Tudor-Locke et al., 2004). Additionally, 
further studies involving objective measurements of physical activity have described 
reduced activity counts (-18% to -35%), greater time spent in sedentary activities (+15%), 
less time spent in moderate activities (-38%) and total energy expenditure (-25%) in HD 
patients compared to healthy individuals (Johansen et al., 2000; Agarwal et al., 2011; 
Cupisti et al., 2011; Baria et al., 2011; Broers et al., 2017). 
Furthermore, the progression of dialysis-independent CKD to CKD-5 seems to be 
associated with a decrease in physical activity. This is supported by the finding that HD 
patients exhibit a significantly higher percentage of sedentary behaviour compared to 
stage 2-4 CKD patients (Agarwal et al., 2011), and also that dialysis initiation is associated 
with a decrease of self-reported and objective measurements of physical activity 
(Johansen et al., 2000a). This phenomenon can be explained partly by the increasing 
comorbidity and consequent progressive decline of physical function observed in CKD-5 
patients (Kurella-Tamura et al., 2009), but also by the fact that HD therapy entails 
prolonged periods of sedentary behaviour due to the imposed sitting time during dialysis. 
The effect of HD therapy on physical activity behaviour has been object of many studies, 
involving objective measurements of physical activity, that consistently reported greater 
sedentary behaviour of CKD-5 patients during dialysis days compared to non-dialysis 
days (Panaye et al., 2015; Cobo et al., 2015; Gomes et al., 2015; da Costa Rosa et al., 
2017). 
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1.2.3.4 Relationship of frailty, physical function, and physical activity with falls in 
CKD-5 
Recent research has shown that frailty is associated with a 2.39-fold higher risk of history 
of falls (Kutner et al., 2014), and is predictive of a 3.09-fold higher number of falls 
(McAdams-DeMarco et al., 2013) in CKD-5 patients on maintenance HD. In addition, 
self-reported frailty has been shown to be associated with adverse outcomes arising from 
falls, such as a higher risk of fractures (Delgado et al., 2015). Consequently, these studies 
strongly suggest that impaired physical function and physical inactivity may be associated 
with falls, in the context of CKD-5, given that these domains contribute to operationalise 
frailty itself (Fried et al., 2001). 
Nevertheless, only approximately 60% of the studies that investigated falls and their risk 
factors, in the CKD-5 population, reported either physical function or physical activity 
information relating to the falling status of these patients (Desmet et al., 2005; Cook et al., 
2006; Rossier et al., 2012; McAdams-DeMarco et al., 2013; Farragher et al., 2014; Kutner 
et al., 2014; Polinder-Bos et al., 2014; Delgado et al., 2015; Wang et al., 2017; Kono et 
al., 2018), showing contrasting results. For instance, Desmet et al., (2005) found a 
significant association between poor walking performance and falls in their study, as 
failing to walk 10 meters was predictive of a 2-fold higher risk of falls. In more recent 
studies, low performance on the SPPB was also found to be associated with an increased 
risk of falling in HD patients (Wang et al., 2017; Kono et al., 2018). Additionally, Delgado 
et al., (2015) reported that self-reported physical function was associated with a 33% 
higher risk of time to first fall or fracture in a large cohort of incident dialysis patients. 
In contrast with these studies, other research did not find any relationship between 
physical function and falls in HD patients. Particularly, Cook et al., (2006) found no 
significant differences in the level of dependency required in activities of daily living, nor 
in TUG performance between fallers and non-fallers. Similarly, Polinder–Bos et al., 
(2014) also did not find any differences in self-reported limitations in the ADLs between 
HD patients with and without falls, while Farragher et al., (2014) did not find significant 
differences in TUG between fallers and non-fallers (although fallers had a lower 
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performance amounting to -12.8% compared to non-fallers) in a small cohort of peritoneal 
dialysis patients. 
In addition to these findings, a few studies reported some significant differences in 
physical function between patients with positive falling status and patients who were falls-
free that did not quite reach statistical significance in multivariate, adjusted-models. For 
instance, Desmet et al., (2005) reported that in univariate analysis, compared with non-
fallers, HD patients with falls had a significant lower performance in rising from a chair 
(-34.9%), in maintaining standing balance with eyes closed (-22%), and in the one-leg 
standing balance test (-22.9%). These differences were no longer significantly associated 
with increased odds of falling in multivariate logistic regression analysis (Desmet et al., 
2005). Analogously, Rossier et al., (2012) assessed physical function in a small cohort of 
HD patients by means of the POMA, and determined the incidence of severe falls 
prospectively in these patients. The baseline comparison of fallers vs non-fallers indicated 
that fallers had a significant lower POMA score compared to non-fallers (-9.3%), although 
no significant association was found in the logistic regression model designed for the 
prediction of falls, and the authors concluded that a lower POMA score was not associated 
with falling in HD patients (Rossier et al., 2012). More recently, Wang et al., (2017) 
reported a significant lower ankle dorsiflexion muscle strength in HD patients who 
reported falls at 12 months compared to those who did not. However, the multivariate 
negative binomial regression analysis did not reveal any significant association between 
lower muscle strength and number of falls experienced by study participants. 
Only one study explored the relationship between physical activity and falls in dialysis 
patients (Delgado et al., 2015). This study highlighted that three components of frailty, 
namely poor physical function, exhaustion, and physical inactivity had similar association 
estimates with falls or fractures (HR 1.33, 95% CI 1.01 – 1.75; HR 1.40, 95% CI 1.10 – 
1.76; HR 1.36, 95% CI 0.78 – 2.37). Nevertheless, only the first two components reached 
statistical significance in the fully adjusted Cox proportional hazards model, and the 
authors concluded that self-reported physical activity was not predictive of falls or 
fractures in the study cohort (Delgado et al., 2015). 
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In conclusion, although the current body of evidence strongly suggests that frailty is 
associated with falling in CKD-5 patients (McAdams-DeMarco et al., 2013; Kutner et al., 
2014; Delgado et al., 2015), very little information on the relationship between the single 
frailty domains of low physical function/activity and falls is currently available. 
Approximately 40% of the studies investigating the risk of falling in HD patients did not 
include physical function/activity assessments at all as potential risk factors for falls 
(Roberts et al., 2003; Cook et al., 2005; Roberts et al., 2007; Abdel-Rahman et al., 2011), 
while other studies only included self-reported measurements of physical function/activity 
(Polinder-Bos et al., 2014; Delgado et al., 2015), which are generally considered less 
reliable than objective measurements (Overend et al., 2010; Ahn et al., 2015). As far as 
the remaining studies are concerned, the results are ultimately inconclusive as only a few 
studies found a significant association between objective physical function measures and 
falls among CKD-5 patients (Desmet et al., 2005; Wang et al., 2017; Kono et al., 2018), 
while others did not show any significant association (Cook et al., 2006; Farragher et al., 
2014).  
Because physical function/activity are potentially exercise-modifiable components of 
frailty, establishing which physical function/activity measures may be more closely 
associated with falls, if any, is of paramount importance, as this would eventually allow 
to tailor exercise-based rehabilitation programs aimed to reduce the occurrence of falls in 
CKD-5 patients on HD. 
 
1.2.4 Cardiovascular disease in CKD-5 
CKD has been consistently shown to constitute an independent risk factor for the 
development of cardiovascular disease (CVD) (Rucker et al., 2009). CVD is the leading 
cause of death in CKD-5 patients, accounting for approximately 40% of deaths in dialysis 
patients (USRDS, 2011), and cardiovascular mortality in dialysis patients is estimated to 
be 10-fold to 100-fold higher than in age and sex-matched people in the general population 
who are free from kidney disease (Foley et al., 1998). The incidence and prevalence of 
CVD in patients affected by CKD is high and the most common clinical manifestations 
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encompass stroke, coronary artery disease/myocardial infarction, congestive heart failure 
and atrial/ventricular arrhythmias (Parfrey et al., 1999; Tonelli et al., 2016). 
The risk of cerebrovascular accidents is increased among all categories of CKD, and 
particularly so in CKD-5: the relative risk of stroke in CKD-5 patients is about 5 to 10 
times higher than the relative risk of their non-uraemic, age-matched counterparts. This 
magnitude of risk is even higher than that of coronaropathy, as the relative risk of 
myocardial infarction in CKD-5 patients is 2.5- to 3 times higher than in general 
population (Toyoda et al., 2014). Nevertheless, it should be acknowledged that the 
epidemiology of coronary disease is confounded by the common co-existence of CKD 
and diabetes, which is a further well-known independent risk factor of myocardial 
infarction. 
Congestive heart failure is also a common complication of CKD, and its clinical 
manifestation is particularly evident in the more advanced stages of kidney dysfunction 
(prevalence 31-36% in dialysis patients), due to the compromised renal excretion of water 
and sodium, or to the primary cardiac dysfunction (Tonelli et al., 2016). 
Finally, sudden cardiac death, defined as any sudden, unexpected death attributable to 
cardiac aetiology, and generally occurring with little or no warning at all, is one of the 
main causes of death among CKD-5 patients on dialysis. It is estimated that about 20 to 
25% of deaths among all dialysis patients are due to sudden cardiac death (Whitman et 
al., 2012). 
The traditional risk factors implicated in the development of CVD include hypertension, 
diabetes mellitus, dyslipidemia and albuminuria: many of these are increased in CKD-5 
patients, and mainly hypertension, hyperlipidemia, and diabetes seem to be implicated in 
the aetiology of CVD in these patients (Parfrey et al., 1999). Some of these traditional risk 
factors of cardiovascular mortality such as hypertension, obesity and dyslipidemia seem 
to have a reverse epidemiology in HD patients. Systolic blood pressure, for instance, 
present a U-shape relationship with mortality, as both high and low blood pressure are 
associated with increased mortality (Tonelli et al., 2016).  
So in the same way, dyslipidemia seems to have the same kind of relationship with 
mortality (Kasiske et al., 1998). Inflammation seems to play a determinant role in this 
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relationship, as dialysis patients without evidence of inflammation have a positive 
relationship between cholesterol and cardiovascular or all-cause mortality, while those 
with signs of inflammation display a U-shape relationship between serum cholesterol and 
cardiovascular mortality. This seems to suggest that low cholesterol levels may reflect 
states of inflammation and malnutrition (Kasiske 1998). 
Obesity, on the other hand, represents a different model of reverse epidemiology. The 
obesity paradox in CKD-5 has been recently described and seems to be responsible for the 
abnormal relationship between increased body weight and mortality: the paradox is that 
the chances of longer survival are better in patients who have a higher BMI compared to 
those who have a lower BMI, probably due to haemodynamic stability, protein-energy 
wasting modulation, and sequestration of uraemia-related toxins in the adipose tissue 
(Park et al., 2014). 
In addition to the traditional risk factors, CKD patients are also exposed to additional risk 
factors involved in the pathophysiology of CVD (Figure 1.3). These factors often result 
from the CKD-related uraemia, which can lead to the accumulation of toxins that are 
detrimental for cardiac function (Tonelli et al., 2016), and they encompass altered 
metabolism of phosphorus and calcium, anemia, chronic inflammation and oxidative 
stress, proteinuria, and hyper-homocysteinemia. Furthermore, dialysis patients might have 
additional potential risk factors such as extracellular fluid volume overload, and 
bacteremia compared to patients who do not depend on dialysis (Rucker et al., 2009). 
These CKD-related risk factors can contribute to the development of CVD by increasing 
vascular stiffness in particular. The stiffening of the arterial walls, especially in the large 
arteries, constitute one of the main risk factors for CVD and is due to multiple factors, 
whereas vascular calcification represents one of the main causes. More precisely, vascular 
calcification contributes to CVD by inducing myocardial ischemia, microvascular damage 
in the brain and in the kidney, and cardiac hypertrophy (London, 2011). Vascular 
calcification is an active process which involves differentiation of contractile vascular 
smooth muscle cells, and other endothelial cells into ‘osteoblast-like’ cells, and has been 
shown to be activated by a multiplicity of factors including cellular senescence, oxidative 
stress, dyslipidemia, glycation by-products, and hyperphosphatemia (Tonelli et al., 2016).  
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In the context of CKD, and CKD-5 in particular, vascular calcification seems to be 
promoted by the abnormal calcium and phosphate homeostasis, which is associated with 
the alteration of the endocrine pathway involving the parathyroid hormone, and the 
vitamin D-fibroblast growth factor-23—Klotho axis (London, 2011; Kusano et al., 2011). 
In the context of CKD however, vascular stiffness is also promoted by endothelial 
dysfunction, a well-documented feature of this clinical population (Moody et al., 2012). 
Impaired endothelial function can negatively impact on CVD not only via vascular 
stiffness, but also by promoting atherosclerosis and, consequently, coronary artery disease 
(Hirata et al., 2014). Carbamylation is one of the mechanisms that have been suggested to 
promote endothelial dysfunction in CKD (Tonelli et al., 2016). This is a chemical reaction 
wherein the accumulating urea in the bloodstream dissociates to form cyanate, which 
would then react irreversibly with free amino groups and other proteins (Tonelli et al., 
2016). Further CKD-related mechanisms involved in endothelial dysfunction are the 
decrease in number of endothelial progenitor cells, which play an important role in 
repairing the vascular endothelium, and the uraemic-related accumulation of indoxyl 
sulfate which would accelerate the arteriosclerosis process (Kusano et al., 2011). 
Moreover, since the kidney is a main source of antioxidant enzymes, the deterioration of 
renal function would inevitably result in the increase of pro-oxidant factors, which are 
known markers of cardiac risk (Tonelli et al., 2016). Analogously, the atherogenesis 
process has been described to be accelerated by some CKD-related inflammatory particles 
such as calciprotein particles, cholesterol crystals, and inflammasomes (Swaminathan et 
al., 2011). 
The combined effects of vascular stiffness and chronic inflammation are also known to 
affect left ventricular hypertrophy (Graham-Brown et al., 2017), one of the most common 
features and risk factors involved in the pathophysiology of CVD in people living with 
CKD (Major et al., 2018). Particularly, left ventricular hypertrophy can lead to a cascade 
of adverse cardiovascular events including malignant arrhythmias and sudden cardiac 
death (Makar et al., 2017), left atrial dilatation with atrial fibrillation (Franczyk et al., 
2016), and heart failure (Di Lullo et al., 2015). 
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In addition to risk factors described above, it should be acknowledged that the worsening 
of renal functioning is also associated with a chronic activation of the renin–angiotensin 
system or sympathetic nervous system, which is thought to accelerate cardiovascular 
disorders. As kidney function deteriorates, the primary hypertension and sympathetic 
over-activation contribute in a synergic manner to the development of CVD by increasing 
the cardiac strain (Kusano et al., 2011). 
 
Figure 1.3. Pathophysiological interactions between CKD and CVD (Ronco et al., 2008, 
p. 1534). 
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1.2.4.1 Autonomic dysfunction in CKD-5 
The progressive decline of renal function is associated with impaired cardiovascular 
autonomic control (Bavanandan et al., 2005). Adequate autonomic control is fundamental 
for the compensatory regulation of blood pressure, and the chronic over-activation of the 
sympathetic nervous system plays a central role in the pathogenesis of hypertension, heart 
failure, and sudden cardiac events (Malpas, 2010). 
Kidney damage can result in sympathetic overactivity by triggering afferent nerve trafﬁc 
to the hypothalamus, where the centers of sympathetic control reside, via the 
spinothalamic tract. Even though the physiologic mechanisms activating the afferent 
nerve traffic are not completely understood, signals such as hypoxia, renal ischemia, 
adenosine, and angiotensin II seem to be implicated in triggering the sympathetic response 
(Vonend et al., 2008). Additional mechanisms that have been proposed to elicit 
sympathetic overactivity in CKD encompass the accumulation of asymmetric 
dimethylarginine, a compound that inhibits nitric oxide, thus promoting sympatho-
excitatory effects, and the impairment of baroreflex function (Grassi et al., 2012). 
A variety of direct and indirect measurements have been used for the assessment of cardiac 
sympathetic nervous system activity in CKD. Traditional techniques such as plasma 
norepinephrine levels and catecholamines turnover revealed contradicting data, as 
reported by a review of Rubinger et al., (2013), with studies reporting both lower and 
higher levels of catecholamines in CKD-5 patients. 
Direct measurements of sympathetic nervous system activity such as regional 
norepinephrine spillover and efferent post-ganglionic muscle sympathetic nerve activity 
might be preferable to the classical techniques involving measurements of plasma 
norepinephrine levels, and have consistently been indicative of increased sympathetic 
activity in CKD-5 patients compared to non-uraemic populations (Rubinger et al., 2013). 
Nevertheless, these techniques have reduced applicability in CKD-5 patients, or may be 
less available in a clinical context. For instance, the norepinephrine spillover technique 
requires catheterisation and tracer infusions, and therefore its use is limited in HD patients, 
while the efferent post-ganglionic muscle sympathetic nerve activity has only been object 
of few studies due to its limited availability in clinical settings (Rubinger et al., 2013). For 
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this reason, indirect assessments of sympathetic activity have found higher applicability 
in CKD-5 patients on HD. 
These indirect assessments of autonomic function are based on non-invasive beat-to-beat 
analysis of heart rate and blood pressure oscillations, and mainly consist of heart rate 
variability and baroreflex function, as assessed by means of baroreflex sensitivity, and 
baroreceptor effectiveness index (Parati et al., 2003). 
 
1.2.4.2 Heart rate variability 
Heart rate variability (HRV) can be described as the difference between the longest and 
the shortest R-R intervals within a predetermined test period (Task Force of the European 
Society of Cardiology and the North American Society of Pacing and Electrophysiology, 
1996). 
The assessment of HRV can be categorised into time-domain methods or frequency-
domain methods. In the time-related method, the variables are derived from the calculation 
of inter-beat intervals during predefined recording periods. Measures such as mean heart 
rates, average duration of R-R intervals, and difference between the longest and shortest 
R-R intervals belong to this kind of method. The most common variable of the time-
domain method is the standard deviation of the total number of R-R intervals between 
QRS complexes following depolarisation of the sinus node. These intervals are named 
normal to normal (NN) intervals, and therefore the variable takes the name of SDNN (Task 
Force of the European Society of Cardiology and the North American Society of Pacing 
and Electrophysiology, 1996). 
The frequency-domain method consists of the spectral analysis of heart rate oscillations, 
in a given time of interest, and is usually presented as a three-dimensional diagram. This 
kind of analysis is classified as frequency-based because it allows the detection of both 
slow and rapid fluctuations of heart rate in predefined periods of time, which reflect the 
haemodynamic adjustment to changing cardiovascular demands. In particular, the spectral 
analysis identifies a low-frequency (LF) component, which is thought to derive from 
neural mechanisms related to vagal and sympathetic outflows, as well as a high-frequency 
(HF) component, representing respiration-mediated and vagally-dependent fluctuations of 
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R-R intervals (Parati et al., 1995). The ratio of the two components (LF/HF ratio) is 
commonly used as a measure of sympatho-vagal balance (Norton et al., 2005).  
The studies that have investigated HRV in HD patients have consistently reported that this 
measure of autonomic function is decreased: both the LF and HF components were found 
to be lower than in non-uraemic individuals (Rubinger et al., 1999), while an increase in 
the LF/HF ratio was believed to represent an impairment of the autonomic function due 
to the shift towards a sympathetic predominance (Giordano et al., 2001). In addition, 
suppressed HRV is thought to convey prognostic value, as it was associated with increased 
cardiac mortality (Hayano et al., 1999; Fukuta et al., 2003). It should be acknowledged 
that a significant limitation of this kind of assessment, and of indirect measurements of 
autonomic function in general, is the limited applicability of this technique in those 
patients who present multiple ectopic beats, as the HRV variables are calculated in the 
context of NN intervals (La Rovere et al., 2008). 
 
1.2.4.3 Baroreflex function 
The baroreceptor reflex, or baroreflex, is one of the main physiologic mechanisms that 
control the cardiovascular and haemodynamic responses to short-lived or more sustained 
physical tasks such as changes in body position or exercise. The main role of the 
baroreflex is that of stabilising arterial pressure in response to perturbations of the 
circulatory homeostasis, which is achieved by various neuronal regulatory adjustments 
(Stauss, 2002). The baroreflex is regulated by specialised blood pressure sensors 
(baroreceptors), located in the aortic arch and in the carotid sinuses, which detect 
variations in the pressure load (Figure 1.4). These baroreceptors are sensitive to the arterial 
pressure by detecting the extent of stretch in the aorta and in the carotid arteries, and they 
provide the central nervous system with beat-to-beat information on the systemic blood 
pressure (Lanfranchi et al., 2002). More specifically, the baroreceptors provide an 
excitatory input to the neurons located in the nucleus of the solitary tract, which represents 
the brain stem centre for afferent baroreflex inputs (Zhang et al., 2000), while the rostral 
ventrolateral medulla is the centre for the efferent modulation of the baroreflex. When the 
baroreceptors detect a rise in arterial blood pressure the baroreflex produces sympathetic 
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inhibition and parasympathetic activation, which in turn results in decreased heart rate and 
vascular resistance (Pang, 2001). When a drop of blood pressure is sensed, the baroreflex 
triggers the opposite response, namely an increase in heart rate and vascular resistance. 
Increasing evidence suggests that this physiological mechanism is impaired in CKD, and 
that it might predict cardiovascular risk and all-cause mortality (Hildreth et al., 2012). 
The baroreflex function is typically assessed by measuring the sensitivity of the reflex, 
also known as baroreceptor reflex sensitivity, and the baroreceptor effectiveness index (Di 
Rienzo et al., 2001; Taylor et al., 2001; Stauss, 2002, Lanfranchi et al., 2002). 
 
Figure 1.4. Baroreceptor reflex. 
 
 
1.2.4.4 Baroreflex sensitivity 
The baroreflex sensitivity (BRS) can be defined as the magnitude of baroreflex response 
per unit of blood pressure deviation from the operating point, whereas the operating point 
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represents the blood pressure at which the baroreflex responds most effectively to 
variations of arterial pressure (Stauss, 2002). 
The first introduction and calculation of BRS was obtained by assessing the heart rate 
responses to perturbations of blood pressure provoked by the injection of vasoactive 
medications with minor effects on the sinus node (Smyth et al., 1969). This methodology 
is the so-called pharmacologic approach, which basically consists of administrating a 
vasoconstrictor drug, typically phenylephrine (Mortara et al., 1997), to measure the 
produced bradycardia. In this kind of assessment, the administration of the drug is 
performed during simultaneous and continuous recordings of beat-to-beat blood pressure 
and electrocardiography (ECG). The quantification of BRS is therefore obtained by 
calculating the slope of the regression line of the blood pressure and R-R interval 
responses, and is usually expressed as the variation in R-R interval in milliseconds (ms) 
per millimeters of mercury (mmHg) change in systolic blood pressure (La Rovere et al., 
1998). Due to the fact that this method implies cannulation, its applicability is limited in 
some instances, thus, overtime, non-invasive methods of assessing BRS have been 
developed. 
Within the non-invasive assessment tools of BRS, techniques such as the Valsalva 
maneuver and the neck chamber techniques are based on provoking abrupt changes of 
blood pressure, while another category of techniques are based on the analysis of 
spontaneous variations (unprovoked) of blood pressure and heart rate. The Valsalva 
maneuver and the neck chamber techniques follow the same principle of the 
pharmacologic approach, namely performing a concomitant measurement of beat-to-beat 
arterial pressure and R-R intervals while a substantial change in blood pressure is being 
provoked. In the Valsalva maneuver technique, this abrupt modification of blood pressure 
is triggered by the elevation in intra-abdominal and intrathoracic pressure caused by the 
forced expiration while the glottis is being kept closed (Palmero et al., 1981). Conversely, 
in the neck chamber technique, the variation of blood pressure is provoked through the 
selective modulation of the baroreceptors located in the carotid sinuses by applying a 
positive or negative pneumatic pressure to the neck of the patient. Particularly, neck 
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suction seems to be the most favourable technique, as this kind of pressure seems to be 
better tolerated by the patient (Eckberg et al., 1975). 
The least invasive assessment of BRS is based on the analysis of spontaneous variations 
of blood pressure and heart rate. This approach is based on the observation that the 
activation of the baroreflex is not solely dependent on abrupt variations of systemic blood 
pressure, but it is also activated by small pressure changes that occur continuously 
throughout the day (La Rovere et al., 1998). The most utilised method based on the 
analysis of spontaneous variations of blood pressure and heart rate is the so-called 
“sequence method” (Pinna et al., 2015). This method is based on the same principles of 
the previous methods, namely that an increase in arterial blood pressure will generate a 
lengthening of the R-R interval and vice versa, and consists of continuous and 
simultaneous recording of beat-to-beat systolic blood pressure and heart rate by means of 
ECG and plethysmography (Pinna et al., 2000). During these recordings, a “sequence” is 
identified as a concomitant change in systolic blood pressure and R-R interval, of 
respectively 1 mmHg and 4 ms (Parati et al., 2000), for a minimum of three consecutive 
cardiac cycles, and it represent a baroreceptor regulatory event (Parati et al., 1988). The 
sensitivity of the baroreflex is therefore assessed by calculating the slope of the regression 
line relating variations in systolic blood pressure to variations in the R-R interval. Finally, 
the calculated slopes are averaged to compute the BRS (La Rovere et al., 2008). 
The increasing popularity of this method is due to the fact that it is low-cost and inherently 
simple since it doesn’t require provocation of an abrupt change in blood pressure (La 
Rovere et al., 2008). In addition, the sequence method has been shown to have the same 
prognostic value of the invasive methods to assess baroreflex function, such as the 
phenylephrine method (Pinna et al., 2000), high reproducibility (Parati et al., 2003) and 
moderate to good absolute and relative reliability (Maestri et al., 2009). Moreover, 
compared to other methods based on the analysis of spontaneous oscillations of blood 
pressure and heart rate, such as the spectral methods (La Rovere et al., 2008), the sequence 
method reduces the artefact effects of ectopic beats on the calculation of BRS, by imposing 
strict constraints on the concomitant change in systolic blood pressure and R-R interval 
(Pinna et al., 2015). For this reason, the sequence method may be preferable for the 
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assessment of baroreflex function in those patients who have a higher degree of 
cardiovascular disease and consequently it has been used extensively in CKD-5 patients 
on HD therapy (Studinger et al., 2006; Johansson et al., 2007; Sapoznikov et al., 2010; 
Sapoznikov et al., 2013; Gupta et al., 2016). 
Several studies have reported that BRS is impaired in CKD (Gerhardt et al., 1999; Gao et 
al., 2005; Studinger et al., 2006; Johansson et al., 2007) and the degree of impairment may 
increase as the severity of CKD progresses, even if it’s still unclear at which stage of 
disease the BRS starts to deteriorate (Hildreth et al., 2012). Although clear normative BRS 
data are currently not available in CKD-5 patients, Studinger et al., (2006) observed a 
markedly reduced BRS (-157%), assessed by means of the sequence method, in HD 
patients compared to healthy controls. 
The aetiology of impaired BRS, and baroreflex function in general, is still unknown 
fundamentally. Nevertheless, it has been suggested that the deterioration of this reflex, in 
the context of CKD, may involve neuropathy of the peripheral nerves and reduced arterial 
distensibility in proximity of the carotid sinuses and in the aortic arch, that could lead to 
increased thresholds of baroreceptors activation and therefore to an impaired capacity of 
regulating blood pressure (Johansson et al., 2007). This last hypothesis seems to be 
supported by the observation that impaired BRS was found to be associated with arterial 
stiffness (Gupta et al., 2016) and vascular calcification (Chesterton et al., 2005). 
Johansson et al., (2007) conducted a prospective observational study aimed to determine 
whether baroreflex function, assessed by means of BRS and baroreceptor effectiveness 
index, had prognostic value in CKD patients. The results from this study indicated that 
BRS was an independent predictor of cardiac death among these patients. Even though 
the exact mechanisms by which impaired BRS could contribute to increased 
cardiovascular mortality are fundamentally unknown, it has been speculated that poor 
BRS may be implicated in the HD-related hypotension, which is a significant cause of 
death in HD patients (Chesterton et al., 2010). 
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1.2.4.5 Baroreceptor effectiveness index 
In 2001, Di Rienzo et al., (2001) introduced a new parameter to assess the baroreflex by 
analysing the spontaneous oscillations of blood pressure and heart rate through the 
sequence method: the authors named this parameter baroreceptor effectiveness index 
(BEI). 
The introduction of this measure originated from the observation that BRS quantifies 
exclusively the magnitude of the baroreflex, by analysing the slope of the regression line 
between systolic blood pressure and R-R intervals of the so-called baroreceptor sequences 
(Parati et al., 1988). Parati et al., (1988) had already observed that, during 24-hour 
recordings of blood pressure and heart rate, the study participants had a number of blood 
pressure ramps that were not coupled with a concomitant variation of the R-R interval. 
Therefore, even though a healthy person could appear to have a normal baroreflex 
function, as assessed by means of BRS, the presence of uncoupled blood pressure ramps 
may be suggestive of a reduced capacity of maintaining the arterial pressure homeostasis 
effectively through the baroreflex. Consequently, the BEI was introduced as a measure of 
how often the baroreflex is effective in driving the heart rate in response to perturbations 
of systolic blood pressure (Di Rienzo et al., 2001). Analogously to BRS, this index is 
obtained by means of the sequence method: a simultaneous change in systolic blood 
pressure and R-R interval for a minimum of three consecutive cardiac cycles is classified 
as a baroreceptor event. These events can be defined as “down-events”, which occur when 
a decrease in blood pressure is coupled with a shortening of the R-R interval, or as “up-
events”, which occur when a rise in blood pressure is coupled with a lengthening of the 
R-R interval. The total events count is then obtained by summing the number of down-
events and up-events recorded within a given time interval, and the BEI is derived by 
calculating the ratio of the total number of baroreceptor events and the total number of 
blood pressure ramps, regardless of whether these ramps are coupled or not with a change 
of the R-R interval (BEI= total n° of baroreceptor events/ total number of systolic blood 
pressure ramps) (Di Rienzo et al., 2001). The specificity of this tool was also assessed by 
Di Rienzo et al., (2001): the authors reported a reduction in BEI of approximately 89% in 
cats following surgical denervation of the aortic baroreceptors. Higher scores of BEI are 
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therefore indicative of a better regulatory response of the baroreflex and, in healthy 
individuals, the normal values of BEI range around 0.58±0.2 (Pitzalis et al., 2003). 
Although the majority of clinical studies conducted on CKD-5 patients assessed 
baroreflex function by means of BRS, given its earlier introduction (Parati et al., 1988), 
BEI has also been shown to be reduced in CKD-5 patients compared to healthy subjects 
(approximately -48%) and to have prognostic value by Johansson et al., (2007), who 
concluded that reduced BEI was an independent predictor of all-cause mortality in CKD 
patients. In light of these findings, and considering the low costs and non-invasiveness of 
this measurement, BEI has increasingly become more popular as a complementary 
measure of baroreflex function and autonomic function in CKD patients (Rubinger et al., 
2013), and some have suggested that this measure should be implemented as part of the 
tests currently used to stratify sudden cardiac death risk in HD patients (Franczyk-Skóra 
et al., 2015). 
 
1.2.4.6 Relationship of baroreflex function and orthostatic blood pressure with falls 
The deterioration of baroreflex function in CKD may be one of the mechanisms that affect 
the regulation of blood pressure in resting conditions (Rubinger et al., 2013), but also in 
the upright position or during the transition from a seated/supine position to upright 
standing. In normal conditions, the baroreflex ensures an efficient regulation of blood 
pressure during orthostasis because the relationships between arterial blood pressure, heart 
rate, respiration and sympathetic nerve activity shift or reset when upright, preventing 
hypotension and brain hypoperfusion by improving the cardiac output through increased 
heart rate, sympathetic activation and the respiratory-abdominal pump (Schwartz et al., 
2012). 
Mattace-Raso et al., (2007) conducted a large observational study aimed to examine the 
association between arterial stiffness, baroreflex function, and changes in blood pressure 
during an orthostatic challenge. The results from this study, conducted in older adults, 
showed that individuals with lower BRS had a more prominent drop of blood pressure 
during the orthostatic challenge. A drop in blood pressure is one of the factors that could 
lead to dizziness symptoms and potentially to falls (Post et al., 2010), as orthostatic 
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hypotension, along with carotid sinus hypersensitivity, is portrayed as one of the main 
cardiovascular disorders that can cause falls or syncope (Task force on syncope, European 
Society of Cardiology, 2004). Interestingly, the relationship between orthostatic 
hypotension and falls has been object of debate in the last five years. Although this 
cardiovascular condition is intuitively linked to an increased risk of falling (Brignole et 
al., 2004), a systematic review of the association between cardiovascular disorders and 
falls highlighted inconclusive evidence of a positive relationship between orthostatic 
hypotension and falls (Jansen et al., 2016). The authors of this review concluded that 
methodological heterogeneity of the studies included, and in particular the lack of standard 
definitions of orthostatic hypotension, was largely responsible for this non-finding. For 
instance, Finucane et al., (2014) reported that, in a large population of people aged ≥ 50 
years living in the community, the prevalence of initial orthostatic hypotension (occurring 
within first 15 seconds) was about 33%, while only about 7% of the population met the 
canonical definition of orthostatic hypotension (Brignole et al., 2004) after one minute of 
standing. Because the systematic review by Jansen et al., (2016) included mainly studies 
wherein orthostatic hypotension was diagnosed after the first minute of orthostatic 
challenge, the authors concluded that the small proportion of studies revealing a positive 
association between orthostatic hypotension and falls may be explained by this 
definitional artefact. In addition, it has been pointed out that lack of apparent association 
between orthostatic hypotension and falling may also result from employing logistic 
analyses rather than time-to-event analyses, which would be more appropriate in light of 
the multifactorial aetiology of falls (Frith 2017). More recently, Mol et al., (2019) 
performed a systematic review with meta-analysis of all cross-sectional and longitudinal 
studies reporting on the association between orthostatic hypotension and falls. The authors 
concluded that this cardiovascular disorder is positively associated with falls (OR: 1.73, 
95% CI: 1.50-1.99) in community-dwelling older adults. It is therefore possible that this 
recent publication may finally put an end to the long-lasting debate on orthostatic 
hypotension and falls (Frith 2017). 
It should also be acknowledged that other investigations focused on the blood pressure 
changes to orthostasis, as a potential risk factor for falls, without necessarily introducing 
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the concept of orthostatic hypotension. For instance, two studies examined the relationship 
between blood pressure changes during orthostasis and falls in older adults (Heitterachi et 
al., 2002; Shaw et al., 2015). Heitterachi et al., (2002), conducted a prospective 
investigation aimed to explore the relationship between the short-term regulation of blood 
pressure during an orthostatic challenge, consisting of head up tilting to 60° for 3 minutes, 
and the incidence of falls over a 12 month period. The results from this study revealed that 
the magnitude of decreases in systolic blood pressure during 3 minutes of upright tilting 
was associated with a two-fold increased risk of falling. More recently, Shaw et al., (2015) 
conducted a similar study which involved an orthostatic challenge consisting of a passive 
transition from a seated position to upright standing. The authors concluded that subjects 
with a history of falls had a larger decrement of systolic blood pressure during the 3-15 
minute period of orthostasis (Figure 1.5). 
Another important finding that may link impaired baroreflex function, the homeostasis of 
blood pressure and falls is that high arterial pulse wave velocity, a measure of arterial 
stiffness, was found to be associated with falls in a large cohort of community-dwelling 
older adults (Wong et al., 2014). Increased arterial stiffness is one of the mechanisms 
thought to cause impairment of the baroreflex by increasing the thresholds of baroreceptor 
activation, which could lead to a decreased capacity of regulating blood pressure 
(Johansson et al., 2007; Hildreth et al., 2012), and potentially to cerebral hypoperfusion 
during orthostasis or during the transition from a resting position to upright standing 
(Wong et al., 2014). 
In addition, it should also be acknowledged that CVD may increase the risk of falling not 
only via cerebral hypoperfusion but also by impairing skeletal muscle function (Keng et 
al., 2019). For instance, heart failure, a highly prevalent comorbidity in HD patients, can 
aggravate muscle wasting due to the fact that exercise capacity is clinically reduced in 
people living with this condition (Fulster et al., 2013). Analogously, peripheral arterial 
disease can also negatively impact on physical function and skeletal muscle mass as a 
result of the restricted blood supply to the leg muscles (King et al., 2015; Harwood et al., 
2017). Moreover, vascular disease is also linked to impaired cognition, a recognized risk 
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factor for falls (Rubenstein et al., 2006), through microvascular damage of the small 
cerebral vessels (Bronas et al., 2017). 
In CKD-5 patients, a further component of risk for dizziness and pre-syncopal symptoms 
is also represented by the extensive use of antihypertensive medications such as alpha/beta 
blockers, and angiotensin-converting enzyme inhibitors (Post et al., 2010), which are 
commonly prescribed to counteract hypertension, one of the main clinical goals in the 
management of CKD (Lees et al., 2015). The use of this class of medications has been 
shown to be strongly associated with the risk of serious fall injuries in a large cohort of 
older people (Tinetti et al., 2014). 
Despite the overwhelming evidence that baroreflex function is impaired in CKD-5 
patients and that the risk of dizziness and falls is high in these patients (Roberts et al., 
2003), no research has explored the relationship between the baroreflex, the 
cardiovascular responses to orthostasis, and falls in CKD-5 patients yet. Physical exercise 
has been shown to improve baroreflex function, assessed by means of BRS and BEI, in 
HD patients (Petraki et al., 2008). Therefore, if a positive association was to emerge 
between baroreflex function and falls, rehabilitation programs aimed to restore baroreflex 
function could be developed and implemented in the context of falls prevention in these 
patients. 
 
Figure 1.5. Response of systolic arterial pressure (SAP) to a passive orthostatic challenge 
in elderly fallers (black) vs non-fallers (white) (Shaw et al., 2015, p. 5 of 8). 
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1.2.5 Summary 
▪ The prevalence of CKD-5 has increased over the last 10 years in the UK, as the 
numbers of patients requiring RRT has grown by 39% compared to 2006 (UKRR, 
2016). HD therapy is the most common modality of RRT in the UK (41% of CKD-5 
patients are maintained on HD), and it is also the most expensive, with a yearly 
estimated cost per patient of over £35K (Baboolal et al., 2008). 
 
▪ The median age of HD patients has increased over the last 10 years, and is now 67 
years (UKRR, 2016). Consequently, adverse outcomes which are typical of the 
geriatric population, such as falls and falls-related injuries, are also expected to rise in 
this population, and are going to raise the economic burden for the NHS, due to the 
medical expenses required to treat the fall-related injuries. 
 
▪ The WHO global report on the prevention of falls in older age (2008) characterised 
the economic burden of falls in terms of direct costs, such as the expenses for the 
health care systems relative to the medications and services for the treatment and 
rehabilitation of injuries arising from falls, and indirect costs, such as the possible 
productivity loss of family caregivers. NHS data (2008) suggests that, over the next 
20 years, the estimated increase in direct costs from falls would amount to £200 
million in the UK. 
 
▪ Prospective cohort studies with a 12-month observational follow-up suggest that 
26.3% to 55% of HD patients experience at least one fall every year (Abdel-Rahman 
et al., 2011; Polinder-Bos et al., 2014), with an incidence of falls ranging from 0.38 to 
1.6 falls/patient-year (Abdel-Rahman et al., 2011; Cook et al., 2006). These reports 
are generally indicative of an increased risk of falling in CKD-5 patients on HD 
compared to the general, non-uraemic, population of community-dwelling older adults 
(WHO, 2008). However, no data from 12-month prospective studies of the incidence 
of falls in HD patients are currently available in the UK. 
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▪ A number of observational studies described various risk factors associated with the 
occurrence of falls in CKD-5 patients on dialysis, with older age, previous history of 
falls, polypharmacy, depression and/or antidepressants use, comorbidities, frailty, and 
low blood pressure with or without symptomatology the most commonly reported. 
Frailty and blood pressure dysregulation are two risk factors that may be, at least 
partly, exercise-modifiable. 
 
▪ A recent systematic review with meta-analysis suggests that the prevalence of frailty 
in CKD-5 patients is 36.8%, which is approximately 5 times higher than in the healthy 
elderly population (Kojima et al., 2017). Although an increasing number of studies 
strongly support the hypothesis that frailty is associated with a higher occurrence of 
falls and fall-related injuries in CKD-5 patients on HD (McAdams-DeMarco et al., 
2013; Kutner et al., 2014; Delgado et al., 2015), the relationship between the single 
frailty domains of low physical function/activity, which are potentially exercise-
modifiable, and falls warrants further investigation. Approximately half of the studies 
investigating falls behaviour in CKD-5 patients did not include physical 
function/activity assessments at all as potential risk factors of falls, or only included 
self-reported measurements of physical function/activity, which are generally 
considered less reliable than objective measurements. The other half of the studies 
reported contrasting results, as only a few studies found a significant association 
between objective measurements of physical function and falls among dialysis 
patients, while others did not highlight any significant association. Further research 
aimed to identify which prevalent risk factors may be more closely associated with 
falls in CKD-5 patients on HD, is of paramount importance, as this would eventually 
allow to tailor interventions aimed to reduce the occurrence of falls in these patients. 
 
▪ Along with frailty, CVD is a common feature of CKD-5 patients and represents the 
lead cause of mortality in these patients. Autonomic dysfunction is one of the main 
mechanism that can lead to CVD, and as some research has suggested, it could also 
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be implicated in the clinical manifestation of dizziness, syncope-like events and 
possibly falls in HD patients (Roberts et al., 2003). Baroreflex function is one of the 
most common assessment, in the context of autonomic function testing, and it has been 
consistently shown to be impaired in CKD-5 patients (Rubinger et al., 2013; Hildreth 
et al., 2012). The deterioration of baroreflex function may be one of the main 
mechanisms to negatively affect the regulation of blood pressure in resting conditions, 
but also in the upright position or during the transition from a seated/supine position 
to upright standing because it is the main physiologic mechanism that controls the 
cardiovascular responses to short-lived changes in body position or during exercise. 
Despite the overwhelming evidence that baroreflex function is impaired in CKD-5 
patients, along with the observations that HD patients often present with dizziness, 
low blood pressure spells, and that around 33% of falls occur during the transition 
from a lying down or seated position to upright standing (Cook et al., 2006), no 
research has explored the relationship between the baroreflex, the cardiovascular 
responses to orthostasis, and falls in CKD-5 patients on HD yet. Because baroreflex 
function is a potentially exercise-modifiable factor (Petraki et al., 2008), rehabilitation 
programs aimed to restore baroreflex function could be developed and implemented 
in the context of falls prevention in HD patients. 
 
1.2.6 Research questions 
 
Question 1: 
Are CKD-5 patients on HD at high risk of falling? (Chapter 3) 
Hypothesis: 
The prevalence of HD patients experiencing at least one fall over 12 months, as well as 
the incidence of falls, will be indicative of an increased risk of falling compared to the 
estimates of falls from the non-uraemic population; 
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Question 2: 
Are frailty and its physical function/activity components associated with falling in CKD-
5 patients on HD? (Chapter 4) 
Hypothesis: 
The Fried’s frailty phenotype, and objective measurements of physical function/activity 
will be associated with the falling status in HD patients; 
 
Question 3: 
Are the cardiovascular responses to orthostasis associated with falling in CKD-5 patients 
on HD? (Chapter 5) 
Hypothesis: 
Baroreflex function, and the haemodynamic responses to a passive orthostatic challenge 
will be associated with the falling status in CKD-5 patients on HD; 
 
Question 4: 
What is the relative importance of frailty and cardiovascular function as potential exercise-
modifiable risk factors for falls in CKD-5 patients on HD? (Chapter 6) 
Hypothesis: 
Modelling the risk of falling by adding an exercise-modifiable cardiovascular function 
variable to a frailty-related variable only will improve the prediction of the number of falls 
sustained over a 12-month period in CKD-5 patients on HD. 
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CHAPTER 2: GENERAL METHODS 
 
2.1 Recruitment 
2.1.1 Ethical approval  
This research project was carried out according to the ethical principles for medical 
research involving human subjects as set out by the world medical association declaration 
of Helsinki. The Research Ethics Committee at Queen Margaret University, and the West 
of Scotland REC 3 reviewed and approved the research project (NHS REC reference 
number: 15/WS/0079; Appendix I). Research and Development approval at Monklands 
Hospital, NHS Lanarkshire, and at Victoria Hospital, Kirkcaldy, NHS Fife were also 
obtained (Appendices II and III). 
All patients undergoing outpatient HD therapy at Monklands Hospital and Victoria 
Hospital were firstly screened for eligibility by a member of the renal team responsible 
for their care, and if they registered a preliminary interest for the study, they were provided 
with a participant information sheet (PIS) detailing all the procedures involved with this 
research (Appendix IV). All patients were given at least seven days to consider the 
information and make a decision and/or enquire further about the study. After this period, 
the researcher approached potential participants and gained written informed consent 
(Appendix V) from all the patients agreeing to take part in the research project. 
 
2.1.2 Participants 
A convenience sample of ambulatory CKD-5 patients meeting the following eligibility 
criteria i) men and women ii) undergoing HD therapy (for at least 3 months) thrice weekly 
iii) older than 18 years iv) able to understand and speak English were recruited from two 
dialysis units at Monklands Hospital, Airdrie, NHS Lanarkshire, and Victoria Hospital, 
Kirkcaldy, NHS Fife. 
Exclusion criteria applied were: i) unstable dialysis and medication treatment as defined 
by renal care team, ii) lower limb amputees without prosthesis, iii) unstable cardiac 
condition, iv) suspected or known aneurysm, v) clinically severe left ventricular outflow 
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obstruction, vi) critical mitral stenosis, vii) critical proximal coronary artery stenosis, viii) 
critical cerebrovascular stenosis, ix) pregnancy, and x) severe cognitive impairment. 
 
2.1.3 Sample size 
In order to establish the association of risk factors with falling status, a logistic regression 
modelling approach was adopted. In logistic regression analysis, Peduzzi et al. (1996) 
recommended a ratio of 10 events per explanatory (independent) variable by the smaller 
proportion of the binary dependent variable, to allow unbiased estimation of associations. 
For the purposes of this research project, the number of events was defined as the number 
of people who experienced at least one fall over an observation period of 12 months 
(assuming prevalence of falls ≤ 50%). Background literature suggests that between 26% 
and 47% of patients on HD experience at least one fall over a period of 12 months (Cook 
et al., 2006, Abdel-Rahman et al., 2011). Hence, by using the smallest prevalence of falls 
reported (26%), a sample of 100 participants will have 26 fallers (events) and, using 
Peduzzi’s rule (10 events per explanatory variable), would allow 2 or 3 (2.6) variables to 
be entered in the same regression model. Assuming a prevalence of falls equal to 47% 
however, the logistic regression model would allow inclusion of 4 or 5 (‘4.7’) independent 
variables for a sample size of 100.  
In order to answer PhD research questions 2, 3 and 4 (Chapter 1, paragraph 1.2.6), at least 
two or three explanatory variables would be required. This would be achieved by 
modelling the risk of falling using one measure of frailty (e.g. gait speed), one measure of 
cardiovascular function (e.g. baroreceptor effectiveness index) and/or adjusting for 
clinical confounders. Table 2.1 further illustrates how many participants would be 
required for a given number of predictor variables depending on different prevalence of 
falls over a range of observation periods.   
 
 
 
 
 
73 
 
Table 2.1. A priori estimation of sample size (n). 
    Prevalence of falls 
    
12.7% 
(Desmet et al. 
2005, over 8 
weeks) 
38% 
(Roberts et al. 
2007, over 6 
months) 
26% 
(Abdel-
Rahman et al. 
2011, over 12 
months) 
47% 
(Cook et al. 
2006, over 12 
months) 
Number 
of  
covariates 
2 n= 157 n= 53 n= 77 n= 43 
4 n= 315 n= 105 n= 154 n= 85 
6 n= 472 n= 158 n= 231 n= 128 
8 n= 630 n= 211 n= 308 n= 170 
10 n= 787 n= 263 n= 385 n= 213 
 
2.1.4 Data protection and confidentiality 
All data from questionnaires and physical tests were collected in accordance with the 
terms of the Data Protection Act (1988), the General Data Protection Regulation (2018), 
and met the criteria of the NHS Lanarkshire, and NHS Fife confidentiality policies. All 
data were treated confidentially and reported anonymously. 
Each participant was allocated a unique identifier code and was identified by this and not 
his/her name. Electronic data were stored on a secure NHS password protected laptop and 
paper data were stored in a locked filing cabinet at Queen Margaret University. Data 
downloaded onto the Task Force® Monitor PC and ActivPal™ chip were removed once 
this information was transferred onto the secure laptop. Anonymised data were analysed 
at Queen Margaret University. At this stage, any information collected had the 
participants' names removed or coded so that they could not be identified at any time 
during data analysis. Electronic data for analyses purposes were transported from the 
hospitals to Queen Margaret University via an encrypted memory stick or password 
protected laptop. 
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2.2 Assessment of frailty 
2.2.1 Fried’s frailty phenotype 
The assessment of frailty was based on the work of Fried and colleagues (2001) who 
defined frailty as a biological syndrome of decreased reserve and resistance to stressors, 
resulting from cumulative declines across multiple physiologic systems, and causing 
vulnerability to adverse outcomes. Fried characterised this syndrome in terms of a frailty 
phenotype consisting of five components:  shrinkage, low levels of PA, poor strength, low 
gait speed, and self-reported exhaustion. These components are operationalised as 
described below (Fried et al., 2001): subjects meeting at least 3 out of these 5 criteria are 
classified as frail. 
 
1. Shrinkage: Unintentional weight loss of at least 10 pounds (4.5 kg) in the 
previous 12 months.  
2. Low levels of PA: This variable is derived from the Minnesota Leisure 
Time Activity questionnaire, and is stratified by gender. Men reporting ˂ 
383 Kcal of PA per week, and women reporting ˂ 270 Kcal of PA per 
week are classified as frail; 
3. Poor strength: This variable is based on handgrip scores and is stratified 
by gender and BMI quartiles. Men and women with handgrip scores lower 
than the cut-off values listed below are classified as frail: 
Men, BMI ≤ 24 Handgrip (kg) ≤ 29 
Men, BMI 24.1 – 26 Handgrip (kg) ≤ 30 
Men, BMI 26.1 – 28 Handgrip (kg) ≤ 30 
Men, BMI > 28 Handgrip (kg) ≤ 32 
Women, BMI ≤ 23 Handgrip (kg) ≤ 17 
Women, BMI 23.1 - 26 Handgrip (kg) ≤ 17.3 
Women, BMI 26.1 - 29 Handgrip (kg) ≤ 18 
Women, BMI > 29 Handgrip (kg) ≤ 21 
4. Low gait speed: This variable is based on the time spent to walk a 15 feet 
(4.57 m) distance, and is stratified by gender and height. Men and women 
75 
 
scoring times lower than the cut-off values listed below are classified as 
frail: 
Men, height ≤ 173 cm Time (s) ≥ 7 
Men, height > 173 cm Time (s) ≥ 6 
Women, height ≤ 159 cm Time (s) ≥ 7 
Women, height > 159 cm Time (s) ≥ 6 
5. Self-reported exhaustion: This variable is assessed by means of the CES-
D Depression Scale. The statements “I felt that everything I did was an 
effort”, and “I could not get going” are read and the following question is 
asked “How often in the last week did you feel this way?”. Four answer 
options are given: 0 = rarely or none of the time; 1 = some or a little of the 
time; 2 = a moderate amount of the time; 3 = most of the time. People 
answering “2” or “3” are classified as frail. 
 
2.2.2 Classification of frailty status 
Participants were classified as frail and non-frail based on an adaptation of the Fried’s 
frailty phenotype described above. Patients scoring at least 3 out of the 5 following criteria 
were classified as frail: 
1. Shrinkage: Unintentional weight loss of at least 10 pounds (4.5 kg) in the 
previous 12 months from the date of assessment. This information was 
retrieved from the renal unit electronic patient record system (SERPR); 
2. Low levels of PA: This frailty component was derived from the Short 
IPAQ questionnaire, and was stratified by gender. Men reporting ˂ 383 
Kcal of total PA per week, and women reporting ˂ 270 Kcal of total PA 
per week were classified as frail (Fried et al., 2001); 
3. Poor strength: This component of frailty was based on the handgrip scores, 
stratified by gender and BMI quartiles, as described by Fried et al., (2001). 
Men and women with handgrip scores lower than the cut-off values listed 
below were classified as frail: 
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Men, BMI ≤ 24 Handgrip (kg) ≤ 29 
Men, BMI 24.1 – 26 Handgrip (kg) ≤ 30 
Men, BMI 26.1 – 28 Handgrip (kg) ≤ 30 
Men, BMI > 28 Handgrip (kg) ≤ 32 
Women, BMI ≤ 23 Handgrip (kg) ≤ 17 
Women, BMI 23.1 - 26 Handgrip (kg) ≤ 17.3 
Women, BMI 26.1 - 29 Handgrip (kg) ≤ 18 
Women, BMI > 29 Handgrip (kg) ≤ 21 
4. Low gait speed: This component was also based on the time spent to walk 
a 15 feet (4.57 m) distance, stratified by gender and height, as described 
in the frailty phenotype (Fried et al., 2001). Men and women scoring times 
lower than the cut-off values listed below are classified as frail 
Men, height ≤ 173 cm Time (s) ≥ 7 
Men, height > 173 cm Time (s) ≥ 6 
Women, height ≤ 159 cm Time (s) ≥ 7 
Women, height > 159 cm Time (s) ≥ 6 
5. Self-reported exhaustion: The exhaustion component was assessed by 
means of the vitality scale of the SF-36 questionnaire. Participants with a 
score ˂ 55 were classified as frail 
 
Two components of the frailty phenotype, namely the low PA and self-reported 
exhaustion, were measured with different tools with respect to the work of Fried and 
colleagues (2001). The Short-IPAQ was used instead of the Minnesota Leisure Time 
Activity questionnaire, as the IPAQ has been used more consistently in CKD patients (Li 
et al., 2010; Rosa et al., 2015; Nah et al., 2019). 
Also, the SF-36 questionnaire was preferred to the CES-D depression scale for the 
assessment of the self-reported exhaustion component of frailty. The vitality scale of the 
SF-36 has become a commonly used tool in assessing this frailty component in dialysis 
populations: a score < 55 on the vitality component of the questionnaire has been used by 
previous literature as a measure of self-reported exhaustion, when assessing the 
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prevalence of frailty in patients undergoing haemodialysis therapy (Johansen et al., 2007; 
Delgado et al., 2013). 
It should be noted that, although the Fried’s phenotype was developed from a population 
of U.S. older adults living in the community, adaptations of this frailty phenotype have 
also been widely used in large UK population-based studies (Hanlon et al., 2018; Kojima 
et al., 2019; Watts et al., 2019). In the operational definition of frailty given by Fried et 
al., (2001), the cut-off values of the objectively recorded components “grip strength” and 
“gait speed” were obtained from the lowest quintile of distribution in the study participants 
(adjusted for gender and BMI/height). Consequently, UK studies conducted in older 
populations have often derived the cut-off values of these two components based on the 
distribution of the grip strength and gait speed scores (lowest quintile) in the actual study 
population (Watts et al., 2019) rather than using the cut-off values presented in the study 
by Fried. Although this is a sensible strategy to account for inter-country differences, our 
study population (CKD-5 patients on HD) is not comparable with the general population 
of community-dwelling older adults. Therefore, we felt that deriving the cut-off values 
from the lowest quintile of distribution would not reflect an accurate estimation of 
weakness and slowness prevalence in the research participants. 
 
2.3 Physical function measurements 
2.3.1 Handgrip strength 
All participants underwent handgrip strength testing using the Jamar hand dynamometer 
(Lafayette Instrument Company®, USA). This instrument has shown the best inter-rater 
and intra-rater reliability in clinical and epidemiological studies, and is commonly referred 
to as the gold standard for the assessment of handgrip strength (Roberts et al., 2011). 
Before starting the test, the dynamometer handle was adjusted to accommodate the palm’s 
size of every participant (Koufaki and Kouidi, 2010). For the assessment (Figure 2.1), 
participants sat on a chair, with the elbow of the testing arm flexed at 90 degrees, and the 
forearm in the neutral position (Roberts et al., 2011). The execution of this test was 
demonstrated beforehand and patients had the chance to familiarize themselves with the 
procedure once or twice. The following standardized verbal instructions were given: “Sit 
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back with your elbow flexed at 90 degrees and your forearm in the neutral position. I will 
count backwards 3… 2… 1… GO. When I say GO, please squeeze the handle as hard as 
you can for five seconds. Remember to breathe out during the test, and don’t hold your 
breath”. Also, standardized verbal encouragement was provided throughout the 
assessment: “Harder! Harder! Relax” (Mathiowetz et al., 1984). Three measurements 
rounded to the nearest kg were recorded and the average of these measurements was used 
for data analysis. After each measurement the peak-hold needle of the dynamometer was 
reset to zero and a 60 seconds recovery time was allowed between one measurement and 
the next. The three measurements were taken from the dominant hand, which in most 
cases corresponded to the limb free from fistulas. Measurements from the fistula arm were 
also allowed granted that this was well healed (Koufaki and Kouidi, 2010). 
 
Figure 2.1. Handgrip strength: standardised grip position. 
 
 
2.3.2 Isometric leg extension maximal voluntary contraction 
The apparatus for the assessment of isometric leg (knee) extension maximal voluntary 
contraction (MVC) consisted of a 45 cm (height) - 50 cm (width) - 40 cm (depth) chair, a 
goniometer, and a digital myometer (MIE, Medical Research Ltd, Leeds, UK). This 
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apparatus has been used to evaluate the effects of an exercise intervention in renal patients 
(Greenwood et al., 2015), and although the validity-reliability characteristics of the digital 
myometer are not available for the renal population, it has been shown to have good intra-
rater and inter-rater reliability in children with cerebral palsy (Thompson et al., 2011), and 
in stroke patients (Bale et al., 2008). 
The participants were asked to sit upright on the chair (90° of trunk flexion), with their 
hands crossed across the chest (Figure 2.2), and with an angle of 80° of knee flexion (full 
knee extension= 0°), which is considered an optimal angle for knee extension torque 
(Aagaard et al., 2000). The terminal part of the dynamometer was strapped to the ankle 
joint just above the malleoli, and the angle at the knee was measured with a goniometer 
while making sure that the strap applied to the ankle was pre-tensioned before 
commencing the test. The task was demonstrated by the researcher and the participants 
practiced once or twice, before commencing the test following these instructions: “I would 
like you to sit upright on this chair and to cross your hands on the shoulders. I will say: 
3… 2… 1… GO. When I say go, please push as strong and as fast as you can, as if you 
were to extend your leg, until I tell you to stop”. 
The force produced in kg was recorded from three measurements from the dominant limb. 
If participants were unsure about which leg to use, they were asked to think about which 
leg they would use to kick a ball, and to use that limb for the assessment. The average of 
the three following measurements was used for data analysis. After every measurement, 
the dynamometer screen was reset to zero, the knee angle was measured again from the 
pre-tensioning position, and a 60 seconds interval was allowed before the following 
measurement. 
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Figure 2.2. Isometric leg extension MVC: standardised assessment position. 
 
 
2.3.3 Postural balance 
An assessment of postural static balance was performed by means of a Bertec® BP5050 
(Bertec Corporation, Columbus, Ohio, USA) force platform, which has been previously 
used to assess fall-risk in elderly people living in the community (Bigelow et al., 2011). 
The assessment protocol consisted of standing as still as possible for 30 seconds on the 
force platform under two different conditions: eyes open and eyes closed. The platform 
was placed distant from walls or other objects that could be used as a support during the 
measurement. For safety reasons, the researcher was standing close to the participant 
during the assessment in case he/she suffered a sudden loss of balance. In addition, a focal 
point for participants to stare at during the assessment was placed 3 metres in front of the 
platform. Participants were instructed how to position their feet on the platform before 
starting the measurements. A 30° angle with heels slightly apart (3-5cm) orientation 
(Figure 2.3) was chosen as this was judged to be more suitable than a position with the 
longitudinal axes of the feet parallel to each other for participants with poor physical 
function and balance (Scoppa et al., 2017). The 30° angle was marked on the platform by 
using adhesive tape to guide the participants on the required position of their feet. An 
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additional piece of tape was placed on the platform to mark the position on which the heels 
should be aligned. The correct feet positioning was demonstrated prior to commencing 
the assessment by the researcher and the following verbal instructions were given: “This 
assessment consists of standing upright on the force platform as still as possible, with your 
arms relaxed along the body sides. Please stare at the focal point that is located just in 
front of you for the whole duration of the assessment. Make sure you place your feet on 
the lines marked by the adhesive stripes, and that you align your heels on the posterior 
line. The measurement will start when I say “START” so please try to stay as still as 
possible from then onwards. I will prompt you when you can move again”. The balance 
assessment was performed in eyes open (EO) and eyes closed (EC) conditions: every 
testing condition was performed twice, and data were recorded for 30 seconds, which is 
recommended in order to achieve acceptable test retest reliability (Le Clair et al., 1996). 
Centre of pressure (COP) data for the anterior-posterior (AP) and medial-lateral (ML) 
sway directions were collected at 1000Hz. The following COP measures were 
subsequently computed from the raw COP data (XY components) using custom written 
MATLAB (Mathworks®, USA) scripts over the 30s period: range of COP displacement 
along the ML (RangeX) and AP (RangeY) axis, root mean square displacement along the 
ML (RMSX) and AP (RMSY) axis, total sway path (SP), mean absolute velocity 
(AbsVel), mean velocity along the ML (VelX), and AP (VelY) axis, and the 95% 
confidence ellipse area (Area95). Finally, the average of the two measurements was 
calculated for every variable and was taken for data analysis purposes. 
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Figure 2.3. Postural balance: apparatus and standardised assessment position. 
 
 
2.3.4 Gait speed  
A simple gait speed test was performed on a flat, anti-slip surfaced hospital corridor. The 
test consisted of the 15 feet walk test used by Fried’s and colleague as a measure of the 
frailty phenotype (Fried’s et al., 2001). The extremities of the 15 feet track (4.57 meters) 
were marked with adhesive tape, and a stopwatch was used to record the time. The 
participants were encouraged to walk with a self-selected speed, reflecting their normal 
walking pace habits. The following instructions were given: “I will say 3… 2… 1… GO. 
When I say go, please walk from this mark on the floor up to the second mark on the floor 
in front of you”. Participants were allowed to use their normal assistive walking devices 
(e.g. cane) if necessary. Participants performed two trials interspersed by a 30 seconds 
interval, and the two measurements were averaged for data analysis purposes. 
 
 
2.3.5 Timed Up and Go 
A Timed Up and Go (TUG) test was performed in a corridor of the hospitals designated 
for the physical function tests. This test was executed along a 3 meters track: a line on the 
floor was marked with coloured adhesive tape 3 meters in front of the chair (45 cm (height) 
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- 50 cm (width) - 40 cm (depth)) that was used for the assessment (Figure 2.4). A digital 
stopwatch was used to record the time. 
The TUG assesses dynamic balance by asking the individual to stand up from a chair, 
walk 3m, turn, walk back to the chair and sit down again, as quickly as possible (Podsiadlo 
et al., 1991). TUG performance is a sensitive measure for identifying individuals at 
increased risk of falls, particularly a time ≥ 14 seconds has been shown to discriminate 
fallers versus non fallers in older but otherwise healthy adults (Shumway-Cook et al., 
2000), and it can be improved with physical exercise in patients undergoing maintenance 
HD therapy (Greenwood et al., 2012). 
Before commencing the test, the researcher demonstrated the TUG procedure to the 
participants, and inspected the floor to make sure it was free from slip or trip hazards. The 
following verbal instructions were provided: “Please sit upright with your back against 
the seatback, rest your hands on your knees, and make sure both your feet are touching 
the ground. I will say: 3… 2… 1… GO. When I say go, please stand up from the chair, 
walk until the mark on the floor, turn back making sure you walk around this mark, and 
go and sit back on the chair. Walk at walking speed you find comfortable but do not run. 
Timing will start when I say GO, and will finish when you sit down on the chair again.” 
Participants were allowed to use their normal walking aids if required, and the researcher 
took a note if this was the case (Schumway-Cook et al., 2000). The test was executed 
twice as performing two trials of the TUG has been suggested to increase the reliability of 
this test in chronic renal failure patients (Mesquita et al., 2013). Up to 60 seconds rest 
between the two measurements was allowed to reduce any possible fatigue effects. The 
average of the two trials was taken for the data analysis. 
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Figure 2.4. TUG: standardised procedure. 
 
 
2.3.6 Chair sit to stand five test 
A Chair sit to stand five (CSTS-5) test was performed using a standard 45 cm (height) - 
50 cm (width) - 40 cm (depth) chair, and a digital stopwatch. 
The CSTS-5 reflects lower limb muscle power generation capacity by measuring the time 
it takes for an individual to rise from a chair repeatedly 5 times, as quickly as possible 
(Guralnik et al., 1994). Low performance in this functional test (time to rise from the chair 
≥16.7 seconds) has recently been associated with an increased risk of injurious falls in 
older adults (Ward et al., 2015). In addition, this physical function test has been shown to 
have good concurrent validity and to discriminate people with and without balance deficits 
(Whitney et al., 2005). The researcher explained and demonstrated the task to the 
participant beforehand. The chair was placed against a wall to prevent any movement 
during the assessment (Figure 2.5). The following verbal instructions were given prior to 
starting the assessment: “Please sit upright in the middle of the chair, keeping your hands 
crossed at shoulder level, and make sure both of your feet are touching the ground. I will 
say: 3… 2… 1… GO. When I say go, you will rise from the chair for 5 consecutive times 
as quickly as possible. It is very important that you achieve a full extension of your knees 
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and trunk and that you don’t lift your feet from the ground when sitting back on the chair. 
Also, don’t sit completely back on the chair when you sit down, but rather you should try 
to stand up again as soon as your buttocks touch the chair. Timing will start when I say 
GO, and will finish when you sit down on the chair after the fifth repetition”. Participants’ 
understanding of the procedure was checked by asking them to repeat the instructions 
given to them. Participants unable to rise from the chair independently were excluded 
from this assessment, or alternatively they executed the test by keeping the hands on their 
knees during the measurement. The researcher took a note of whether the person could 
perform the assessment as per instructions given, or whether he/she was unable/required 
assistance. One recording rounded to the hundredth of a second was taken for the data 
analysis. 
 
Figure 2.5. CSTS-5: standardised procedure. 
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2.3.7 SF-36™ Health Survey 
The UK Standard English (Version 2) SF-36™ Health Survey was completed by all 
participants as a measure of perceived quality of life (Appendix VI).  
The SF-36™ Health Survey is a multi-item scale measuring 8 health concepts: physical 
functioning, role limitations due to physical health problems, bodily pain, general health, 
vitality, social functioning, role limitations due to emotional problems, and mental health 
(Ware et al., 1993). The SF-36™ questionnaire has been used extensively to assess health-
related quality of life in patients undergoing HD therapy, including the dialysis outcomes 
and practice patterns study (DOPPS) (Mapes et al., 2004), and is a strong predictor of 
hospitalization and mortality (Lowrie et al., 2003). The questionnaire has good 
psychometric properties with high reliability and construct validity (Korevaar et al., 2002). 
Participants completed this self-administered questionnaire at the start of their assessment 
visit. Instructions for the completion of the SF-36™ were available on the front pages of 
the questionnaire, and the researcher also rendered himself available for further 
clarifications in case of any possible doubts. The questionnaire was administered by the 
researcher if the participant had a significant visual impairment. The raw scores from the 
completed questionnaires were entered onto an SPSS spreadsheet and an appropriate 
SPSS syntax, depending on sex (males syntax or females syntax) was used to transform 
the raw scores in aggregated scores (0-100 range) for the 8 health domains. The physical 
component summary score (PCS) and mental component summary score (MCS) were also 
computed by means of SPPS syntaxes. 
 
2.4 Assessment of physical activity levels 
2.4.1 ActivPal™ monitor 
The ActivPal™ physical activity monitor (PAL technologies Ltd, Glasgow) was used to 
objectively record habitual physical activity (PA). 
This device is a uniaxial accelerometer that measures time spent standing, sitting/lying 
and, stepping and the pace of stepping. It also records the number of steps and the number 
of sit-to-stand and stand-to-sit transitions. This information is captured by a piezoresistive 
accelerometer that detects posture changes and movement from inclination of the thigh. 
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The ActivPal™ monitor software utilizes algorithms to convert the information coming 
from the inclination of the thigh in the outcomes of interest. The monitor has been shown 
to be valid and reliable in discerning sedentary and upright activities, and in recognizing 
body transitions from sitting and lying positions to the upright standing position 
(Taraldsen et al., 2011). In addition, the ActivPal™ has been shown to have good 
concurrent validity and reliability in assessing the number of steps taken in healthy adults 
(Ryan et al., 2006) and in inpatients admitted to a rehabilitation unit (Treacy et al., 2017). 
More recently, it has been suggested that this PA monitor is a valid tool in discerning 
activity intensity levels in healthy adults (Lyden et al., 2017). Data are captured at a 
frequency of 10 Hz, and the monitor is able to record data for more than 8 days 
continuously. 
 
2.4.1.1 Wear protocol 
Participants were given standardised written instructions on how to use and position the 
ActivPal™ monitor correctly by means of a leaflet (Appendix VII), and the researcher 
also explained all the procedures on the assessment day, when the monitor was attached 
to their thigh. The device was worn on the anterior aspect of the thigh as per manual 
instructions: on the front mid-line of the thigh a third of the way between the hip and knee 
(Figure 2.6). PALstickies™ and hypoallergenic adhesive tape were used to keep the 
monitor in place during data acquisition. 
Participants were asked to remove the monitor prior to showering or taking a bath, and 
were also allowed to take it off at night time for their own comfort if they wished. In 
addition, they were provided with a physical activity diary to be filled out daily: they were 
instructed to take a note of the exact times the monitor was worn throughout the day, and 
also the time they removed it for any reasons. Participants were required to wear the 
ActivPal™ monitor for at least five consecutive days, starting from the day of the 
assessment. The monitor was collected from the participant, at the end of the recording 
period, during a routine HD session at Monklands Hospital, or at Victoria Hospital. The 
data were downloaded onto a PC and processed using the ActivPal™ software (Version 
6.4.1). 
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2.4.1.2 Data cleaning and outcomes 
The first day of ActivPal™ monitor wearing was discarded from the data analysis, because 
it was considered a practice day. The minimum wearing time required for the data to be 
included in the final analysis was at least three days consisting of two non HD days and 
one HD day, with at least 8 hours of daily wearing (Prescott et al., 2014). Participants not 
achieving this duration were removed from the data analysis. The ActivPal™ software 
was used to double check the minimum required wearing time, as well as to convert the 
raw accelerometry data to the outcomes of interest, namely time spent standing, time spent 
stepping, number of sit to stands, and number of steps taken. An Excel spreadsheet 
summarising the daily and weekly breakdown of the various outcome measures was 
generated from the ActivPal™ software, and the 24 hours averages of each variable were 
calculated and used for data analysis. 
 
Figure 2.6. ActivPal monitor: standardised positioning. 
 
 
2.4.2 International physical activity questionnaire short format 
Participants completed the International physical activity questionnaire (IPAQ) short 
format during the assessment day as a subjective measure of PA (Appendix VIII). 
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The Short IPAQ is a self-administered 4-item questionnaire on the participants’ physical 
activity levels during the last 7 days, and has been demonstrated to have good validity and 
reliability (Craig et al., 2003). Three of these items assess the frequency and duration of 
the following types of activities: walking, moderate-intensity activities, and vigorous-
intensity activities. The fourth item assesses sedentary behaviour by asking how many 
hours the person spends sitting on a daily basis. The raw scores of frequency and duration, 
expressed in days and minutes respectively, were entered onto an Excel spread sheet and 
they were transformed to MET-minutes/week and Kcal/week by using a physical activity 
compendium (Ainsworth et al., 2000) as described in the guidelines for data processing 
and analysis of the IPAQ. The following formulae were used 
 
• Walking MET-minutes/week = 3.3* walking minutes * walking days; 
• Moderate MET-minutes/week = 4.0* moderate-intensity activity minutes * 
moderate-intensity activity days; 
• Vigorous MET-minutes/week = 8.0* vigorous-intensity activity minutes * 
vigorous-intensity activity days; 
• Total PA MET-minutes/week = sum of walking + moderate + vigorous MET-
minutes/week scores. 
• Walking Kcal/week = (3.3* walking minutes * walking days)*(body mass/60); 
• Moderate Kcal/week = (4.0* moderate-intensity activity minutes * moderate-
intensity activity days)*(body mass/60); 
• Vigorous Kcal/week = (8.0* vigorous-intensity activity minutes * vigorous-
intensity activity days)*(body mass/60); 
• Total Kcal/week = sum of walking + moderate + vigorous Kcal/week scores. 
 
A categorical score of PA was also obtained from the IPAQ scoring guidelines. 
Participants were classified as high, moderate, or low self-reported levels of PA following 
the guidelines’ recommendations: 
 
• High PA = participants meeting either of these 2 criteria: 
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a) At least 3 days of vigorous-intensity activity achieving a Total PA of at 
least 1500 MET-minutes/week; 
b) Total PA of at least 3000 MET-minutes/week deriving from 7 or more days 
of any combination of walking, moderate-intensity, or vigorous-intensity 
activities; 
• Moderate PA = participants meeting any of the following criteria: 
a) At least 20 minutes per day of vigorous-intensity activity on 3 or more 
days; 
b) At least 30 minutes per day of walking and/or moderate-intensity activity 
on 5 or more days; 
c) Total PA of at least 600 MET-minutes/week deriving from 5 or more days 
of any combination of walking, moderate-intensity, or vigorous-intensity 
activities; 
• Low PA = participants not meeting any of the criteria described above.  
  
The IPAQ has been previously used in patients undergoing HD (range of age: 18-86 years 
old), and its scores have been positively associated with physical function, as assessed by 
the SF-36 Health Survey, in this clinical population (Li et al., 2010). 
 
2.5 Assessment of baroreflex and haemodynamic function   
2.5.1 Head up tilt test: introduction 
In 1986, the head up tilt (HUT) test was first reported to represent a useful procedure to 
investigate episodes of syncope (Kenny et al., 1986), namely an event characterised by 
transient loss of consciousness as a result of sudden cerebral hypoperfusion arising 
(typically) from low blood pressure (BP) (Brignole et al., 2004). In that study, the authors 
described an abnormal response of systolic blood pressure and heart rate in patients with 
history of unexplained syncope after 60 minutes of HUT at 40°. Ten years later, the HUT 
test was appointed as the gold standard for the clinical evaluation of patients presenting 
with syncope-related symptoms by an expert consensus document (Benditt et al., 1996), 
and the combined use of HUT and non-invasive measurements of BP, heart rate (HR), and 
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other haemodynamic parameters have become routinely integrated in clinical practice for 
the diagnosis of syncopal events.  
Given the relatively recent implementation of the HUT test in clinical practice, several 
approaches, with regard to the assessment protocol, are available and the most common 
strategies relating to the testing procedure aspects are synthesized below: 
 
Tilt angle 
The first work of Kenny et al., (1986) proposed a tilting angle of 40° over 60 minutes of 
HUT. Since this first publication, the effect of various protocols adopting different tilt 
angles on the haemodynamic responses and onset of syncope have been described in the 
literature: a range of tilt angles between 20° and 90° has been investigated (Khurana et al., 
1996). A study by Fitzpatrick et al., (1991) showed that using a tilt angle of 45° resulted 
in a significant lower rate of positive responses (syncopal events) compared to a 60° angle, 
and lower specificity for tilt angles ˂60° was also reported by Kapoor et al., (1994). At 
the same time, tilt angles between 60° and 90° don’t seem to differ substantially in terms 
of the predictive ability of the test (Khurana et al., 1996), therefore 60° became the 
threshold tilt angle for the diagnosis of syncopal events. Tilt angles between 60°-80° are 
widely accepted in clinical practice, whereas the 60°-70° range is the most commonly 
used (Benditt et al., 1996).  
Another common recommendation, regarding the tilt angle, is that the table should be 
designed to achieve the desired angle as smoothly as possible and in a relatively rapid 
time (10-15 seconds). The tilt-down should also be achieved as rapidly as possible in case 
of positive response to the HUT test, or if any signs lead the medical team to wish 
interrupting the assessment (Benditt et al., 1996). 
 
Tilt duration 
Another crucial aspect of the HUT test, even more important than the tilt angle, is the 
duration of the tilting phase. Research protocols with tilting durations between 2 and 60 
minutes have been described in the literature (Khurana et al., 1996). 
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Despite the great heterogeneity, the recommendation for the tilt duration is of at least 30-
45 minutes, if the purpose of the HUT test is that of diagnosing syncope (Benditt et al., 
1996), as the onset of syncope at 60° occurs on average after 22-24 minutes of HUT 
(Fitzpatrick et al., 1991; Kapoor et al., 1994). The duration of the tilting phase also 
depends on whether or not vasodilator drugs are administered during the assessment: a 
shortened protocol consisting of 20 minutes of HUT at 60° followed by sublingual 
administration of nitroglycerin was shown to have similar specificity to a more time 
demanding HUT protocol (Del Rosso et al., 2000). 
 
Drug challenge 
Although the HUT test was first introduced as a drug-free assessment (Kenny et al., 1986), 
some research explored the effects of combing drugs that could potentially facilitate the 
occurrence of syncopal events with HUT, in order to improve the predictive ability of this 
kind of assessment. Particularly, the infusion of isoproterenol (Almquist et al., 1989) and 
sublingual administration of nitroglycerin (Raviele et al., 1995) were shown to be useful 
tools in diagnosing neurally mediated syncope, and their use became widely popular in 
clinical practice since then. 
 
2.5.1.1 Testing protocol: premise 
For the purposes of this PhD project, a HUT test with relatively short tilting duration (five 
minutes) was employed. This choice was based on the current guidelines on the 
management of syncope which define orthostatic hypotension as a fall in systolic BP 
(SBP) ≥20mmHg and diastolic BP (DBP) ≥10mmHg within the first 3 minutes of standing 
up from a supine position or during HUT at 60° (Brignole et al., 2004).  
In healthy individuals, the transition from supine position to upright standing results into 
a gravitational shift and pooling of 300-800 ml of blood to the lower extremities and the 
venous capacitance system within the first 10 seconds (Freeman et al., 2011). This 
mechanical gravitational pooling of blood volume in the lower extremities triggers a series 
of integrated physiological events and adjustments that all ultimately aim to maintain 
adequate pressure in the cardiovascular system as indicated by mean arterial pressure 
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(MAP). In brief, gravitational pooling of blood volume results in a decreased venous 
return to the heart, and subsequent reduced cardiac filling, which leads to decreased stroke 
volume and cardiac output and thus drop in MAP. The autonomic nervous system prevents 
hypotension by increasing the sympathetic outflow which stabilizes BP through increased 
vascular tone, cardiac contractility and HR. The component of the autonomic nervous 
system that is mainly responsible for these short-term inotropic (vasoconstriction) and 
chronotropic (HR increase) responses is the arterial baroreceptor reflex, while other 
mechanisms like the renin-angiotensin-aldosterone system are involved during prolonged 
standing (Freeman et al., 2011). 
Therefore, the purpose of the HUT protocol used in this PhD research project was to 
identify the possible inadequate short term reflex mechanisms that could lead to 
orthostatic hypotension and associated symptoms such as dizziness and possibly falls 
(Roberts et al., 2003), by assessing the short-term regulation of BP and other 
haemodynamic responses, including the baroreceptor reflex activity, rather than 
diagnosing syncope which would require a longer tilting duration, a procedure that could 
be less well tolerated by patients on HD (Benditt et al., 1996). 
 
2.5.1.2 Testing protocol: HUT-60° 
Participants underwent a 60° HUT test (HUT-60°) to assess the short-lived baroreceptor 
reflex and haemodynamic responses to a passive orthostatic challenge. 
The Task Force® Monitor 3040i (CNS systems, Graz, Austria) was used to record the BP 
and HR responses continuously throughout the assessment. This device allows the 
simultaneous measurement of HR, BP, and other haemodynamic variables (total 
peripheral resistance, stroke volume, cardiac output, heart rate and blood pressure 
variability) by means of 6-lead electrocardiography (ECG), continuous photoelectric 
plethysmography, and impedance cardiography (ICG). Oscillometric blood pressure 
(oscBP) was also measured with an electronically controlled sphygmomanometer. The 
Task Force® Monitor has been shown to provide valid and reliable haemodynamic data 
(Fortin et al., 2001): the ICG system has been shown to be at least as reliable as the BioZ-
PC (CardioDynamics, San Diego, CA, USA), while the continuous BP recordings are 
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comparable to the Finapres®, which are two widely used devices for the assessment of 
haemodynamic variables. In particular, as opposed to the Finapres® device, the Task 
Force® Monitor has the advantage of not requiring interruptions of the continuous BP 
measurement for the readjustment of the set point, because the set point is continuously 
readjusted throughout the assessment (Fortin et al., 2001).    
Before starting the HUT-60° test, participants were connected to the Task Force® Monitor 
as per manual instructions (Figure 2.7): they were donned with four ECG electrodes, three 
ICG electrodes, and a neutral electrode on the right foot. The respective skin parts were 
cleaned with some alcohol wipes before the electrodes were donned, and the researcher 
also made sure that the skin was absolutely dry before attaching all electrodes. The two 
superior ECG electrodes were placed in correspondence of the acromion processes on the 
shoulders, while the two inferior electrodes were placed on the abdomen, just above the 
umbilical region. The ICG electrodes consisted of 3 adhesive stripes to be placed on the 
patient’s neck and thorax. More precisely, the superior ICG electrode was positioned in 
the area between the patient’s neck and the hairline, while the remainder electrodes were 
positioned as parallel as possible at the lateral sides of the thorax at the xiphoid process 
level. The neutral electrode was attached on the right lower leg of the participants, just 
above the lateral malleolus. 
The equipment for the measurement of continuous blood pressure consisted of a flying-V 
finger cuff (available in different sizes, e.g. small/medium/large), the Task Force® BP 
monitor, a removable Velcro fastener to fix the monitor to the forearm, and a compressed 
air hose. A flying-V finger cuff of appropriate size was fitted to the patient’s index and 
middle fingers, as proximally as possible to ensure that the sensors weren’t positioned on 
the fingers’ knuckles. The finger cuff was subsequently connected to the continuous BP 
monitor, which was secured to the patient’s forearm by means of the Velcro fastener. The 
continuous BP monitor was kept at heart level throughout the measurement.  
The Task Force® sphygmomanometer was positioned on the patient’s arm that was free 
from arteriovenous fistulas. Three cuff sizes were available, depending on the patient’s 
arm circumference (small: arm circumference of 19-29cm, standard: arm circumference 
of 29-40cm, large: arm circumference over 40cm). The cuff was fit tightly to the upper 
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arm making sure that the air outlet was directly above the brachial artery, and that the 
lower edge of the cuff was approximately 2.5 cm above the elbow.  
 
Figure 2.7. Task Force® Monitor: set up. 
 
  
 
The HUT-60o test commenced with the participant lying in the supine position (Figure 
2.8) on an electronically controlled tilt-table, with feet rested against a foot platform. Two 
Velcro straps placed over the participant’s knees and hips secured the patients in position 
and prevented falling over during the tilt up manoeuvre. The participant was instructed 
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beforehand to lie quietly for 15 minutes, limiting any movement and avoiding speaking 
and sleeping during the measurement. The first 10 minutes were used to allow the 
calibration of the Task Force® Monitor and to ensure the haemodynamic equilibrium of 
the patient (Brignole et al., 2004). All variables of interest were then recorded for five 
minutes in the supine position. The electronically controlled table was subsequently tilted 
head-up by 60 (HUT-60°) with a smooth transition of approximately 4°/s (Benditt et al., 
1996) for a period of five minutes during which time the patients’ haemodynamic 
responses were continuously recorded (Figure 2.9). The HUT-60° protocol, as submitted 
to the REC, is further synthesised in Appendix IX. 
 
Figure 2.8. HUT-60° test: supine position. 
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Figure 2.9. HUT-60° test: head-up tilt position. 
 
 
2.5.1.3 Standardisation of pre-test conditions 
All patients performed the HUT-60° on a non-dialysis day to minimise the acute effects 
of either fluid overload or fluid removal on data collected. The HUT-60° was performed 
in a quiet room with dim light and comfortable temperature between 18-22Co. 
On the assessment day, participants were advised to arrive in a rested state: they were 
instructed to have a light meal before testing and to be fasted for at least 2 hours. In 
addition, they were instructed not to smoke or consume caffeine/alcohol on the assessment 
day, and to avoid unaccustomed physical exercise on the 24 hours preceding testing. 
Medical staff and resuscitation equipment were immediately available in case of any 
possible adverse events. The assessment was conducted without the administration of any 
additional drugs but with patients being on their normal daily medication. 
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2.5.1.4 Test termination criteria 
The HUT-60° was terminated upon completing the testing protocol described above or, 
alternatively, if any of the following events occurred during the assessment: 
1. Induction of syncope or pre-syncope symptoms associated with marked 
hypotension or bradycardia or both (dizziness, palpitations, blurred vision, nausea, 
lightheadedness, headache); 
2. Patient distress or discomfort; 
3. Patient request; 
4. Acute malignant arrhythmia (atrial fibrillation, supraventricular tachycardia, 
HR<40bpm); 
5. SBP falling >80mmHg or falling rapidly; 
6. Substantial reductions in BP (SBP>20 mmHg and/or DBP>10mmHg) compared 
to their baseline values without compensatory changes in other haemodynamic 
variables (HR, peripheral vascular resistance, stroke volume, cardiac output). This 
is defined as orthostatic syncope, where there are no compensatory adjustments 
due to failure of sympathetic tone to increase;  
7. HR rising to ≥ 170/min; 
8. Chest pain; 
9. Asystole; 
10. Any other adverse/unexpected event. 
 
2.5.2 Baroreceptor reflex function indices 
The baroreceptor reflex function, or baroreflex function, was assessed by means of the 
sequence method, a validated method which has been described to provide equivalent 
prognostic information to the invasive methods used to measure the baroreflex (Pinna et 
al., 2000). 
The Task Force® monitor uses this method to assess the spontaneous activity of 
baroreceptors through the continuous beat-to-beat measurement of HR and BP. This 
method assesses the baroreflex function by considering the relationship between 
variations in SBP and simultaneous changes in R-R interval (RRI) (Parati et al., 2003). 
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This relationship provides information as to how many times a change in SBP is coupled 
with a concomitant change in RRI (n° of baroreceptor events), the steepness of the 
regression line between changes in mmHg of blood pressure and changes in milliseconds 
of RRI (baroreflex sensitivity), and how often the baroreflex produces a change in HR in 
response to a perturbation in BP (baroreceptor effectiveness index) (Di Rienzo et al., 
2001). 
 
2.5.2.1 Baroreceptor events: definition  
A baroreceptor sequence or baroreceptor event is defined as the simultaneous coupling of 
a BP ramp with an increase or decrease of HR for at least 3 consecutive cardiac cycles 
(Kardos et al., 2001). In accordance with previous research, BP ramps were defined as 
either an increase or decrease in SBP of at least 1 mmHg for 3 consecutive heart beats: a 
“down-ramp” was defined as a decrease of at least 1 mmHg for three consecutive beats, 
while an “up-ramp” was defined as an increase of at least 1 mmHg for three consecutive 
beats. “Total-ramps” were defined as the sum of all down-ramps and up-ramps (Kardos 
et al., 2001). A baroreceptor event was then classified as the simultaneous coupling of a 
BP ramp with either an increase or decrease of the R-R interval (RRI) of at least 4 
milliseconds (ms) (Pinna et al., 2015). More precisely, a “down-event” was classified as 
a concomitant decrease of continuous systolic blood pressure (contSBP) and RRI of at 
least 1 mmHg and 4ms respectively (-contSBP/-RRI sequence), while an “up-event” was 
classified as a concomitant increase of contSBP and RRI of at least 1 mmHg and 4ms 
respectively (+contSBP/+RRI sequence). “Total-events” were classified as the sum of all 
down-events and up-events. 
 
2.5.2.2 Baroreflex sensitivity 
The Task Force® Monitor software uses the sequence method to assess the sensitivity of 
the baroreflex (Parati et al., 1988). Baroreflex sensitivity (BRS) describes the steepness of 
the regression line between contSBP change in mmHg and the RRI change in ms, and it 
was automatically computed by the Task Force® Monitor software which averages the 
slopes of these regression lines (La Rovere et al., 2008). 
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2.5.2.3 Baroreceptor effectiveness index 
The baroreceptor effectiveness index (BEI) represents how often the baroreflex produces 
a change in HR in response to a perturbation in BP (Di Rienzo et al., 2001). This index 
was introduced as a complementary measure to the BRS as it conveys additional 
information about the overall function of the baroreflex: while the BRS reflects the 
magnitude of the reflex HR response with respect to the amplitude of the SBP change only 
when the sinus node drive is activated, the BEI quantifies the number of times the 
baroreflex is effective in driving the sinus node (Di Rienzo et al., 2001). 
The BEI was calculated as the ratio of occurred baroreceptor events and detected BP 
ramps expressed as a percentage {[(n° RRI/contSBP sequences)/n° BP ramps] *100}. This 
index can be characterised by three components: the “down-BEI” that represents the ratio 
of occurred down-events and detected down-ramps {[(n° -RRI/-contSBP sequences)/ n° 
down-ramps] *100}, the “up-BEI” that represents the ratio of occurred up-events and 
detected up-ramps {[(n° +RRI/+contSBP sequences)/ n° up-ramps] *100}, and the “total-
BEI” that represents the ratio of occurred total-events and detected total-ramps {[(n° total 
RRI/contSBP sequences)/ n° total-ramps] *100}. 
 
2.5.3 Haemodynamic regulation indices 
In addition to the baroreflex measures, the following haemodynamic variables were 
recorded at rest, in the supine position, and during HUT-60°: RRI, HR, contSBP, 
continuous diastolic BP (contDBP), continuous mean BP (contmBP), stroke volume (SV), 
cardiac output (CO), total peripheral resistance (TPR), and oscillometric BP (OscBP).  
The Task Force® Monitor uses a 6-lead ECG for the measurement of RRI. Data was 
collected at 1000Hz with cut-off frequencies of 0.08Hz and 150Hz. HR was derived from 
the ECG with the algorithm: (60*1000)/RRI (Pan et Tompkins., 1985; Li et al., 1995). 
SV, CO, and TPR were measured non-invasively by means of the Task Force® Monitor’s 
ICG four-wire module, which operates at a measuring current of approximately 400μA at 
40Hz (Fortin et al., 2006). ContSBP, contDBP, contmBP were measured by means of the 
beat-to-beat finger BP recordings through application of the vascular unloading technique 
(Parati et al., 2003). The finger BP recordings were self-calibrated against the brachial 
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artery BP, which was measured by means of the Task Force® Monitor’s oscillometric BP 
cuff. This cuff was used to record OscBP at rest, during the supine position, and during 
HUT-60°.   
 
2.6 Assessment of falls prevalence and incidence  
2.6.1 Retrospective history of falls 
The participants’ history of falls, relative to the previous 12 months, was documented 
during the assessment visit by means of a standardised falls survey instrument (Appendix 
X). In this questionnaire, participants were asked to report any falls experienced in the 
previous 12 months. A fall was operationally defined as an unexpected event in which the 
participant comes to rest on the ground, floor, or lower level (Lamb et al., 2005). 
Participants were classified as having a positive history of falls if they reported at least 
one fall in the previous 12 months. The critical incident reporting of falls in the Renal Unit 
at Monklands Hospital was also used to double check whether or not the study participants 
had experienced any falls in the Renal Unit. 
 
2.6.2 Prospective collection of falls related information 
After completing the assessment visit, every participant was followed up for 12 months, 
by means of monthly face to face contacts to ensure as accurate documentation as possible 
of any falls and circumstances. The PhD researcher and a research nurse met with all the 
patients taking part in the study from Monklands Renal Unit and Victoria hospital Renal 
Unit once a month, during one of their usual HD treatment, and used a standardised falls 
diary (Appendix XI) to document the number of falls experienced, and the circumstances 
associated with these falls (e.g. timing of the fall, location, kind of activity resulting in the 
fall, precipitating factors, whether or not injuries were sustained, whether or not any action 
was taken). The prospective collection of falls-related information was used to classify 
the study participants as “fallers” and “non-fallers” to minimise the recollection bias that 
may be associated with self-reported information (Cummings et al., 1988; Ganz et al., 
2005; Hauer et al., 2006). Participants were classified as fallers if they reported at least 
one fall over the course of the 12-month follow-up, or as non-fallers if they did not 
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experience any falls. Study termination criteria included reaching the end of the 
observational period (12 months after the first assessment visit), participants receiving 
kidney transplantation, or death. 
It should also be acknowledged that a copy of the falls diary (Appendix XI) was provided 
to all research participants, at the time of baseline assessment, to encourage reporting of 
the falls experienced during follow-up. This approach has been particularly recommended 
by the Prevention of Falls Network Europe and Outcomes Consensus Group (Lamb et al., 
2005) in order to minimise the recall bias. Participants were instructed to complete the 
falls diaries and to return them to the PhD researcher on a monthly basis (during follow-
up visit). However, due to the initial very poor compliance of participants, the research 
team made the decision to discard this additional source of information and to rely only 
on the prospective information recorded by the PhD researcher during the monthly follow-
ups. It is possible that a more integrated network of research nurses could have reduced 
the objective logistic issues encountered in collecting the falls diaries from study 
participants (Roberts et al., 2007). 
 
2.6.3 Tinetti falls efficacy scale questionnaire 
The Tinetti falls efficacy scale (FES) questionnaire was completed by all participants as a 
measure of fear of falling (Appendix XII). This questionnaire is a 10-item rating scale to 
assess an individual's perceived level of confidence in undertaking a range of activities of 
daily living without fear of falling (Tinetti et al., 1990). This scale is a widely used tool 
with good validity and reliability for the assessment of fear of falling (Tinetti et al., 1990; 
Huang et al., 2009). The researcher administered this questionnaire to participants during 
the assessment visit: they were asked to rate their fear of falling-related confidence when 
performing 10 common activities of daily living from 1 to 10, with 1 being extremely 
confident, and 10 being not confident at all. The final score was obtained by summing the 
10 ratings and was used for data analysis purposes. Low falls-related self-efficacy, 
assessed by means of this questionnaire has been associated with impairments in 
performing activities of daily living, and with an increased risk of future falls in elderly 
people (Cumming et al., 2000). 
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2.7 Assessment visit 
All frailty, physical and cardiovascular data were collected during a single assessment 
visit lasting about a couple of hours. Participants on a Monday-Wednesday-Friday dialysis 
schedule were assessed on a Tuesday, while participants on a Tuesday-Thursday-Saturday 
dialysis schedule were assessed on a Wednesday. The assessment visit took place in a 
designated room, equipped for the use of the Task Force® Monitor, in the Renal Units at 
Monklands and Victoria Hospitals. Resuscitation equipment was readily available, and 
nursing and medical staff support was also immediately available in case of emergency. 
On the day preceding the assessment, participants were provided with a leaflet reminding 
them to fast for at least two hours before the visit, as well as to refrain from consuming 
caffeine/alcohol, and to avoid unaccustomed physical exercise (Appendix XIII). 
On the assessment day participants were explained all the procedures involved in the study 
and were given the chance to ask any information about the various measurements. Before 
commencing the cardiovascular and physical assessments, the researcher obtained the 
retrospective history of falls information from the participant and administered the Tinetti 
FES questionnaire. Participants then completed the SF-36 Health Survey, and the Short 
IPAQ questionnaires. Following the completion of all questionnaires, participants 
underwent the baroreflex and haemodynamic function assessment by means of HUT-60°: 
they were asked to undress their top half and they were donned with all the Task Force® 
Monitor electrodes as per manual instructions. After completing the testing protocol 
(described in section 2.5.1.2), they were returned to the supine position for an additional 
five minutes, during which time all the cardiovascular parameters (e.g. HR, BP) were 
monitored until they returned to the pre-test values. At this point the test was terminated 
and the participant was disconnected from the Task Force® Monitor. 
The researcher subsequently instructed the participant on how to perform the handgrip 
test, and the three measurements with the dominant hand were taken. Following this test, 
participants were asked to remove their shoes for the balance assessments. It was then 
explained how to position the feet on the force platform and all verbal instructions relating 
to the testing protocol were given (described in section 2.3.3). Two measurements for each 
testing condition (EO and EC) were taken. After the balance assessment, participants 
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performed the isometric leg extension MVC test by means of the digital myometer 
(described in section 2.3.2). At this point, participants were asked to put their shoes back 
on and the testing session continued in a corridor purposively designated for the physical 
function tests, which was located right next to the assessment room. The gait speed, TUG 
and CSTS-5 tests were performed in this corridor. Following the physical functioning 
tests, the researcher explained the ActivPal™ wearing protocol and provided the 
participant with a leaflet reminding the main instructions on how to use and position the 
accelerometer. The monitor was then set up and given to the participant. 
At the end of the assessment session, the researcher thanked the participant for his/her 
time and for contributing to the research project. 
 
2.8 Biochemistry 
Participants’ clinical characteristics were extracted from the Scottish Electronic Renal 
Patient Record (SERPR). The following blood values were extracted from the SERPR at 
Monklands and Victoria hospitals: high-density lipoprotein (HDL), low-density 
lipoprotein (LDL), triglycerides, haemoglobin (Hb), C-reactive protein (CRP), 
bicarbonate, sodium (Na), potassium (K), chloride (Cl), urea, phosphate, parathyroid 
hormone (PTH), albumin, adjusted calcium, urea reduction ratio (URR), creatinine, 
haematocrit. These values refer to the monthly bloods that are routinely collected from the 
HD patients at Monklands and Victoria hospitals: the values closest to the date of 
assessment (within 1-month period) of the different participants were taken for the data 
analysis. 
 
2.9 Medications 
The medications prescribed to the study participants, up until the date of assessment, were 
recorded from the SERPR at Monklands and Victoria hospitals. The use of 
antihypertensive and antidepressant medications was recorded as these classes of drugs 
might be associated with falls in HD patients (Desmet et al., 2005). In addition, before 
coming for the assessment, participants were provided with a leaflet (Appendix XII) 
reminding them to bring the most up to date list of medications with them on the day of 
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assessment. This list was double-checked by the researcher to highlight any possible 
discrepancies between the list of prescribed medications appearing on SERPR and the 
medications reported by the participant. 
 
2.10 Comorbidities 
The Charlson comorbidity index (CCI) (Charlson et al., 1987) was used to score the 
comorbidity levels of the study participants. The CCI is used to predict the 1-year 
mortality of an individual based on the presence or co-presence of several disease 
conditions: every disease is attributed a score of “1”, “2”, “3”, or “6” depending on the 
severity of the pathology, as listed below. 
• One point: 
 Myocardial infarction; 
 Congestive heart failure; 
 Peripheral disease; 
 Cerebrovascular disease; 
 Dementia; 
 Chronic pulmonary disease; 
 Connective tissue disease; 
 Peptic ulcer disease; 
 Mild liver disease; 
 Diabetes without end-organ damage; 
• Two points: 
 Hemiplegia; 
 Moderate or severe renal disease; 
 Diabetes with end-organ damage; 
 Tumor without metastasis; 
 Lymphoma; 
 Leukemia; 
• Three points: 
 Moderate or severe liver disease; 
• Six points: 
 Metastatic solid tumor; 
 AIDS 
 
The final CCI score is obtained by summing the points attributed to the disease conditions 
that the patient has. The medical conditions of the study participants were extracted from 
106 
 
SERPR and the CCI was calculated manually by applying the appropriate scores to their 
various disease conditions. 
 
2.11 Anthropometric measurements 
Body mass and height were measured on the day of assessment. Body mass was measured 
by means of the Bertec® BP5050 force platform to the nearest tenth of a kilogram: 
participants were asked to remove their shoes, empty their pockets and wear light clothing 
only during the measurement. They were instructed to stand centrally and as still as 
possible on the force platform, until a clear reading was obtained. 
Height was measured by means of a portable stadiometer to the nearest 0.1 cm (Leicester 
Height Measure, Invicta plastics, Leicester). Participants were instructed to stand upright 
and barefoot on the stadiometer base of support and heels alignment was checked by the 
researcher. The head alignment on the Frankfort horizontal plane was also checked by 
ensuring the upper margin of the external auditory canal was at the same level of the lower 
margin of the eye socket. When the alignment was reached, the measuring rule was 
lowered until it made contact with the participant’s head. The participant was therefore 
asked to step off the stadiometer and the measurement was recorded. The body mass index 
(BMI) was calculated from the body weight and height measurements by using the 
canonical formula: BMI= body mass (kg)/height (m)2. 
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CHAPTER 3: ESTIMATES OF FALLS IN CKD-5 PATIENTS ON HD 
 
Abstract 
Background: CKD-5 patients on HD have commonly been reported to be at high risk of 
falls. While most studies conducted on HD patients have highlighted estimates of falls 
higher than in community-dwelling older adults, the findings on falls prevalence in this 
patient population vary greatly across studies, and some of them seem to suggest that the 
risk of falling in HD patients may not differ substantially from that of the general 
population. Therefore, we conducted a prospective observational study aiming to 
investigate whether CKD-5 patients on HD are at higher risk of falls compared to the 
community dwelling, non-uraemic, population. 
Methods: We prospectively documented falls for 12 months in a convenience sample of 
prevalent HD patients from two research sites in North Lanarkshire and Fife, UK, and we 
calculated the prevalence of patients experiencing at least one fall per year, as well as the 
incidence of falls/person-year. We discussed how these estimates of falls compare to those 
of non-uraemic individuals living in the community. In addition, we critically reported the 
characteristics of the falls experienced by the study participants. 
Results: Seventy-six patients were enrolled in this prospective investigation. Seven 
participants were lost to follow-up due to renal transplantation or death. Overall, 37.7% 
of patients experienced at least one fall during the 12-month follow-up. The total number 
of falls documented was 80, resulting in an incidence of 1.16 falls/person-year. The most 
common location of the falls reported was at home (72.5% of falls). The most common 
activity that led to falls was walking (31.3% of falls), and the most common precipitating 
factor was dizziness (36.3% of falls). The majority of the falls (61.3%) were non-injurious. 
Conclusions: This prospective investigation confirms that CKD-5 patients on HD are at 
higher risk of falls compared to the community-dwelling, non-uraemic, population. The 
characteristics of the falls experienced suggest that low BP spells and orthostatic 
hypotension may be implicated in the aetiology of a high number of falls in CKD-5 
patients on HD. Worryingly, the large majority of falls remains unreported in this patient 
population.  
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3.1 Introduction 
In Lanarkshire, Scotland, 33835 falls were documented in 2006 (General Register Office 
for Scotland (GROS), 2006), and 3150 people aged 60 years and older presented to the 
A&E with fractures as a direct result of a fall. Of these fractures, 724 involved the neck 
of femur, for a cost of £8.8 million to acute services and over £9 million in social care, 
and it was suggested that a quarter to one third of these falls could have been prevented. 
In the last 15 years, several observational studies have investigated falls prevalence, fall-
related injuries, and relative risk factors in CKD-5 patients undergoing HD therapy 
(Roberts et al., 2003; Cook et al., 2005; Desmet et al., 2005; Cook et al., 2006; Roberts et 
al., 2007; Abdel-Rahman et al., 2011; Rossier et al., 2012; McAdams-DeMarco et al., 
2013; Kutner et al., 2014; Polinder-Bos et al., 2014; Farragher et al., 2014; Delgado et al., 
2015; Noto-Kadou-Kaza et al., 2015; Wang et al., 2017; Kono et al., 2018), and a recent 
literature review on falls in CKD patients concluded that HD patients are a patient group 
at high risk of falls (Lopez-Soto et al., 2015). However, the prevalence of patients 
experiencing at least one fall per year has been reported to vary greatly from one study to 
another, as 16.7% (Wang et al., 2017) to 55% (Polinder-Bos et al., 2014) of patients on 
HD have been described to report at least one fall in prospective cohort studies with a 12-
month follow-up.  
The WHO global report on falls prevention in older age (2008) states that about 30% of 
community-dwelling individuals aged 65 years or older incur in at least one fall every 
year, and are classified as a segment of the population at higher risk of falls. Theoretically, 
such a prevalence would constitute the null hypothesis in the context of comparing falls 
estimates between older CKD-5 patients on HD and community dwelling, non-uraemic, 
age-matched individuals, as one would expect to find a prevalence of fallers higher than 
30% in this group of patients in order to classify them at higher risk of falling compared 
to the general population. 
While many studies conducted on HD patients older than 65 years of age reported a higher 
yearly prevalence of fallers, ranging from 38% to 55% (Roberts et al., 2007; Abdel-
Rahman et al., 2011; Farragher et al., 2014; Polinder-Bos et al., 2014), other studies 
(Roberts et al., 2003; Cook et al., 2005; Wang et al., 2017) found a lower prevalence, 
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ranging from 16.7% to 27.7%, which seem to partly suggest that the falls’ risk profile of 
older HD patients may not differ substantially from that of the community-dwelling 
population of older adults. 
Nevertheless, the risk of falling in a given population cannot be characterised exclusively 
in terms of prevalence of fallers, namely the proportion of subjects experiencing at least 
one fall per year. The number of falls experienced by every person is also a potentially 
important factor, as a higher number of falls is more likely to result in adverse outcomes 
such as fractures, hospitalisation, and even death (Abdel-Rahman et al., 2011; Rossier et 
al., 2012). This factor has been considered in several prospective cohort studies conducted 
on HD patients, where the number of falls experienced by the study participants was 
recorded during the follow-up period in order to measure the incidence of falls/person-
year (Desmet et al., 2005; Cook et al., 2006; Roberts et al., 2007; Abdel-Rahman et al., 
2011; McAdams-DeMarco et al., 2013; Farragher et al., 2014; Polinder-Bos et al., 2014). 
The results from these studies generally indicate that the incidence of falls/person-year in 
HD patients is greater than in community-dwelling older adults. Six out of 7 studies 
reported that HD patients had an incidence of falls 1.5 (McAdams-DeMarco et al., 2013) 
to 3.5 times (Roberts et al., 2007) higher than community-dwelling individuals aged 65 
years or older (O’Loughlin et al., 1993), while only one study found a 1.2 times lower 
incidence of falls in HD patients compared to community-dwelling older adults (Abdel-
Rahman et al., 2011). 
Although the majority of observational studies conducted on HD patients seem to suggest 
that, overall, they are at increased risk of falls compared to the general population (Desmet 
et al., 2005; Cook et al., 2006; Roberts et al., 2007; McAdams-DeMarco et al., 2013; 
Kutner et al., 2014; Farragher et al., 2014; Polinder-Bos et al., 2014; Noto-Kadou-Kaza et 
al., 2015), as also concluded by a recent literature review (Lopez-Soto et al., 2015), 
contrasting results on falls estimates from other studies (Roberts et al., 2003; Cook et al., 
2005; Abdel-Rahman et al., 2011; Wang et al., 2017) conducted in HD populations do not 
seem to support this finding. In addition, there is a lack of information on the 
characteristics of the falls experienced by patients, as only a few studies provided detailed 
information on the circumstances accompanying the fall events (Chapter 1, paragraph 
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1.2.2.5), and only two studies described the kind of activity leading to falls (Cook et al., 
2006; Farragher et al., 2014), which could convey important information on the aetiology 
of falls in this patient group.     
The main objective of this chapter was to contribute to the current body of knowledge on 
the epidemiology of falls in CKD in order to establish whether the risk of falling in CKD-
5 patients on HD is increased compared to the non-uraemic population. We hypothesised 
that 1) the prevalence of participants experiencing at least one fall over 12 months and, 2) 
the incidence of falls/person-year will be indicative of an increased risk of falling 
compared to the estimates of falls from the non-uraemic population. The secondary aim 
of this chapter was to critically report the characteristics of falls experienced by the study 
participants in order to delineate the most common circumstances (location, activities, 
precipitating factors, and consequences) around the fall events. 
 
3.2 Materials and methods 
3.2.1 Study design  
We conducted a prospective investigation of the prevalence of people experiencing at least 
one fall during a 12-month observational follow-up, as well as the incidence of 
falls/person-year in a group of prevalent HD patients. 
 
3.2.2 Setting  
The study was conducted in two Renal Units located in North Lanarkshire and Fife, United 
Kingdom, between October 2015 and August 2018. Recruitment started in October 2015 
and continued on a rolling basis until December 2017, while the observational follow-ups 
ran from November 2015 to August 2018. Ethical approval was granted, as detailed in 
Chapter 2, paragraph 2.1.1. 
 
3.2.3 Participants  
A convenience sample of ambulatory CKD-5 patients undergoing HD therapy thrice 
weekly were recruited from the two dialysis units at Monklands Hospital, Airdrie, NHS 
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North Lanarkshire, and Victoria Hospital, Kirkcaldy, NHS Fife. Inclusion and exclusion 
criteria are detailed in Chapter 2, paragraph 2.1.2. 
 
3.2.4 Falls  
A fall was operationally defined as an unexpected event in which the participant comes to 
rest to the ground, floor, or lower level (Lamb et al., 2005). The PhD researcher and two 
research nurses administered a falls questionnaire, once a month for a period of 12 months 
(as detailed in Chapter 2, paragraph 2.6.2), to all study participants during dialysis. The 
number of falls were recorded during every follow-up visit along with the characteristics 
of these falls (i.e. location, activities, precipitating factors) and their consequences. In 
addition, the retrospective history of falls of the study participants was also documented 
at the time of enrolment in the study (as detailed in Chapter 2, paragraph 2.6.1). 
 
3.3 Results 
3.3.1 Recruitment and loss to follow-up 
Three hundred and five patients undergoing outpatient HD therapy at the two Renal Units 
were screened for eligibility by members of the renal team. Of these, 215 patients were 
deemed eligible to participate and therefore approached for recruitment and consenting. 
The recruitment rate was 35.3%, with 76 patients agreeing to participate in the study. Nine 
patients (11.8%) were lost to follow-up due to renal transplantation (n= 4; 5.3%) and death 
(n= 5; 6.6%), although two of these patients were retained in the calculation of the falls 
estimates due to the fact that they had experienced falls during the prospective 
observational period before they were lost to follow-up. Therefore, a total of 69 patients 
completed the prospective follow-ups and were included in the calculation of the falls 
estimates (Figure 3.1). In addition, all 76 study participants completed the falls survey 
documenting their history of falls in the previous 12 months. 
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Figure 3.1. Participant recruitment: flow chart. 
 
 
3.3.2 Demographic and clinical characteristics 
The demographic and clinical characteristics of study participants are summarised in 
Table 3.1. 
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Table 3.1. Demographic and clinical characteristics of study participants: results are 
expressed as percentages for categorical variables and mean ± SD for continuous data. 
Variables All patients 
(69) 
Fallers 
(26) 
Non-fallers 
(43) 
P-value 
Demographic characteristics     
Sex, M (n) (%) 38 (55.1) 11 (42.3) 27 (62.8) 0.097 
Age (years) (SD)  61.7 (13.3) 58.3 (14.1) 63.8 (12.6) 0.151 
Body mass (Kg) (SD) 80.3 (18.7) 75.7 (18.6) 83.1 (18.5) 0.114 
Height (cm) (SD) 166.2 (9) 166 (9) 166.3 (9) 0.892 
BMI (Kg * m-2) (SD) 29.1 (6.4) 27.6 (7) 30 (5.9) 0.144 
Clinical history     
Dialysis vintage (days) (SD) 713 (714) 732 (636) 701 (765) 0.465 
CCI (score) (SD) 5.3 (2.2) 5.1 (2.1) 5.4 (2.3) 0.639 
Primary renal disease (n) (%)     
    Diabetic nephropathy 17 (25) 7 (26.9) 10 (23.8) 0.773 
    Glomerulonephritis 13 (19.1) 5 (19.2) 8 (19) 1.000 
    Polycystic kidney 6 (8.8) 0 (0) 6 (14.3) 0.075 
    Renovascular or hypertensive 6 (8.8) 0 (0) 6 (14.3) 0.075 
    Other 14 (20.6) 6 (23.1) 8 (19) 0.690 
    Uncertain aetiology 12 (17.6) 8 (30.8) 4 (9.5) 0.046 
Type of vascular access (n) (%)     
    Arteriovenous fistula 45 (64.7) 16 (61.5) 29 (66.7) 0.667 
    Central-venous  24 (35.3) 10 (38.5) 14 (33.3) 0.667 
Inter-dialytic weight gain (Kg) (SD) 1.6 (1.2) 1.6 (1) 1.6 (1.4) 0.923 
Prescribed medications     
Medications (n°) (SD) 11.8 (3.4) 12.4 (3.3) 11.5 (3.5) 0.262 
Beta blockers use (n) (%) 35 (50) 11 (42.3) 24 (54.8) 0.318 
ACE-inhibitors use (n) (%) 5 (7.4) 2 (7.7) 3 (7.1) 1.000 
Ca-channel blockers use (n) (%) 40 (57.4) 13 (50) 27 (61.9) 0.335 
AngII-receptor antagonists use (n) (%) 11 (16.2) 3 (11.5) 8 (19) 0.512 
Alpha blockers use (n) (%) 22 (32.4) 10 (38.5) 12 (28.6) 0.397 
Antihypertensive use (n) (%) 58 (83.8) 21 (80.8) 37 (85.7) 0.737 
>1 antihypertensive use (n) (%) 36 (51.5) 11 (42.3) 25 (57.1) 0.234 
Opiates use (n) (%) 13 (19.1) 3 (11.5) 10 (23.8) 0.342 
Antidepressants use (n) (%) 23 (33.8) 13 (50) 10 (23.8) 0.027 
Diuretics use (n) (%) 23 (33.8) 6 (23.1) 17 (40.5) 0.141 
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Laboratory values     
Hb (g/dL) (SD) 11.2 (1.2) 11 (1) 11.2 (1.2) 0.317 
CRP (mg/L) (SD) 25.8 (45.4) 37.6 (59.2) 18.3 (32.7) 0.027 
Bicarbonate (mmol/L) (SD) 21.2 (3.2) 21.5 (3.1) 21.1 (3.4) 0.546 
Na (mmol/L) (SD) 139 (2.8) 138.4 (3.3) 139.4 (2.4) 0.388 
K (mmol/L) (SD) 4.6 (0.7) 4.6 (0.7) 4.6 (0.6) 0.992 
Urea (mg/dL) (SD) 16.4 (5.1) 15.7 (6.1) 16.7 (4.5) 0.276 
Phosphate (mmol/L) (SD) 1.5 (0.6) 1.5 (0.6) 1.5 (0.5) 0.978 
PTH (ρmol/L) (SD) 27.2 (32.1) 28.9 (43.4) 26.2 (23.1) 0.586 
Albumin (g/L) (SD) 37.1 (4.3) 36.1 (5.2) 37.7 (3.7) 0.146 
Adjusted calcium (mmol/L) (SD) 2.4 (0.1) 2.3 (0.1) 2.4 (0.1) 0.511 
URR (%) (SD) 71.1 (6.2) 71.1 (7.7) 71 (5.1) 0.994 
Creatinine (μmol/L) (SD) 638.1 (161.3) 592(175.7) 666 (147.1) 0.064 
Abbreviations: SD: standard deviation; BMI: body mass index; CCI: Charlson 
comorbidity index; ACE: angiotensin-converting enzyme; Ca: calcium; AngII: 
angiotensin II; Hb: hemoglobin; CRP: C-reactive protein; Na: sodium; K: potassium; 
PTH: parathyroid hormone; URR: urea reduction ratio. 
 
3.3.3 Estimates of falls 
During the 12-month follow-up, 26 of 69 patients (37.7%) experienced at least one fall, 
of which 14 (53.8%) experienced multiple falls. The distribution of number of falls 
occurred during the prospective observational period is displayed in Figure 3.2. The 
maximum amount of falls experienced by one patient was 21, and a total of 80 falls were 
recorded, resulting in an incidence of 1.16 falls/patient-year. In addition, in the 
retrospective history of falls survey, 33 of 76 patients (43.4%) reported falling at least 
once in the previous 12 months and, overall, 44 of 76 patients (57.9%) reported either a 
fall in the previous year or during follow-up. 
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Figure 3.2. Distribution of number of falls in the study participants. 
 
 
3.3.4 Characteristics of falls 
3.3.4.1 Location of falls 
The most common location where the study participants experienced falls was their home, 
as 17 of the 26 patients who suffered falls (65.4%) reported falling at least once at home. 
In addition, 13 out of 26 (50%) experienced at least one fall outdoors, and 7 (26.9%) 
reported at least one fall in another public site. Two patients out of the 26 fallers (7.7%) 
reported falling in all these locations at least once during the study period. Overall, 58 out 
of 80 falls (72.5%) were sustained at home, 15 (18.8%) occurred outdoors, and 7 (8.8%) 
in another public site (Figure 3.3). 
 
3.3.4.2 Activities leading to falls 
The most common activity leading to falls was walking, as 19 of the 26 patients who 
suffered falls (73.1%) reported falling while walking at least once over the study period. 
Other commonly reported activities leading to falls were getting up from either a supine 
or a sitting position to upright standing, turning around, and walking up or down the stairs. 
More precisely, 12 out 26 fallers (46.2%) reported falling during the transition from a 
supine/sitting position to upright standing at least once, five (19.2%) reported falling at 
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least once while turning around, and the remaining five (19.2%) reported experiencing 
one fall while walking up or down the stairs at least one time.  
Overall, 25 out of 80 falls (31.3%) were experienced by the study participants while they 
were walking (18.8% of all falls occurred while walking indoors, and 12.5% occurred 
outdoors). Seventeen out of 80 falls (21.3%) occurred during the transition from a 
supine/sitting position to upright standing (6.3% from the supine position, and 15% from 
a sitting position). Twelve falls (15%) occurred while patients were turning around and a 
further five falls (6.3%) happened while they were walking up (2.5%) or down (3.8%) the 
stairs. In addition, 21 falls (26.3%) were caused by other activities, namely unspecified 
falls from the standing position (6.3%), tripping over an obstacle (5%), bending over to 
pick up an object (3.8%), slipping on ice (3.8%), sitting down (1.3%), hoovering (1.3%), 
alcohol-related (1.3%), or unknown (i.e. no recollection) (3.8%). 
 
3.3.4.3 Precipitating factors 
The precipitating factors represent the predominant perceived cause/symptomatology 
reported by the patient when describing the fall event. The most commonly reported 
factors were dizziness/passing out, loss of balance/unsteadiness of the legs, and 
environmental factors. More specifically, 12 out of the 26 fallers (46.2%) reported either 
dizziness or passing out as the predominant factor leading to at least one fall during the 
study period. Fifteen out of 26 (57.7%) reported either a loss of balance or unsteadiness 
of the legs, and 13 (50%) reported factors such as a slip or a trip due to environmental 
hazards. 
Overall, 33 out of 80 falls (41.3%) were accompanied by dizziness symptoms or passing 
out (36.3% due to dizziness, and 5% due to a loss of consciousness). Twenty-five out of 
80 falls (31.3%) were accompanied by a loss of balance or unsteadiness of the legs (18.8% 
due to loss of balance, and 12.5% due to unsteadiness of the legs). Sixteen falls (20%) 
were due to a slip or trip arising from environmental hazards (11.3% due to a slip, and 
8.8% due to a trip). In addition, the symptomatology of six of the 80 falls (7.5%) was 
unspecified/unclear.     
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3.3.4.4 Timing of falls 
In the sub-group of study participants from the NHS Fife research site, we also extracted 
information on the timing of the falls experienced, which was classified in relation to 
whether these falls occurred on a non-HD day, or on a HD day (pre or post-HD) as 
reported in previous studies (Desmet et al., 2005; Cook et al., 2006; Abdel-Rahman et al., 
2011; Rossier et al., 2012; Polinder-Bos et al., 2014). 
Nine patients out of the 24 from this research site (37.5%) experienced falls, eight of which 
(33.3%) reported having at least one fall on a non-HD day, while four (16.7%) and one 
(4.2%), respectively, reported falling at least once pre-HD and post-HD. Overall, 16 of 
the 23 falls recorded at this research site (69.6%) occurred on a non-HD day, while five 
(20.8%) and two (8.3%) occurred pre-HD and post-HD respectively. 
 
3.3.4.5 Consequences of falls 
The consequences of a fall were documented in terms of injury sustained by the patient, 
and in terms of whether or not healthcare was sought to treat these injuries. The majority 
of falls experienced by the study participants (61.3%) were non-injurious, while the 
remaining falls resulted in minor/major injuries that were classified as bruising, non-
specified soft tissue/joint injuries, and fracture. Thirteen out of the 26 fallers (50%) 
reported bruising to a variety of areas of the body at least once as a result of the falls 
experienced during the study period. Eight patients (30.8%) reported a non-specified soft 
tissue/joint injury, and one patient (3.8%) suffered a fracture. 
Overall, 16 of the 80 falls recorded (20%) resulted in various bruises in the following body 
areas: knee (5%), back (3.8%), leg (3.8%), hand (2.5%), forearm (1.3%), chest (1.3%), 
buttocks (1.3%), and eye (1.3%). Nine falls (11.3%) resulted in other soft tissue/joint 
injuries in the following locations: face (2.5%), arm (2.5%), back (2.5%), knee (2.5%), 
unspecified location (1.3%). One fall (1.3%) was complicated by a fracture of the 
shoulder. Moreover, four patients (15.4%) reported banging the head at least once as a 
result of the falls experienced. 
As far as healthcare required is concerned, eight falls (10%) were reported to the 
GP/medical care team and either treatment or medical advice was provided. Three patients 
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(11.5%) were hospitalised following the fall experienced (one patient required an X-ray, 
one required medical treatment, and one was hospitalised with sepsis and confusion). 
Overall, three falls (3.8%) required hospitalisation. 
 
Figure 3.3. Summary of characteristics of falls experienced by the study participants.
 
 
 
3.3.5 Critical incident reporting of falls at Monklands Hospital 
We also reviewed the critical incident reporting of falls in one of the two research sites 
(Monklands Hospital, NHS North Lanarkshire) as a secondary source of information 
about falls occurring within the hospital environment. The critical incident reporting of 
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falls at Monklands hospital is routinely performed by the renal nursing staff, who are 
responsible for documenting all accidental falls occurring in the Renal Unit. 
In the 12 months preceding the start of the study, between October 2014 and October 
2015, 48 falls were recorded in the Renal Unit. These falls were experienced by 39 
patients, three of whom participated in the study. Therefore, three out of the 52 study 
participants from Monklands hospital (5.8%) had a history of falls occurring in the Renal 
Unit, in the previous 12 months. 
The severity of the documented falls was graded by the nursing staff, as per standard NHS 
protocol, in three categories of injury: category 3 (CAT3) representing all of those falls 
which resulted in no injury and requiring no medical attention, category 2 (CAT2) 
representing falls resulting in minor injuries (e.g. haematomas, abrasions, cuts) and/or 
requiring a minor level of medical attention or treatment, and category 1 (CAT1) 
representing falls complicated by major injuries (e.g. fractures, death) and requiring more 
urgent medical attention or treatment. Overall, 36 falls (75%) were classified as non-
injurious (CAT3), 11 falls (22.9%) resulted in minor injuries (CAT2), and one fall (2.1%) 
was complicated by a major injury (CAT1).  
 
3.4 Discussion 
We hypothesised that the estimates of falls in HD patients, as defined by the prevalence 
of participants experiencing at least one fall over 12 months and the incidence of 
falls/person-year, would be indicative of an increased risk of falling compared to those 
reported in non-uraemic individuals living in the community. 
The prevalence of study participants reporting at least one fall over 12 months was 37.7%, 
an estimate somewhat higher than the yearly prevalence of community-dwelling older 
adults who fall at least once (30%), as outlined by the WHO global report on falls (2008). 
Additionally, the prevalence emerging from the study is also considerably higher than the 
prevalence of community-dwelling individuals, aged 40 years and older, reporting at least 
one fall in the past year (7.9% to 12.1%), as observed in larger epidemiological studies 
(Agrawal et al., 2009; Schumacher et al., 2014), and also higher than the prevalence of 
middle-aged women with a history of falls in the previous 12 months (20.5% to 30.7%), 
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as described in a more recent study (White et al., 2018). Moreover, 43.4% of the study 
participants reported that they had experienced at least one fall in the previous year, which 
is also indicative of an increased risk of falling compared to the community-dwelling, 
non-uraemic population. 
Analogously, the number of falls experienced by the study participants during the 
prospective follow-up period equated to an incidence of 1.16 falls/person-year, 
approximately 2.3 times higher than in community-dwelling older adults (O’Loughlin et 
al., 1993). The observations that both the falls estimates emerging from this prospective 
investigation are higher than those relative to the non-uraemic, elderly population, and 
that our study participants were generally even younger than 65 years old (mean age= 61.1 
years), strongly support the hypothesis that CKD-5 patients on HD are at higher risk of 
falls compared with the community-dwelling, non-uraemic, age-matched population. 
Although the study was conducted in a small cohort of patients, our findings are broadly 
in agreement with those of larger observational studies. For instance, Desmet et al., 
(2005), reported a yearly incidence of 1.18 falls/person-year for their HD patients, which 
is very similar to the estimate observed in our study (1.16 falls/patient-year). Additionally, 
the proportion of patients who experienced at least one fall during the 12-month follow-
up (37.7%), is also very similar to that reported in previous research (38%) (Roberts et al., 
2007). 
Interestingly, the study findings are aligned with the large majority of those studies that 
investigated falls prospectively by means of monthly, or even more frequent, 
observational follow-ups (Table 1.4 & Table 1.5, Chapter 1). Six out of seven of these 
studies reported a prevalence of patients experiencing at least one fall greater than the 
30% estimate of community-dwelling older adults (WHO, 2008), with a range of 34% to 
55% (Desmet et al., 2005; Cook et al., 2006; Roberts et al., 2007; Farragher 2014; 
Polinder-Bos et al., 2014; Kono et al., 2018). Only one study out of seven with such 
characteristics, i.e. prospective design and a minimum monthly follow-up frequency, 
reported a slightly lower prevalence of fallers (26.3%), although it should be 
acknowledged that the mean age of the study participants in this investigation was less 
than 65 years old (Abdel-Rahman et al., 2011). 
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In addition, the prevalence of fallers emerging from the current investigation appears to 
be higher than that previously reported in retrospective observational studies (24% to 
28.4%). However, it is noteworthy that these published prevalences were based on 
estimates derived from self-reports of falls occurrence in the previous 12 months (Roberts 
et al., 2003; Cook et al., 2005; Kutner et al., 2014; Wang et al., 2017), as summarised in 
Table 1.4, Chapter 1. This difference might be explained in light of the fact that 
retrospective self-reporting of falls is often subject to recall bias that leads to under-
reporting (Hauer et al., 2006). Particularly, observational studies with retrospective design 
are more subject to this kind of misreporting given the longer recall interval (Ganz et al., 
2005). For instance, while all of the retrospective studies assessed whether patients had 
fallen or not by means of a single-item falls survey (e.g. “have you had any falls in the 
past year?”), we prospectively followed-up the study participants on a monthly basis for 
12 months, in an attempt to minimise this bias, which is likely to have resulted in a more 
accurate estimation of the prevalence of fallers (Hauer et al., 2006). 
Similarly, the incidence of falls/person-year emerging from this investigation (1.16 
falls/person-year; 2.3 times higher than non-uraemic older adults) is in agreement with the 
findings of the large majority of studies that reported, directly or indirectly, this measure 
(Desmet et al., 2005; Cook et al., 2006; Roberts et al., 2007; McAdams-DeMarco et al., 
2013; Kutner et al., 2014; Farragher et al., 2014; Polinder-Bos et al., 2014). Therefore, 
our findings on falls prevalence and incidence in HD patients seem to be representative of 
this patient group, and results from this study may be generalised to the general population 
of CKD-5 patients undergoing HD therapy. 
The secondary aim of this investigation was to report the characteristics of the falls 
experienced by study participants in order to document the circumstances of the fall events 
in the CKD-5 population on HD. The critical reporting of these circumstances is often 
neglected and very little information is available from prospective cohort studies 
conducted on HD patients (Lopez-Soto et al., 2015), nevertheless this kind of data may 
convey useful information on the aetiology of falling in this patient population. 
The results from the falls survey administered to the study participants during every 
follow-up visit revealed that the most common location of the falls experienced was at 
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home (72.5% of falls). In addition, it was evident that the most common activity leading 
to the falls was walking (31.3% of falls), the most common precipitating factor was 
dizziness (36.3% of falls), and the majority of falls (61.3%) were non-injurious (Figure 
3.3). 
The findings on the location of falls is in agreement with all the studies that reported this 
kind of information, as 54.2% to 82% of the falls recorded in these studies occurred at 
home, which also resulted to be the most common location (Desmet et al., 2005; Rossier 
et al., 2012; Polinder-Bos et al., 2014). On the other hand, the relatively small proportion 
of falls occurring outdoors (18.8%), as observed in our study, may reflect the well-known 
sedentary habits of HD patients (Delgado et al., 2012). 
The most common activity preceding falls, as reported by the study participants, was 
walking (31.3% of falls). This figure is also in agreement with the only two studies that 
reported this information (Cook et al., 2006; Farragher et al., 2014). Particularly, these 
studies revealed that 29.8% (Cook et al., 2006) and 51% (Farragher et al., 2014) of the 
falls recorded during the prospective follow-up occurred while walking indoors, which 
may also reflect the high proportion of falls occurring at home. However, it should also 
be noted that a high number of falls, in our study, were preceded by a transition from the 
supine/sitting position to upright standing (21.3% of falls), or by a sudden rotation (15% 
of falls occurred when turning around). This information is interesting in light of the 
symptoms reported by the study participants as precipitating factors: 36.3% of the falls 
were precipitated by dizziness, which was also the factor most commonly reported. 
Therefore, the observations that about 40% of the falls occurred during a sudden change 
of body position, and were accompanied by dizziness seem to indirectly support the 
hypothesis put forward by previous research that the aetiology of a high number of falls 
in HD patients may be due to low BP spells and/or orthostatic hypotension (Roberts et al., 
2003). Moreover, this finding seems to be consistent with the results of Cook et al., (2006), 
who also reported that 33% of the recorded falls occurred during the transition from the 
supine/sitting position to upright standing. 
Although some researchers hypothesised that during the post-HD timeframe patients 
might be particularly susceptible to an increased risk of dizziness, postural hypotension, 
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and potentially falls, due to the fluid shifts associated with dialysis (Roberts et al., 2003), 
most studies did not highlight any relationship between the post-HD timeframe and falls 
(Cook et al., 2006; Abdel-Rahman et al., 2011; Rossier et al., 2012; Polinder-Bos et al., 
2014). The results of our investigation are also aligned with these studies. Even though 
we collected this information from one research site only (with only 9 fallers), the 
descriptive analysis revealed that most falls (69.6%) occurred on non-dialysis days, and 
only 8.3% were reported post-HD. Ultimately, the relationship between the post-HD 
timeframe and the occurrence of falls may be confounded by the fact that HD patients 
may experience post-dialysis fatigue, which is associated with sedentary behaviour 
(Gordon et al., 2011). Therefore, although HD patients may be at higher risk of dizziness 
and postural hypotension after HD (Roberts et al., 2003), the post-HD sedentary behaviour 
may mediate the risk of falling by reducing it due to the actual lack of movement. 
The findings on the consequences of falls indicate that the large majority of these were 
non-injurious, as 61.3% of falls resulted in no consequences and 20% in minor bruises 
only. Only one patient (3.8%) suffered a fracture as a result of falls, a similar estimate to 
the findings from previous studies reporting that 4% to 6% only of HD patients 
experienced a fracture following a fall (Cook et al., 2005; Cook et al., 2006; Farragher et 
al., 2014). Additionally, the critical incident reporting at Monklands Hospital revealed that 
only 2.1% of the falls recorded during the 12 months preceding the study initiation 
resulted in a major injury, which indirectly highlights the small proportion of falls that 
result in a severe accident. This observation should be considered by nephrologists 
because very often falls are brought to medical attention only when a severe injury is 
sustained as a result of the fall (Rossier et al., 2012), and many falling accidents remain 
undetected or underreported (Hauer et al., 2006). Our investigation revealed that only 10% 
of the falls experienced by the study participants were reported to the GP/medical care 
team, while the remaining 90% would have remained completely undetected if they had 
not been documented during the prospective follow-up period. Moreover, the number of 
falls documented in the study participants from Monklands Hospital (57) was higher than 
the number of falls documented by means of the critical incident reporting at the same 
hospital (48) in the previous 12 months: it should be kept in mind that only a small sample 
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of HD patients (52) took part in our study from this research site, while the critical incident 
reporting of falls by means of the nursing staff has a much larger constituency of patients 
(> 200) because it aims to document all falls experienced by any patient (HD or not) in 
the renal ward. Altogether, these observations strongly suggest that the majority of falls 
suffered by HD patients are not commonly reported in hospital records. 
 
3.4.1 Limitations 
First of all, the patient sample was relatively small compared to larger observational 
studies and this could have resulted in a potentially larger inflation/deflation of the falls 
estimates than if the patient sample was larger. However, the findings on falls prevalence 
and incidence seem to be representative of this patient population, and the results from the 
study may be generalised to the population of CKD-5 patients on HD. 
Secondly, the documentation of falls was based on self-reported information, and a 
previous systematic review has highlighted how recalling information about falls might 
be subjected to misreporting (Hauer et al., 2006). Although we sought to minimise this 
bias by prospectively following up the participants every month, rather than 
retrospectively, (Cummings et al., 1988), it is still possible that a small proportion of falls 
might have been misreported, potentially resulting in some degree of error in the estimates 
of falls obtained. 
 
3.4.2. Conclusions 
The results from this prospective investigation confirm that CKD-5 patients on HD are at 
higher risk of falls compared to the community dwelling, non-uraemic, population, as 
evidenced by the higher prevalence of patients experiencing at least one fall per annum, 
as well as the higher incidence of falls/person-year. The high proportion of falls occurring 
during a change in body position, and precipitated by dizziness, suggest that low BP spells 
and orthostatic hypotension may be implicated in the aetiology of a high number of falls 
in CKD-5 patients on HD. Worryingly, the large majority of falls remains unreported in 
this patient population.          
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CHAPTER 4: FRAILTY, PHYSICAL FUNCTION AND FALLS IN CKD-5 
PATIENTS ON HD 
 
Abstract 
Background: Frailty and poor physical function are common in CKD-5 patients 
undergoing HD therapy, and they may be implicated in the aetiology of falls in this patient 
population. Therefore, we explored the relationship between frailty, physical function and 
falls in a convenience sample of CKD-5 patients on HD.  
Methods: Seventy-six prevalent HD patients recruited from two Renal Units were enrolled 
in this cross-sectional study. Participants were classified as “fallers” and “non-fallers” and 
completed a comprehensive physical function assessment consisting of objectively 
measured physical activity (PA), handgrip strength, isometric leg extension strength, gait 
speed, timed up and go (TUG), 5 repetitions chair sit to stands (CSTS-5), and postural 
balance testing by means of a force platform. In addition, participants were classified as 
“frail” or “non-frail” by means of the Fried’s frailty phenotype. All assessments were 
performed during a single visit on a non-HD day. The differences in frailty status and 
physical function between fallers and non-fallers were preliminarily analysed by means 
of a Chi-square test and either parametric (independent t-tests) or non-parametric (Mann-
Whitney U) independent comparisons, as appropriate. The association of frailty/physical 
function and falls (yes or no) was analysed by means of logistic regression. Statistical 
limits for interpretation were set at an alpha level of p = .05. 
Results: Patients classified as fallers had significant lower objectively measured levels of 
PA, such as time spent standing (2.1±1.1h vs 2.7±1.2h, p= 0.034), time spent stepping 
(0.6±0.3h vs 0.8±0.4h, p= 0.016), and number of daily steps (2566±1462 vs 
3731±1966, p= 0.015) compared to non-fallers. In addition, fallers had a worse postural 
balance performance in seven and nine out the nine variables assessed in eyes open (EO) 
and eyes closed (EC) conditions. No significant differences in strength and physical 
function tests were detected between fallers and non-fallers. Frailty (OR: 3.15, 95% CI: 
1.04-9.54, p= 0.04) and postural balance (OR: 1.14, 95% CI: 1.02-1.28, p= 0.022) were 
associated with increased odds of falling in multivariate logistic regression analysis.   
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Conclusions: This cross-sectional investigation indicates that frailty and postural balance 
are associated with falls in CKD-5 patients undergoing HD therapy. Postural balance is a 
physical function outcome at least partially independent from frailty, and it may represent 
an additional risk factor for falls. Further research is warranted to identify which physical 
function measures may be more closely associated with falls in this patient population. 
 
4.1 Introduction 
Frailty and poor physical function are associated with worse outcomes such as 
hospitalisations and increased mortality in people living with CKD-5 (Johansen et al., 
2007; Bao et al., 2012; Roshanravan et al., 2013). Recent evidence suggests that frail HD 
patients are also more likely to experience a higher number of falls (McAdams-DeMarco 
et al., 2013). 
Frailty is typically defined as a clinical phenotype consisting of low PA, gait speed, 
strength, unintentional weight loss, and exhaustion (Fried et al., 2001). All these 
components are intrinsically related to physical function, and they might represent risk 
factors for falls, not only when combined to assign a positive physical frailty score 
(McAdams-DeMarco et al., 2013), but also individually. In spite of the relatively high 
number of observational studies which consistently documented an increased risk of 
falling in dialysis populations (Desmet et al., 2005; Cook et al., 2006; Farragher et al., 
2014), only a few studies explored the relationship between objective frailty/physical 
function measures and falls (Desmet et al., 2005; Cook et al., 2006; McAdams-DeMarco 
et al., 2013; Kutner et al., 2014; Wang et al., 2017; Kono et al., 2018), and reported 
contrasting results as to whether physical function is associated with falls in HD patients 
(paragraph 1.2.3.4, Chapter 1). The identification of which physical function/activity 
outcomes may be more closely associated with falls in people with CKD, if any, is of 
paramount importance, as this would eventually allow to develop new or tailor existing 
interventions that aim to reduce the occurrence of falls in CKD-5 patients on HD. One 
example of an evidence-based intervention that is effective in reducing symptoms 
associated with frailty such as falls in elderly, but otherwise healthy, individuals is 
strength and balance training exercise programmes (Sherrington et al., 2011). Therefore, 
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the main objective of this study was to perform a comprehensive assessment of frailty and 
physical function in a group of HD patients, and to explore the relationship with the risk 
of falling. The specific aims were to test the association between the Fried’s frailty 
phenotype and falls, and to test the association between physical function and falls in a 
group of CKD-5 patients on HD. We hypothesised that 1) frailty would be positively 
associated with falling status and that, 2) physical function determinants, such as PA, 
upper and lower body strength, gait speed, TUG, CTSS-5 and postural balance would also 
be associated with falls. 
 
4.2 Essential methods 
4.2.1 Study design  
A cross-sectional study design was used to explore the relationship between frailty, 
physical function, PA and falls in a group of prevalent CKD-5 patients on HD. The study 
participants underwent a comprehensive assessment of frailty and physical function 
measures at baseline, and they were subsequently classified as fallers or non-fallers based 
on the occurrence or not of at least one fall during a 12-month prospective observational 
period. In addition, patients with a history of at least one fall in the previous 12 months 
were also classified as fallers, so as to minimize the chances of misclassifying patients as 
non-fallers.  
 
4.2.2 Data collection 
Falls, frailty and physical function determinants such as PA levels, muscle strength, TUG, 
CSTS-5 and postural balance were assessed, as fully detailed in Chapter 2. 
 
4.2.3 Sample size  
Preliminary study size considerations are described in Chapter 2, paragraph 2.1.3. 
The sample size (N) calculation was based on the smaller proportion (P1) of the dependent 
variable, as recommended in logistic regression analysis by Peduzzi et al., (1996), with 
the following formula: N= (10 K)/ P1. The dependent variable was defined as membership 
to the group “fallers” (≥ 1 fall sustained), and P1 was defined, based on the study results, 
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as P1= .389 (proportion of non-fallers, as reported in paragraph 4.3.3). “K” represents the 
number of independent (explanatory) variables, and equals to K= 2, as we entered 2 
variables simultaneously in the model: the explanatory variable, e.g. frailty/physical 
function (one variable entered at a time) AND the diabetic status, which was 
retrospectively identified as a potential confounder of the study results. Therefore, 
substituting the values into the equation results in: N= (10* 2)/.389, which equates to N= 
52. This is the minimum sample size required to provide an unbiased association for each 
explanatory variable in the logistic regression model (Peduzzi et al., 1996). 
 
4.2.4 Statistical analysis  
All statistical analyses were performed with SPSS (Version 23.0 for Windows, SPSS Inc., 
Chicago, IL). The Shapiro-Wilk test was used to check normality characteristics of data. 
Participants were classified and grouped as fallers and non-fallers. Between-groups 
differences in demographic, clinical characteristics, frailty status and physical function 
outcomes were assessed using a Chi-Square test for categorical variables, and by either 
Mann-Whitney U or independent t-tests, as appropriate, for continuous variables. Results 
are expressed as mean and standard deviation (SD) and percentages. Statistical limits for 
interpretation were set at an alpha level of p = .05. The association between frailty/physical 
function and falls (yes or no) was analysed by means of logistic regression analysis: 
variables reaching a statistical significance level of p≤ 0.10, in the preliminary 
independent comparisons, were entered in a univariate logistic regression model, which 
was adjusted a posteriori in a multivariate analysis.  
In a sensitivity analysis, we also analysed the association between frailty/physical function 
and the number of falls recorded during the 12-month prospective follow-up by means of 
negative binomial regression analysis: variables reaching a statistical significance level of 
p≤ 0.10 in the univariate negative binomial regression model were entered in multivariate 
analysis. Statistical limits for interpretation of the logistic and negative binomial 
regression analyses were also set at an alpha level of p = .05. 
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4.3 Results 
4.3.1 Participants  
The screening and recruitment figures of the study are detailed in Chapter 3 (paragraph 
3.3.1). Seventy-six patients were enrolled in the study and completed the baseline 
assessments. Nine patients were lost to follow-up, as detailed in paragraph 3.3.1, however 
five of these patients were retained in the data analysis due to their positive history of falls, 
which automatically classified these patients as fallers for the purposes of this cross-
sectional investigation. All participants completed the physical function, strength and 
balance assessments, with the only exception of one patient (1.3%), who refused to 
undergo the balance and gait speed assessments. Moreover, two (2.6%) and five (6.6%) 
participants were removed from the TUG and CSTS-5 analysis respectively as they were 
unable to perform these tests as per protocol. In addition, 17 patients (22.4%) were 
excluded from the ActivPal data analysis, as they did not meet the minimum wearing time 
requirements described in Chapter 2, paragraph 2.4.1.2. 
 
4.3.2 Demographic and clinical characteristics  
Participants classified as fallers were more likely to have diabetes as primary renal disease 
(PRD) (34.9% vs 12.9%), and less likely to use diuretics (27.3% vs 53.3%) compared to 
non-fallers. No other differences were noted between the groups. 
 
4.3.3 Falls  
Forty-four patients out of the 72 included in the analysis (61.1%) reported at least 1 fall 
either in the previous 12 months, or during the 12-month follow-up period, and were 
therefore classified as “fallers”. The remaining 28 patients (38.9%) did not report any 
falls, and were classified as “non-fallers”. Further information on the falls estimates 
emerging from the study is detailed in Chapter 3, paragraph 3.3.3. 
 
4.3.4 Frailty  
Overall, 28 out of 76 patients (36.8%) were classified as frail. Fallers were more likely to 
be frail compared with non-fallers (Table 4.1). In addition, considering the single 
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components of frailty, fallers were also more likely to have low self-reported PA and more 
likely to meet the exhaustion criteria of frailty compared to non-fallers. 
 
Table 4.1. Frailty characteristics of study participants: differences between fallers and 
non-fallers. 
Variables All patients 
(76) 
Fallers 
(44) 
Non-fallers 
(28) 
P-value 
Single frailty components     
Low PA (n) (%) 36 (47.2) 26 (59.1) 8 (28.6) 0.011 
Low gait speed (n) (%) 22 (29.2) 16 (36.4) 5 (17.9) 0.092 
Low strength (n) (%) 37 (48.6) 22 (50) 13 (46.4) 0.768 
Exhaustion (n) (%) 57 (74.7) 37 (84.1) 17 (59.3) 0.020 
Unintentional weight loss (n) (%) 13 (16.9) 9 (20.9) 3 (10.7) 0.262 
Fried’s frailty phenotype     
Frail (n) (%) 28 (36.8) 21 (47.7) 6 (21.4) 0.025 
Abbreviations: PA: physical activity. 
 
4.3.5 Physical activity  
The differences between fallers and non-fallers in objective levels of PA are summarised 
in Table 4.2. Fallers had a significant lower count of daily steps, and lower time spent 
standing and stepping, compared with non-fallers. 
 
Table 4.2. Objective measurements of PA: differences between fallers and non-fallers 
(mean ± SD). 
Variables All patients 
(72) 
Fallers 
(44) 
Non-fallers 
(28) 
P-value 
Time spent standing (h/day) (SD) 2.3 (1.1) 2.1 (1.1) 2.7 (1.2) 0.034 
Time spent stepping (h/day) (SD) 0.7 (0.4) 0.6 (0.3) 0.8 (0.4) 0.016 
Daily steps (n°) (SD) 3129 (1769) 2566 (1462) 3731 (1966) 0.015 
Daily sit to stands (n°) (SD) 37.3 (12.2) 37.9 (13.8) 37.3 (10.7) 0.987 
Abbreviations: SD: standard deviation; PA: physical activity. 
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4.3.6 Physical function performance  
Physical function performance results are reported in Table 4.3. No significant differences 
between fallers and non-fallers were observed. As expected, handgrip strength was 
significantly higher in men compared to women (32.3±8.6 Kg vs 20.7±7 Kg, p˂ 0.001). 
 
Table 4.3. Physical function performance tests: differences between fallers and non-
fallers (mean ± SD). 
Variables All patients 
(72) 
Fallers 
(44) 
Non-fallers 
(28) 
P-value 
Strength     
Handgrip (Kg) (SD) 26.9 (9.8) 25.9 (9.6) 27.9 (8.9) 0.388 
Leg extension (Kg) (SD) 19.8 (8.9) 19.1 (8.8) 21.5 (8.9) 0.259 
Functional tests     
Gait speed (m/s) (SD) 0.86 (0.26) 0.81 (0.25) 0.93 (0.27) 0.060 
TUG (s) (SD) 11.4 (4.9) 12.3 (5.6) 10.4 (3.7) 0.112 
CSTS-5 (s) (SD) 17 (8.8) 17.7 (10) 16.2 (7) 0.789 
Abbreviations: SD: standard deviation; TUG: timed up and go test; CSTS-5: 5 repetitions 
chair sit to stand test. 
 
4.3.7 Postural balance  
Compared to non-fallers, fallers had a significantly lower performance in seven (RangeY, 
RMSY, SP, AbsVel, VelX, VelY, and Area95) out of the nine balance variables in the EO 
condition, and in all nine variables in the EC condition (Table 4.4). 
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Table 4.4. Postural balance in EO and EC conditions: differences between fallers and non-
fallers (mean ± SD).  
 EO  EC  
Variables Fallers (44) Non-fallers (28) Fallers (44) Non-fallers (28) 
RangeX (mm) (SD) 26.7 (15.7) 20.9 (6.6) 40.4 (20.6)* 28.1 (9.7) 
RangeY (mm) (SD) 32.1 (16.7)* 24.1 (7.3) 46.8 (20.9)** 34.4 (10.8) 
RMSX (mm) (SD) 5.4 (3.4) 4.2 (1.3) 7.3 (3.7)* 5.2 (1.8) 
RMSY (mm) (SD) 6.3 (3.3)* 4.8 (1.6) 8.8 (4.8)* 6.5 (2.2) 
SP (mm/s) (SD) 1081.3 (221.4)** 953.2 (200.7) 1329.1 (327)** 1124.2 (218.2) 
AbsVel (mm/s) (SD) 43.3 (8.9)** 38.1 (8) 53.2 (13.1)** 45 (8.7) 
VelX (mm/s) (SD) 27.2 (5.7)* 24.6 (5.7) 30.9 (6.6)** 27.1 (5.7) 
VelY (mm/s) (SD) 27.8 (6)** 24 (4.8) 36.5 (11.2)** 30.1 (6.8) 
Area95 (mm2) (SD) 3218.2 (4252.8)* 1586.9 (947.8) 5778.5 (6831.7)* 2733.6 (1741.7) 
Abbreviations: SD: standard deviation; EO: eyes open; EC: eyes closed; RangeX: range 
of centre of pressure (COP) displacement along the medial-lateral (ML) axis; RangeY: 
range of COP displacement along the anterior-posterior (AP) axis; RMSX: root mean 
square displacement along the ML axis; RMSY: root mean square displacement along the 
AP axis; SP: sway path; AbsVel: absolute velocity; VelX: velocity along the ML axis; 
VelY: velocity along the AP axis; Area95: 95% confidence ellipse area. * indicates a 
statistical significant difference between groups (p < .05); ** indicates a statistical 
significant difference between groups (p < .01). 
 
4.3.8 Factors associated with falls 
In univariate logistic regression, diabetic nephropathy, frailty, number of daily steps, and 
postural balance were associated with increased odds of falling (Table 4.5). In 
consideration of multicollinearity, and given the revealed high correlations among the 
different static postural balance variables (Appendix XIV), only one postural balance 
variable that had the strongest correlation (highest R2) with falls, namely VelY in EO, was 
entered in the logistic regression model. The univariate analysis was adjusted for diabetic 
status, as we retrospectively identified this factor to be potentially a significant confounder 
of the study results. In the multivariate logistic regression model, frailty and postural 
balance were still significantly associated with increased odds of falling (Table 4.5). 
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Table 4.5. Logistic regression analysis: assessment outcomes associated with falls. 
 Univariate  Adjusted  
Factors OR (95% CI) P-value OR (95% CI) P-value 
Clinical characteristics     
Diabetic nephropathy (yes/no) 3.616 (1.064–12.286) 0.039 - - 
Fried’s frailty phenotype     
Frailty (yes/no) 3.348 (1.138-9.851) 0.028 3.153 (1.042-9.542) 0.042 
Physical activity     
Time spent standing (h/day) 0.642 (0.387-1.066) 0.087 0.676 (0.401-1.139) 0.141 
Daily steps (n°) 1.000 (0.999-1.000) 0.022 1.000 (0.999-1.000) 0.077 
Physical function     
Gait speed (m/s) 0.160 (0.023-1.113) 0.064 0.161 (0.022-1.119) 0.074 
Postural balance     
VelY in EO (mm/s) 1.149 (1.031-1.280) 0.012 1.140 (1.019-1.275) 0.022 
Abbreviations: OR: odds ratio; CI: confidence interval; EO: eyes open; VelY: absolute 
velocity of centre of pressure (COP) along the anterior-posterior (AP) axis. 
 
4.3.9 Sensitivity analyses 
The results of the negative binomial regression analysis are summarised in Table 4.6. In 
univariate analysis, frailty, number of daily steps, number of daily sit-to-stands, handgrip 
strength, gait speed and TUG were associated with a higher number of falls. When this 
model was adjusted for diabetic nephropathy, only frailty, handgrip strength, gait speed 
and TUG remained significantly associated with falls. 
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Table 4.6. Sensitivity analyses. Negative binomial regression analysis. 
 Univariate  Adjusted*  
Factors RR (95% CI) P-value RR (95% CI) P-value 
Clinical characteristics     
Diabetic nephropathy (yes/no) 3.00 (1.04-8.64) 0.042 - - 
Frailty & physical function     
Frailty (yes/no) 4.10 (1.60-10.51) 0.003 3.53 (1.39-8.94) 0.008 
Time spent standing (h/day) 0.59 (0.32-1.08) 0.086 0.67 (0.37-1.20) 0.177 
Daily steps (n°) 0.99 (0.99-1.00) 0.006 1.00 (0.99-1.00) 0.076 
Daily sit to stands (n°) 0.96 (0.93-0.99) 0.042 0.98 (0.94-1.02) 0.384 
Handgrip (Kg) 0.94 (0.88-0.99) 0.034 0.94 (0.89-0.99) 0.018 
Gait speed (m/s) 0.08 (0.01-0.62) 0.016 0.11 (0.01-0.84) 0.034 
TUG (s) 1.16 (1.02-1.32) 0.021 1.14 (1.00-1.29) 0.044 
RangeY in EO (mm) 1.04 (0.99-1.10) 0.099 1.04 (0.99-1.09) 0.128 
Abbreviations: RR: rate ratio; CI: confidence interval; TUG: timed up and go test; 
RangeY: range of COP displacement along the anterior-posterior (AP) axis: EO: eyes 
open. * This model was adjusted for diabetic nephropathy. 
 
4.3.10 Further analyses 
We also explored the differences in PA, strength, physical function tests, and postural 
balance between frail and non-frail patients, as an auxiliary analysis. The independent 
comparisons between these two groups revealed that all of these outcomes were markedly 
decreased in frail patients (Figures 4.1, 4.2, 4.3, 4.4). 
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Figure 4.1. Differences in PA between frail and non-frail patients (mean ± SEM) 
 
Abbreviations: SEM: standard error of the mean; PA: physical activity; * indicates a 
statistical significant difference between groups (p < .05); ** indicates a statistical 
significant difference between groups (p < .01). 
 
Figure 4.2. Differences in strength between frail and non-frail patients (mean ± SEM) 
 
Abbreviations: SEM: standard error of the mean; * indicates a statistical significant 
difference between groups (p < .05); ** indicates a statistical significant difference 
between groups (p < .01). 
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Figure 4.3. Differences in functional tests. Frail vs non-frail patients (mean ± SEM) 
 
Abbreviations: SEM: standard error of the mean; TUG: timed up and go test; CSTS-5: 5 
repetitions chair sit to stand test; * indicates a statistical significant difference between 
groups (p < .05); ** indicates a statistical significant difference between groups (p < .01). 
 
Figure 4.4. Differences in postural balance (EO). Frail vs non-frail patients (mean ± SEM) 
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Abbreviations: EO: eyes open; SEM: standard error of the mean; RangeX: range of centre 
of pressure (COP) displacement along the medial-lateral (ML) axis; RangeY: range of 
COP displacement along the anterior-posterior (AP) axis; RMSX: root mean square 
displacement along the ML axis; RMSY: root mean square displacement along the AP 
axis; AbsVel: absolute velocity; VelX: velocity along the ML axis; VelY: velocity along 
the AP axis; Area95: 95% confidence ellipse area; * indicates a statistical significant 
difference between groups (p < .05); ** indicates a statistical significant difference 
between groups (p < .01). 
 
Additionally, we explored the relationships among PA, strength, physical function tests, 
and postural balance in the whole sample of study participants by means of Spearman’s 
bivariate correlations. Overall, the PA variables did not correlate with postural balance in 
EO and strength. Time spent standing did not correlate to any of the physical function 
tests, while time spent stepping, number of daily steps, and number of daily sit to stands 
were moderately to strongly correlated with gait speed, TUG, and CSTS-5 
(.295≤Rs≤.522). Handgrip and leg extension strength were weakly to moderately (-
.234≤Rs≤-.499) correlated with the velocity-based measures of postural balance (AbsVel, 
VelX, and VelY) in both EO and EC conditions, and moderately to strongly correlated 
with physical function tests (-.340≤Rs≤-.508). The physical function tests had weak to 
moderate correlations with postural balance (-.232≤Rs≤.500). Lastly, three postural 
balance variables (RangeY, RMSY, Area95) in EC had weak to moderate correlations 
with time spent standing, time spent stepping, and number of daily steps (-.259≤Rs≤-.360). 
The complete correlation tables of PA, strength, functional tests, and postural balance are 
summarised in the Appendices XV and XVI. 
The relationship between diabetes and PA, strength, physical function tests, and postural 
control was also explored by means of Spearman’s correlation (Tables 4.7 & 4.8). 
Diabetes as PRD did not correlate with physical function tests and postural balance. On 
the other hand, diabetes had a moderate negative correlation with time spent stepping and 
number of daily steps, as well as a moderate positive correlation with leg extension. Figure 
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4.5 displays the Venn’s diagram summarising the distributions of falls, frailty, and 
diabetic status in the study population. 
 
 Table 4.7. Correlations of diabetes (PRD) and postural balance 
Variables 
RangeX 
in EO 
RangeY 
in EO 
RMSX 
in EO 
RMSY 
in EO 
AbsVel 
in EO 
VelX 
in EO 
VelY 
in EO 
Area95 
in EO 
Diabetes 
(yes/no) 
-0.068 0.088 -0.093 0.007 0.065 -0.053 0.125 -0.019 
Sig. 0.566 0.453 0.431 0.950 0.583 0.653 0.287 0.871 
 RangeX 
in EC 
RangeY 
in EC 
RMSX 
in EC 
RMSY 
in EC 
AbsVel 
in EC 
VelX 
in EC 
VelY 
in EC 
Area95 
in EC 
 0.035 0.184 0.009 0.118 0.124 -0.016 0.183 0.065 
Sig. 0.765 0.116 0.940 0.317 0.293 0.891 0.119 0.583 
Abbreviations: PRD: primary renal disease; EO: eyes open; EC: eyes closed; RangeX: 
range of centre of pressure (COP) displacement along the medial-lateral (ML) axis; 
RangeY: range of COP displacement along the anterior-posterior (AP) axis; RMSX: root 
mean square displacement along the ML axis; RMSY: root mean square displacement 
along the AP axis; AbsVel: absolute velocity; VelX: velocity along the ML axis; VelY: 
velocity along the AP axis; Area95: 95% confidence ellipse area. 
 
Table 4.8. Correlations of diabetes (PRD) and PA, strength, physical function 
Variables 
Time 
spent 
standing 
Time 
spent 
stepping 
Daily 
steps 
Daily 
sit to 
stands Handgrip 
Leg 
extension 
Gait 
speed TUG 
CSTS-
5 
Diabetes 
(yes/no) 
-0.099 
-.343 -.363 -0.204 0.067 .313 -0.075 0.085 -0.120 
Sig. 0.454 0.008 0.005 0.122 0.566 0.006 0.524 0.473 0.324 
Abbreviations: PRD: primary renal disease; PA: physical activity; TUG: timed up and go 
test; CSTS-5: 5 repetitions chair sit to stand test. 
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Figure 4.5. Venn’s diagram: distribution of falls, frailty and diabetic status in the study 
population. 
 
 
4.4 Discussion 
We hypothesised that frailty and the falling status would be associated in CKD-5 patients 
on HD, and that physical function components such as PA, strength, TUG, CSTS-5 and 
postural balance would also be associated with falling. 
The study findings seem to confirm the first research hypothesis, as the Fried’s frailty 
phenotype, and its single components of self-reported exhaustion, and low PA levels were 
Falls
DiabetesFrailty
9.2% 
61.1% 
36.8% 26.7% 
29.2% 21.1% 
10.7% 
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significantly more prevalent in fallers compared to non-fallers. Moreover, frailty was 
associated with an approximately three-fold higher risk of falling in logistic regression 
analysis. As for the second research hypothesis, this appears to be at least partially 
supported as we found significant differences between fallers and non-fallers in postural 
balance, both in EO and EC condition, and in objectively measured PA variables, namely 
the number of daily steps and the time spent standing and stepping. Nevertheless, other 
physical function measures, such as the TUG, CSTS-5, handgrip, and leg extension did 
not differ significantly between the two groups. Moreover, only postural balance was 
associated with increased odds of falling in logistic regression analysis. 
In agreement with a previous study, which reported frailty to be an independent predictor 
of a higher number of falls (McAdams-DeMarco et al., 2013), our study results also 
highlight a significant association of frailty with a positive falling status. Although 
McAdams-DeMarco et al., (2013) analysed the association between frailty and number of 
falls experienced, rather than the falling status (i.e. whether patients fell or not), the results 
from the two studies are remarkably similar, as highlighted by the odds ratios reported in 
the univariate (3.55, 95% CI: 1.68-7.46; vs 3.35, 95% CI: 1.14-9.85) and multivariate 
(3.09, 95% CI: 1.38-6.90; vs 3.15, 95% CI: 1.04-9.54) regression analysis, and they both 
suggest that frailty is associated with a roughly three-fold higher risk of falls in the CKD-
5 population on HD. The single frailty components of self-reported exhaustion and low 
PA levels seemed to be the main drivers responsible for the positive association observed 
between frailty and falls, since these components were significantly more prevalent in 
fallers compared with non-fallers (84.1% vs 59.3%, and 59.1% vs 28.6% respectively). 
On the other hand, the unintentional weight loss, low strength and slow gait speed 
components were not significantly different in fallers and non-fallers, and consequently 
they may not contribute substantially to a higher risk of falls. Besides, the study results 
suggest that handgrip and leg extension strength were not significantly different between 
fallers and non-fallers, which further corroborates this observation. A more cautious 
interpretation should be made for the low gait speed component of frailty. Although the 
statistical analysis did not reveal a significant difference in this frailty component between 
the two groups, fallers tended to meet the Fried’s criteria of low gait speed more frequently 
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than non-fallers (36.4% vs 17.9%, p= .092), and to have lower gait speed in absolute terms 
(0.81±0.25 m/s vs 0.93±0.27m/s, p= .06). Therefore, it should be acknowledged that this 
borderline statistical significance may be the result of the relatively small sample size of 
the study. Particularly, the small study size could have inflated the chances of committing 
a type II error, namely the probability of retaining a null hypothesis that is actually false. 
Interestingly, both objective measurements of PA and strength had moderate to strong 
correlations with the physical function tests, in the whole sample of patients, but they did 
not correlate with each other. This observation seems to reflect the fact that low levels of 
PA and low strength are two independent components of frailty, and only the former 
seemed to be linked to an increased risk of falling. A study finding in support of this 
statement is that, additionally to the higher frequency of low self-reported PA in fallers 
compared to non-fallers, as highlighted by the Short IPAQ (Table 4.1), we also found 
lower objective measures of PA in the group of fallers (Table 4.2). The ActivPal results 
revealed that time spent standing and stepping, as well as the number of daily steps were 
significantly lower in fallers. Particularly, the average number of daily steps taken by the 
study participants (2566±1462 in fallers vs 3731±1966 in non-fallers) was considerably 
lower than the 7000-8000 steps/day threshold recommended to maintain a good physical 
fitness in elderly adults (Aoyagi et al., 2009). This was not surprising in light of the fact 
that dialysis patients have self-reported levels of PA below the 5th percentile of healthy 
individuals (Johansen et al., 2010), and the association between low PA and falls, 
emerging from the study results, may ultimately reflect the effect of poor physical fitness 
on the occurrence of falls in this patient population. 
Interestingly, we did not find any significant differences in physical function, as assessed 
by means of gait speed, TUG, and CSTS-5 in fallers vs non-fallers. These tests assess the 
physical function of the lower limbs in particular, which is strongly associated with all-
cause mortality in CKD (Roshanravan et al., 2013). Despite the fact that both the TUG 
and the CSTS-5 have been suggested to be useful tools in predicting the probability of 
falls in older adults (Schumway-Cook et al., 2000; Ward et al., 2015), studies conducted 
in dialysis patients do not seem to confirm this relationship. Particularly, two studies 
examined, among other risk factors, the association between physical function and falls in 
142 
 
dialysis patients, and concluded that the TUG was not predictive of falls (Cook et al., 
2006; Farragher et al., 2014), while other two studies (Desmet et al., 2005; Rossier et al., 
2012) found significant differences in the arising test (the ability to rise from a chair 
without help from the arms) and in the performance-oriented mobility assessment 
(POMA) between fallers and non-fallers, in univariate but not in multivariate analysis. 
Only one study reported failing to walk 10 meters unassisted as an independent predictor 
of falls in HD patients (Desmet et al., 2005). Although this kind of test assesses walking 
performance in a similar way to the 15 feet gait speed test, which was used in our study, 
the outcome of this assessment is a categorical binary variable (able/unable) as opposed 
to a continuous variable. The categorisation of walking performance in terms of 
able/unable to walk 10 meters independently implies arguably worse clinical outcomes 
compared to the low gait speed component of frailty (Chapter 2, paragraph 2.2.1) 
according to the Fried’s criteria (Fried et al., 2001). Consequently, it is not surprising that 
the walking performance test administered by Desmet et al., (2005) resulted into a 
significant association with falls. 
Ultimately, based on the study results and on the previous body of literature, it is not 
possible to pinpoint which, if any, physical function tests may be more closely associated 
with falling status in CKD-5 patients on HD. However, the observations that physical 
function, as assessed by the gait speed, TUG, and CSTS-5 tests, was the only component 
to correlate (moderately to strongly) with all the other physical function determinants, 
namely PA, strength and balance, and that frailty is intrinsically linked to lower physical 
function (Fried et al., 2001), seem to indirectly suggest that poor physical function may 
be inherently linked to falls, even if we didn’t observe it in the current study. Further 
research is warranted to identify which tests may better predict falls in this patient 
population.       
To the best of our knowledge, no previous research has explored the relationship between 
maximal isometric leg strength and falls, and our results did not reveal any significant 
association. Even though handgrip and isometric leg strength were markedly decreased in 
frail patients (Figure 4.2), as expected given that poor muscle strength is a defining 
component of frailty (Fried et al., 2001), we did not find any significant differences in 
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these variables between fallers and non-fallers. This finding suggests that, despite being 
closely related to frailty, muscle strength may not be a good predictor of falls in CKD-5 
patients on HD. 
The significant association between balance and falls is one of the most interesting 
findings of this investigation. Many significant differences in the postural balance 
variables emerged from the independent comparison of fallers and non-fallers, and most 
importantly postural balance (VelY in EO) was associated with increased odds of falling 
(OR: 1.14, 95% CI: 1.02-1.28, p= 0.022) in multivariate logistic regression analysis. 
Overall, patients with falls had statistically significant higher sway measures, indicating a 
worse balance performance and potentially a higher risk of falling (Maki et al., 1994). 
Particularly, seven and nine out of the nine variables taken for the analysis, in the EO and 
EC condition respectively, were significantly lower in fallers: this might indicate that 
static balance control is more closely associated with falls when vision is removed, a 
condition that highlights the importance of the proprioceptive regulatory component of 
balance (Horak et al., 1997). There are several possible explanations as to why 
proprioception might be impaired in CKD-5 patients undergoing HD. For instance, 
patients may present with peripheral neuropathy as a result of diabetes, uremia, or drug 
toxicity (Baluarte et al., 2017), while physical inactivity and low muscle mass could also 
hinder the proprioceptive integration processes. A further noteworthy finding was that 
postural balance (VelY in EO) resulted significantly associated with increased odds of 
falling even when the logistic regression analysis was adjusted for frailty status (OR: 1.12, 
95% CI: 1.01-1.26, p= 0.04). This finding suggests that postural balance may be a risk 
factor for falls independent from frailty. Moreover, the observation that postural balance 
showed weak to moderate correlations with muscle strength and functional tests, but no 
correlation with PA, also indicates that postural balance represents a physical function 
outcome at least partially independent from frailty.  
The prevalence of frailty in our study was 36.8%. Remarkably, a recent systematic review 
with meta-analysis concluded that the pooled prevalence of objectively measured frailty 
in CKD-5 patients is 36.8% (Kojima, 2017). Therefore, our findings are perfectly aligned 
with this estimate, and we are led to conclude that the study results relating to prevalence 
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of frailty may be generalised to the CKD-5 population. It should be highlighted that this 
prevalence is considerably lower than the 67-73% reported in larger observational studies 
that used a self-reported definition of frailty (Johansen et al., 2007; Bao et al. 2012), which 
further questions the validity of the frailty estimates obtained from these studies (Kojima 
et al., 2017). The prevalence of frailty emerging from our study is also fairly similar to the 
41.8% found by McAdams-DeMarco et al., (2013), who also measured frailty objectively 
by means of the Fried’s criteria (Fried et al., 2001). It should also be noted that the slightly 
smaller prevalence of frailty in our study, compared to McAdams-DeMarco et al., (2013), 
could be due to the stricter inclusion criteria. Because non-ambulatory patients, who are 
more likely to be frail, were not eligible to take part in the study, it is possible that this 
may have resulted in a slight underestimation of frailty in our cohort. Nevertheless, the 
prevalence of frailty was substantially higher than the 7% generally reported for the 
general population over 65 years of age (Fried et al., 2001), and we can conclude that our 
study results fully support the already overwhelming evidence that CKD-5 patients on HD 
are frailer than their non-uraemic, age-matched, counterparts (Kojima et al., 2017). 
Interestingly, despite the self-evident relationship between age and frailty (Fried et al., 
2001), age was not statistically different in fallers (59.9±13.2 years) compared to non-
fallers (62.3±15.2 years). Although many studies reported age to be a significant risk 
factor for falls in dialysis patients (Desmet et al., 2005; Roberts et al., 2007; Rossier et al., 
2012; Kutner et al., 2014; Farragher et al., 2014; Delgado et al., 2015; Kono et al., 2018), 
our finding is not an anomaly and is aligned with previous research that found no 
interaction between age and falls in HD patients (McAdams-DeMarco et al., 2013). 
Ultimately, in the context of CKD-5, the relationship between falls and age may be 
confounded by the presence of chronic inflammation, oxidative stress, and consequent 
muscle wasting, all of which contribute to a model of premature aging (Kooman et al., 
2014). 
As highlighted in paragraph 4.3.2, fallers were more likely to have diabetes as PRD 
compared to non-fallers (34.9% vs 12.9%). Although both diabetes and frailty were 
associated with falls, frailty was not significantly associated with diabetes, and when the 
logistic regression analysis was adjusted for diabetic status (Table 4.5) frailty was still 
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significantly associated with increased odds of falling (OR: 3.15, 95% CI: 1.04-9.54, p= 
0.04). This finding seems to indicate that frailty is a risk factor for falls independent from 
diabetes. Moreover, diabetes did not correlate with most of the physical function measures 
(Tables 4.7 & 4.8) which further suggests that this factor may be linked to falls via a 
different aetiology in this patient group. The potential role of diabetes on falls will be 
further discussed in Chapter 5. 
 
4.4.1 Study limitations 
Because the study size was relatively small, we could not perform a more exhaustive a 
priori multivariate logistic regression analysis, which would be required to test more 
robustly the interrelationships between frailty, the physical performance outcomes, and 
falls. 
In addition, the classification of fallers and non-fallers was based on self-reported 
information, which might be subjected to some degree of misreporting (Hauer et al., 
2006). Although we sought to minimise the risk of underreporting falls by following up 
prospectively the participants every month (Cummings et al., 1988), patients were also 
classified as fallers if they recalled at least one fall in the previous 12 months and, since 
this is a longer recall interval, the potential for misreporting is higher (Ganz et al., 2005). 
It should be acknowledged that such a classification was made to counterbalance the risk 
of misclassifying patients with a significant, and fairly recent, history of falls as non-
fallers just because they did not report any further falls during the prospective follow-ups. 
 
4.4.2 Conclusions 
In conclusion, this cross-sectional investigation indicates that frailty is associated with 
falls in CKD-5 patients undergoing HD therapy. Although frail patients had markedly 
decreased physical performance measures, such as lower PA, muscle strength, physical 
function, and postural balance, patients classified as fallers only showed lower levels of 
PA, and worse postural balance performance compared to non-fallers. Postural balance 
was also associated with increased odds of falling. This physical performance outcome is 
not traditionally included in the operational definition of frailty, and it might represent an 
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additional risk factor of falls. Further research is warranted to identify which physical 
function measures may be more closely associated with falls in the CKD-5 population on 
HD. 
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CHAPTER 5: BAROREFLEX FUNCTION, HAEMODYNAMIC RESPONSES 
TO AN ORTHOSTATIC CHALLENGE, AND FALLS IN HD PATIENTS 
 
Abstract 
Background: CKD-5 patients maintained on HD often present with dizziness and pre-
syncopal events as a result of the combined effect of HD therapy and cardiovascular 
disease. The dysregulation of blood pressure (BP) during orthostasis may be implicated 
in the aetiology of falls in these patients. Therefore, we explored the relationship between 
baroreflex function, the haemodynamic responses to a passive orthostatic challenge, and 
falls in HD patients. 
Methods: Seventy-six HD patients were enrolled in this cross-sectional study. Participants 
were classified as “fallers” and “non-fallers” and completed a passive head up tilting to 
60o (HUT-60°) test on an automated tilt table. ECG signals, continuous and oscillometric 
BP measurements and impedance cardiography were recorded. The following variables 
were derived from these measurements: heart rate (HR) stroke volume (SV), cardiac 
output (CO), total peripheral resistance (TPR), number of baroreceptor events, and 
baroreceptor effectiveness index (BEI). 
Results: The forty-four participants who were classified as fallers (57.9%) had a lower 
number of baroreceptor events (6.5±8.5 vs 14±16.7, p= .027) and BEI (20.8±24.2% vs 
33.4±23.3%, p= .025). In addition, fallers experienced a significantly larger drop in 
systolic (-6.4±10.9 vs -0.4±7.7 mmHg, p= .011) and diastolic (-2.7±7.3 vs 1.8±6 mmHg, 
p= .027) oscillometric BP from supine to HUT-60° compared with non-fallers. None of 
the variables taken for the analysis were significantly associated with falls in multivariate 
logistic regression analysis. 
Conclusions: This cross-sectional comparison indicates that, at rest, HD patients with a 
positive history of falls present with a lower count of baroreceptor sequences and BEI.  
Short-term BP regulation warrants further investigation as BP drops during a passive 
orthostatic challenge may be implicated in the aetiology of falls in HD. 
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5.1 Introduction 
Cardiovascular disease is the most prevalent comorbidity in the CKD population (UKRR, 
2016) and indices of poor cardiovascular function such as arterial stiffness (Wong et al., 
2014), impaired BP responses to a passive orthostatic challenge (Shaw et al., 2015), and 
antihypertensive drug therapies (Tinetti et al., 2014; Angelousi et al., 2014), have been 
linked to a higher prevalence or incidence of falls in elderly but otherwise healthy 
individuals. In two prospective cohort studies, a lower pre-dialysis systolic BP was found 
to be associated with falling status in a group of elderly dialysis patients (Cook et al., 
2006; Polinder-Bos et al., 2014) suggesting that falls might be mediated by low BP spells 
in these patients. Other researchers suggested that autonomic failure and the significant 
fluid shifts associated with HD therapy might place HD patients at an increased risk of 
postural dizziness and hypotensive symptoms, possibly resulting in falls (Roberts et al., 
2003). In addition, Cook et al., (2006) reported that 31% of falls experienced by HD 
patients occurred during the transition from the seated to the upright position, suggesting 
that abnormal BP regulation, leading to dizziness spells, and potentially orthostatic 
hypotension, may be implicated in the aetiology of falls in these patients. All these 
observations lead us to hypothesise that impaired BP regulation particularly during 
postural changes may be an additional risk factor for falls that further exacerbates the risks 
coming from physical frailty and chronological aging alone.  
The baroreceptor reflex, or baroreflex, is the main physiological mechanism involved in 
the short-lived haemodynamic responses to change in body position, by regulating BP, 
heart rate, cardiac output, peripheral resistance, and thus preventing hypotension 
(Schwartz et al., 2012). This mechanism may be altered in CKD patients, and its 
impairment has been linked to vascular stiffness, increased cardiovascular risk and all-
cause mortality in CKD patients (Hildreth et al., 2012; Johansson et al., 2007).  Despite 
the association of an impaired baroreflex control with the dysregulation of BP during 
orthostasis (Mattace-Raso et al., 2007), which could lead to hypotensive symptoms and 
falls, the relationship between baroreflex function and falls in HD patients has been largely 
unexplored. Therefore, our study is the first step in the process of collecting and 
documenting evidence of potential relationships between falls and BP control during an 
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orthostatic challenge in HD patients. We hypothesised that 1) lower baroreflex function 
would be associated with falling status, and that 2) self-reported fallers would be more 
likely to have worse haemodynamic responses to an orthostatic challenge. 
 
5.2 Essential methods 
5.2.1 Study design 
A cross-sectional study design was used to explore the relationship between 
baroreflex/haemodynamic function and the falling status (“faller” vs “non-faller”) in a 
group of prevalent CKD-5 patients on HD. The study participants underwent a 
comprehensive assessment of cardiovascular function measures at baseline, and they were 
subsequently classified as fallers or non-fallers based on the occurrence or not of at least 
one fall during a 12-month prospective observational period. In addition, patients with a 
history of at least one fall in the previous 12 months were also classified as fallers, so as 
to minimize the chances of misclassifying patients as non-fallers. 
 
5.2.2 Data collection 
Falls, baroreflex and haemodynamic function at rest, and in response to a passive 
orthostatic challenge consisting of HUT-60° were assessed, as fully detailed in Chapter 2.  
 
5.2.3 Sample size 
Preliminary study size considerations are described in Chapter 2, paragraph 2.1.3. 
The sample size (N) calculation was based on the smaller proportion (P1) of the dependent 
variable, as recommended in logistic regression analysis by Peduzzi et al., (1996), with 
the following formula: N= (10 K)/ P1. The dependent variable was defined as membership 
to the group “fallers” (≥ 1 fall sustained), and P1 was defined, based on the study results, 
as P1= .389 (proportion of non-fallers, as reported in Chapter 4, paragraph 4.3.3). “K” 
represents the number of independent (explanatory) variables, and equals to K= 2, as we 
entered 2 variables simultaneously in the model: the explanatory variable, e.g. 
baroreflex/haemodynamic function (one variable entered at a time) AND the diabetic 
status, which was retrospectively identified as a potential confounder of the study results 
150 
 
(Chapter 4, paragraph 4.3.2). Therefore, substituting the values into the equation results 
in: N= (10* 2)/.389, which equates to N= 52. This is the minimum sample size required 
to provide an unbiased association for each explanatory variable in the logistic regression 
model (Peduzzi et al., 1996). 
 
5.2.4 Statistical analysis 
Statistical analyses were performed with SPSS (Version 23.0 for Windows, SPSS Inc., 
Chicago, IL). The Shapiro-Wilk Test (S-W) was used for the normal distribution checks 
of all data. Differences between fallers and non-fallers in demographic and clinical 
characteristics were analysed by means of a Chi-Squared test for categorical variables, 
and by either Mann-Whitney U or independent t-tests, as appropriate, for continuous 
variables: results are expressed as mean and standard deviation (SD). The effect of 
grouping, i.e. fallers vs non-fallers, on the baroreflex and haemodynamic variables was 
analysed by means of either parametric (independent t-tests) or non-parametric (Mann-
Whitney U) independent comparisons, based on normal distribution assumptions. 
Statistical limits for interpretation were set at an alpha level of p = .05. 
The association between the baroreflex function/haemodynamic responses and falls (yes 
or no) was analysed by means of logistic regression analysis: variables reaching a 
statistical significance level of p≤ 0.10, in the preliminary independent comparisons, were 
entered in a univariate logistic regression model, which was adjusted a posteriori in a 
multivariate analysis. 
In a sensitivity analysis, we also analysed the association between cardiovascular function 
and the number of falls recorded during the 12-month prospective follow-up by means of 
negative binomial regression analysis: variables reaching a statistical significance level of 
p≤ 0.10 in the univariate negative binomial regression model were entered in multivariate 
analysis. Statistical limits for interpretation of the logistic and negative binomial 
regression analyses were also set at an alpha level of p = .05. 
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5.3 Results 
5.3.1 Recruitment and loss to follow-up 
The screening and recruitment figures of the study are detailed in Chapter 3 (paragraph 
3.3.1). Seventy-six patients were enrolled in the study and completed the baseline 
assessments. As detailed in paragraph 3.3.1, nine patients were lost to follow-up. 
However, five of these patients were retained in the data analysis due to their positive 
history of falls, which automatically classified them as fallers for the purposes of this 
cross-sectional investigation. Moreover, 14 patients were excluded from the baroreflex 
function data analysis due to atrial fibrillation (n= 7; 9.2%) and to poor circulatory blood 
flow to the fingers, which rendered the contBP measurement unusable (n= 7; 9.2%). This 
resulted in the inclusion of 62 patients in the baroreflex function analysis. After the 
exclusion of the seven patients with poor blood circulation, 69 patients were retained for 
the haemodynamic responses analysis.  
 
5.3.2 Demographic and clinical characteristics 
Participants classified as fallers were more likely to have diabetes as primary renal disease 
(PRD) (34.9% vs 12.9%), and less likely to use diuretics (27.3% vs 53.3%) compared to 
non-fallers. No differences in other clinical characteristics were detected. 
 
5.3.3 Falls 
Forty-four and 28 patients were classified as fallers and non-fallers respectively, as 
detailed in Chapter 4 (paragraph 4.3.3). Further information on the falls estimates 
emerging from the study is detailed in Chapter 3, paragraph 3.3.3. The most commonly 
reported precipitating factors leading to a fall are synthesised in Chapter 3 (paragraph 
3.3.4.3). 
    
5.3.4 Haemodynamic and baroreflex function 
The differences between fallers and non-fallers in all baroreflex variables are summarised 
in Table 5.1. At rest, fallers had a statistically significant lower count of baroreceptor 
“down-events” and “total-events”, which also resulted in a significant lower “down-BEI” 
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and “total-BEI”, compared to non-fallers. In addition, the “up-BEI” during HUT-60° was 
also significantly lower in fallers. No significant differences in BRS were detected 
between the two groups. 
 
Table 5.1. Baroreflex function: differences between fallers and non-fallers (mean ± SD). 
Group means reflect averaged data for the total duration of five minutes in each postural 
position.  
 Supine  HUT-60  
Variables Fallers (44) Non-fallers (28) Fallers (44) Non-fallers (28) 
Up-ramps (n°) (SD) 20.6 (21) 19.5 (13.5) 23.2 (15.9) 17.8 (13.5) 
Down-ramps (n°) (SD) 18.9 (17.7) 17.4 (11.9) 22.3 (14.2) 16.6 (12.9) 
Total-ramps (n°) (SD) 39.5 (38.2) 36.8 (25) 45.5 (29.2) 34.5 (26) 
Up-events (n°) (SD) 3.1 (4) 6.8 (9.5) 2.3 (3.5) 3.6 (4.4) 
Down-events (n°) (SD) 3.4 (4.8)* 7.1 (7.8) 3 (3.6) 3.9 (4.5) 
Total-events (n°) (SD) 6.5 (8.5)* 14 (16.7) 5.2 (6.3) 7.5 (8.4) 
Up-BEI (%) (SD) 15.5 (20.1) 29.2 (29.4) 10.7 (13.6)* 19 (15.7) 
Down-BEI (%) (SD) 23.3 (27)* 36.6 (22.8) 13.5 (15.7) 19.2 (15.7) 
Total-BEI (%) (SD) 20.8 (24.2)* 33.4 (23.3) 12.6 (13.4) 19.1 (13.2) 
BRS (ms/mmHg) (SD) 9.2 (8.3) 10 (6.1) 6.8 (4.9) 9.8 (8.3) 
Abbreviations: SD: standard deviation; HUT-60: head-up tilt at 60°; Up-BEI: up-events 
baroreceptor effectiveness index; Down-BEI: down-events baroreceptor effectiveness 
index; Total-BEI: total-events baroreceptor effectiveness index; BRS: baroreflex 
sensitivity; * indicates a statistical significant difference between groups (p < .05). 
 
The haemodynamic variables of fallers and non-fallers, in the supine position and during 
HUT-60°, are described in Table 5.2. The differences in SV, CO, TPR, HR, contSBP, 
contDBP, OscSBP, and OscDBP from the supine position to HUT-60° are expressed as 
absolute values. A significant larger decrement of OscSBP and OscDBP from supine to 
HUT-60° was detected between fallers and non-fallers, while no differences in the 
remaining haemodynamic variables were found. 
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Table 5.2. Haemodynamic variables: differences between fallers and non-fallers (mean ± 
SD). 
 Supine (1)  HUT60 (2)   Δ(1) - (2)  
 Fallers (44) Non-fallers(28) Fallers (44) Non-fallers (28) Fallers (44) Non-fallers(28) 
RRI (ms) (SD) 869.2 (134.1) 926.6 (187.5) 809.4 (168) 868.4 (192.8) -57.9 (70.2) -58.1 (64.5) 
HR (bpm) (SD) 70.9 (10.7) 67.7 (13.2) 77.7 (15.2) 72.9 (15.2) 6.6 (8.3) 5.5 (5.8) 
contSBP (mmHg) (SD) 125.4 (23.5) 122 (21.6) 126.6 (21.8) 125.1 (20.3) 3.5 (15.6) 3 (8) 
contDBP (mmHg) (SD) 76.5 (14) 79.4 (16.4) 82 (15.2) 85.4 (16.3) 6.1 (10.2) 6 (7.6) 
contmBP (mmHg)(SD) 97.3 (10.3) 97 (18.3) 100.8 (17.7) 101.9 (17.9) 4.7 (12.1) 4.9 (7.3) 
SV (ml) (SD) 63.6 (14) 69.1 (16.1) 59.1 (11.8) 62.9 (15.5) -4.1 (12.9)  -6.2 (16.3) 
CO (L/min) (SD) 4.5 (1.1) 4.7 (1.5) 4.5 (0.9) 4.5 (1.2) 0.03 (0.9) -0.2 (1.2) 
TPR (dyne*s/cm5)(SD) 1731.8 (432.4) 1763.9 (610.8) 1797.7 (451.5) 1919.5 (583.1) 77.9 (347.2) 155.5 (416.4) 
SI (ml/m2) (SD) 34.8 (8.3) 37 (10.7) 32.4 (7.4) 33.4 (8.5) -2.2 (7) -3.7 (9.1) 
CI (L/min*m2) (SD) 2.5 (0.7) 2.5 (1) 2.5 (0.5) 2.4 (0.7) 0.01 (0.5) -0.1 (0.6) 
TPRI(dyne*s*m2/cm5) 3168.5 (789.6) 3381.1 (1340.9) 3292.1 (807) 3645.1 (1260) 146.7 (624) 264.1 (773.5) 
TFC (1/kOhm) (SD) 32.3 (10.6) 34.4 (11.1) 30.3 (10.1) 32.4 (11.1) -1.6 (1.7) -2 (1.8) 
OscSBP (mmHg) (SD) 131.3 (22.6) 124.1 (19.8) 122.2 (18.3) 123.9 (13.1) -6.4 (10.9)* -0.4 (7.7) 
OscDBP (mmHg) (SD) 81.9 (12.9) 79.9 (15.8) 79.1 (13.2) 81.6 (17.4) -2.7 (7.3)* 1.8 (6) 
Abbreviations: SD: standard deviation; HUT60: head-up tilt at 60°; RRI: R-R interval; 
HR: heart rate; contSBP: continuous systolic blood pressure; contDBP: continuous 
diastolic blood pressure; contmBP: continuous mean blood pressure; SV: stroke volume; 
CO: cardiac output; TPR: total peripheral resistance; SI: stroke index; CI: cardiax index; 
TPRI: total peripheral resistance index; TFC: thoracic fluid content; OscSBP: 
oscillometric systolic blood pressure; OscDBP: oscillometric diastolic blood pressure; 
Δ(1) - (2) represents the difference between the variables averaged over five minutes of 
HUT-60° and the variables averaged over five minutes of supine recording; * indicates a 
statistical significant difference between groups (p < .05). 
 
5.3.5 Factors associated with falls 
In univariate logistic regression, diabetic nephropathy, number of “down-events” and 
“total-events” in the supine position, “up-BEI” in the supine position, “up-BEI” in HUT-
60°, OscSBP and OscDBP difference from the supine position to HUT-60° were 
associated with increased odds of falling (Table 5.3).  
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The univariate analysis was adjusted for diabetic status, as we retrospectively identified 
this factor to be potentially a significant confounder of the study results. In this 
multivariate logistic regression model, none of the variables were significantly associated 
with falling (Table 5.3). 
 
Table 5.3. Logistic regression analysis: factors associated with falls. 
 Univariate  Adjusted  
Factors Odds Ratio (95% CI) P-value Odds Ratio (95% CI) P-value 
Clinical characteristics     
Diabetic nephropathy (%) 3.616 (1.064–12.286) 0.039 - - 
Baroreflex function     
Down-events supine (n°) 0.909 (0.832-0.993) 0.034 0.932 (0.851-1.021) 0.130 
Total-events supine (n°) 0.953 (0.910-0.997) 0.037 0.961 (0.919-1.006) 0.087 
Up-BEI supine (%) 0.977 (0.956-0.999) 0.045 0.978 (0.954-1.001) 0.066 
Up-BEI HUT-60 (%) 0.961 (0.925-1.000) 0.048 0.975 (0.936-1.015) 0.221 
Down-BEI supine (%) 0.980 (0.959-1.001) 0.058 0.986 (0.964-1.008) 0.216 
Total-BEI supine (%) 0.978 (0.956-1.001) 0.060 0.983 (0.960-1.008) 0.175 
Total-BEI HUT-60 (%) 0.964 (0.925-1.005) 0.085 0.983 (0.940-1.027) 0.437 
Haemodynamic variables     
OscSBP Δsupine – HUT60 (mmHg) 0.930 (0.871-0.992) 0.028 0.939 (0.876-1.008) 0.080 
OscDBP Δsupine – HUT60 (mmHg) 0.894 (0.813-0.983) 0.021 0.908 (0.816-1.010) 0.075 
Abbreviations: CI: confidence interval; Up-BEI: up-events baroreceptor effectiveness 
index; Down-BEI: down-events baroreceptor effectiveness index; Total-BEI: total-events 
baroreceptor effectiveness index; HUT60: head-up tilt at 60°; OscSBP: oscillometric 
systolic blood pressure; OscDBP: oscillometric diastolic blood pressure; ΔSupine-HUT60 
represents the difference between the variables averaged over five minutes of HUT-60° 
and the variables averaged over five minutes of supine recording. 
 
5.3.6 Sensitivity analyses 
The results of the negative binomial regression analysis are summarised in Table 5.4. In 
univariate analysis, baroreflex indices of frequency such as number of up-events, number 
of down-events, number of total-events, up-BEI, down-BEI and total-BEI in the supine 
position were associated with a higher number of falls. In addition, the CO and OscDBP 
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responses to HUT-60° were also associated with a higher number of falls. When the 
univariate model was adjusted for diabetic nephropathy, all baroreflex measures remained 
significantly associated with falls, while only the CO response to HUT-60° remained 
significantly associated. 
 
Table 5.4. Sensitivity analyses. Negative binomial regression analysis. 
 Univariate  Adjusted*  
Factors RR (95% CI) P-value RR (95% CI) P-value 
Clinical characteristics     
Diabetic nephropathy (yes/no) 3.00 (1.04-8.64) 0.042 - - 
Cardiovascular function     
Up-events supine (n°) 0.83 (0.72-0.96) 0.010 0.86 (0.75-0.99) 0.032 
Down-events supine (n°) 0.86 (0.76-0.96) 0.009 0.88 (0.78-0.99) 0.042 
Total-events supine (n°) 0.91 (0.86-0.98) 0.008 0.93 (0.87-0.99) 0.029 
Up-BEI supine (%) 0.96 (0.94-0.99) 0.004 0.97 (0.95-0.99) 0.015 
Down-BEI supine (%) 0.96 (0.94-0.98) 0.001 0.97 (0.95-0.99) 0.005 
Total-BEI supine (%) 0.96 (0.93-0.98) ˂0.001 0.96 (0.94-0.99) 0.003 
RRI Δsupine – HUT60 (mmHg) 1.01 (0.99-1.02) 0.074 1.00 (0.99-1.01) 0.714 
CO Δsupine – HUT60 (L/min) 0.51 (0.27-0.98) 0.043 0.55 (0.31-0.98) 0.043 
CI Δsupine – HUT60 (L/min*m2) 0.32 (0.10-1.06) 0.063 0.40 (0.15-1.05) 0.061 
OscSBP Δsupine – HUT60 (mmHg) 0.95 (0.89-1.01) 0.084 0.98 (0.92-1.04) 0.507 
OscDBP Δsupine – HUT60 (mmHg) 0.90 (0.83-0.98) 0.010 0.95 (0.86-1.04) 0.240 
Abbreviations: RR: rate ratio; CI: confidence interval; Up-BEI: up-events baroreceptor 
effectiveness index; Down-BEI: down-events baroreceptor effectiveness index; Total-
BEI: total-events baroreceptor effectiveness index; CO: cardiac output; RRI: R-R interval; 
CI: cardiac index; OscSBP: oscillometric systolic blood pressure; OscDBP: oscillometric 
diastolic blood pressure; Δsupine-HUT60 represents the difference between the variables 
averaged over five minutes of HUT-60° and the variables averaged over five minutes of 
supine recording. * This model was adjusted for diabetic nephropathy. 
 
5.3.7 Further analyses 
In order to evaluate the weight of the confounding effect of diabetes on the study results, 
we compared diabetic vs non-diabetic patients in terms of baroreflex function and BP 
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response to HUT-60°. The independent comparisons between the two groups indicate that 
these variables were markedly decreased in diabetic patients (Figure 5.1 & 5.2). 
In addition, we also performed a point biserial correlation analysis in the sub-group of 
non-diabetic patients (N=44) to explore the relationship between the factors entered in 
logistic regression analysis and falls. No significant correlations were found for any of the 
baroreflex function/haemodynamic variables and falls (-0.223 ≤Rs ≤ -0.088; 0.151 ≤P-
values≤ 0.583) when diabetic patients were removed. 
The heart rate variability (HRV) characteristics of the study participants are also 
summarised in the appendix XVII.  
 
Figure 5.1. Baroreflex function in diabetic vs non-diabetic patients.  
 
Abbreviations: BEI: baroreceptor effectiveness index. Figure 1A shows the number of 
baroreceptor events in the supine position; Figure 1B shows the number of baroreceptor 
events in HUT-60°; Figure 1C shows the BEI measured in the supine position; Figure 1D 
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shows the BEI measured in HUT-60°. * indicates a statistically significant difference (p˂ 
.05). ** indicates a statistically significant difference (p˂ .01). 
 
Figure 5.2. Changes in BP during transition from the supine position to HUT-60° 
(diabetic vs non diabetic).  
 
Abbreviations: OscBP: oscillometric blood pressure; SBP: systolic blood pressure; DBP: 
diastolic blood pressure; ** indicates the statistically significant drop in OscBP in diabetic 
patients (p˂ .01). 
 
5.4 Discussion 
We hypothesised that HD patients classified as fallers would have worse baroreflex 
function than patients free from falls. In addition, we hypothesised that patients with falls 
would have worse haemodynamic responses to an orthostatic challenge.  
We found that at rest, fallers had lower counts of baroreceptor “down-events” and “total-
events”, as well as a lower down-BEI and total-BEI compared to non-fallers. Although 
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we also expected to see a significantly impaired ability to effectively regulate the 
haemodynamic variables via the arterial baroreflex mechanism in the fallers group, in 
response to a passive orthostatic challenge, this was not confirmed. However, we noted a 
significantly larger drop in OscBP during the transition from supine to HUT-60o which 
warrants further investigation.  
Our findings on baroreflex function suggest that a lower number of baroreceptor 
sequences might discriminate patients with falls from those who are falls-free. Although 
no differences in the baroreflex slope, as assessed by BRS, were detected between fallers 
and non-fallers, measures reflecting how often the baroreflex is activated, such as the 
number of “down-events” and the “total-events”, among other BEI indices, were 
significantly lower in the group of fallers. Interestingly, in resting conditions, the 
baroreceptor down-regulation seemed to better discriminate fallers from non-fallers. A 
baroreceptor down-event occurs when a systolic BP drop is coupled with a concomitant 
decrease of the RRI, namely an increase in HR. This is a physiologic response to a 
spontaneous perturbation of BP, which allows the maintenance of haemodynamic 
homeostasis (Schwartz et al., 2012). Therefore, the lower count of baroreceptor “down-
events” observed in fallers, as well as the lower “down-BEI” might indicate a relationship 
between the failure to increase HR in response to a spontaneous drop in BP and falls. 
It should also be noted that, even though we did not assess a control group of healthy 
participants, the BEI indices measured in our patients (20.8±24.2% in fallers, and 
33.4±23.3% in non-fallers) are considerably lower than the average 58±20% BEI 
measured in healthy individuals (Pitzalis et al., 2003), while their BRS values were only 
slightly inferior (-15% to -25%) to those of an age-matched healthy population (Tang et 
al., 2014). Because a reduced BEI has already been shown to be an independent predictor 
of all-cause mortality in patients with CKD (Johansson et al., 2007), it is possible that this 
index might predict other adverse outcomes such as falls in this population. Potentially, 
the lower BEI as well as the lower number of baroreceptor events could be linked to 
syncope-related falls due to an impaired homeostasis of the HR and BP responses, which 
may lead to cerebral hypoperfusion with sudden onset of dizziness and pre-syncopal 
symptoms, which are commonplace among HD patients (Roberts et al., 2003). 
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Interestingly, in the current study, almost half of the patients who experienced falls during 
the prospective observational follow-ups (46.2%) reported dizziness or syncope-like 
events as one of the symptoms preceding a falling event, which indirectly implicates this 
mechanism in the aetiology of falls in HD patients.  
Although a direct biologic mechanism may exist between baroreflex function and falls, 
given the relationship between impaired baroreflex function and orthostatic BP 
decrements (Mattace-Raso et al., 2007), the study results do not seem to fully support the 
hypothesis that poor baroreflex function and orthostatic BP regulation are independent 
risk factors for falls in HD patients. While several baroreflex indices, as well as OscBP, 
were associated with falls in univariate logistic regression, adjusting the model for diabetic 
status resulted in no significant association between the baroreflex 
function/haemodynamic responses and falls. 
The role of diabetes, in the context of our study, plays a crucial role as 34.9% of the 
patients classified as fallers had diabetic nephropathy as PRD, compared to only 12.9% in 
the group of non-fallers. Diabetic nephropathy represents an advanced stage of diabetes, 
which is commonly associated with cardiovascular autonomic neuropathy and chronic 
sympathetic over-activity, both of which can affect the baroreflex and potentially the 
haemodynamic responses to orthostasis (Fisher et al., 2017). Therefore, the higher 
proportion of diabetic patients amongst fallers is likely to be a main driver of the 
significant differences observed between fallers and non-fallers in terms of baroreflex 
function and BP response to orthostasis. 
The point biserial correlation analysis performed in the subgroup of non-diabetic patients 
did not reveal any significant correlations between any of the baroreflex/haemodynamic 
variables and falls, which highlights the mediating effect of diabetes on the study results. 
This is an interesting finding considering that diabetes has been found to be an 
independent risk factor for falls in HD patients (Desmet et al., 2005), and our study results 
seem to indirectly suggest that impaired baroreflex and BP dysregulation may be one of 
the biological mechanisms underlying the higher occurrence of falls amongst diabetic HD 
patients.  
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Surprisingly, we did not find any differences in the SV, CO, TPR, HR, contSBP, and 
contDBP responses to the HUT-60° between fallers and non-fallers. This lack of effect 
may be explained in light of the relatively short duration of the orthostatic challenge. 
Although five minutes of orthostasis are considered to be sufficient for the diagnosis of 
orthostatic hypotension, according to the current guidelines (Brignole et al., 2004), it is 
possible that a longer orthostatic challenge could have yielded different results. For 
instance, Shaw et al., (2015) examined the cardiovascular responses to orthostasis in a 
group of elderly residents in long-term facilities. They found that, during an orthostatic 
challenge, the decreases in contBP were larger in those with a history of falls, but only in 
the delayed phase of orthostasis (3-15 minutes) rather than at the initial phase (0-3 
minutes). This might explain why we found a significant larger decrement in OscBP, but 
not in contBP between fallers and non-fallers: whilst OscBP assessment consists of single 
measurements, which capture the BP at a single time-frame, contBP may provide more 
useful information than single sphygmomanometer assessments, in terms of actual beat-
to-beat variations of BP (Pasma et al., 2014), but its measurement represents an average 
of several measurements over a given interval of interest. Therefore, the two type of BP 
measurements, despite being performed in the same phases, do not represent exactly the 
same haemodynamic data. 
During HUT-60°, for instance, the contSBP and contDBP reflect the overall BP 
performance over the five minutes of data acquisition and it is possible that a longer 
recording interval may also have revealed a larger decrement of BP in fallers. Moreover, 
the discrepancy between contBP and OscBP measurements during HUT-60° could also 
be explained in light of a possible hydrostatic effect: because postural changes can modify 
the distribution of hydrostatic pressures in fluid-filled body compartments (Hinghofer-
Szalkay, 2011), it is possible that the transition from supine to HUT-60° may have 
influenced to some extent the response of contBP due to the initial gravitational shift. On 
the other hand, during HUT-60°, OscBP was measured when the patient was already in 
the upright position, and therefore this measurement would be less subjected to hydrostatic 
adjustments arising from the tilting procedure. Although we sought to minimise the 
hydrostatic effects of tilting by standardising the testing procedures, as described in 
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appendix IX, it is possible that these may have played a role in the discrepancy observed 
between the two kinds of BP assessments. 
It should also be acknowledged that the resting BP of the study participants was 
surprisingly low considering that HD patients are usually hypertensive. This relatively 
low BP may be explained in light of the strict testing standardisation procedures which 
were designed to ensure the best possible haemodynamic state balance (e.g. no caffeine, 
supine rest prior to the assessment, non-dialysis day), and also by a possible 
underestimation of BP from the Task Force® Monitor (Brittain et al., 2018). Although 
this should not affect the study results, since the research aim was focused on exploring 
the relationship between the relative change in BP and falls, rather than the absolute values 
of BP, the generalisability of the study results to patients with higher or more poorly 
controlled resting BP should be cautious.  
Only a few studies examined the BP changes in response to orthostasis in HD patients, 
and found no association between the BP response to a pre-dialysis (Cook et al., 2006) or 
post-dialysis (Desmet et al., 2005; Roberts et al., 2007) orthostatic assessment and the 
patients’ falling status. Nevertheless, these studies assessed the BP response by means of 
OscBP measurements after active standing, a procedure that may be subjected to 
standardisation issues compared to the head-up tilt test, which is considered the reference 
standard for the assessment of orthostatic hypotension (Cooke et al., 2009). In addition, it 
should be acknowledged that the tilting angle might also be partly responsible for the lack 
of response. Typically, angles of 60°-90° are widely implemented in clinical practice 
(Khurana et al., 1996) and thus tilting patients beyond 60° could have constituted a larger 
haemodynamic challenge and concomitant response.  
The incidence of falls recorded was 1.16 falls/patient-year and is approximately 2.3 times 
greater than seen in the non-uraemic, community-dwelling elderly (O’Loughlin et al., 
1993). This confirms the increased risk of falling of HD patients compared with the 
general healthy population (Desmet et al., 2005). Although the current study was 
conducted in a small cohort of patients, our findings relating to the incidence of falls are 
broadly in agreement with those of larger observational studies. In particular, Desmet et 
al., (Desmet et al., 2005), reported a yearly incidence of 1.18 falls/patient-year for their 
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HD patients, which is very similar to that observed in our study (1.16 falls/patient-year). 
Additionally, the proportion of patients observed in our study, who experienced at least 
one fall during the 12-month follow-up (37.7%), is also very similar to that reported in 
previous research (28.3%) (McAdams-DeMarco et al., 2013). Therefore, our findings on 
falling behaviour in HD patients seem to be representative of this patient group, and results 
from this study may be generalised to the general population of CKD-5 patients 
undergoing HD therapy. 
 
5.4.1 Study limitations  
First of all, the classification of patients in fallers and non-fallers was based on self-
reported information. As previous research has highlighted how recalling information 
about falls might be subjected to misreporting (Hauer et al., 2006), this could have resulted 
in some degree of misclassification in the group allocation. We sought to minimise this 
bias by following up prospectively the participants every month (Cummings et al., 1988), 
although patients were also classified as fallers if they had experienced at least one fall in 
the previous 12 months: this kind of information is theoretically more susceptible to 
misreporting given the longer recall interval (Ganz et al., 2005). The decision to classify 
the patients with a previous history of falls also as fallers, regardless of the occurrence of 
any new fall event during the observational follow-up, was made to counterbalance 
another risk of bias, namely that of blindly assuming that all patients were free from the 
clinical outcome of interest, i.e. falls, at the beginning of the study. 
In addition, the relatively small sample size did not allow the application of a more 
exhaustive, a priori, multivariate logistic regression analysis to more robustly test the 
interrelationships between baroreflex function, haemodynamic responses, and falls. 
 
5.4.2 Conclusions  
This study indicates that, at rest, HD patients classed as “fallers” present with worse 
baroreflex indices reflecting how often the baroreflex is activated, as highlighted by the 
lower number of baroreceptor-mediated sequences of coupled HR and BP. Additionally, 
a significantly larger decrement of OscBP was observed in “fallers”, even though other 
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haemodynamic responses to HUT-60° were not seen to differ between fallers and non-
fallers. Patients with falls were also more likely to have diabetes as PRD, and the diabetic 
status seems to at least partly mediate the relationship between baroreflex function/BP 
responses to orthostasis and falls. The short-term BP regulation warrants further 
investigation as BP drops during the transition from supine to an upright position may be 
implicated in the aetiology of falls in HD. 
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CHAPTER 6: THE RELATIVE IMPORTANCE OF FRAILTY, PHYSICAL AND 
CARDIOVASCULAR FUNCTION AS PREDICTORS OF FALLS IN CKD-5 
PATIENTS ON HD 
 
Abstract 
Background: The population of CKD-5 patients on HD is at greater risk of falling 
compared to non-uraemic individuals living in the community. Previous research has 
suggested that frailty may be the primary contributor to the increased risk of falling in this 
clinical population. However, HD patients often present with abnormalities of 
cardiovascular function such as baroreflex impairment and orthostatic dysregulation of 
BP which may also be implicated in the aetiology of falling. Therefore, we aimed to 
explore the relative importance of frailty and cardiovascular function as potential exercise-
modifiable predictors of falls in these patients. 
Methods: A convenience sample of prevalent CKD-5 patients on HD was enrolled in this 
prospective study. Participants completed a comprehensive assessment of frailty, physical 
and cardiovascular function as detailed in Chapters 4 and 5 (paragraphs 4.2 and 5.2), and 
the number of falls experienced during a 12-month observational follow-up was recorded. 
Sixty-nine participants completed the observational follow-ups and were included in the 
data analysis of this Chapter. The association between the potential frailty and 
cardiovascular predictors of falls and the number of falls documented during follow-up 
was analysed by means of negative binomial regression modelling. Sensitivity analyses 
by means of receiver operating characteristics (ROC) curve analysis were also performed. 
Statistical limits for interpretation were set at an alpha level of p = .05. 
Results: In multivariate analysis, only worse baroreflex function, as assessed by means of 
total-BEI (RR: 0.96, 95%CI: 0.94-0.99, p= 0.004), and orthostatic decrements of OscDBP 
to HUT-60° (RR: 0.93, 95%CI: 0.87-0.99, p= 0.033) were associated with a greater 
number of falls. In ROC curve analysis, frailty alone did not discriminate significantly 
fallers from non-fallers, while adding the cardiovascular index total-BEI resulted in a 
significant 6% improvement of the area under the curve (AUC). 
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Conclusions: This prospective study indicates that cardiovascular mechanisms implicated 
in the short-term regulation of BP showed a greater relative importance than frailty in 
predicting falls in CKD-5 patients on HD. These findings challenge the current 
assumption that frailty is the primary factor in the aetiology of falling in this clinical 
population. 
 
6.1 Introduction 
Falls, and fall-related injuries may be one of the most frequently observed frailty-related 
adverse outcomes in the population of CKD patients (Lopez-Soto et al., 2015). 
Consequently, a few observational studies conducted in CKD-5 patients on HD have 
recently explored the relationship between frailty and falls in this patient group, and they 
all concluded that, not surprisingly, these are significantly associated (McAdams-
DeMarco et al., 2013; Kutner et al., 2014; Delgado et al., 2015). Moreover, the study 
findings reported in Chapter 4 of this PhD thesis (paragraphs 4.3.4 and 4.3.8) further 
corroborate the observation that frail HD patients have increased odds of falling compared 
to those who are not frail. 
Along with frailty, CVD is also highly prevalent in CKD-5 patients and impaired 
cardiovascular function is associated with multiple adverse clinical outcomes (Foley et 
al., 1997). A few studies have also begun to better explore the link between clinical 
outcomes such as falls and cardiovascular dysregulation in this patient group (Roberts et 
al., 2003; Roberts et al., 2007). In particular, it appears that the CKD-5 population on 
dialysis may be at risk of hypotension that can lead to postural dizziness, and potentially 
falls. This is further exacerbated by the combined effect of autonomic failure and the 
significant fluid shifts associated with dialysis (Roberts et al., 2003). In Chapter 5 of this 
PhD thesis (paragraph 5.3.4), we highlighted a significant larger drop of BP, in response 
to a passive orthostatic challenge, in patients with falls compared to those who were falls-
free. Moreover, this orthostatic decrement in BP, as well as worse indices of baroreflex 
function, were also significantly associated with falls in univariate logistic regression 
analysis (paragraph 5.3.5). All of these observations seem to indirectly suggest that 
impaired BP control, to maintain haemodynamic stability, might be implicated as an 
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additional factor in the aetiology of falls in the CKD-5 population on dialysis, due to the 
CKD-related autonomic failure and/or the dialysis-related hypotension. From a 
rehabilitation/therapeutic perspective, this could have important translational impact, 
since the short-term regulation of BP, as assessed by means of baroreflex function, has 
been shown to improve following active interventions such as exercise (Petraki et al., 
2008). The objective of this investigation was to explore the relative importance of frailty 
and cardiovascular function as potential exercise-modifiable predictors of falls in CKD-5 
patients on HD. We hypothesised that 1) frailty and cardiovascular function would be 
associated with a higher number of falls, and that 2) modelling the risk of falling by adding 
a cardiovascular function variable to frailty would improve the prediction of falls 
sustained and recorded over a 12-month period in CKD-5 patients on HD. 
 
6.2 Essential methods 
6.2.1 Study design 
An observational prospective cohort study design was used to investigate the association 
between potential predictors of falls (e.g. frailty, cardiovascular function) and the number 
of falls sustained over a 12-month follow-up period in CKD-5 patients on HD. 
 
6.2.2 Data collection 
Falls, frailty, physical function determinants (PA levels, muscle strength, TUG, CSTS-5, 
postural balance), baroreflex and haemodynamic function at rest, and in response to a 
passive orthostatic challenge consisting of HUT-60° were assessed, as fully detailed in 
Chapter 2. 
 
6.2.3 Statistical analysis 
Statistical analyses were performed with SPSS (Version 23.0 for Windows, SPSS Inc., 
Chicago, IL). The Shapiro-Wilk Test (S-W) was used to assess whether data were 
normally distributed. Differences between fallers and non-fallers in demographic, clinical, 
frailty, and cardiovascular characteristics were analysed by means of a Chi-Squared test 
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for categorical variables, and by either Mann-Whitney U or independent t-tests, as 
appropriate, for continuous variables. 
The association between baseline factors and the number of falls recorded during follow-
up was analysed by means of negative binomial regression with an overdispersion 
parameter estimated on the actual distribution of the dependent variable (i.e. number of 
falls). All frailty and cardiovascular factors were initially entered in a univariate negative 
binomial regression model, and those factors reaching statistical significance (p-value ≤ 
.05) were taken forward to the multivariate stage. The multivariate analysis consisted of a 
first model (Model 1), in which all factors were adjusted for clinical confounders, while a 
second model was designed to assess the second research hypothesis. In this second model 
(Model 2), frailty and physical function factors were adjusted for all variables in Model 1 
and for the cardiovascular function variable showing the highest correlation (R2) with 
number of falls, while cardiovascular factors were adjusted for all variables in Model 1 
and for frailty. In a further analysis, we explored the goodness of fit of the regression 
models by reporting the relative change in Akaike’s Information criterion (AIC) occurring 
when frailty and cardiovascular function were modelled together. 
Sensitivity analyses were undertaken using the receiver operating characteristic (ROC) 
analysis of those potential factors associated with falls (yes or no), and the area under the 
curve (AUC) was used to compare the predictive ability of frailty alone with a model 
composed of frailty and a cardiovascular predictor. Statistical limits for significance were 
set at an alpha level of p ≤ .05. 
 
6.3 Results 
6.3.1 Participants 
The screening and recruitment details of the study were described in Chapter 3 (paragraph 
3.3.1). Nine out of the 76 patients who were enrolled in the study (11.8%) were lost to 
follow-up due to renal transplantation (n= 4; 5.3%) and death (n= 5; 6.6%). However, 2 
of these patients were retained in the data analysis because they had experienced falls 
during the prospective observational follow-up prior to renal transplantation/death. 
Therefore, 69 patients were entered in the final analysis. 
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6.3.2 Demographic and clinical characteristics 
The demographic and clinical characteristics of the study participants are summarised in 
Table 3.1. Fallers were more likely to be prescribed antidepressants, and had significantly 
higher CRP compared to non-fallers. No statistically significant differences in other 
clinical characteristics were detected. 
 
6.3.3 Falls 
As previously reported in Chapter 3, paragraph 3.3.3, 26 of 69 patients (37.7%) 
experienced at least one fall during the 12-month observational follow-up. A total number 
of 80 falls were recorded, resulting in an incidence of 1.16 falls/patient-year. Figure 3.2 
shows the distribution of number of falls occurred during the study period. 
 
6.3.4 Frailty and physical function 
The frailty and physical function characteristics of the study participants are summarised 
in Table 6.1. Fallers were more likely to meet the frailty component of self-reported 
exhaustion. In addition, fallers had significantly higher postural sway measures, such as 
AbsVel, VelX, VeY, and Area95, indicating a worse postural balance compared to non-
fallers. 
 
Table 6.1. Frailty and physical function characteristics of study participants: results are 
expressed as percentages for categorical variables and mean ± SD for continuous data. 
Variables All patients 
(69) 
Fallers 
(26) 
Non-fallers 
(43) 
P-value 
Frailty components and phenotype     
Low PA (n) (%) 33 (47.8) 12 (46.2) 21 (48.8) 0.829 
Low gait speed (n) (%) 20 (29) 11 (42.3) 9 (20.9) 0.058 
Low strength (n) (%) 33 (47.8) 12 (46.2) 21 (48.8) 0.829 
Exhaustion (n) (%) 51 (73.5) 24 (92.3) 27 (61.9) 0.006 
Unintentional weight loss (n) (%) 12 (17.6) 7 (28) 5 (11.6) 0.108 
Fried’s frailty phenotype (n) (%) 26 (37.7) 13 (50) 13 (30.2) 0.101 
Objectively measured PA     
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Time spent standing (h) (SD) 2.4 (1.2) 2.1 (1.1) 2.5 (1.2) 0.177 
Time spent stepping (h) (SD) 0.7 (0.4) 0.6 (0.3) 0.8 (0.4) 0.218 
Daily steps (n°) (SD) 3086 (1810) 2601 (1325) 3366 (2004) 0.144 
Daily sit to stands (n°) (SD) 37.5 (12.6) 38.3 (16.1) 37.1 (10.3) 0.894 
Strength     
Handgrip (Kg) (SD) 26.9 (9.5) 24.5 (10) 28.4 (9) 0.101 
Leg extension (Kg) (SD) 20.1 (9) 17.4 (8.3) 21.8 (9.1) 0.050 
Functional tests     
Gait speed (m/s) (SD) 0.85 (0.26) 0.78 (0.26) 0.9 (0.25) 0.067 
TUG (s) (SD) 11.5 (4.8) 13.3 (6.4) 10.4 (3.4) 0.055 
CSTS-5 (s) (SD) 17.1 (8.9) 19.6 (12.3) 15.7 (6.3) 0.355 
Postural balance in EO     
RangeX (mm) (SD) 23.9 (11.4) 27.3 (13.4) 22 (9.6) 0.052 
RangeY (mm) (SD) 28.5 (12.7) 31.5 (14.2) 26.8 (11.6) 0.078 
RMSX (mm) (SD) 4.8 (2.5) 5.6 (3.2) 4.4 (2) 0.056 
RMSY (mm) (SD) 5.6 (2.7) 6.3 (3.2) 5.2 (2.2) 0.132 
AbsVel (mm/s) (SD) 40.9 (8.6) 43.6 (8.6) 39.3 (8.3) 0.013 
VelX (mm/s) (SD) 26 (5.8) 27.6 (5.7) 25.1 (5.7) 0.017 
VelY (mm/s) (SD) 26 (5.5) 28 (5.8) 24.9 (5.1) 0.010 
Area95 (mm2) (SD) 2427 (3067) 3206 (4274) 1974 (1999) 0.039 
Abbreviations: SD: standard deviation; PA: physical activity; TUG: timed up and go test; 
CSTS-5: 5 repetitions chair sit to stand test; EO: eyes open; RangeX: range of centre of 
pressure (COP) displacement along the medial-lateral (ML) axis; RangeY: range of COP 
displacement along the anterior-posterior (AP) axis; RMSX: root mean square 
displacement along the ML axis; RMSY: root mean square displacement along the AP 
axis; AbsVel: absolute velocity; VelX: velocity along the ML axis; VelY: velocity along 
the AP axis; Area95: 95% confidence ellipse area. 
 
6.3.5 Cardiovascular function 
The cardiovascular function characteristics of study participants at rest are summarised in 
Table 6.2, while the haemodynamic responses to HUT-60° are reported in Table 6.3. 
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Table 6.2. Cardiovascular function characteristics of study participants. Baroreflex and 
haemodynamic variables at rest: results are expressed as mean ± SD. 
Variables All patients 
(69) 
Fallers 
(26) 
Non-fallers 
(43) 
P-value 
Baroreflex function     
Up-ramps (n°) (SD) 20.4 (18.9) 20.9 (22.9) 20.1 (15.8) 0.632 
Down-ramps (n°) (SD) 18.4 (15.9) 19.1 (18.3) 17.9 (14.2) 0.811 
Total-ramps (n°) (SD) 38.8 (34.3) 40 (40.7) 38 (29.8) 0.688 
Up-events (n°) (SD) 4.5 (7.1) 2.6 (3.7) 5.7 (8.4) 0.125 
Down-events (n°) (SD) 4.8 (6.4) 3.3 (4.5) 5.7 (7.3) 0.347 
Total-events (n°) (SD) 9.3 (13) 6 (7.9) 11.4 (15.1) 0.129 
Up-BEI (%) (SD) 20.6 (25.2) 14.6 (20.2) 24.7 (27.7) 0.165 
Down-BEI (%) (SD) 27.9 (26.4) 20.3 (22.7) 32.9 (27.7) 0.103 
Total-BEI (%) (SD) 25.4 (25) 17.7 (19.1) 30.6 (27.4) 0.078 
BRS (ms/mmHg) (SD) 9.3 (7.1) 10.3 (9.3) 8.8 (5.9) 0.806 
Haemodynamic variables     
RRI (ms) (SD) 894.9 (163.1) 867.7(112.4) 911.4 (186.8) 0.240 
HR (bpm) (SD) 69.5 (12) 70.7 (9.3) 68.8 (13.4) 0.506 
contSBP (mmHg) (SD) 124 (23.1) 127 (26.2) 122.1 (21.1) 0.462 
contDBP (mmHg) (SD) 77.8 (14.8) 76.8 (12.5) 78.4 (16.1) 0.756 
contmBP (mmHg) (SD) 97.2 (17.7) 97.9 (16.9) 96.8 (18.4) 0.801 
SV (ml) (SD) 64.4 (14.4) 63.6 (12.1) 64.8 (15.7) 0.921 
CO (L/min) (SD) 4.4 (1.2) 4.5 (0.9) 4.4 (1.3) 0.416 
TPR (dyne*s/cm5) (SD) 1777 (501) 1716 (371) 1816 (570) 0.440 
SI (ml/m2) (SD) 34.8 (8.8) 35.2 (7.8) 34.5 (9.5) 0.455 
CI (L/min*m2) (SD) 2.4 (0.7) 2.5 (0.5) 2.4 (0.8) 0.167 
TPRI(dyne*s*m2/cm5) (SD) 3330 (1037) 3121 (710) 3464 (1190) 0.154 
TFC (1/kOhm) (SD) 32.9 (10.8) 34.6 (12.1) 31.9 (10) 0.365 
OscSBP (mmHg) (SD) 128.2 (22) 134.4 (26.3) 124.8 (18.7) 0.094 
OscDBP (mmHg) (SD) 81 (13.9) 82.4 (12.8) 80.2 (14.5) 0.553 
Abbreviations: SD: standard deviation; Up-BEI: up-events baroreceptor effectiveness 
index; Down-BEI: down-events baroreceptor effectiveness index; Total-BEI: total-events 
baroreceptor effectiveness index; BRS: baroreflex sensitivity; RRI: R-R interval; HR: 
heart rate; contSBP: continuous systolic blood pressure; contDBP: continuous diastolic 
blood pressure; contmBP: continuous mean blood pressure; SV: stroke volume; CO: 
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cardiac output; TPR: total peripheral resistance; SI: stroke index; CI: cardiax index; TPRI: 
total peripheral resistance index; TFC: thoracic fluid content; OscSBP: oscillometric 
systolic blood pressure; OscDBP: oscillometric diastolic blood pressure. 
 
No differences in baroreflex/haemodynamic function, as assessed at rest or in response to 
HUT-60°, were detected between fallers and non-fallers. 
 
Table 6.3. Haemodynamic responses to HUT-60°: results are expressed as mean ± SD. 
Variables All patients 
(69) 
Fallers 
(26) 
Non-fallers 
(43) 
P-value 
RRI (ms) (SD) -60.4 (66.8) -55.9 (71.1) -63 (65) 0.514 
HR (bpm) (SD) 6.2 (7.3) 6.9 (9.6) 5.8 (5.7) 0.860 
contSBP (mmHg) (SD) 3.9 (11.9) 4.8 (14.9) 3.4 (9.9) 0.178 
contDBP (mmHg) (SD) 6.3 (8.5) 6.3 (10.6) 6.3 (7.1) 0.575 
contmBP (mmHg) (SD) 5.3 (9.4) 5.4 (12) 5.2 (7.8) 0.436 
SV (ml) (SD) -4.1 (13.8) -4.5 (12.7) -3.9 (14.5) 0.693 
CO (L/min) (SD) 0.01 (1) 0 (0.9) 0.02 (1) 0.734 
TPR (dyne*s/cm5) (SD) 98.3 (374.8) 102.8(367.4) 95.5 (384.1) 0.941 
SI (ml/m2) (SD) -2.3 (7.6) -2.3 (6.9) -2.3 (8) 0.703 
CI (L/min*m2) (SD) -0.01 (0.5) 0.01 (0.5) -0.01 (0.5) 0.887 
TPRI(dyne*s*m2/cm5) (SD) 173.7 (684) 193.8 (655.3) 161.3 (709) 0.856 
TFC (1/kOhm) (SD) -1.9 (1.8) -2 (1.9) -1.8 (1.8) 0.632 
OscSBP (mmHg) (SD) -3.6 (9.8) -5.6 (10.9) -2.5 (9) 0.249 
OscDBP (mmHg) (SD) -0.7 (6.9) -2.6 (7.5) 0.3 (6.4) 0.432 
Abbreviations: SD: standard deviation; RRI: R-R interval; HR: heart rate; contSBP: 
continuous systolic blood pressure; contDBP: continuous diastolic blood pressure; 
contmBP: continuous mean blood pressure; SV: stroke volume; CO: cardiac output; TPR: 
total peripheral resistance; SI: stroke index; CI: cardiax index; TPRI: total peripheral 
resistance index; TFC: thoracic fluid content; OscSBP: oscillometric systolic blood 
pressure; OscDBP: oscillometric diastolic blood pressure. 
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6.3.6 Predictors of falls 
In univariate negative binomial regression analysis, frailty and physical function measures 
such as number of daily steps, number of daily sit to stands, handgrip, gait speed, and 
TUG predicted a higher number of falls. In addition, total-BEI and the responses of CO 
and OscDBP to HUT-60° also predicted a higher number of falls (Table 6.4). 
All frailty/physical function and cardiovascular function factors reaching statistical 
significance in univariate analysis were adjusted in Model 1 for CRP and antidepressant 
use, as we identified these variables as potential clinical confounders (Table 3.1). 
Moreover, with concern for multi-collinearity, we only reported the baroreflex function 
index showing the highest correlation with number of falls (total-BEI). In fully adjusted 
analyses (Model 2), total-BEI, and the haemodynamic response of OscDBP to HUT-60° 
were associated with a higher number of falls. 
 
Table 6.4. Negative binomial regression analysis: predictors of falls. 
 Univariate  Multivariate    
   Model 1  Model 2  
Factors RR (95% CI) P-value RR (95% CI) P-value RR (95% CI) P-value 
Frailty & physical function       
Frailty (yes/no) 4.10 (1.60-10.51) 0.003 2.23 (0.85-5.87) 0.103 1.78 (0.70-4.51) 0.224 
Daily steps (n°) 0.99 (0.99-1.00) 0.006 1.00 (0.99-1.00) 0.137 1.00 (0.99-1.00) 0.106 
Daily sit to stands (n°) 0.96 (0.93-0.99) 0.042 0.98 (0.94-1.02) 0.387 0.99 (0.95-1.04) 0.707 
Handgrip (Kg) 0.94 (0.88-0.99) 0.034 0.97 (0.92-1.02) 0.216 0.98 (0.93-1.04) 0.448 
Gait speed (m/s) 0.08 (0.01-0.62) 0.016 0.26 (0.03-2.08) 0.205 0.36 (0.04-3.32) 0.363 
TUG (s) 1.16 (1.02-1.32) 0.021 1.08 (0.96-1.21) 0.220 1.03 (0.91-1.17) 0.643 
Cardiovascular function       
Total-BEI (%) 0.96 (0.93-0.98) ˂0.001 0.96 (0.94-0.99) 0.003 0.96 (0.94-0.99) 0.004 
CO (L/min) 0.51 (0.27-0.98) 0.043 0.66 (0.37-1.15) 0.143 0.67 (0.39-1.13) 0.134 
OscDBP (mmHg) 0.90 (0.83-0.98) 0.010 0.93 (0.87-0.99) 0.036 0.93 (0.87-0.99) 0.033 
Abbreviations: RR: rate ratio; CI: confidence interval; TUG: timed up and go test; Total-
BEI: total-events baroreceptor effectiveness index; CO: cardiac output response to HUT-
60°; OscDBP: oscillometric diastolic blood pressure response to HUT-60°; Model 1: All 
factors are adjusted for CRP and antidepressant use; Model 2: Frailty and physical 
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function factors are adjusted for all variables in Model 1 and for Total-BEI. 
Cardiovascular function factors are adjusted for all variables in Model 1 and for frailty. 
 
Table 6.5 shows the goodness of fit (AIC) of the univariate regression models and its 
relative change following forced entry modelling of frailty and cardiovascular function 
(multivariate stage). The multivariate model composed of frailty and total-BEI resulted in 
a 19.1% decrease in AIC compared to frailty alone. 
 
Table 6.5. Further analyses: goodness of fit of regression models. 
 Univariate   Multivariate*    
Factors RR (95% CI) P-value AIC RR (95% CI) P-value AIC ΔAIC 
Frailty and physical function        
Frailty (yes/no) 4.10 (1.60-10.5) 0.003 185 2.53 (0.96-6.70) 0.060 149.6 -19.1% 
Daily steps (n°) 0.99 (0.99-1.00) 0.006 142.3 1.00 (0.99-1.00) 0.036 113.2 -20.4% 
Daily sit to stands (n°) 0.96 (0.93-0.99) 0.042 146.7 0.99 (0.95-1.03) 0.543 116.7 -20.4% 
Handgrip (Kg) 0.94 (0.88-0.99) 0.034 188.6 0.97 (0.91-1.03) 0.330 151.8 -19.5% 
Gait speed (m/s) 0.08 (0.01-0.62) 0.016 176.3 0.14 (0.02-1.39) 0.094 141.1 -20.0% 
TUG (s) 1.16 (1.02-1.32) 0.021 171.7 1.10 (0.95-1.27) 0.226 138.5 -19.3% 
Cardiovascular function        
Total-BEI (%) 0.96 (0.93-0.98) ˂0.001 150.8 0.96 (0.94-0.99) 0.003 149.6 -0.8% 
CO (L/min) 0.51 (0.27-0.98) 0.043 168.6 0.58 (0.33-1.04) 0.068 165.7 -1.7% 
OscDBP (mmHg) 0.90 (0.83-0.98) 0.010 144.1 0.92 (0.85-0.99) 0.028 142.6 -1.0% 
Abbreviations: RR: rate ratio; CI: confidence interval; AIC: Akaike’s information 
criterion; TUG: timed up and go test; Total-BEI: total-events baroreceptor effectiveness 
index; CO: cardiac output; OscDBP: oscillometric diastolic blood pressure; *Frailty and 
physical function variables are adjusted by Total-BEI, cardiovascular function variables 
are adjusted by frailty. 
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6.3.7 Sensitivity analyses 
Figure 6.1 shows the ROC curves of frailty alone and the model composed of frailty and 
total-BEI. Frailty alone did not discriminate significantly fallers from non-fallers, while 
adding the cardiovascular variable total-BEI resulted in a significant improvement of the 
AUC. Postural balance was the only factor that individually discriminated significantly 
fallers from non-fallers, and VelY (Appendix XVIII), in particular, showed the best 
predictive ability (AUC= 0.69, 95%CI: 0.55-0.82, p= 0.01). 
 
Figure 6.1. Sensitivity analyses: ROC curve analysis. 
  
 
Abbreviations: AUC: area under the curve; CI: confidence interval. 
 
6.4 Discussion 
We hypothesised that frailty and cardiovascular function would be associated with a 
higher number of falls in CKD-5 patients on HD. Additionally, we hypothesised that 
modelling the risk of falling by adding a cardiovascular function variable to frailty would 
improve the prediction of falls sustained over 12 months in this patient population. 
The univariate negative binomial regression analysis revealed that frailty and other 
physical function measures, such as number of daily steps and sit to stands, handgrip 
strength, gait speed, and TUG were associated with a higher number of falls in the study 
population. In addition, cardiovascular function indices such as total-BEI, CO and 
OscDBP responses to HUT-60° were also associated with a higher number of falls (Table 
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6.4). However, in multivariate analysis, only total-BEI and the OscDBP response to HUT-
60° were significantly predictive of a greater number of falls. In addition, modelling the 
risk of falling by adding a cardiovascular function index (total-BEI) to frailty resulted in 
a 19.1% reduction in AIC, indicating a better goodness of fit, while adding frailty to 
cardiovascular indices such as total-BEI, CO and OscDBP responses to HUT-60°, hardly 
modified the AICs (-0.8% to -1.7%, Table 6.5). Moreover, the sensitivity analyses 
performed by means of ROC curve analysis revealed that adding total-BEI to the frailty 
model corresponded to a net 6% improvement of the AUC and resulted in a statistically 
significant prediction of falling status (Figure 6.1). 
The overall implications of these findings are that the addition of a baroreflex function 
index to an exclusively physical frailty-based model, did not only improve the prediction 
of falls, but it also highlighted the greater relative importance of a cardiovascular function 
index, implicated in the short-term regulation of BP, in predicting the occurrence of these 
falls. In particular, the forced entry modelling performed in Model 2 of the negative 
binomial regression analysis (Table 6.4) suggests that lower baroreflex function and 
orthostatic decrements of BP may have a higher impact than frailty on the prediction of 
falls in CKD-5 patients on HD. 
The predominant role of these cardiovascular factors appeared to be also indirectly 
confirmed by the falls-related symptomatology reported by study participants (Chapter 3, 
Figure 3.3). The most common precipitating factors reported by fallers were dizziness/loss 
of consciousness (41.3% of falls), followed by loss of balance/unsteadiness of the legs 
(31.3% of falls), and environmental hazards (20% of falls). These symptoms seem to point 
out that the majority of falls were probably related to some underlying 
cardiovascular/haemodynamic type of mechanism. Because impairments of baroreflex 
function are linked to orthostatic decrements of BP (Mattace-Raso et al., 2007), the 
dysregulation of BP during a sudden change in body position, or during prolonged 
standing may be one of the main mechanisms implicated in the aetiology of falls in CKD-
5 patients on HD. Both of these factors predicted a higher number of falls in our study. 
Many dialysis-specific or idiopathic risk factors may be involved in the dysregulation of 
BP which could possibly lead to dizziness symptoms and falls in this clinical population. 
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First of all, the uremia-related cardiac autonomic dysfunction, characterised by alterations 
of the sympathetic, parasympathetic, and baroreflex components of the autonomic nervous 
system, is a factor that has been linked to symptomatic hypotension in CKD-5 patients 
(Robinson et al., 2002). Moreover, autonomic neuropathy, a common clinical 
complication of advanced diabetes and the most common cause of CKD (GBD, 2015), 
can also lead to a diminished response of BP to standing (Vinik et al., 2018). Secondly, 
dialysis patients are often treated with one or more antihypertensive drugs (83.8% and 
51.5% of patients in our study). While this is often an unavoidable therapy for the 
treatment of hypertension, such antihypertensive polypharmacy has been linked to an 
increased risk of falling by inducing dizziness and postural hypotension (Tinetti et al., 
2014). Thirdly, some research has postulated that fluid shifts, as part of regular HD, may 
pose these patients at risk of postural dizziness in the immediate post-dialysis period 
(Roberts et al., 2003). Our findings on the timing of falls recorded throughout the study 
do not support this last hypothesis, as only 8.3% of falls occurred after HD (Chapter 3, 
paragraph 3.3.4.4). 
As expected from the findings of Chapter 5 (Table 5.3), diabetic nephropathy as PRD was 
significantly associated with a higher number of falls in univariate negative binomial 
regression analysis (RR: 3.0, 95%CI: 1.042-8.639, p= 0.042), which indirectly highlights 
how diabetes may be a confounding factor on the findings relating to the relationship 
between baroreflex function/haemodynamic responses to HUT-60° and falls. However, 
on a separate multivariate negative binomial regression analysis adjusted for diabetic 
status, baroreflex function assessed by means of total-BEI (RR: 0.961, 95%CI: 0.936-
0.986, p= 0.003), and the CO response to HUT-60° (RR: 0.548, 95%CI: 0.306-0.982, p= 
0.043) were still predictive of a higher number of falls. Interestingly, the OscDBP 
response to HUT-60° was no longer significantly associated with falls when the analysis 
was adjusted for diabetic status (RR: 0.945, 95%CI: 0.859-1.039, p= 0.240), which may 
reflect once again the mediating effect of diabetes on the study findings. 
The estimates of association between frailty and number of falls experienced emerging 
from this study are remarkably similar to those observed by McAdams-DeMarco et al., 
(2013), who also explored the association between the Fried’s frailty phenotype and falls. 
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In their study, authors found that frailty roughly predicted a three-fold higher number of 
falls in univariate Poisson regression analysis, while we found an approximately four-
times higher number of falls predicted in the univariate regression (Table 6.4). The slightly 
higher estimate observed in our study may be due to the fact that we recorded falls for a 
longer observational period (12 months vs 6 months), and therefore frail patients in our 
study may have experienced a significantly higher number of falls, as also evidenced by 
the higher incidence of falls recorded in our study (1.16 vs 0.74 fall/person-year), which 
is likely to have resulted in a slightly more inflated rate ratio (4.1 vs 3.55). It should also 
be noted that a meaningful comparison of the predictive estimates emerging from the two 
studies is possible considering the univariate model only, as we adjusted the model for 
another predictor of falls (total-BEI) in order to address the second research hypothesis, 
whereas McAdams-DeMarco et al., (2013) adjusted the model for a number of classic 
demographic and clinical characteristics. Therefore, the two multivariate models represent 
different clinical findings and their interpretation should be applied with caution. 
It should also be acknowledged that, although the negative binomial regression analysis 
revealed that postural balance did not predict a higher number of falls in the study 
participants, fallers had significantly higher postural sway measures, meaning a worse 
postural balance (Maki et al., 1994), compared to non-fallers (Table 6.1). Moreover, the 
ROC analysis showed that, among all physical function variables, postural balance was 
the only factor to significantly discriminate fallers from non-fallers, with VelY showing 
the highest AUC (Appendix XVIII). This finding indicates that, despite the apparent lack 
of association with number of falls, postural balance may still have a significant prognostic 
value of falling status in CKD-5 patients on HD. 
Interestingly, the exploratory independent comparisons of fallers and non-fallers revealed 
that those who fell were more likely to use antidepressants (50% vs 23.8%) and had higher 
CRP levels (37.6±59.2 mg/L vs 18.3±32.7mg/L). Because both antidepressant use and 
high CRP have been linked to a higher risk of falling by previous research conducted on 
HD patients (Desmet et al., 2005; Kono et al., 2018), we adjusted the analysis for these 
possible clinical confounders (Model 1). In this first model of multivariate analysis, 
neither frailty nor the additional physical function measures were significantly associated 
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with a higher number of falls (Table 6.4). This finding further reinforces the observation 
that total-BEI and the OscDBP response to HUT-60° had a greater relative importance 
than frailty in predicting the number of falls experienced by study participants during the 
12-month follow up. 
 
6.4.1 Study limitations 
It should be acknowledged that because the sample size was relatively small we could not 
apply a more exhaustive, a priori, multivariate negative binomial regression analysis to 
more robustly test the interrelationships between frailty/physical function, cardiovascular 
function, and falls. In addition, we should also acknowledge that, while orthostatic 
decrements of OscDBP were significantly associated with falls (Table 6.4), orthostatic 
decrements of OscSBP were not. However, in univariate negative binomial regression 
analysis, OscSBP decrements also exhibited a potential trend of association with falls 
(RR: 0.95, 95%CI: 0.89-1.01, p= 0.084), and it is possible that a larger sample size may 
have also resulted into better chances of detecting a significant association between 
OscSBP decrements and falls, by decreasing the chances of committing a type II error. 
 
6.4.2 Conclusions 
In conclusion, this prospective cohort study indicates that by adding a cardiovascular 
index, implicated in the short-term regulation of BP, to a frailty-only model it was possible 
to improve significantly the prediction of falls in CKD-5 patients on HD. Baroreflex 
function, as assessed by means of BEI, and orthostatic decrements of BP showed a higher 
impact, and thus greater relative importance, than frailty in predicting number of falls in 
this clinical population. Therefore, findings from this study challenge the current 
assumption that frailty is primarily involved in the aetiology of falling in people living 
with CKD-5. The clinical implications of these findings indicate that a simple non-
invasive, time-efficient, assessment consisting of a continuous and simultaneous 
recording of BP and HR may be more useful than frailty assessment alone when predicting 
falls in HD patients. A high number of falls appear to be mediated by a degree of 
cardiovascular dysregulation, evidenced by the predominance of self-reported dizziness 
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symptoms. We therefore recommend that interventions designed to improve baroreflex 
function/short-term regulation of BP should be included when implementing falls 
prevention programmes in this patient population. 
In addition, an assessment of postural balance by means of a force platform also showed 
to have a significant predictive value in ROC curve analysis. Postural balance is usually 
not incorporated in frailty assessments, and it may be a further meaningful outcome to 
evaluate in the context of falls prediction and prevention in HD patients. 
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CHAPTER 7: GENERAL DISCUSSION AND CONCLUSIONS 
 
7.1 Research project management 
The timeline and milestones of this PhD research project are summarised in Figure 7.1.  
From the moment of first submission to the REC (31/03/2015), the ethics of the study 
were reviewed and approved in 80 days, which is generally considered a relatively rapid 
time to gain ethical approval for research based in a healthcare environment (Smith-Merry 
et al., 2014; Varley et al., 2016). Patient recruitment was a crucial aspect of the research 
project, as evidenced by the lengthy process (roughly 25 months) shown in Figure 7.1. 
Although the recruitment rate achieved (35.3%) was reasonable, considering that CKD-5 
patients on HD are a group of people with multiple barriers to clinical research 
participation (Flythe et al., 2017), the time necessary to enrol an adequate sample size 
resulted in a delay of the observational follow-up period completion (August 2018). In the 
context of this PhD study, the main barrier to research participation that emerged from the 
recruitment process was unwillingness of patients to travel to the hospital on an extra day 
to complete the baseline assessments. While this is an understandable reason of why many 
patients declined to take part in our research, given that HD is an extremely time-
demanding treatment and patients often feel overwhelmed with the amount of time spent 
at the hospital (Kopple et al., 2017), the study design dictated that participants had to 
complete all baseline assessments on a non-HD day to optimise the standardisation of 
testing procedures (Chapter 2, paragraph 2.5.1.3). It is possible that performing data 
collection on a HD day could have inflated the recruitment rate, with consequent higher 
number of participants in the study. However, the stricter testing conditions used in our 
study are likely to have impacted positively on the quality of all data collected, for the 
reasons described in paragraph 2.5.1.3, as well as on external validity and generalisability 
of study findings. 
According to the original REC submission, patients were initially recruited only from the 
North Lanarkshire (Monklands Hospital) research site until December 2016. However, 
after the acquisition of a British Renal Society – British Kidney Patient Association (BRS-
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BKPA) grant (16-003), awarded in December 2016, we were able to continue patient 
recruitment until November 2017 in a second research site in Fife (Victoria Hospital). 
The research data were preliminarily explored starting from January 2018 to allow the 
preparation of two abstracts that were presented at the European Renal Association – 
European Dialysis & Transplant Association (ERA-EDTA) Congress 2018 and at the UK 
Kidney week (UKKW) 2018. A first research article (Appendix XIX) was published in 
December 2018 and data analysis was also completed in December 2018. The first draft 
of the PhD thesis was produced by February 2019, and its revised version was submitted 
in June 2019.   
 
Figure 7.1. GANTT chart of study timeline and milestones. 
 
 
7.2 Research findings 
7.2.1 Estimates of falls’ risk in CKD-5 patients on HD 
One of the most important premises upon which the rationale of this PhD research project 
was developed is that the population of CKD-5 patients on HD is at high risk of falls, as 
evidenced by previous studies (Desmet et al., 2005; Cook et al., 2006; Roberts et al., 2007; 
Farragher et al., 2014; Polinder-Bos et al., 2014; Kono et al., 2018) that were described in 
Chapter 1.  
182 
 
The findings on the estimates of falls from this PhD programme of research were reported 
and discussed in Chapter 3. It should be acknowledged that, because a healthy and age-
matched control group was not assessed, we can only interpret these findings by critically 
comparing them with the current body of literature reporting information on the risk of 
falls in the non-uraemic population. Both the prevalence of study participants 
experiencing at least one fall during the 12 month follow-up (37.7%), and the incidence 
of falls/person-year (1.16) emerging from this PhD are aligned with the findings from 
previous studies (Desmet et al., 2005; Roberts et al., 2007), and most importantly they 
reinforce the evidence that HD patients are a clinical population at high risk of falls 
(Lopez-Soto et al., 2015). 
One of the most valuable methodological improvements in this PhD research programme 
compared to previous studies was that falls related data were prospectively and 
contemporaneously recorded by a researcher, as close to the falling event as possible. 
Therefore, the resulting estimates of falls are less likely to be subjected to significant recall 
biases and misreporting (Hauer et al., 2006). To the best of our knowledge, this is the 
seventh out of eight prospective studies (conducted in HD patients) reporting an incidence 
of falls/person-year higher than in community-dwelling older adults (≥ 65 years), an 
established group of people at high risk of falls (WHO 2008). 
Because the mean age of fallers in our study was approximately 58 years, we are led to 
think that HD patients are predisposed to a high risk of falling even before the onset of 
older age (65 years old), an observation also supported by previous research that reported 
a similar risk of falls in young and older HD patients (McAdams-DeMarco et al., 2013). 
The WHO global report on falls prevention in older age states that about 30% of 
community-dwelling older (>65 years) adults fall at least once every year (WHO, 2008). 
This estimate may seem to suggest that our study population could have a similar falls’ 
risk profile to the general elderly population (37.7% of patients falling at least once in 12 
months). Despite the observation that CKD patients experience this risk at younger age, 
an additional distinction in terms of the aetiology of falling should be made. A further 
merit of our study design is that, as part of the observational follow-up, we documented 
the precipitating factors occurring immediately prior to any fall. These additional data 
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revealed that most falls (41.3%) were associated with the occurrence of dizziness 
symptoms, followed by loss of balance/strength (31.3%), and only 20% of falls were 
precipitated by environmental factors such as a slip or trip. Because previous research has 
reported that the large majority of falls (77%) in healthy older adults are due to 
slipping/tripping accidents resulting from environmental hazards (Hill et al., 1999), it is 
plausible that many of these falls could be prevented. In particular, falls risk might be 
reduced if the potential fallers increased their attention to environmental hazards and/or 
through the improvement of the local environment (e.g. wet surfaces, poor lighting, 
obstacles etc.). Conversely, HD patients may suffer a greater number of falls due to more 
structured physiological impairments of cardiovascular and physical function (Roberts et 
al., 2003; McAdams-DeMarco et al., 2013), making these falls more difficult to prevent 
without recourse to structured physical rehabilitation. In addition, many falls prevention 
policies are already operationalised in dialysis facilities by the nursing staff (Kliger et al., 
2006; Heung et al., 2010), who typically seek to promote safety by minimising 
environmental risk factors (Garrick et al., 2015). Moreover, many HD patients have access 
to occupational therapy services which also focus on the reduction of environmental 
hazards in daily life to prevent falls (Woodland et al., 2003). These observations seem to 
suggest that, in comparison to community-dwelling older adults, the population of CKD-
5 patients on HD may benefit already from a general safety culture promoted by nursing 
and occupational therapy staff. However, the estimates of falls reported in dialysis 
populations are still considerably higher than those seen in the non-uraemic geriatric 
population (Desmet et al., 2005; Cook et al., 2006; Roberts et al., 2007; Farragher et al., 
2014). 
While many falls in healthy older adults seem to be of accidental aetiology and may be 
associated with increased engagement in physical activities such as jogging or fast 
walking (with and without sudden accelerations) that could lead to falls/slips/trips (Hill et 
al., 1999) it is noteworthy that HD patients tend to be extremely inactive (Johansen et al., 
2010). The very low number of daily steps recorded for our study participants (Chapter 4, 
Table 4.2) reinforces this idea. Another factor that is reported to influence sedentary 
behaviour in this patient group is fear of falling (Jayaseelan et al., 2018). Consequently, 
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physical activity avoidance may paradoxically reduce the occurrence of falls in HD 
patients compared to healthy older adults. Unsurprisingly, this is not an effective strategy 
to prevent falls in the long term, as limiting physical activity is one of the elements 
involved in initiating the vicious circle of frailty (Fried et al., 2001), and it is linked to a 
cascade of negative health outcomes (Cecchini et al., 2010; Johansen et al., 2018). 
 
7.2.2 Frailty, physical function, and falls in HD patients 
One of the objectives of this PhD thesis was to explore the relationship between frailty, 
physical function, and falls in the population of CKD-5 patients on HD. Both frailty and 
physical function measures are linked to an increased risk of falling in community-
dwelling older adults (Fried et al., 2001; Shumway-Cook et al., 2000; Ward et al., 2015). 
Because there is now strong evidence that the prevalence of frailty in the CKD-5 
population is much higher than in community-dwelling elderly individuals (36.8% vs 7%), 
as reported by a recent systematic review with meta-analysis (Kojima et al., 2017), we 
hypothesised that this syndrome may have a great impact on falls in HD patients. Indeed, 
recent observational studies highlighted that frailty may be one of the predominant risk 
factors for falls and fall-related injuries in dialysis populations (McAdams-DeMarco et 
al., 2013; Kutner et al., 2014; Delgado et al., 2015). 
Although frailty and physical function are intrinsically related (Fried et al., 2001), 
relatively few studies have examined the relationship between low physical function and 
falls, with contrasting findings as to which measures may better predict falls in HD 
patients (Chapter 1, paragraph 1.2.3.4). Moreover, due to time and resource constraints or 
other logistic issues, some of these studies exclusively reported data on self-reported 
measures of physical function and frailty (Polinder-Bos et al., 2014; Delgado et al., 2015), 
which are generally considered less reliable and accurate than objective assessments. 
In Chapter 4 of this PhD thesis we sought to address these common methodological issues 
by performing a comprehensive assessment of objectively measured frailty and physical 
function, and by exploring the association of these factors with the falling status of study 
participants. We also aimed to identify which frailty/physical function components are 
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more strongly associated with falls in order to pinpoint possible rehabilitation strategies 
for falls prevention in HD patients. 
 
7.2.2.1 Frailty and falls 
An important preface to this discussion section is that, while there is a general agreement 
in defining frailty as a syndrome of decreased resistance to stressors describing a state of 
increased vulnerability to various health problems (Fried et al., 2001; McMillan et al., 
2012), there are two main conceptualisations of this state. Fried et al., (2001) developed 
an approach to frailty, whose predominant feature is the physical function deterioration 
mainly arising from sarcopenia, while a second approach is portrayed by the Frailty 
Deficit Accumulation Index (Rockwood et al., 2007), an instrument that focuses on the 
accumulation of deficits across multiple systems. The reported prevalence of frailty in the 
population of CKD-5 patients on HD does not seem to differ substantially when measured 
by means of either of the two methods (Painter et al., 2013; Salter et al., 2015; Alfaadhel 
et al., 2015; Isayere et al., 2016; Drost et al., 2016; Kojima et al., 2017). However, it 
should be acknowledged that the relationship with falls (or other clinical outcomes) may 
vary significantly according to the operationalisation of frailty used. For instance, the 
prevalence of the Fried’s frailty phenotype in our study was about 37%, an estimate 
approximately two times higher than the prevalence from another study conducted in 
dialysis patients that assessed frailty with the FRAIL scale (Chao et al., 2015). Thus, these 
methodological discrepancies may impact greatly on the estimated magnitude of 
association between frailty and falls.   
At least three studies have presently investigated the relationship between frailty and falls, 
or falls-related fractures in HD patients, and they all concluded that frailty is a significant 
risk factor for falls in this clinical population (McAdams-DeMarco et al., 2013; Kutner et 
al., 2014; Delgado et al., 2015). Out of these studies, our investigation is more similar to 
the work by McAdams-DeMarco et al., (2013), from a methodological point of view, 
because both studies employed the Fried’s frailty phenotype, a prospective design, and the 
same operational definition of a “fall”. Not surprisingly, the results were similar as both 
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studies found that frailty was associated with a roughly 3-fold higher risk of falls (Chapter 
4, Table 4.5). 
Frailty, as assessed in our study, is closely related to sarcopenia (Fried et al., 2001), a 
typical geriatric syndrome whose diagnosis entails low muscle mass and impaired 
physical function (Cruz-Jentoft et al., 2010). The loss of muscle mass and function is 
inevitable with ageing due to the hormonal changes and declines across various 
physiologic systems (Frontera et al., 2017), however, in the context of CKD-5, these 
processes are accelerated by chronic inflammation and oxidative stress, as well as by other 
CKD-specific factors including acidemia, hyperphosphataemia, and hypernatremia 
(Kooman et al., 2014). Therefore, these pathophysiological abnormalities may also be 
indirectly implicated in the aetiology of falling in HD patients and, as we observed in our 
study, they may confound the well-established relationship between ageing and falling. 
The finding that fallers were younger than 65 years old, and generally even younger than 
non-fallers (although non-significantly) may reflect the premature ageing of HD patients 
(Kooman et al., 2017). 
Physical inactivity and exhaustion seemed to be the main factors driving the significant 
association between frailty and falls observed in the current study, as the distribution of 
only these two frailty components was significantly different between fallers and non-
fallers (Chapter 4, Table 4.1). This finding is interesting for a couple of reasons. First of 
all, CKD-5 patients tend to avoid many physical activities due to fear of falling (Jayaseelan 
et al., 2018) which may deceptively reduce the occurrence of falls in the first place. 
However, in the long-run, this strategy may have catastrophic implications not only for 
the maintenance of a general good state of health but also for falls. The logistic and 
negative binomial regression analyses performed in Chapters 4 and 6 revealed that low 
PA levels, assessed by means of number of daily steps, were associated with the falling 
status of study participants (Table 4.5) and were also predictive of a higher number of falls 
(Table 6.4). This could mean that physical inactivity may both be an outcome of a fall 
suffered from a patient but also a significant predictor of future falls. Moreover, physical 
inactivity is also likely to indirectly increase exhaustion levels (through general 
deconditioning) observed in dialysis patients (Roshanravan et al., 2012). Unsurprisingly, 
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this was the other element of frailty observed to be significantly different between fallers 
and non-fallers (Table 4.1). Secondly, and perhaps more importantly, the finding that 
physical inactivity seemed to drive the association between frailty and falls has important 
implications for preventive and rehabilitative interventions. PA is often the frailty 
component most responsive to exercise interventions and, despite the possible fear of 
falling and objective functional limitations, the findings from this study strongly support 
the notion that HD patients should be encouraged to increase their PA levels to preserve 
independence and reduce their risk of falls in the long-term. 
 
7.2.2.2 Physical function and falls 
Physical function is one of the main constituents of frailty (Morley et al., 2013). The 
results from the exploratory analyses of frail versus non-frail study participants performed 
in Chapter 4 clearly revealed marked decreases for physical function performance in 
measures such as gait speed, TUG, and CSTS-5 in frail patients (Figure 4.3). The Fried’s 
frailty phenotype defines slowness, assessed by means of gait speed, as one of the core 
elements of frailty (Fried et al., 2001). In our study, we also assessed TUG and CSTS-5 
as additional physical function measures potentially linked to falls. Previous research 
conducted on community-dwelling older adults has suggested that cut-off values of 14 
and 16.7 seconds, in the TUG and CSTS-5 respectively, are indicative of an increased risk 
of falling (Shumway-Cook et al., 2000; Ward et al., 2015). Although fallers tended to have 
a worse performance in these outcomes compared to non-fallers (Table 4.3 & Table 6.1), 
the independent comparisons performed in our study did not reveal any statistically 
significant differences between these two groups. Because two previous studies conducted 
on dialysis populations also did not highlight any significant differences between fallers 
and non-fallers in terms of TUG performance (Cook et al., 2006; Farragher et al., 2014), 
we may plausibly conclude that these measures are not useful in predicting falls in HD 
patients. However, more detailed analysis of the findings from these studies revealed that 
the mean TUG performance in the study population (11.5±4.8s) was poor compared with 
normative data from healthy elderly people, being 29% lower than individuals aged 60-
69 years and comparable to the TUG reference values of those aged 80 years and older 
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(Bohannon et al., 2006). Secondly, in the study conducted by Shumway-Cook et al., 
(2000), participants were defined as fallers if they had experienced at least two falls in the 
previous 6 months, and the mean age of fallers was 86.2 years old, significantly higher 
than in the group of non-fallers, whose mean age was 78.4 years (p= 0.002). Consequently, 
the resulting difference in TUG performance between fallers and non-fallers (22.2±9.3s 
vs 8.4±1.7s) was significantly higher than the difference observed in our study (fallers: 
13.3±6.4s vs non-fallers: 10.4±3.4s), and in the study by Farragher et al., (2014) (fallers: 
11.7±2.6s vs non-fallers: 10.2±2.0s), in which the same definition of fallers was used. 
Therefore, the 14 seconds cut-off value proposed by Shumway-Cook et al., (2000) should 
be interpreted carefully by considering that different classifications of “fall” and “faller” 
will inevitably result in different cut-off values or degrees of relationship between risk 
factor and outcome.  
Analogously, Ward et al., (2015) concluded that CSTS-5 performance is associated with 
falling, and that a cut-off value of 16.7 seconds is predictive of falls. In this study though, 
the operational definition of a fall was “an injurious fall leading to 
fractures/sprains/dislocations/pulled or torn muscles/ligaments/tendons, or to seeking 
medical attention”, and the association between CSTS-5 and the risk of sustaining an 
injurious fall over 4 years was analysed. Therefore, the lack of association between CSTS-
5 and falls observed in our study, and apparent discrepancy with the findings of Ward et 
al., (2015) should be contextualised in light of the different methodological approaches 
and prognostic implications. Notably however, the 16.7 seconds cut-off value proposed 
by Ward et al., (2015) seems to fit well in the context of our data, as fallers had a mean 
CSTS-5 performance of 17.7±10s as opposed to non-fallers, whose mean performance 
was 16.2±7s (Table 4.3). 
It should also be noted that, while no association between TUG/CSTS-5 and falls was 
found in logistic regression analysis, the univariate negative binomial regression analysis 
revealed that both gait speed and TUG were predictive of a higher number of falls (Table 
6.4). Nevertheless, these variables were no longer significantly associated with falls when 
the analysis was adjusted for conventional clinical status indicators such as CRP and 
antidepressant use (gait speed= RR: 0.26, 95%CI: 0.03-2.08, p= 0.205; TUG= RR: 1.08, 
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95%CI: 0.96-1.21, p= 0.220). Because we observed this association in negative binomial 
regression analysis, we cannot exclude that gait speed and TUG test may be useful 
instruments to predict falls in the population of CKD-5 patients on HD. However, we 
plausibly hypothesise that perhaps a composite score of physical function obtained from 
multiple field tests may be more useful than single assessments in detecting an increased 
risk of falling. For instance, a couple of recent prospective studies conducted on HD 
patients have concluded that the SPPB test, a composite assessment of physical function 
including the CSTS-5 among other tests (Ortega-Perez de Villar et al., 2018), was 
predictive of falls in multivariate regression analyses (Wang et al., 2017; Kono et al., 
2018). 
 
7.2.2.3 Physical activity and falls 
Although the role of PA on falls has already been discussed, in part, in the last paragraph 
of section 7.2.2.1, some observations emerging from the study need to be further 
examined. First of all, the PA status of the study population was assessed by means of 
subjective and objective measurements, both of which revealed a significant sedentary 
behaviour comparable to the findings on PA estimates in HD patients from the current 
literature. For instance, 47.2% of the study participants met the low PA component of 
frailty (Chapter 4, Table 4.1), an estimate that mirrors the findings from the large scale 
study DOPPS, which reported that 44% of dialysis patients never engage in any form of 
exercise (Tentori et al., 2010). Similarly, another investigation that assessed PA by means 
of the IPAQ questionnaire (the same instrument we used to categorise the low PA 
component of frailty) reported that 40% of HD patients were classified as completely 
inactive (Stringuetta-Belik et al., 2012). In addition, objective measurements of PA such 
as number of daily steps taken by the study participants (3129±1769, Table 4.2) were also 
consistent with the findings of Mafra et al., (2011), who reported that dialysis patients in 
their study walked an average of 2800 steps per day. Therefore, our findings on PA are 
indicative of marked sedentary behaviour (Tudor-Locke et al., 2004), and may be 
generalised to the population of CKD-5 patients on dialysis. 
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Although PA, as assessed by means of the ActivPal monitor, was not associated with 
increased odds of falling in multivariate logistic regression analysis (Table 4.5), patients 
classified as fallers had a significantly lower number of daily steps compared to non-
fallers (Table 4.2). Additionally, objective measurements such as the number of daily 
steps and sit to stand transitions were associated with a higher number of falls in univariate 
negative binomial regression (Table 6.4). Moreover, low PA seemed to be one of the main 
drivers of the association observed between frailty and falls (Table 4.1). Therefore, 
although we cannot definitively conclude that physical inactivity is an independent risk 
factor for falls, our data suggest that low PA may be implicated in the aetiology of falling 
in HD patients. 
To the best of our knowledge, only one other study examined the relationship between PA 
and falls in dialysis patients (Delgado et al., 2015). This investigation explored the 
association between a modified version of the Fried’s frailty phenotype, consisting of 
three self-reported components (physical function, exhaustion, and PA), and falls or 
fractures in a large cohort of dialysis patients. The main findings of this study were that 
frailty was associated with time to first fall or fracture, and that the physical function (HR 
1.33, 95% CI 1.01 – 1.75, p-value not reported) and exhaustion (HR 1.40, 95% CI 1.10 – 
1.76, p-value not reported) components were also individually associated with an 
increased risk of falling. Physical inactivity had a similar point estimate (HR 1.36, 95% 
CI 0.78 – 2.37, p-value not reported) but it did not reach statistical significance in fully 
adjusted Cox regression analysis (Delgado et al., 2015). Even though the study could not 
provide evidence of a significant association with falls, one important observation should 
be highlighted to better interpret the meaning of these findings. In this study, the PA 
component of frailty was defined as a score in the lowest quintile of the Adjusted Activity 
Score of the Human Activity Profile (Johansen et al., 2001). This operationalisation of PA 
resulted in 94% of the study participants meeting the criteria of physical inactivity, a 
significantly higher estimate than what we found in our study (47.2%) and also contrasting 
with the prevalence of physical inactivity in dialysis populations emerging from the larger 
DMMS (35%) and DOPPS (44%) studies (O’Hare et al., 2003; Tentori et al., 2010). 
Therefore, as correctly acknowledged by the authors, the very small proportion of patients 
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classed as “physically active” may explain why the point estimate of PA did not reach 
statistical significance in their study (Delgado et al., 2015). Moreover, it is possible that a 
different operational definition of PA may have resulted in a significant association 
between this frailty component and falls also. 
Although the findings from Delgado et al., (2015) and from our study do not provide 
ultimate evidence that physical inactivity contributes independently to an increased risk 
of falling in the population of CKD-5 patients on HD, they seem to suggest that increasing 
the levels of PA may be beneficial to the prevention of falls in this patient group. From a 
rehabilitation perspective, increasing the number of daily steps may be an effective 
preventive strategy to reduce the risk of falling, and it would also be a significantly low-
cost intervention because it needs no or minimal supervision. A recent multicenter 
randomised clinical trial has shown that a simple walking program significantly improved 
physical function and quality of life in dialysis patients (Manfredini et al., 2017). 
However, future research is required to explore whether this kind of physical activity 
intervention is effective in reducing the occurrence of falls, among other adverse clinical 
outcomes, in HD patients. 
 
7.2.2.4 Muscle strength and falls 
One of the secondary objectives of this PhD thesis was to explore the relationship between 
muscle strength and falls in CKD-5 patients on HD. Low muscle strength is one of the 
defining components of the Fried’s frailty phenotype (Fried et al., 2001), an 
operationalisation of the frailty syndrome that has been consistently found to be associated 
with an increased risk of falling in HD patients (McAdams-DeMarco et al., 2013; Kutner 
et al., 2014). In addition, at least two systematic reviews, with meta-analysis, investigating 
the role of exercise on falls prevention have concluded that strength training should be 
incorporated in exercise-based interventions aimed to decrease falls in the community-
dwelling population of older adults (Sherrington et al., 2011; Sherrington et al., 2017). 
Therefore, we hypothesised that muscle strength would be associated with falls in our 
study participants. 
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Although we expected to observe a strikingly lower muscle strength, as assessed by means 
of handgrip and leg extension, in fallers compared to non-fallers, this was not confirmed 
by our findings (Chapter 4, Table 4.3). Likewise, handgrip and leg extension strength were 
not associated with increased odds of falling in logistic regression analysis (Table 4.5). 
However, in Chapter 6, we found that low handgrip strength was associated with a higher 
number of falls in univariate negative binomial regression analysis (Table 6.4). Overall, 
the discrepancies emerging from Chapters 4 and 6 do not underpin any conclusive 
statements as to whether muscle strength is a useful predictor of falls in the CKD-5 
population of HD patients. One important observation though is that, contrary to the 
current best practice recommendations on exercise prescription for falls prevention, which 
emphasise the greater utility of strength training compared to walking programs 
(Sherrington et al., 2011), low PA levels were more consistently associated with an 
increased risk of falling in our study population. Therefore, our findings seem to suggest 
that increasing PA may be more beneficial than strength training for the prevention of falls 
in this patient group. 
However, because we only performed two assessments of muscle strength, we cannot 
exclude that this component of frailty may play an important role in the aetiology of falls 
in this clinical population, and perhaps other measurements of isometric/dynamic muscle 
strength could have revealed a stronger association with the risk of falling. For instance, 
Wang et al., (2017) recently reported that low ankle dorsiflexion strength was associated 
with a higher number of falls in a group of dialysis patients. Because a high number of 
falls are precipitated by tripping over an obstacle, or by a misstep (Timsina et al., 2017), 
both of which seem to be linked to poor ankle mobility/strength, we are led to think that 
this measure of strength may be more useful than isometric handgrip strength or isometric 
knee extension strength in predicting the risk of falling. 
Another methodological limitation that should be acknowledged is that we did not perform 
any direct measurements of muscle mass in our study. The alteration of muscle 
quality/quantity would be an important factor mediating the relationship between strength 
and falls, as sarcopenia is also a known risk factor for falls (Zhang et al., 2019). Many 
CKD-related conditions such as elevated uraemia, increased glucocorticoid activity, 
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insulin resistance, metabolic acidosis, chronic inflammation, malnutrition, and the dialytic 
treatment itself can contribute to muscle wasting and loss of muscle strength in HD 
patients (Battaglia et al., 2016). Although we did not collect direct muscle mass 
characteristics, it should be noted that patients classified as fallers tended to have lower 
BMI (28±6.7kg*m-2 vs 30.3±5.6kg*m-2, p= 0.131), lower creatinine (617.4±173.7μmol/L 
vs 654.6±139.6μmol/L ,p=0.326), and higher CRP (28.7±49.8mg/L vs 17.6±33.4mg/L, 
p=0.083) than non-fallers. All of these characteristics seem to be associated with lower 
muscle mass and strength (Hamer et al., 2009; Wong et al., 2016; Kim et al., 2016). 
Although these differences were not statistically significant, they may be indicative of 
lower muscle mass in fallers, and therefore we cannot exclude that low muscle mass may 
also be a significant risk factor for falls in this clinical population. 
 
7.2.2.5 Postural balance and falls 
While the previous components of physical function assessed (PA, TUG, CSTS-5, muscle 
strength) were all implicitly linked to the Fried’s frailty phenotype (Fried et al., 2001), 
postural balance is an element of physical performance independent from this construct 
of frailty. Although our results suggest that these factors are related, as frail participants 
consistently showed lower postural balance compared to those who were not frail (Chapter 
4, Figure 4.4), an assessment of balance performance has never been incorporated in any 
operationalisation of frailty to the best of our knowledge. However, we decided to assess 
postural balance as a further potentially falls-related measure (King et al., 1995). 
We found that fallers had worse postural balance than non-fallers in both Chapters 4 and 
6 (Table 4.4 & Table 6.1). The logistic regression analysis also revealed that worse balance 
was significantly associated with increased odds of falling (Table 4.5). In addition, the 
ROC analysis performed in Chapter 6 showed that postural balance was the only factor to 
significantly discriminate fallers from non-fallers, with VelY showing the best predictive 
ability (AUC= 0.69, 95%CI: 0.55-0.82, p= 0.01). Nevertheless, balance performance was 
not associated with a higher number of falls in the negative binomial regression analysis 
performed in Chapter 6. To the best of our knowledge, this is the first study reporting a 
significant association between postural balance, as assessed by means of a force platform, 
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and falls in a group of CKD-5 patients on HD. Previous research had only examined the 
relationship between single field-tests of balance, such as one leg stands (Desmet et al., 
2005), or composite scores of physical function including a balance element (Rossier et 
al., 2012; Wang et al., 2017; Kono et al., 2018) and falls in dialysis populations. These 
revealed a significant relationship for composite scores only (Wang et al., 2017; Kono et 
al., 2018). 
Many CKD-related alterations may result in impaired postural balance in HD patients. 
First of all, muscle atrophy is very common in these patients and is one of the main factors 
potentially leading to impairments of postural control, due to reduced ability of the 
proximal and distal lower limb muscles to actively compensate the small perturbations of 
balance that occur continuously throughout the day (Horlings et al., 2009). Additionally, 
the extreme sedentary behaviour imposed by the dialysis treatment can lead to a general 
physical deconditioning that can also affect postural balance (Kiers et al., 2013). Thirdly, 
HD patients may also be affected by peripheral neuropathy as a consequence of advanced 
diabetes (the most common cause of CKD), elevated uraemia, and drug toxicity (Baluarte 
et al., 2017), which is also a well-established risk factor for impaired balance, since it 
affects directly the efferent component (e.g. motor nerves) of balance control (Hewston et 
al., 2016). Not surprisingly, previous research has shown that postural balance, assessed 
by means of force platforms, is significantly worse in HD patients than in healthy age-
matched individuals (Blake et al., 2004; Shin et al., 2014; Magnard et al., 2014), however, 
ours is the first study to provide evidence of a significant association between postural 
balance and falls in this patient group. 
Another interesting finding from our investigation is that velocity-based measures of 
balance (such as VelY) seemed to better discriminate fallers from non-fallers compared 
to position-based measures (e.g. RangeY), as highlighted in Chapter 6 (Table 6.1). This is 
in agreement with the findings of Magnard et al., (2014), who postulated that these kind 
of outcomes may be more useful in assessing balance and predicting falls in this patient 
population. 
Overall, the interpretation of our study results on balance and falls leads us to confirm the 
already existing recommendation that exercise-based interventions aiming to reduce falls 
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should incorporate balance training (Sherrington et al., 2011) in HD patients also. Since 
postural balance was associated with increased odds of falling independently from frailty, 
and because a “loss of balance” was the second most commonly reported precipitating 
factor accompanying the falls (18.8% of falls) experienced by study participants, we are 
led to think that impaired postural balance may be an independent risk factor implicated 
in the aetiology of falls in the population of CKD-5 patients on HD. 
 
7.2.3 Cardiovascular function and falls in HD patients 
Cardiovascular function is a broad concept that involves the maintenance of the major 
functions of the cardiovascular system. One of the main functions is the homeostasis of 
fluid balance within the different body compartments. This is achieved by regulating HR, 
BP and peripheral resistance. In the context of cardiovascular disease, these mechanisms 
can be impaired and this can result in orthostatic hypotension and cardiovascular-mediated 
syncope, two known risk factors for falls (Finucane et al., 2017). We already know that 
community-dwelling older adults are at high risk of orthostatic hypotension and syncope-
related falls due to the cardiovascular impairment resulting from the ageing process 
(Finucane et al., 2014; Jansen et al., 2015). Because the population of CKD-5 patients on 
HD is growing older (UKRR 2016), and CVD is the leading cause of death in these 
patients (USRDS, 2011; UKRR, 2016), we were inclined to hypothesise that a high 
number of falls may be due to impairment of cardiovascular function in people living with 
CKD-5. Therefore, one of the main objectives of this PhD thesis was to explore the 
relationship between cardiovascular function and falls in HD patients. 
This possible relationship has not received much attention by previous research on HD 
and falls, as most studies have focused on the relationship between clinical characteristics 
or physical function/frailty and falls (Lopez-Soto et al., 2015). The only cardiovascular 
function factor that was consistently examined across studies was BP (Desmet et al., 2005; 
Cook et al., 2006; Roberts et al., 2007; Abdel-Rahman et al., 2011; Polinder-Bos et al., 
2014; Kono et al., 2018). These investigations reported contrasting results as to whether 
impaired BP regulation may contribute to falls. In particular, two studies found that low 
pre-dialysis SBP was associated with a higher number of falls (Cook et al., 2006) or time 
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to first fall event (Polinder-Bos et al., 2014). In addition, three other studies did not 
highlight any significant relationship between pre or post-dialysis BP and falls in logistic 
regression analysis (Desmet et al., 2005; Roberts et al., 2007; Abdel-Rahman et al., 2011). 
More importantly, only three studies examined the possible relationship between 
orthostatic decrements of BP and falls (Desmet et al., 2005; Cook et al., 2006; Roberts et 
al., 2007). These investigations did not find any association between the BP response to 
an orthostatic challenge and falls via logistic regression analysis. However, all of these 
studies employed an orthostatic challenge consisting of an active stand with standard 
oscillometric BP measurements, an examination that is widely used in clinical settings for 
a time-efficient assessment of orthostatic intolerance symptoms but also subjected to 
standardisation issues of testing procedures (Cooke et al., 2009; Pasma et al., 2014). 
Therefore, in Chapter 5 of this PhD thesis we sought to further explore the relationship 
between cardiovascular function and falls by performing a comprehensive assessment of 
haemodynamic function at rest, and in response to HUT-60°, using more advanced 
continuous beat-to-beat technology (Shaw et al., 2015). In addition, we also aimed to 
explore the relationship between baroreflex function, the main physiologic mechanism 
involved in the short-term regulation of haemodynamic variables in response to standing 
(Chapter 1, paragraph 1.2.4.3), and falling status in CKD-5 patients on HD. 
 
7.2.3.1 Baroreflex function and falls 
To the best of our knowledge, this is the first research project investigating the relationship 
between baroreflex function and falls in CKD-5 patients on HD. The cross-sectional study 
presented in Chapter 5 revealed that lower number of baroreceptor events, measured using 
the sequence method (La Rovere et al., 2008), were associated with increased odds of 
falling in univariate regression analysis (Table 5.3). More importantly, the negative 
binomial regression analysis performed in Chapter 6 showed that low number of 
baroreceptor events and BEI predicted a higher number of falls (Table 6.4). Therefore, the 
overall findings from this PhD thesis suggest that poor baroreflex function may be an 
important risk factor for falls in this clinical population. 
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Despite no previous studies reporting a possible association between baroreflex function 
and falls, the observations that impaired baroreflex control is associated with BP 
decrements in response to orthostasis (Mattace-Raso et al., 2007), and that these 
decrements can lead to falls in non-uraemic older adults (Heitterachi et al., 2002), would 
seem to indirectly suggest that impaired baroreflex may be a significant risk factor for 
falls in the general population. However, people living with CKD-5 have a significantly 
higher burden of cardiovascular comorbidities compared with community-dwelling older 
adults (Foley et al., 1997) which is responsible for the common impairment of baroreflex 
function in these patients, as observed by many studies conducted on dialysis patients 
(Hildreth et al., 2012). Therefore, it is possible that this factor may contribute more 
markedly to the aetiology of falling in the CKD-5 population compared to non-uraemic, 
age-matched individuals. 
One interesting finding, emerging from both Chapters 5 and 6, was that BEI but not BRS 
was associated with an increased risk of falling. The BEI is a measure that describes how 
often the baroreflex is activated (Di Rienzo et al., 2001), contrary to the BRS which is 
linked to the gain/strength of baroreflex activation (Pinna et al., 2015). Therefore, we 
plausibly take the view that frequency, rather than intensity, of baroreflex activation may 
contribute predominantly to an increased risk of falling. Because many spontaneous 
fluctuations of BP manifest suddenly throughout the day, as a result of changes in body 
position or more or less prolonged periods of standing (Silvani et al., 2017), the baroreflex 
has to constantly adjust HR and peripheral resistance to maintain cardiac output. Thus, a 
reduced frequency of baroreflex activation (i.e. low BEI) would imply that sudden drops 
in BP are not coupled effectively with concomitant increases of HR, which may result in 
a suboptimal cerebral perfusion possibly leading to dizziness symptoms and, 
consequently, falls (Shaw et al., 2015). As reported in Chapter 5, the number of down-
events and down-BEI were significantly lower in fallers compared to non-fallers (Table 
5.1). In the sequence method, the “down” component of baroreflex activation is indicative 
of vagal withdrawal (Martin-Vazquez et al., 2010) because a down-event occurs when a 
drop in BP triggers an increase in HR arising from sympathetic activation. Because the 
number of down-events appeared to better discriminate fallers from non-fallers (Table 
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5.1), we are led to think that the “down” component of baroreflex, representing vagal 
withdrawal, may contribute primarily to an increased risk of falling. 
It should also be acknowledged that the relationship between baroreflex function and falls 
may vary depending on the method of measurement employed to assess the baroreflex. In 
this PhD research, baroreflex function was assessed with the sequence method (Pinna et 
al., 2000), however other invasive and non-invasive methods have been used historically 
(Chapter 1, paragraph 1.2.4.4). The sequence method belongs to the class of non-invasive 
methods based on the spontaneous fluctuations of BP and HR. Pinna et al., (2015) 
synthesised the advantages and limitations of this method. The main advantages of this 
method are that 1) it conveys prognostic information comparable to the invasive methods 
(Pinna et al., 2000), 2) it is a low-cost, and time-efficient non-invasive assessment, and 3) 
it allows a lower estimation bias on BRS due to the strict constraints on ectopic beats. 
Therefore, in light of our study findings, baroreflex function assessed using this method 
may be a valuable screening tool to identify patients at high risk of falls. However, two 
limitations of this method need to be taken into consideration. First of all, the stringent 
restrictions imposed on the simultaneous change of BP and HR may result in lack of 
suitable baroreceptor sequences for the calculation of BRS. Secondly, the non-invasive 
measurements of BP were taken from the index or middle fingers: as encountered in our 
investigation (Chapter 5, paragraph 5.3.1), this measurement could be compromised in 
those individuals suffering from distal ischemia. Consequently, the combined effect of 
these two limitations is that this method is very often associated with a high failure rate 
(Pinna et al., 2015). As previously reported, these failure rates can be as high as 28% in 
people with history of myocardial infarction (Maestri et al., 2009). Because patients living 
with CKD-5 have a high burden of cardiovascular comorbidities, researchers should 
cautiously allow for a 30% failure rate in the calculation of baroreflex indices when 
designing research studies. 
The findings on baroreflex function and falls arising from this PhD thesis have a potential 
translational impact that warrants further investigation, as previous research has reported 
on the efficacy of multiple interventions to improve baroreflex function in various 
populations. In particular, orthostatic training has recently been shown to be a viable 
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passive therapy to improve baroreflex indices in adults with recurrent syncope (Mitro et 
al., 2018), and it may represent a valuable rehabilitation strategy for HD patients also in 
light of the high prevalence of syncope in this clinical population (Roberts et al., 2003; 
Roberts et al., 2007). Moreover, some research has shown that transitioning to nocturnal 
HD treatment improved both BRS (Chan et al., 2005) and BEI (Chan et al., 2008) by 
lowering BP, peripheral resistance, and by improving distensibility of conduit vessels in 
dialysis patients. Finally, there is now increasing evidence that physical exercise can 
improve baroreflex function in various patient populations (Deley et al., 2009; Sato et al., 
2010; Green et al., 2011; Straznicky et al., 2011; Ganesan et al., 2014) including HD 
patients (Petraki et al., 2008). The exercise interventions in these studies consisted of 
aerobic training mostly (Petraki et al., 2008; Deley et al., 2009; Straznicky et al., 2011; 
Ganesan et al., 2014), and therefore this exercise modality may be a useful component of 
rehabilitation programs aiming to reduce the occurrence of falls by improving baroreflex 
function. 
 
7.2.3.2 Haemodynamic responses to orthostasis and falls 
We hypothesised that worse haemodynamic responses to HUT-60° would be associated 
with an increased risk of falling in CKD-5 patients on HD. The findings from Chapter 5 
of this PhD thesis were that decrements of OscBP in response to HUT-60° were 
significantly associated with increased odds of falling in univariate but not multivariate 
analysis (Table 5.3), while in Chapter 6, the OscDBP response predicted a higher number 
of falls in negative binomial regression analysis (Table 6.4). Moreover, fallers also tended 
to have larger decrements of OscSBP compared to non-fallers (Table 6.3), possibly 
indicating that the inclusion of a larger sample size may have resulted in a significant 
association between OscSBP decrements and number of falls sustained by study 
participants. Overall, the findings from both Chapter 5 and 6 suggest that the aetiology of 
the high number of falls experienced by HD patients might be associated with an impaired 
orthostatic response of BP. 
These results are in apparent disagreement with previous investigations that did not 
highlight any significant relationship between orthostatic changes of BP and falls in 
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dialysis populations (Desmet et al., 2005; Cook et al., 2006; Roberts et al., 2007). 
However, important methodological distinctions between these studies and our 
investigation are that 1) we employed a passive orthostatic challenge as opposed to an 
active stand, 2) the specific protocols of the active stand are not described in these studies, 
and 3) we computed the BP change from supine to HUT-60°, rather than measuring 
standing BP only (Roberts et al., 2007). Therefore, it is possible that merely the better 
standardisation of testing procedures in our study is responsible for the observed 
discrepancy. In addition, fallers had worse baroreflex function indices compared to non-
fallers (Table 5.1), and therefore the emerging association between OscBP decrements to 
orthostasis and falls makes physiological sense since the baroreflex is the primary 
mechanism responsible for the short-lived responses of BP to orthostasis. 
Although we also expected to observe a different orthostatic response of other 
haemodynamic variables (e.g. HR, SV, TPR, and contBP) in fallers compared to non-
fallers, this was not confirmed (Table 5.2 and Table 6.3), and only CO was associated 
with a higher number of falls in univariate negative binomial regression (Table 6.4). This 
overall lack of response may be associated with the orthostatic challenge used in our study. 
Previous research has interestingly shown that, compared to active standing procedures, 
the initial response of contBP to passive tilting is less pronounced or even absent (Imholz 
et al., 1990; van Wijnen et al., 2017) (Figure 7.2). Consequently, all other concomitant 
haemodynamic responses may have not been triggered strongly enough due to the 
inadequate orthostatic challenge. Because all haemodynamic responses were recorded 
only over a short period (five minutes) of HUT-60°, it is possible that a longer duration of 
tilting might have elicited a more marked decrease of contBP and concomitant responses. 
Although previous research employing active stands did not find any relationship between 
orthostatic BP and falls (Desmet et al., 2005; Cook et al., 2006), it should be noted that 
these studies measured BP exclusively by means of intermittent sphygmomanometer 
assessments (protocols not described), and it cannot be excluded that continuous beat-to-
beat measurements may have yielded different results. A recent literature review has 
suggested that an orthostatic challenge consisting of an active stand with contBP 
monitoring may be ideal to more accurately interpret the short term (first 180 seconds) 
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cardiovascular adjustments to orthostasis (van Wijnen et al., 2017). Moreover, this kind 
of assessment would be low-cost, time-efficient, and it would recreate real-world 
conditions, therefore it may have useful applications in clinical settings. 
 
Figure 7.2. Typical response of contBP and HR to three orthostatic challenges. Active 
stand from supine position (left), active stand from sitting position (centre), and HUT 
(right) (van Wijnen et al., 2017, p.470). 
 
Although we did not observe a significant relationship between contBP and an increased 
risk of falling, the finding that orthostatic decrements of OscBP were associated with 
participants’ falling status (Chapter 5, Table 5.3), and predictive of a higher number of 
falls (Chapter 6, Table 6.4) has important translational implications. Particularly, these 
observations reinforce the evidence that simple OscBP measurements are generally 
considered adequate to evaluate the circulatory response to orthostasis (van Wijnen et al., 
2017) and, in conjunction with a HUT-60° assessment, they may represent a valuable 
screening tool for practitioners to detect an increased risk of falling.  
Because the findings from both Chapters 5 and 6 of this PhD thesis seem to suggest that 
orthostatic drops of BP are implicated in the aetiology of falling in CKD-5 patients on 
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HD, this raises the question of which interventions may be more suitable in reducing falls 
by improving this haemodynamic response. Even though many studies have now shown 
the benefits of physical exercise on baroreflex function (as described in paragraph 7.2.3.2), 
the question as to whether exercise programs can ameliorate the BP response to orthostasis 
requires careful examination. Some researchers have described a paradoxical relationship 
between exercise and orthostatic intolerance (van Lieshout, 2003) because aerobic 
training can improve orthostatic tolerance by increasing the plasma volume (Mtinangi et 
al., 1999; Wieling et al., 2002). However, trained individuals may have lower tolerance to 
orthostatic stress as a result of structural cardiac modifications that could lead to reduced 
stroke volume during prolonged standing (Levine et al., 1991). Nevertheless, CKD-5 
patients on HD are known to be extremely inactive (Johansen et al., 2010) and, since 
marked sedentary behaviour is likely to negatively impact on orthostatic tolerance 
(Bonnin et al., 2001), they could benefit from exercise programs to improve the 
cardiovascular responses to orthostasis. Some authors have postulated that isotonic rather 
than isometric exercise may be advisable to minimise breathing patterns mimicking the 
Valsalva maneuver which could decrease the venous return and possibly result in brain 
hypoperfusion (Figueroa et al., 2010). Interestingly, there is also some evidence that 
orthostatic training (tilt training) may be beneficial in reducing the number of syncope-
like events in healthy adults with history of syncope (Zeng et al., 2008). Because some 
research has shown that orthostatic training can also improve the orthostatic OscBP 
decrements (Sutcliffe et al., 2010), it may be a possible rehabilitation tool to reduce falls 
precipitated by orthostatic intolerance. 
 
7.2.4 Diabetes and falls in HD patients 
In Chapter 4 of this PhD thesis we observed that study participants classified as fallers 
were more likely to have diabetic nephropathy as PRD compared to non-fallers (34.9% vs 
12.9%, p= 0.033). Moreover, diabetic nephropathy was also associated with increased 
odds of falling in logistic regression analysis (Table 4.5). A previous prospective cohort 
study conducted on a larger group of dialysis patients revealed that diabetes was an 
independent risk factor for falls in the study population (Desmet et al., 2005), and a recent 
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systematic review with meta-analysis concluded that diabetes is associated with an 
increased risk of falling in community-dwelling older adults (Yang et al., 2016). 
Therefore, we explored the confounding effect of diabetes on the study results in both 
Chapter 4 and 5 of this thesis. 
Potentially, an advanced state of diabetes could have an adverse effect on falls via multiple 
pathways. For instance, falls may be precipitated by impaired physical function, due to 
the diabetes-related loss of muscle mass and strength (Park et al., 2007), or as a 
consequence of peripheral neuropathy which could negatively affect proprioception and 
postural balance (Hewston et al., 2016). In addition, advanced diabetes may negatively 
impact on cardiovascular function as a result of autonomic neuropathy (Vinik et al., 2018), 
which could impair the ability to regulate BP in response to orthostasis or during 
prolonged bouts of standing via the baroreflex. Moreover, diabetes may contribute to a 
higher risk of falls secondarily to impairments of vision, arising from retinopathy 
(Hewston et al., 2016), or as a consequence of hypoglycemia which may result from a 
high intensity treatment with insulin (Chiba et al., 2015). In addition, poor glycemic 
control with chronic hyperglycemia can trigger neurodegenerative processes potentially 
leading to cognitive impairment, which has been postulated to be one of the main risk 
factors for falls in people living with diabetes (Hewston et al., 2016). 
While we did not find significant correlations between diabetes and physical function 
measures (with the only exception of low PA levels: Tables 4.7 & 4.8), diabetic 
nephropathy seemed to have an important mediating effect on the relationship between 
cardiovascular function and falls. In Chapter 5, we observed that adjusting the logistic 
regression analysis for diabetic nephropathy removed the significant associations between 
baroreflex function/haemodynamic responses to HUT-60° and falling status that were 
found in univariate stage (Table 5.3). In addition, diabetic patients had significant worse 
baroreflex function and orthostatic OscBP control compared to non-diabetics (Figures 5.1 
& 5.2). Further analyses by means of point bivariate correlations revealed that no 
relationship between baroreflex/haemodynamic function and falling status persisted when 
patients with diabetic nephropathy were removed from the analysis. Therefore, we are led 
to think that, in CKD-5 patients on HD, diabetes may contribute to an increased risk of 
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falling predominantly via alterations of cardiovascular (e.g. autonomic neuropathy) rather 
than physical function (e.g. loss of muscle mass, or peripheral neuropathy). 
Due to the fact that diabetic nephropathy is the main cause of CKD (UKRR, 2016), and 
that the prevalence of diabetes in CKD-5 patients is more than three times higher than in 
the general population (Guariguata et al., 2014), this comorbidity is likely to contribute to 
a high number of falls in this clinical population. Consequently, practitioners should 
consider implementing falls’ risk screenings in those patients having diabetic nephropathy 
as PRD. 
 
7.2.5 Impact of frailty and cardiovascular function on falls 
Many recent systematic reviews have concluded that multiple risk factors such as older 
age, comorbidities, polypharmacy, and frailty or impaired physical function contribute to 
an increased risk of falling in the general population (Ambrose et al., 2013; Enderlin et 
al., 2015; Lusardi et al., 2017). In addition to these risk factors, CKD-5 patients on HD 
are characterised by severe CVD burden that often manifests with symptoms of orthostatic 
intolerance, impaired BP control and syncope, all of which may be implicated in the 
aetiology of falling. Therefore, one of the main objectives of this PhD research project 
was to explore the relative importance of frailty and cardiovascular function as potential 
exercise-modifiable risk factors for falls in the population of CKD-5 patients on HD. This 
research question was explored in the study presented in Chapter 6 of this PhD thesis. 
In this study, we used a prospective design to explore the association between potential 
frailty and cardiovascular predictors, assessed at baseline, and the number of falls 
experienced by study participants during a 12-month follow-up. We hypothesised that 1) 
frailty/physical function and cardiovascular function (baroreflex function and 
haemodynamic responses to HUT-60°) would predict a higher number of falls, and 2) 
modelling the risk of falling by adding a cardiovascular function variable to a frailty-
related variable only would improve the prediction of the number of falls sustained by 
study participants. The main findings from this study (as more fully discussed in paragraph 
6.4) were that not only did cardiovascular function improve the prediction of falls, when 
combined with frailty (Figure 6.1), but it also showed a predominant contribution to the 
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number of falls experienced by study participants (Table 6.4). Moreover, this observation 
was also reinforced by the symptomatology described by fallers, who reported dizziness 
as most common precipitating factor leading to the falls experienced (41.3% of falls). The 
finding that baroreflex function and orthostatic decrements of blood pressure seemed to 
play a central role in the aetiology of falling is particularly important for a couple of 
reasons. First of all, we know that the high prevalence and incidence of CVD among CKD-
5 patients on HD is responsible for multiple impairments of cardiovascular function such 
as, autonomic dysfunction, baroreflex impairment, BP dysregulation which could lead to 
many adverse clinical outcomes like recurrent hospitalisations, intradialytic hypotension, 
and sudden cardiac death (Kanbay et al., 2010; Di Lullo et al., 2016; Shafi et al., 2017; 
Mandel et al., 2017). Therefore, in addition to these common adverse outcomes, 
impairments of cardiovascular function may also constitute a CKD-specific risk factor for 
falls in this clinical population. Secondly, and more importantly, our findings challenge 
the current assumption that frailty is the factor primarily involved in the aetiology of 
falling in dialysis patients (McAdams-DeMarco et al., 2013; Kutner et al., 2014; Delgado 
et al., 2015). This second observation has noteworthy implications for potential preventive 
and rehabilitative interventions aimed to reduce falls in this patient group, since both 
baroreflex function and orthostatic BP decrements are modifiable risk factors. While the 
current rehabilitation approach to decrease the risk of falling in those individuals who may 
be at high risk, or who have already suffered a fall, recommends exercise programs to 
modify balance predominantly (Sherrington et al., 2011; Sherrington et al., 2017; 
Sherrington et al., 2019), the importance of aerobic training in reducing falls has not been 
emphasised. Current recommendations on falls prevention in the general elderly 
population tend to discourage exercise programs with a predominant walking component, 
as this kind of activity, and especially brisk walking, may expose those who are at high 
risk of falls already to a further risk (Sherrington et al., 2017). Although this is sensible 
advice, considering that many falls occur while walking (31.3% of falls in our study), our 
findings also suggest that some form of aerobic exercise may be beneficial in the 
prevention of falls. This is due to the fact that this type of exercise can positively impact 
on the baroreflex and orthostatic tolerance (Wieling et al., 2002; Petraki et al., 2008; Deley 
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et al., 2009). Moreover, some research has suggested that a simple gait training program 
on a treadmill may improve baroreflex function (Ganesan et al., 2014). Because a low 
number of daily steps predicted a higher number of falls in our study (Chapter 6, Table 
6.4), we are further led to think that simply increasing the number of daily steps, by means 
of a low-cost walking program, may be effective in reducing the risk of falls (as previously 
postulated in paragraph 7.2.2.3). However, as highlighted by Sherrington et al., (2019), 
prescribing walking is not always possible, especially in those individuals whose physical 
deconditioning is so severe that a simple walking program would paradoxically result in 
an augmented risk of falling. For this reason, alternative exercise programs comprising a 
central aerobic component should be considered. For instance, a considerable amount of 
information relating to the clinical effectiveness and safety of intra-dialytic exercise 
programs is now available (Greenwood et al., 2014). In particular, an intradialytic exercise 
program consisting of cycling has been shown to improve baroreflex in a group of HD 
patients (Petraki et al., 2008). This exercise modality may be safer than brisk walking 
because it would not expose patients to an immediate risk of falling arising from 
stumbling, tripping or other environmental hazards, while increasing the levels of physical 
activity and improving baroreflex function. 
 
7.3 Research limitations 
As previously acknowledged in Chapters 4, 5 and 6, one of the main limitations of this 
PhD research project concerns the relatively low sample size. Although the patient sample 
achieved was reasonable to justify the statistical analyses performed (paragraph 2.1.3), a 
larger number of research participants would have increased the power of our observations 
and decreased the chances of committing a type II error. Particularly, the choice of 
covariates in our regression models was affected by the limited statistical power. Because 
only a small number of independent variables could be entered simultaneously in the 
logistic/negative binomial regression analysis, we used a data-driven approach to 
prioritise covariate selection. For instance, in Chapter 6 (paragraph 6.3.6) we adjusted the 
first multivariate stage of negative binomial regression analysis for antidepressant use and 
CRP, due to the fact that these factors were significantly different in fallers and non-fallers 
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(Table 3.1). However, it should be acknowledged that, when covariates are selected based 
on a data-driven approach, some genuine associations between risk factors and the 
dependent variable may be missed due to theoretical multicollinearity. For example, it 
could be speculated that since inflammation, and thus high CRP, has a mechanistic role in 
frailty (Walker et al., 2019), adjusting the analysis for CRP may cancel out the significant 
association between frailty and falls (Table 6.4). Nevertheless, in more detailed analysis, 
we did not observe statistical multicollinearity between CRP and frailty (r= -0.008, p= 
0.947) and adjusting the negative binomial regression analysis for CRP only did not 
eliminate the significant association between frailty and falls (RR: 4.48, 95%CI: 1.71-
11.70, p= 0.002). Ultimately, the possibility of studying a larger patient sample would 
have allowed us to design a more exhaustive statistical analysis with a priori, and theory-
driven, selection of confounding variables. Moreover, due to the relatively high number 
of outcomes assessed, it should be acknowledged that some variables may have differed 
by chance between fallers and non-fallers. 
Additionally, in Chapters 4 and 5, the categorisation into fallers and non-fallers was not 
exclusively based on the occurrence (or not) of falls recorded prospectively, as 
recommended by the Prevention of Falls Network Europe and Outcomes Consensus 
Group (Lamb et al., 2005). On the contrary, participants were also classified as fallers if 
they reported at least one fall in the previous 12 months. Although this decision was made 
to counterbalance the risk of misallocating patients with a significant history of falls in 
the non-fallers group, which would particularly bias the results of logistic regression 
analyses, it is well-known that recalling fall-related information in the previous 12 months 
is subject to misreporting (Hauer et al., 2006). Particularly, Ganz et al., (2005) estimated 
that recalling information on falls occurred in the past year has high specificity (91-95%) 
but relatively lower sensitivity (80-89%) compared to the criterion standard of prospective 
fall monitoring using fall diaries. Moreover, because the classification of fallers and non-
fallers included a retrospective component (i.e. categorisation occurring prior to the 
assessment of potential risk factors), both Chapters 4 and 5 are classed as cross-sectional 
studies. Therefore, although these chapters provide an estimate of association between 
frailty/physical/cardiovascular function and falls, the cross-sectional design does not 
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allow to establish a possible causal relationship between these potential risk factors and 
the clinical outcome (i.e. falls). 
Lastly, it should be acknowledged that the relationship between BP response to orthostasis 
and falls emerging from the study results remains somewhat unclear. While OscBP 
decrements to HUT-60° were significantly associated with increased risk of falling (Table 
6.4), we did not find any association between contBP response to orthostasis and falls. 
This apparent discrepancy could simply be explained in light of the orthostatic challenge 
employed in this research project (HUT-60°). Although this passive orthostatic challenge 
has multiple benefits, such as easier standardisation of testing procedures and mitigation 
of skeletal muscle contraction effects on the baroreflex, a recent systematic review has 
pointed out that an active stand with concomitant contBP recording might be more suitable 
than HUT-60° to investigate the short-term cardiovascular responses to orthostasis (van 
Wijnen et al., 2017). Particularly, an active stand seems to trigger a more marked initial 
drop of contBP and concomitant haemodynamic responses, while the initial BP response 
to HUT-60° is often absent due to the slower transition to the upright position (van Wijnen 
et al., 2017). Therefore, it is possible that using an active orthostatic challenge might have 
been more useful than HUT-60° to interpret the relationship between BP response to 
orthostasis and falls. 
 
7.4 Assessment of falls’ risk in clinical research: further reflections 
In addition to the study findings arising from Chapters 3, 4, 5 and 6, this PhD research 
project has also stimulated further reflections on the assessment of falls’ risk in the context 
of clinical research that will be object of discussion in this section. 
The investigation of falls as adverse clinical outcomes poses some unique challenges for 
researchers wishing to determine which risk factors are more likely to cause a fall in a 
specific population. As highlighted by a systematic review (Hauer et al., 2006), one of 
these challenges pertains to the operational definition of a fall. While the concept of falling 
is fairly intuitive for the lay public, in the context of clinical research, scientists should 
define what constitutes a fall or not as clearly as possible because different operational 
definitions may imply different aetiologies and prognostic relevance. For instance, some 
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researchers opted not to include those falls arising from an external force or a particular 
medical event, such as syncope, in the operational definition of a fall (Wang et al., 2017), 
with the rationale that these kind of fall events would be unavoidable, as opposed to those 
falls potentially linked to a more modifiable physiological mechanism. However, as 
pointed out by Hauer et al., (2006) such a strategy is at high risk of introducing a 
definitional artefact that may result in researcher bias, and therefore excluding falls 
deemed unavoidable should not be necessary. In agreement with most studies that 
investigated the risk of falling in HD patients (Desmet et al., 2005; Cook et al., 2006; 
Abdel-Rahman et al., 2011; Rossier et al., 2012; Kutner et al., 2014; Farragher et al., 2014; 
Polinder-Bos et al., 2014), we employed the operational definition given by Lamb et al., 
(2005) (i.e. “an unexpected event in which the participant comes to rest on the ground, 
floor, or lower level”). We used this definition as it minimises researcher bias, and is 
considered to be simple and reliably understandable by lay people (Hauer et al., 2006). 
Other studies have considered exclusively severe falls, such as fall-related fractures or 
injuries verifiable through medical care claims (Rossier et al., 2012; Delgado et al., 2015), 
while other investigations only focused on in-hospital falls (Lan et al., 2019). The main 
advantage of these studies is that falls operationalised in this manner can be easily 
reported, both prospectively and retrospectively, because the information is traceable via 
objectively documented medical records. Nevertheless, they only offer a restricted picture 
of the falls phenomenon, as only a small proportion of falls results in an injury requiring 
medical attention or fracture (Berry et al., 2008), while falls occurring in hospitalised 
patients may be due to primarily to an acutely altered physiological state (Oliver et al., 
2010). Therefore, it is plausible that different risk factors may be implicated in the 
aetiology of these aggravated fall-events. Moreover, the estimates of falls emerging from 
these studies need to be interpreted carefully, as a direct comparison with the prevalence 
and incidence of generic falls is not possible. 
Another common challenge encountered in clinical research aiming to investigate falls’ 
risk is the well-known “recall bias”, namely the possible error associated with recalling 
information on falls that may have occurred in a relatively distant time (Cummings et al., 
2005). Not surprisingly, this bias affects mostly retrospective studies with a longer recall 
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interval (Ganz et al., 2005), but it can also manifest in studies with prospective design if 
falls are reported/documented infrequently (Hauer et al., 2006). A Cochrane review 
conducted by Gillespie et al., (2012) concluded that 29% of the studies included in their 
systematic review were classified at high risk of recall bias, making it the most common 
bias in clinical research investigating falls’ risk. The Prevention of Falls Network Europe 
(ProFaNE) group suggested that, in order to minimise this bias, the most suitable method 
to ascertain falls should consist of daily diaries to be completed prospectively by the study 
participants and to be returned on a monthly basis for at least 12 months (Lamb et al., 
2005). Moreover, there is now a general consensus that a study should be classified at 
high risk of recall bias if the method used to ascertain falls involves information self-
reported by study participants at intervals longer than a month, or only at the end of the 
study (Gillespie et al., 2012). Therefore, according to the criteria proposed by Gillespie et 
al., (2012), the methodological approach used in this PhD research project should be 
classed at low risk of recall bias because information on falls was recorded prospectively 
by a researcher using a standardised diary at least once every month. 
A further possible source of bias may occur during the recruitment process. It is well 
known that many observational studies aiming to identify risk factors for falls collect 
physical function data by means of various exercise-based assessments (Sherrington et al., 
2019). This is done due to the fact that frailty and physical deconditioning are implicated 
in the aetiology of falling (Lusardi et al., 2017). Although highly frail people may be more 
prone to experience falls, they may also be more reluctant to engage in clinical research 
involving any kind of physical/exercise assessments due to physical activity avoidance 
behaviour (Delbaere et al., 2004). Consequently, the results emerging from these 
investigations may be influenced by the fact that a significant part of the population would 
not be able/willing to participate in the study. 
In addition to the challenges listed above, we would like to highlight another issue relating 
to the nature of a fall as a clinical outcome in the context of falls’ risk studies with 
prospective cohort design. In prospective cohort studies, participants are observed over 
time: researchers typically assess the potential risk factors and exposures at baseline, and 
ascertain the occurrence of clinical outcomes from the moment of study enrolment 
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onwards (Vandenbroucke et al., 2014). The main assumption of this study design is that 
all participants should be free from the clinical outcome of interest at the beginning of the 
study, and failing to ensure that this criterion is met would therefore constitute an overt 
violation of the study design. In studies assessing the risk of developing traditional adverse 
outcomes such as myocardial infarction, stroke, or cancer, the inclusion of patients who 
have suffered these outcomes before the actual enrolment in the study would be 
unilaterally highlighted as an example of bad science, and justly criticised by the medical 
research community. However, in the context of the assessment of falls risk, it is more 
difficult to ascertain whether or not patients are falls-free at the beginning of the study due 
to the fact that this clinical outcome is not routinely recorded by health care systems, 
unless the fall accident results in a fracture or another serious injury requiring some form 
of medical treatment. Consequently, researchers have often assumed artificially that all 
study participants were free from falls at the beginning of the study. In our opinion, this 
assumption introduces a high bias of group misallocation (i.e. patients wrongly classified 
as non-fallers) because it blindly implies that all those patients who remain falls-free for 
the whole duration of the prospective follow-up never suffered any falls in proximity of 
the study initiation. On the contrary, it is quite possible that individuals with a significant 
history of falls may not experience further falls from the moment of enrolment in the 
study, as a result of a complex interaction of environmental, behavioural, or physiological 
modifications (WHO, 2008). If researchers do not take any precautions to investigate the 
study participants’ previous history of falls, then these individuals will be incorrectly 
classified as non-fallers. The repercussions of this misclassification would particularly 
affect those studies employing logistic regression analyses, where the dependent variable 
is dichotomised (i.e. falls: “yes” or “no”), and even more so if the sample size is relatively 
low. If the falling status cannot be ascertained beyond any reasonable doubt, a potential 
misclassification of fallers into non-fallers will drive the emerging association between 
potential risk factors and falls in the opposite direction, and would therefore significantly 
inflate the chances of committing a type II error. 
To minimise this bias, we would encourage three main courses of actions when designing 
a prospective cohort study aiming to explore the risk of falling: 1) logistic regression 
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analysis may be used in studies with relatively limited sample size only if researchers can 
ensure that all participants are free from falls at the time of enrolment in the study. Ideally, 
the participants’ history of falls should be documentable according to the principles 
outlined by Lamb et al., (2005) to minimise the “recall bias”; 2) In absence of this 
fundamental preliminary information, the risk of falling may be explored by analysing 
count data (i.e. number of falls) rather than falling status, using Poisson or negative 
binomial regression modelling. Such a methodological approach would be less subject to 
misclassification issues because the effect of one participant being falsely classified as a 
non-faller would not influence the estimate of association emerging from the analysis; 3) 
Logistic regression analysis may be used cautiously in large cohort studies regardless of 
the assumptions on participants’ previous history of falls, as the high statistical power 
achieved in these studies is likely to override the risk of committing a type II error arising 
from misallocation. 
In addition, some researchers also postulate that a time-to-event analysis using Cox 
regression may be preferable to logistic regression (Polinder-Bos et al., 2014) because 
some factors assessed at baseline can be subjected to more or less sudden changes, and 
therefore they would be more likely to contribute to the falls occurring closer to the time 
of assessment. Moreover, it should also be considered that a fall may result in a 
paradoxical latency period from further falls ascribable to a serious injury requiring 
prolonged bedridden recovery. From this perspective, a time-to-event analysis may be 
more appropriate for those studies investigating risk factors of severe falls or fall-related 
fractures, since the hospitalisation required for the treatment of these fall events could 
partially prevent the study participants to experience further falls. In contrast, Poisson or 
negative binomial regression models may be used reasonably for the analysis of 
predominantly non-injurious falls. 
 
7.5 Future research perspectives 
The U.S Preventive Services Task Force (USPSTF) has recently updated the 
recommendations on falls prevention in community-dwelling older adults (Grossman et 
al., 2018). This document concluded that exercise interventions have shown a moderate 
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to substantial benefit, and they should therefore be considered the primary 
recommendation to prevent falls in older people at high risk of falling. The USPSTF has 
also highlighted that, due to great heterogeneity of trials, it is difficult to pinpoint precisely 
what kind of exercise modalities may be more beneficial. However, the most common 
exercise components were balance, gait and functional training (17 trails), followed by 
resistance (13 trials), flexibility (8 trials), and endurance (5 trials) training (Grossman et 
al., 2018). The recommendations also included multifactorial interventions, consisting of 
initial assessments of potentially modifiable risk factors (vision, gait, balance, postural 
blood pressure, environment, medication, psychological health and cognition) followed 
by prescription of individualized interventions, although the net benefit of these programs 
was only classified as “small”. In addition, the USPSTF recommended for the first time 
against vitamin D supplementation as a preventive measure for falls in those individuals 
who are not known to have vitamin D deficiencies or osteoporosis. Moreover, the 
document also pointed out that the level of evidence for single interventions such as 
environment modification, psychological interventions or medication management does 
not allow the USPSTF to make a recommendation in favour or against these programs at 
the moment (Grossman et al., 2018). 
Several research findings from this PhD thesis have potential translational implications to 
expand the current evidence around falls prevention in the CKD-5 population. These 
translational implications and future research perspectives will be object of discussion in 
the next paragraphs (7.5.1 & 7.5.2). Moreover, some observations from this thesis raise 
additional research questions that also need to be investigated to obtain a fuller 
understanding of the falls’ risk phenomenon in CKD-5 patients on HD. For instance, many 
studies including ours (Chapter 3, paragraph 3.4.2) have concluded that dialysis 
populations are at higher risk of falling compared to the non-uraemic, age-matched 
population (Lopez-Soto et al., 2015). However, there is still no current evidence synthesis 
as to what extent this falls’ risk is higher compared to the general population. 
Consequently, a systematic review with meta-analysis of the pooled estimates of falls (i.e. 
prevalence and incidence) in the CKD-5 population on HD is needed to allow a direct 
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comparison of the falls’ risk profile of these patients with the general or other clinical 
populations. 
 
7.5.1 Frailty, physical function, and falls 
While frailty seemed to be consistently associated with an increased risk of falling in this 
PhD research project, the relationship between single physical function measures and falls 
was less clear. Because lower performance in TUG was associated with a higher number 
of falls in univariate negative binomial regression analysis, a composite assessment of 
physical function encompassing this measure may be useful in detecting falls’ risk and 
should be explored by further research. Moreover, additional observational studies would 
be required to pinpoint which single physical function outcomes may predict falls more 
accurately. 
The observations that low PA was one of the frailty components more strongly associated 
with falling, and that a lower number of daily steps was associated with a greater number 
of falls have important implications for future preventive and rehabilitative strategies. As 
outlined earlier (paragraph 7.2.2.3), simple interventions consisting of a walking program 
have been successfully administered to dialysis patients, and proved able to ameliorate 
quality of life and physical function (Manfredini et al. 2017). Therefore, future research 
should seek to determine whether this kind of intervention can also reduce the rate of falls 
in this clinical population. However, researchers should also attempt to maximise safety 
when designing a walking program because, as highlighted by Sherrington et al., (2011), 
the activity of walking may expose patients to a transiently high risk of falls, and 
ultimately this kind of intervention may not be prescribed to highly frail individuals since 
the risks could outweigh the possible benefits. This last observation should also underline 
the importance of early intervention. Since dialysis initiation is associated with increased 
sedentary behaviour and progressive deterioration of physical function (Kurella-Tamura 
et al., 2009), patients should be encouraged to increase their PA levels through walking at 
the very early stages of CKD-5 (or even earlier), before the physical deconditioning 
becomes so severe that the simple action of walking could represent a substantial threat 
for falls. In this regard, some researchers have suggested that “pre-habilitation” may be 
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effective in delaying the deterioration of physical function and loss of independence 
(Sheshadri et al., 2017). A practical example of pre-habilitation may be training muscle 
strength and balance before starting a walking program. Particularly, since worse postural 
balance was associated with increased odds of falling (Table 4.5), future exercise trials 
should explore the efficacy of balance training, or other multidimensional exercise 
programs including a postural balance component, not only in reducing the risk of falling 
but also in maximising walking stability in this patient group. 
 
7.5.2 Cardiovascular function and falls 
One of the most interesting findings arising from this PhD thesis is that baroreflex 
function, as assessed through BEI, was associated with an increased risk of falling. 
Although a direct biological mechanism may exist between impaired baroreflex function 
and falls (Mattace-Raso et al., 2007), further research would be required to clarify the 
physiologic processes linking baroreflex control and falls. In particular, Hildreth et al., 
(2012) have postulated that baroreflex may be impaired via two main aetiological 
pathways in CKD patients. The first pathway involves vascular stiffness and/or 
calcification across multiple arterial sites which would impede the aortic arch and carotid 
sinuses baroreceptors to sense BP changes effectively. In alternative, the baroreflex 
impairment could be due to abnormalities in central processing of the baroreflex, or to 
dysfunction of the sympathetic or cardiac vagal efferent pathways. Because arterial 
stiffness was already found to be an independent risk factor for falls in community-
dwelling elderly individuals (Wong et al., 2014), further research should be designed to 
explore the interrelationships among arterial pulse wave velocity, baroreflex function, and 
falls in CKD-5 patients on HD. 
In addition, as already acknowledged in paragraph 7.2.3.2, future studies should also 
explore the relationship between the haemodynamic responses to an active stand and falls 
in this patient population, as this type of orthostatic challenge may provide a more marked 
drop of contBP and concomitant haemodynamic responses (van Wijnen et al., 2017). 
Moreover, alternative orthostatic challenges such as passive sit to stand (Shaw et al., 2015) 
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can be implemented for those patients whose mobility is too poor to perform an active 
stand satisfactorily. 
Finally, from a preventive and rehabilitative perspective, future exercise trials aiming to 
reduce the rate of falls in HD patients should consider incorporating an aerobic 
component, as this kind of training has been proved useful in improving baroreflex 
function (Petraki et al., 2008; Deley et al., 2009; Ganesan et al., 2014). Moreover, aerobic 
training would also increase significantly the PA levels, thus counteracting a further risk 
factor for falls. We are led to think that an intra-dialytic exercise intervention consisting 
of cycling may be the most viable rehabilitation strategy as, in contrast to walking 
programs, it would not expose patients to an immediate increased risk of falling 
(Sherrington et al., 2011). Furthermore, the benefits of this type of training would be 
twofold as it would improve baroreflex function on one side (Petraki et al., 2008), and 
counteract the dialysis-related physical inactivity on the other. Alternative or 
complementary interventions may involve orthostatic training, as this type of therapy has 
been shown to improve both baroreflex function and the orthostatic response of BP 
(Sutcliffe et al., 2010; Mitro et al., 2018). In addition, it should also be acknowledged that 
submaximal resistance training (30%-80% of 1RM) has been shown to improve markers 
of cardiovascular health such as blood pressure, VO2, and plasma triglycerides 
(Cornelissen et al., 2011). Because this exercise modality would also positively impact on 
bone and muscle health, it could represent a viable rehabilitation strategy to target multiple 
needs of HD patients. Moreover, combining traditional aerobic training with resistance 
exercise seems to have a positive synergistic effect on cardiac function in people affected 
by CVD (Zhang et al., 2018). 
 
7.6 Conclusions 
• Findings from this PhD research project further reinforce the evidence that CKD-
5 patients undergoing HD therapy are a clinical population at high risk of falls. 
Both the prevalence of study participants experiencing at least one fall per annum 
(37.7%), and the incidence of falls (1.16 falls/person-year) were high and 
indicative of an increased risk of falling compared to the non-uraemic, age-
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matched population. This was the first 12-month prospective investigation of the 
prevalence/incidence of falls in HD patients conducted in the UK. 
• As expected, frailty seemed to contribute significantly to the elevated risk of 
falling, as the Fried’s frailty phenotype was associated with both increased odds 
of falling and a greater number of falls experienced by participants during the 12-
month follow-up. Although patients classified as fallers did not appear to differ 
substantially in physical function measures such as TUG and CSTS-5, nor in 
muscle strength measures, lower postural balance performance was associated 
with increased odds of falling and it may represent an additional exercise-
modifiable risk factor for falls independent from frailty. Moreover, subjectively 
and objectively measured low levels of PA were also associated with an increased 
risk of falling. This observation reflects the well-known detrimental effects of 
sedentary behaviour on general health. Moreover, it also highlights the importance 
of early intervention to increase the PA levels in HD patients. 
• In addition to frailty, measures of cardiovascular function were also associated 
with an increased risk of falling. Particularly, baroreflex function indices reflecting 
frequency of baroreflex activation (i.e. BEI and number of baroreceptor mediated 
sequences of coupled HR and BP), as well as the OscBP response to HUT-60° 
were associated with increased odds of falling and a greater number of falls. 
Therefore, we conclude that both of these factors may be implicated in the 
aetiology of falling in the context of CKD-5. Moreover, the high number of falls 
precipitated by dizziness (41.3% of falls) seemed to indirectly suggest that an 
impaired short-term regulation of BP might contribute to a high number of falls 
experienced by HD patients. Diabetic nephropathy as primary renal disease was 
also associated with an increased risk of falling and it may partially mediate the 
relationship between cardiovascular function and falls, due to multiple 
complications arising from advanced diabetes such as autonomic neuropathy. 
• The results from this PhD thesis indicate that modelling the risk of falling by 
adding a cardiovascular function variable to a frailty-only model improves 
significantly the prediction of number of falls experienced by CKD-5 patients 
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undergoing HD. More importantly, baroreflex function and the BP response to a 
passive orthostatic challenge showed a greater relative importance than frailty in 
predicting falls in this patient group. To the best of our knowledge, this is a novel 
finding and it challenges the current assumption that traditional risk factors such 
as older age, comorbidity, polypharmacy, and frailty contribute primarily to the 
aetiology of falls in this clinical population. 
• From a preventive and rehabilitative perspective, the sum of observations arising 
from this PhD research project suggest that, in agreement with the current exercise 
recommendations for the prevention of falls in the general geriatric population, 
exercise-based interventions should target balance training with a high priority. 
However, due to the high number of falls that were ascribable to a degree of 
cardiovascular dysregulation, exercise interventions should also incorporate an 
aerobic training component. Aerobic exercise would improve baroreflex function 
as well as increase the PA levels and it may represent a CKD-5 specific 
rehabilitation strategy to reduce the number of falls experienced by HD patients. 
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Appendix II. Monklands Hospital R&D ethical approval. 
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Appendix III. Victoria Hospital R&D ethical approval. 
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Appendix IV. PIS. 
 
PARTICIPANT INFORMATION SHEET 
 
Study Title: “Risk of falling in haemodialysis” 
 
You are being invited to take part in the research study entitled as above. This 
study is being done in part fulfilment of a PhD. Before you agree to take part, it 
is important for you to understand why the research is being done and what it 
will involve.  Please take time to read this information sheet carefully and discuss 
it with others if you wish.  Please ask if you have any questions or are unclear 
about anything.  Take time to consider your decision. 
 
What is the purpose of the study? 
The consequences of a fall can be huge, and include injury, a break to your bones, 
reduced mobility and function, and admissions to hospital. Patients undergoing 
dialysis have been found to experience a higher number of falls compared to the 
general population.  This may be due to lots of various reasons.   
 
This study aims to investigate the number of falls occurring in patients on 
haemodialysis and explore some of the main reasons why they are falling.  This 
may then allow us to plan and develop appropriate treatment measures to try and 
reduce dialysis patients’ risk of future falls. 
 
Why have I been invited? 
You have been invited as you are a patient on dialysis at the Renal Unit, 
Monklands Hospital. A maximum of 100 participants will be involved in this study. 
 
Do I have to take part? 
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No. It is up to you to decide whether or not to take part.  If you do decide to take 
part, you will be given this information sheet to keep and be asked to sign a 
consent form.  If you do decide to take part, you are still free to withdraw at any 
time without giving a reason.  A decision to withdraw at any time, or a decision 
not to take part, will not affect the standard of care you receive. 
 
What will happen to me if I take part? 
If you agree to participate in the study, the researcher will meet with you while 
you are on dialysis. He will explain the structure of the study, give you an 
opportunity to ask questions, make sure that you understand what is required of 
you and ask you to sign a consent form.  You will be given a copy of the consent 
form to keep.  Your GP will be notified of your participation in the study.  The 
researcher will review your medical notes to verify any falls information you 
provide, and to gain details on your medical history, dialysis, and blood results. 
You will be asked to attend one session lasting about 2 hours, on a non dialysis 
day, to perform a range of tests that aim to assess physical and cardiovascular 
function while performing physical activities that are commonly encountered 
during daily living.   Before you attend for the assessments you would be advised 
not to drink/eat anything other than water for 2 hours before the scheduled time. 
Also, you would have to bring your reading glasses, any medications you may 
need, for example, if you have asthma bring your inhalers with you or a light 
snack if you have diabetes. This one-off assessment session encompasses:  
- The completion of three questionnaires on your levels of physical activity, 
quality of life, and confidence in performing various daily activities; 
- A passive standing-up test to assess how quickly your blood pressure and 
heart rate adjust to new levels, when you move from the lying down 
position to a standing up position.  This test involves continuous 
measurement of blood pressure and heart rate using ECG and blood 
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pressure cuffs positioned around your arm  on your finger and 3 electrodes 
on your chest to monitor your heart rhythm. You will be asked to lie down 
and rest for 20 minutes on a special bed that can be electronically brought 
up to an almost standing position. Your blood pressure, heart rate and 
other cardiac function measures will be continuously monitored. After 20 
minutes of quiet resting you will be passively brought up to an almost 
standing position and will be asked to remain as still as possible and try 
not to squeeze your muscles for 5 minutes. You will be strapped in place 
with a velcro strap over the hips, in order to prevent you falling over.  
- A non invasive assessment of arterial stiffness: a thin collar and a blood 
pressure cuff will be placed around your neck and the top of your leg 
respectively. Three blood pressure measurements will then be recorded 
while you lie supine. 
- Hand and Leg strength assessment: You will be asked to squeeze a 
handheld device that measures your hand grip strength. You will have to 
repeat this 3 times.  You will also be asked to sit on a chair and kick your 
leg forward against resistance in order to measure your thigh muscles’ 
strength.  
- Three physical functioning tests: we will assess how fast you walk along a 
15 feet track and how quickly you rise up from a chair, walk 3 meters, turn 
around and walk back again to sit on the same chair. The last test will 
assess how quickly you can stand up and sit down on a chair five times. 
- A balance test: you will be asked to stand still on a special platform for 30 
seconds under three conditions (open eyes, closed eyes and counting 
backwards aloud). 
- Lastly, you will be asked to wear a physical activity monitor for 5 
consecutive days, in order to assess how physically active you are on your 
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daily life. This involves having a small device attached to your thigh that 
records your activity levels.  
 
Following completion of baseline assessments you will then be monitored over 
the next year for any falls and will be asked to report in a weekly diary if you have 
fallen. Details will be taken on any falls experienced.  This will be completed when 
you are at home. The researcher may also arrange periodic telephone calls with 
you to ask how you are doing, and if you have experienced any falls.  
 
What are the possible disadvantages and risks of taking part? 
There are no known serious disadvantages and risks of taking part in this study. 
It is recognised that asking for information on any falls you may have experienced 
may be upsetting for you and we will respect your wish not to reveal any 
information if you do not want to.  All physical function tests, are designed to 
imitate activities of daily living and therefore the risk of a serious adverse event, 
such as for example a heart attack or a fall is not greater than the risk you are 
exposed to in your daily life when you perform tasks such as standing up from a 
chair, walking, or carrying a shopping bag.  
There is a small risk of feeling tired and local muscle soreness, because you will 
be asked to perform a number of physical tasks within a 2 hour period, especially 
if you are not generally physically active in your daily life. However, muscle 
soreness during physical tasks that you are not accustomed to, is a normal body 
response and is temporary. It normally goes away after 48 hours.  
You may also experience some dizziness, lightheadedness, faster heart beat and 
perhaps some physical discomfort during the transition from the supine to the 
upright position. There is also a very small possibility that you may faint or develop 
an abnormal heart beat during the passive transition from lying to standing. These 
side effects normally resolve by going back into the lying position. However, we 
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will terminate the test immediately upon request or if we notice any unusual 
responses of your blood pressure and heart rate. All tests involved in this study, 
are carefully chosen because they are proven to be safe with the large majority 
of elderly people and with people with chronic illnesses. In addition, your renal 
consultant will carefully review you medical history and ensure that you do not 
have any known conditions that may increase your risk of fainting and that you 
are free from any acute infections at the time of testing. We will also perform 
resting 12 lead ECG before you perform the passive stand to ensure you are free 
from any abnormal cardiac rhythms that may also increase your risk of fainting. 
All tests will be performed in a private room in the renal dialysis unit, so in the 
rare occasion you may become unwell, medical staff will be readily available to 
help you.  
Should you wish to ask for more information, the contact details of the consultant 
nephrologist (Dr Shilliday) who is the clinical supervisor of this study can be found 
at the end of this document.  
 
Expenses and payments 
You will not be paid for taking part in this study. You may be provided with 
expenses to cover your travel costs. 
 
Involvement of your General Practitioner (GP) 
With your consent, your GP will be notified of your participation in the trial. You 
should also make other medical practitioners not involved in the study, but who 
may be treating you, aware of your participation in the trial. 
 
What are the possible benefits of taking part? 
While there will be no immediate benefits to you following participation; 
discussing any falls experiences you may have had over the last year may 
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highlight certain factors that can be reviewed by the renal team. The information 
collected from you may be used to help develop falls prevention interventions for 
dialysis patients and reduce their risk of future falls. 
 
Will my taking part in this study be kept confidential? 
All information collected about you during the course of the research will be kept 
strictly confidential.  Your medical notes will be reviewed by the researcher and 
renal consultant only.  Data, relative to research purposes only, will be exclusively 
reviewed if you agree to take part and provide written consent.  Any information 
about you will have your name removed so that you cannot be identified at any 
time during the research, or in the final results.  This is in accordance with the 
Data Protection Act (1998).  All data produced by the research will be stored for 
5 years. 
 
What if relevant new information becomes available? 
If new information becomes available that might influence your decision to be in 
the study you will be provided with a new Participant Information Sheet and will 
be asked to sign a new consent form. 
In the unlikely event that you lose capacity to consent during the study, you will 
be withdrawn from the study. Data up to the point of withdrawal will be used for 
participants who lose capacity to consent during the study. 
 
What if I don’t want to carry on with the study? 
You are free to withdraw from the study at any time. If you wish to withdraw, 
please contact your research team so that they can discuss your concerns with 
you. Information which has already been collected may still be used. If you decide 
to withdraw at any time we will ask your consent to use all the data collected up 
until the time when you decided to leave the study.  
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What will happen to the results of the research study? 
The results will be written up and analysed as part of the researcher’s PhD 
dissertation.  This will be completed by August 2017. The results may also be 
published in a physiotherapy related journal at a later date. If you indicate on the 
consent form, we will let you know when the results will be published externally 
and how you will be able to gain access. 
 
What happens at the end of the study? 
When the study is over, we will send you a summary of the results and will be 
happy to discuss this with you further if you wish. Your data will be anonymised 
and stored for 5 years to be used by researchers for scientific studies. 
 
What if there is a problem? 
If you have any difficulties or problems, we will discuss these with you and treat 
as necessary. 
If you believe that you have been harmed in any way by taking part in this study, 
you have the right to pursue a complaint and seek any resulting compensation 
through Queen Margaret University who is acting as the research sponsor. The 
person to contact is:  
Mrs Kim Gilchrist,  
Head of research and knowledge exchange development unit, 
Queen Margaret University, 
Email: kgilchrist@qmu.ac.uk 
Telephone: 01314740000 (ask for Kim Gilchrist when prompted). 
 
Also, as a patient of the NHS, you have the right to pursue a complaint through 
the usual NHS process. To do so, you can submit a written complaint to: 
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Mrs Melanie MacLean, 
Patient Affairs  Manager,  
Monklands Hospital,  
Email: Melanie.MacLean@lanarkshire.scot.nhs.uk 
Telephone: 01236 713 065.  
Note that the NHS has no legal liability for non-negligent harm. However, if you 
are harmed and this is due to someone’s negligence, you may have grounds for 
a legal action against NHS Lanarkshire, but you may have to pay your legal costs. 
 
Who has reviewed the study? 
The Research Ethics Committee at Queen Margaret University, and the West of 
Scotland REC 3 have reviewed this study.  Research and Development, NHS 
Lanarkshire have also reviewed. 
The West of Scotland REC 3, which has responsibility for scrutinising all proposals 
for medical research on humans, has examined the proposal and has raised no 
objections from the point of view of medical ethics.  
It is a requirement that your records, be made available for scrutiny by monitors 
from Queen Margaret University and NHS Lanarkshire, whose role is to check that 
research is properly conducted and the interests of those taking part are 
adequately protected. 
 
Who is organising and funding the research? 
This research study is being organised and sponsored by Queen Margaret 
University. None of the staff involved in the study will receive any additional 
income as a result of performing the study. 
 
Contact for further information 
For further information, please contact: 
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Mr Tobia Zanotto (PI) 
Address: School of Health Sciences, Queen Margaret University, Queen Margaret 
University Drive, Musselburgh, East Lothian, EH216UU. 
Email: TZanotto@qmu.ac.uk  
Telephone: 07899337941 
 
Contact details of medical lead 
For further information, please contact  
Dr Ilona Shilliday, Consultant Nephrologist 
Address: Monklands Hospital, Monkscourt Avenue, Airdrie, ML6 0JS 
Email: Ilona.Shilliday@lanarkshire.scot.nhs.uk 
Telephone: 01236713167  
 
Independent contact 
Mr Alan Sommerville, Renal nurse. 
Address: Monklands Hospital, Monkscourt Avenue, Airdrie, ML6 0JS. 
E-mail: Alan.Sommerville@lanarkshire.scot.nhs.uk 
 
 
 
Thank you very much for taking the time to read this information and for 
considering to participate in this study. 
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Appendix V. Consent form. 
 
 
 
279 
 
Appendix VI. SF-36 questionnaire. 
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Appendix VII. ActivPal instructions leaflet. 
 
“Risk of falling in haemodialysis” 
 
Dear Sir/Madam, 
 
Thank you very much for agreeing to take part in this PhD research study. 
With regard to the ActivPal Physical Activity Monitor, please ensure you remember the 
following points for a correct use: 
 
 
• Remember to wear the device with its vertical axis always aligned with your thigh; 
 
• The image displayed in the ActivPal monitor must always be upright; 
 
• Remember to take the device off before you shower/take a bath; 
 
• You can remove the device before you go to sleep; 
 
• You can replace the adhesive tape/sticker whenever you feel it might come off. 
We recommend you replace the tape at least once a day. 
 
• After the fifth day you can take the ActivPal off and return it to the Renal Unit 
when you’re next in for dialysis. 
 
 
Many thanks for your co-operation and help with this study. 
If you have any questions or you need more information do not hesitate to contact me. 
Yours faithfully, 
 
Tobia Zanotto 
PhD candidate, 
School of Health Sciences, 
Queen Margaret University, 
Edinburgh, 
TZanotto@qmu.ac.uk 
07899337941 
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Appendix VIII. Short IPAQ questionnaire. 
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Appendix IX. HUT-60° protocol. 
 
Head-Up Tilt to 60 degrees (HUT-60o) protocol 
 
1. The assessment room will be private, quiet, of adequate size for all equipment, 
well ventilated with a constant temperature of approximately 20-22°C and 
humidity < 60%.  
2. The assessment room is located within the Monklands Hospital renal dialysis 
unit and has immediate access to resuscitation equipment and medical staff 
trained in immediate life support.   
3. Participants will be asked to have a light meal about 2-3 hours before testing, 
and they will be asked not to smoke or to consume caffeine/alcohol for at least 
2 hours before the appointment. They will also be asked to avoid 
unaccustomed physical exercise or vigorous exercise in the 24 hours preceding 
testing. 
4. Participants will attend on a non-dialysis day, ideally one day post dialysis, on 
their usual medication only.  
5. Upon arrival, patients will be connected to the TFM as per manual instructions 
and helped onto the tilt table and will be secured in place by straps around 
their thighs and feet. There is a foot platform where they can rest their feet 
whilst in the HUT position. 
6. The TFM continuous blood pressure monitor will be kept at heart level 
throughout the measurement (as per manual instructions) in order to correct 
the hydrostatic effects of head-up tilting. The monitor will be fastened to the 
patient’s forearm by means of a Velcro fastener, and the patient’s arm will be 
supported by an arm sling that will secure the monitor at heart level during 
the HUT-60°. 
7. Patients will be instructed not to talk or sleep during the procedure, and that 
they can request to stop at any point if they wish.  Patients will also be asked 
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to remain as still as possible (avoid isometric muscular contractions) during 
the whole duration of the procedure 
8. Following patient set up, patients rest horizontally for 10 minutes before 
baseline measurements are taken. 
9. Baseline measurements in the supine position are taken for a further 5 min. 
10. The Tilt table is then inclined with a smooth transition and all haemodynamic 
data is recorded (from the start of transition) for a period of 5 minutes on 60 
degrees head up (60 degrees is the recommended tilt angle for activation of 
baroreflex), if no symptoms develop.   
11. If symptoms develop during this 5 minute period (see Termination Criteria), 
the patient is immediately returned to the supine position and nature of 
symptoms recorded from a list. 
12. Patients will then return to horizontal supine position and remain there for 5 
minutes.  During this period, all physiological data will continue to be recorded. 
13. Patients will be supervised in the assessment area until all indices of 
cardiovascular function have stabilised to pre-testing levels. 
 
 
 
 
Summary of patient time with TFM 
 
 Time 
period 
(min) 
Action 
1. 10 Preparation/set up 
2. 10 Rest period in the supine position 
3. 5  Baseline measurements taken in the supine position 
4. 5 Measurements taken whilst at 60 degrees HUT 
5. 5 Return to supine position  
6.  Supervised until all physiological measures return to baseline figures 
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Exclusion criteria for HUT 
 
• Unable/refuses to provide informed consent  
• ˂18 years or>90 years 
• Non ambulatory or lower limb amputee without prosthesis 
• Unstable on dialysis and medications treatment (e.g. volume overloaded 
or uncontrolled cardiac arrhythmias such as atrial fibrillation, severe AV 
blocks, SVTs) 
• Unstable medical conditions (e.g. recent MI, or TIA, uncontrolled diabetes) 
• Suspected or known aneurysm 
• A known severe stenosis anywhere (e.g. heart valves, LV outflow 
obstruction, coronary or carotid or cerebrovascular artery stenosis) 
• pregnancy 
 
 
Test Termination Criteria 
 
The test will be terminated and the patient will be laid flat immediately and alarm 
will be raised if any of the following occurs: 
 
11. Induction of syncope or presyncope symptoms associated with marked 
hypotension or bradycardia or both (dizziness, palpitations, blurred vision, 
nausea, lightheadedness, headache) 
12. Completion of planned duration of test 
13. Patient distress or discomfort 
14. Patient request 
15. Acute malignant arrhythmia (AF, SVT, HR<40bpm) 
16. SBP falls >80mmHg or falls rapidly 
17. Substantial reductions in BP (SBP>20 mmHg and/or DBP>10mmHg) 
compared to their baseline values without compensatory changes in other 
heamodynamic variables (HR, peripheral vascular resistance, stroke 
volume, cardiac output). This is defined as orthostatic syncope, where 
there are no compensatory adjustments due to failure of sympathetic tone 
to increase.  
18. HR rises to greater than 170/min 
19. Chest pain 
20. Asystole 
21. Any other adverse/unexpected  event develops 
 
The test will be interrupted immediately if any of the above criteria develop and 
the participant will be returned to the supine position.  Loss of consciousness will 
289 
 
be prevented by continuous monitoring of HR and BP and termination of the test 
when both start decreasing substantially, without any other observations of 
compensatory mechanisms. A tilt duration of 20- 45 minutes has become widely 
accepted within the literature.  However, these studies aim to induce syncope and 
use results diagnostically.  The aim of this study is to gain an index marker of BRS 
and so a timeframe of 5 minutes tilt will be used.  
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Appendix X. History of falls survey. 
 
Participant ID:                                                                                     Date of Assessment:  
 
History of Falls Questionnaire 
 
 
Date and time of fall: Details Comments 
  
 
 
Activities prior to falling:   
 
 
(1) Ambulation 
(2) Transferring 
(3) Running 
(4) Sports 
(5) Stairs/curb 
(6) Other 
Examples: (please circle) 
 
Walking    Turning    Standing 
Bed    Chair    Toilet    Car    w/c    Shower/ bath 
 
Exercising    Dancing    Cycling 
 
Reaching overhead    Bending down 
 
 
Perceived causes:   
 
 
(1) Accident/environment 
 
(2) Collapse episode 
(3) Dizziness/vertigo 
(4) Balance/gait impairment 
(5) Other 
(6) Uncertain of cause 
Examples (please circle) 
 
Slip    Missed seat    Bumped/pushed     
Slid off surface    Furniture/equipment broke 
Passing out    Legs gave way 
Dizziness    Lightheaded    Weakness 
Trip/stumble    Quick movement   Lost balance 
 
 
 
 
Environmental factors:   
 
 
(1) Wet surface/slippery 
footwear 
(2) Uneven surface/steps 
 
(3) External forces 
 
(4) Lay surface 
(5) Other 
(6) Uncertain 
Examples (please circle) 
 
 
 
Steps of unequal height    Indistinguishable surface 
colours 
Furniture/railing broke    Something moved/bumped 
the patient 
 
Visual glasses    Darkness/dimness    Glare 
 
 
 
 
 
Where did the fall occur?   
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(1) Inside the home 
(2) Inside a building but not 
at home 
(3) Outside 
Examples (please circle) 
 
 
 
Footpath    Kerb/gutter    Steps    Garden 
 
 
When did the fall occur?   
 
(1) A HD day before dialysis 
(2) A HD after dialysis 
(3) A non-HD day 
 
 
 
 
 
 
 
 
 
 
 
 
Fall-related injuries Details Comments 
 
(1) Fracture 
(2) Head injury 
(3) Joint dislocation 
(4) Ligament sprain 
(5) Non specified joint injury 
(6) Laceration 
(7) Bruising 
(8) No injury 
 
 
 
 
 
 
 
 
 
 
 
Healthcare sought   
 
(1) GP 
(2) Accident & Emergency 
(3) Hospitalised 
(4) NHS24 
(5) Dentist 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
292 
 
Appendix XI. Falls diary. 
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Appendix XII. Tinetti FES questionnaire. 
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Appendix XIII. Leaflet pre-assessment. 
 
“Risk of falling in haemodialysis” 
Dear Sir/Madam, 
 
Thank you very much for agreeing to take part in this PhD research study. 
Before coming to the hospital for the assessment tests, please remember the following 
points, which help us standardise testing conditions across different individuals, but also 
for your own safety and comfort: 
• Have a light meal at least 2 hours before your scheduled appointment for the 
assessments; 
 
• Do not consume caffeine, or alcohol, or smoke in the 2 hours preceding the 
assessments; 
 
• Avoid any strenuous exercise in the 24 hours before the assessment day; 
 
• On the assessment day, remember to wear or bring with you comfortable clothes 
and shoes that you can change into, that are suitable for physical tasks such as 
walking; 
 
• Remember to bring with you a list of your medications and any other medication 
that your doctor may have prescribed for occasional use, such as your GTN spray 
for chest pain, or inhalers if you have asthma. If you suffer from diabetes, please 
remember to bring with you the type of snack that you normally have if you 
experience low blood glucose symptoms and your own glucose meter device if 
you have one. 
Many thanks for your co-operation and help with this study. 
If you have any questions or you need more information do not hesitate to contact me. 
Yours faithfully, 
 
Tobia Zanotto 
PhD candidate, 
School of Health Sciences, 
Queen Margaret University, 
Edinburgh, 
TZanotto@qmu.ac.uk 
07899337941 
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Appendix XIV. Correlations among postural balance variables. 
Variables 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. Falls 
(yes/no) 
1.000 
.287* .235* .373** .373** .298* .408** .235* .278* .328** .250* .297* .353** .353** .349** .332** .300* 
2. RangeY 
in EO 
.287* 1.000 .954** 0.153 0.153 0.006 .246* .891** .679** .790** .695** .781** .254* .254* 0.115 .315** .785** 
3. RMSY 
in EO 
.235* .954** 1.000 0.090 0.090 -0.024 0.163 .891** .652** .737** .664** .736** 0.166 0.166 0.065 0.214 .751** 
4. SP in 
EO 
.373** 0.153 0.090 1.000 1.000** .956** .977** 0.162 0.206 0.076 0.203 0.058 .758** .758** .854** .639** 0.146 
5. AbsVel 
in EO 
.373** 0.153 0.090 1.000** 1.000 .956** .977** 0.162 0.206 0.076 0.203 0.058 .758** .758** .854** .639** 0.146 
6. VelX in 
EO 
.298* 0.006 -0.024 .956** .956** 1.000 .885** 0.075 0.127 
-
0.056 
0.130 
-
0.061 
.668** .668** .836** .523** 0.046 
7. VelY in 
EO 
.408** .246* 0.163 .977** .977** .885** 1.000 0.215 .275* 0.180 .266* 0.149 .794** .794** .831** .707** 0.225 
8. Area95 
in EO 
.235* .891** .891** 0.162 0.162 0.075 0.215 1.000 .788** .711** .805** .736** 0.188 0.188 0.144 0.197 .826** 
9. RangeX 
in EC 
.278* .679** .652** 0.206 0.206 0.127 .275* .788** 1.000 .777** .968** .744** .435** .435** .376** .444** .920** 
10. 
RangeY in 
EC 
.328** .790** .737** 0.076 0.076 -0.056 0.180 .711** .777** 1.000 .776** .953** .386** .386** 0.182 .471** .910** 
11. 
RMSX in 
EC 
.250* .695** .664** 0.203 0.203 0.130 .266* .805** .968** .776** 1.000 .777** .411** .411** .367** .415** .951** 
12. 
RMSY in 
EC 
.297* .781** .736** 0.058 0.058 -0.061 0.149 .736** .744** .953** .777** 1.000 .362** .362** 0.157 .434** .926** 
13. SP in 
EC 
.353** .254* 0.166 .758** .758** .668** .794** 0.188 .435** .386** .411** .362** 1.000 1.000** .889** .964** .405** 
14. 
AbsVel in 
EC 
.353** .254* 0.166 .758** .758** .668** .794** 0.188 .435** .386** .411** .362** 1.000** 1.000 .889** .964** .405** 
15. VelX 
in EC 
.349** 0.115 0.065 .854** .854** .836** .831** 0.144 .376** 0.182 .367** 0.157 .889** .889** 1.000 .759** .284* 
16. VelY 
in EC 
.332** .315** 0.214 .639** .639** .523** .707** 0.197 .444** .471** .415** .434** .964** .964** .759** 1.000 .441** 
17. 
Area95 in 
EC 
.300* .785** .751** 0.146 0.146 0.046 0.225 .826** .920** .910** .951** .926** .405** .405** .284* .441** 1.000 
Abbreviations: EO: eyes open; EC: eyes closed; RangeX: range of centre of pressure 
(COP) displacement along the medial-lateral (ML) axis; RangeY: range of COP 
displacement along the anterior-posterior (AP) axis; RMSX: root mean square 
displacement along the ML axis; RMSY: root mean square displacement along the AP 
axis; SP: sway path; AbsVel: absolute velocity; VelX: velocity along the ML axis; VelY: 
velocity along the AP axis; Area95: 95% confidence ellipse area;  * indicates a significant 
correlation (p-value ˂ .05); ** indicates a significant correlation (p-value ˂ .01). 
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Appendix XV. Correlations among PA, strength, physical function, and postural 
balance in EO 
Variables 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. Range 
X in EO 
1.000 
.682** .971** .651** 0.215 0.169 .241* .892** -0.103 -0.086 -0.121 -0.074 -0.097 -0.004 -.300** .400** .323** 
2. Range 
Y in EO .682** 1.000 .669** .954** 0.153 0.006 .246* .891** -0.141 -0.185 -0.209 -0.131 -0.127 -0.096 -.373** .500** .384** 
3. RMSX 
in EO .971** .669** 1.000 .654** 0.207 0.171 0.224 .910** -0.101 -0.053 -0.091 -0.039 -0.082 -0.004 -.256* .361** .315** 
4. RMSY 
in EO .651** .954** .654** 1.000 0.090 -0.024 0.163 .891** -0.088 -0.102 -0.119 -0.081 -0.069 -0.124 -.306** .424** .352** 
5. AbsVel 
in EO 0.215 0.153 0.207 0.090 1.000 .956** .977** 0.162 -0.022 0.031 -0.010 0.113 -.477** -.361** -0.152 0.072 0.125 
6. VelX in 
EO 0.169 0.006 0.171 -0.024 .956** 1.000 .885** 0.075 0.007 0.088 0.041 0.153 -.402** -.339** -0.062 -0.032 0.095 
7. VelY in 
EO .241* .246* 0.224 0.163 .977** .885** 1.000 0.215 -0.047 -0.006 -0.044 0.091 -.499** -.376** -.232* 0.159 0.167 
8. Area95 
in EO .892** .891** .910** .891** 0.162 0.075 0.215 1.000 -0.149 -0.102 -0.133 -0.066 -0.092 -0.059 -.308** .439** .377** 
9. Time 
standing -0.103 -0.141 -0.101 -0.088 -0.022 0.007 -0.047 -0.149 1.000 .341** .310* 0.214 -0.123 -0.065 0.187 -0.070 -0.156 
10. Time 
stepping -0.086 -0.185 -0.053 -0.102 0.031 0.088 -0.006 -0.102 .341** 1.000 .986** .631** 0.042 0.072 .473** -.473** -.399** 
11. Daily 
steps -0.121 -0.209 -0.091 -0.119 -0.010 0.041 -0.044 -0.133 .310* .986** 1.000 .648** 0.071 0.083 .514** -.522** -.450** 
12. Daily 
sit to 
stands 
-0.074 -0.131 -0.039 -0.081 0.113 0.153 0.091 -0.066 0.214 .631** .648** 1.000 0.104 0.029 .349** -.376** -.295* 
13. 
Handgrip -0.097 -0.127 -0.082 -0.069 -.477** -.402** -.499** -0.092 -0.123 0.042 0.071 0.104 1.000 .592** .364** -.340** -.343** 
14.Leg 
extension -0.004 -0.096 -0.004 -0.124 -.361** -.339** -.376** -0.059 -0.065 0.072 0.083 0.029 .592** 1.000 .407** -.353** -.508** 
15. Gait 
speed -.300** -.373** -.256* -.306** -0.152 -0.062 -.232* -.308** 0.187 .473** .514** .349** .364** .407** 1.000 -.900** -.729** 
16. TUG 
.400** .500** .361** .424** 0.072 -0.032 0.159 .439** -0.070 -.473** -.522** -.376** -.340** -.353** -.900** 1.000 .756** 
17. CSTS-
5 .323** .384** .315** .352** 0.125 0.095 0.167 .377** -0.156 -.399** -.450** -.295* -.343** -.508** -.729** .756** 1.000 
Abbreviations: PA: physical activity; EO: eyes open; RangeX: range of centre of pressure 
(COP) displacement along the medial-lateral (ML) axis; RangeY: range of COP 
displacement along the anterior-posterior (AP) axis; RMSX: root mean square 
displacement along the ML axis; RMSY: root mean square displacement along the AP 
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axis; AbsVel: absolute velocity; VelX: velocity along the ML axis; VelY: velocity along 
the AP axis; Area95: 95% confidence ellipse area; TUG: timed up and go test; CSTS-5: 5 
repetitions chair sit to stand test; * indicates a significant correlation (p-value ˂ .05); ** 
indicates a significant correlation (p-value ˂ .01). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
298 
 
Appendix XVI. Correlations among PA, strength, physical function, and postural 
balance in EC 
Variables 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. Range 
X in EC 
1.000 
.777** .968** .744** .435** .376** .444** .920** -0.232 -0.166 -0.186 0.032 0.029 -0.006 -.259* .349** .289* 
2. Range 
Y in EC .777** 1.000 .776** .953** .386** 0.182 .471** .910** -.360** -.319* -.342** -0.167 -0.027 -0.068 -.402** .478** .338** 
3. RMSX 
in EC .968** .776** 1.000 .777** .411** .367** .415** .951** -0.252 -0.212 -0.230 0.000 -0.015 -0.050 -.301** .395** .335** 
4. RMSY 
in EC .744** .953** .777** 1.000 .362** 0.157 .434** .926** -.279* -0.254 -.280* -0.134 -0.087 -0.118 -.376** .451** .319** 
5. AbsVel 
in EC .435** .386** .411** .362** 1.000 .889** .964** .405** -0.175 -0.044 -0.054 0.173 -.246* -.234* -0.187 0.102 0.129 
6. VelX in 
EC .376** 0.182 .367** 0.157 .889** 1.000 .759** .284* -0.130 0.034 0.011 0.244 -.250* -.252* -0.072 -0.023 0.097 
7. VelY in 
EC .444** .471** .415** .434** .964** .759** 1.000 .441** -0.191 -0.112 -0.118 0.131 -.239* -0.217 -.259* 0.189 0.184 
8. Area95 
in EC .920** .910** .951** .926** .405** .284* .441** 1.000 -.303* -.259* -.280* -0.078 -0.049 -0.090 -.361** .446** .358** 
9. Time 
standing -0.232 -.360** -0.252 -.279* -0.175 -0.130 -0.191 -.303* 1.000 .341** .310* 0.214 -0.123 -0.065 0.187 -0.070 -0.156 
10. Time 
stepping -0.166 -.319* -0.212 -0.254 -0.044 0.034 -0.112 -.259* .341** 1.000 .986** .631** 0.042 0.072 .473** -.473** -.399** 
11. Daily 
steps -0.186 -.342** -0.230 -.280* -0.054 0.011 -0.118 -.280* .310* .986** 1.000 .648** 0.071 0.083 .514** -.522** -.450** 
12. Daily 
sit to 
stands 
0.032 -0.167 0.000 -0.134 0.173 0.244 0.131 -0.078 0.214 .631** .648** 1.000 0.104 0.029 .349** -.376** -.295* 
13. 
Handgrip 0.029 -0.027 -0.015 -0.087 -.246* -.250* -.239* -0.049 -0.123 0.042 0.071 0.104 1.000 .592** .364** -.340** -.343** 
14.Leg 
extension -0.006 -0.068 -0.050 -0.118 -.234* -.252* -0.217 -0.090 -0.065 0.072 0.083 0.029 .592** 1.000 .407** -.353** -.508** 
15. Gait 
speed -.259* -.402** -.301** -.376** -0.187 -0.072 -.259* -.361** 0.187 .473** .514** .349** .364** .407** 1.000 -.900** -.729** 
16. TUG 
.349** .478** .395** .451** 0.102 -0.023 0.189 .446** -0.070 -.473** -.522** -.376** -.340** -.353** -.900** 1.000 .756** 
17. CSTS-
5 .289* .338** .335** .319** 0.129 0.097 0.184 .358** -0.156 -.399** -.450** -.295* -.343** -.508** -.729** .756** 1.000 
Abbreviations: PA: physical activity; EC: eyes closed; RangeX: range of centre of 
pressure (COP) displacement along the medial-lateral (ML) axis; RangeY: range of COP 
displacement along the anterior-posterior (AP) axis; RMSX: root mean square 
displacement along the ML axis; RMSY: root mean square displacement along the AP 
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axis; AbsVel: absolute velocity; VelX: velocity along the ML axis; VelY: velocity along 
the AP axis; Area95: 95% confidence ellipse area; TUG: timed up and go test; CSTS-5: 5 
repetitions chair sit to stand test; * indicates a significant correlation (p-value ˂ .05); ** 
indicates a significant correlation (p-value ˂ .01). 
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Appendix XVII. HRV and BPV characteristics of study participants. 
Variables All patients 
 
Fallers 
 
Non-fallers 
 
P-value 
Heart rate variability     
LFnu-RRI (%) 42.1±21.8 44.8±21.1 38.5±22.8 0.192 
HFnu-RRI (%) 57.9±21.8 55.2±21.1 61.5±22.7 0.192 
VLF-RRI (ms2) 123.8±250.2 120.1±273.7 128.9±217.9 0.136 
LF-RRI (ms2) 119.7±342.8 135.5±437.7 97.5±125.8 0.143 
HF-RRI (ms2) 234.8±753.8 178.8±584.6 313.8±949.4 0.007 
PSD-RRI (ms2) 478.3±1175.6 434.4±1251.6 540.2±1079.6 0.040 
LF/HF-RRI (1) 1.5±2.7 1.4±1.5 1.7±3.8 0.192 
LF/HF (1) 0.9±1.9 08±0.5 1.2±2.9 0.271 
Blood pressure variability - systolic     
LFnu-sBP (%) 29±13.1 26.8±11.3 31.7±15.1 0.126 
HFnu-sBP (%) 29.3±17.7 32±19.7 24.9±13.6 0.132 
VLF-sBP (mmHg2) 6.2±16.3 4.8±7.3 8.3±23.8 0.424 
LF-sBP (mmHg2) 4.8±14.3 3±4.3 7.3±21.5 0.461 
HF-sBP (mmHg2) 3.6±10.6 2.7±2.8 4.9±16.1 0.790 
PSD-sBP (mmHg2) 14.5±40.6 10.4±12.6 20.5±61 0.515 
LF/HF-sBP (1) 1.6±2.6 1.2±0.9 2.1±3.9 0.163 
LF/HF (1) 0.9±2 0.7±0.6 1.2±3 0.995 
Blood pressure variability - diastolic     
LFnu-dBP (%) 30.4±11.2 29.8±10.1 30.9±12.7 0.701 
HFnu-dBP (%) 28.9±16.3 28.3±15.7 28.9±17.2 0.866 
VLF-dBP (mmHg2) 2.3±3.9 2.2±4 2.4±3.8 0.249 
LF-dBP (mmHg2) 1.5±1.8 1.4±1.9 1.7±1.7 0.126 
HF-dBP (mmHg2) 1.4±2.5 1.1±1.5 1.8±3.4 0.123 
PSD-dBP (mmHg2) 5.2±6.7 4.7±6.7 5.9±7 0.088 
LF/HF-dBP (1) 1.6±1.5 1.5±1.2 1.6±1.9 0.926 
LF/HF (1) 0.9±1.8 0.7±0.5 1.1±2.7 0.413 
Abbreviations: LFnu-RRI: Normalized low frequency component of HRV; HFnu-RRI: 
Normalized high frequency component of HRV; VLF-RRI: Very low frequency 
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component of HRV; LF-RRI: Low frequency component of HRV; HF-RRI: High 
frequency component of HRV; PSD-RRI: Power spectral density of HRV; LF/HF-RRI: 
Low frequency/high frequency ratio of HRV; LF/HF: Low frequency-diastolic blood 
pressure/HF-RRI; LFnu-sBP: Normalized low frequency component of systolic BPV; HF-
nu-sBP: Normalized high frequency component of systolic BPV; VLF-sBP: Very low 
frequency component of systolic BPV; LF-sBP: Low frequency component of systolic 
BPV; HF-sBP: High frequency component of systolic BPV; PSD-sBP: Power spectral 
density of systolic BPV; LF/HF-sBP: Low frequency/high frequency ratio of systolic 
BPV; LFnu-dBP: Normalized low frequency component of diastolic BPV; HF-nu-dBP: 
Normalized high frequency component of diastolic BPV; VLF-dBP: Very low frequency 
component of diastolic BPV; LF-dBP: Low frequency component of diastolic BPV; HF-
dBP: High frequency component of diastolic BPV; PSD-dBP: Power spectral density of 
diastolic BPV; LF/HF-dBP: Low frequency/high frequency ratio of diastolic BPV.
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Appendix XVIII. ROC curve analysis of VelY. 
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Appendix XIX. Research article (Chapter 5). 
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